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Under genotoxic stress conditions, the genome of any organism may become 
compromised thus undermining cellular functions and the high fidelity 
transmission of the genome. Should integrity become compromised, cells have 
evolved a plethora of pathways to monitor, assess and direct the removal or 
bypass of genomic lesions. Collectively, this response is known as the DNA 
damage response (DDR). At the forefront of the DDR are specialised enzymes 
known as protein kinases (PKs), which act to co-ordinate many aspects of this 
response. 
In the kinetoplastid parasite Trypanosoma brucei, the role of PKs in other 
processes, such as the control of the cell cycle and during differentiation 
between the mammalian and insect lifecycle stages, have already been 
investigated using mutant cells lines, RNA interference (RNAi) and genome wide 
and kinome focused screens. However, virtually no work has examined the role 
of PKs in the context of genome repair. To this end, two RNAi targeted screens 
(RITseqs), one to examine the genome as a whole and the other to focus directly 
on the kinome compliment, were performed by others in the mammalian 
infection stage of T. brucei, searching for genes whose loss sensitises the cells to 
the presence of the DNA alkylating agent Methyl methanesulfonate (MMS). 
To validate both screens here, putative DNA damage associated PKs were 
examined by RNA interference (RNAi). Across both screens, a total of eleven 
PKs, whose loss sensitised cells to MMS, were validated in this study by 
monitoring their proliferation. Amongst these novel PKs were a pseudokinase 
(Tb6560) and an aurora kinase (TbAUK2), whose functions were investigated 
using disruption mutants generated in BSF T. brucei cells combined with 
immunolocalisaton. Analysis of the Tb6560 mutants revealed the pseudokinase to 
be non-essential in vitro and uncovered a potential role for Tb6560 during 
endocytosis or internal trafficking. Analysis of the TbAUK2 mutants also revealed 
this PK to be non-essential in vitro. However, when exposed to a variety of 
genotoxic agents, the growth of the mutants was significantly reduced 
suggesting TbAUK2 is required for parasite survival under DNA damage 
conditions. Further phenotypic analysis revealed a potential role for TbAUK2 in 




Additionally, the roles of two PKs central to the DDR in other organisms were 
examined by RNAi. The atypical PKs Ataxia Telangiectasia Mutated (ATM) and 
the related PK ATM and Rad3 related (ATR) are activated in response to double 
stranded break (DSB) lesions or replicative lesions, respectively, in other 
eukaryotes. RNAi of TbATR was associated with perturbation of proliferation, 
extensive nuclear defects and sensitivity to genotoxic agents. Further analysis 
also revealed a potential role for this kinase in maintaining transcriptional 
silencing of bloodstream VSG expression sites (BESs). Conversely, RNAi of TbATM 
did not disrupt cellular proliferation in vitro and nor were TbATM deficient cells 
sensitised to alkylating or replication blocking agents, suggesting TbATM is not 
required for T. brucei survival or for maintenance of growth in these conditions. 
Collectively, these data reveal a diverse array of PKs required for genome 
maintainance, in BSF parasites, under genotoxic stress conditions. An indepth 
characterisation of three DNA damage associated PKs uncovered a variety of 
putative roles ranging from nuclear and chromosomal segregation to cell cycle 
regulation, proliferation and endocytosis. These data in particular highlight the 
complexity underpinning a cell’s response when threatened with genomic 
instability. Furthermore, depletion of one kinase, TbATR, was also associated 
with loss of transcriptional silencing within BESs suggesting that PK activity could 
operate during antigenic variation, a process vital for the persistence of this 
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1.1 The Kinetoplastida 
The class Kinetoplastae embodies a highly diverse group of evolutionary 
ancestral protozoans ranging from free-living Bodonoids to the parasitic African 
trypanosomes (Lukeš et al. 2014). Kinetoplastids are currently recognised under 
the phylum Eulgenozoa (supergroup Excavata, group Discoba, subgroup 
Discicristata, phylum Euglenozoa, class Kinetoplastae). The Kinetoplastae 
themselves are further divided into the Prokinetoplastina (a subclass currently 
consisting of two parasitic species; Ichthyobodo and Perskinsela) and the 
Metakinetoplastina (a subclass divided into four clades; the Parabodonida, 
Eubodonida, Neobodonida and the Trypanosomatida; (Lukeš et al. 2014; Adl et 
al. 2012). Unlike the majority of the Metakinetoplastina, the clade 
Trypanosomatida consists of only obligate parasites1, several of which are known 
aetiological agents of diseases with severe medical and veterinary 
consequences, in addition to their presence being economically damaging 
(Steverding 2008; Lukeš et al. 2014). Examples of parasitic trypanosomatids 
include the African Trypanosoma brucei subspecies2, (‘Salivarian Trypanosomes’; 
the causative agents of Human African Trypanosomiasis), the Trypanosoma 
species that are causative agents of Nagana (including T. congolense and T. 
vivax), Trypanosoma cruzi (Chagas Disease or American Trypanosomaisis), and 
the Leishmania species, the causative agents of Leishmaniasis (Leishamaniasis 
can manifest in two major forms; cutaneous and visceral; leishmaniasis is 
reviewed in general by Kaye & Scott 2011). Collectively, trypanosomatid 
parasites cause a range of diseases world-wide, though predominantly the 
diseases are encountered in the tropics and sub-tropics. 
Kinetoplastidae organisms are highly divergent in terms of core biological 
processes; most notable (and from whence they derive their name) is the 
presence of the unusual arrangement of their mitochondrial genome referred to 
as the kinetoplast (or kDNA; Vickerman and Preston, 1976). The kinetoplast is 
organized as unique arrangement of interlocked DNA circles, known as maxi and 
                                         
1
 Evidence of parasitism by Trypanosomatids is present in invertebrates, plants and vertebrate organisms across a range of 
habitats. 
2
 Though numerous trypanosomatid species are present in Africa, T.brucei brucei, T.brucei rhodesiense, T.brucei 
gambiense, T. equiperdum, T.evansi, T.congolense, T.simiae, T.godfreyi and T.vivax are all known to infect mammals. 
Only T.brucei rhodesiense and T.brucei gambiense are considered human infective. 
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mini circles (the number of each circle type is dependent upon the species; 
reviewed by Morris et al. 2001; Jensen & Englund 2012). In addition, 
kinetoplastids are also unusual with respect to the multigenic transcription and 
replication of the genomes (Marques et al. 2016; Muhich & Boothroyd 1988), 
their ability to extensively edit their mitochondrial RNA (a process in which 
minicircle-encoded guide RNAs are involved; reviewed by Stuart et al. 2016), 
their reliance on post-transcriptional gene expression controls, and the 
compartmentalisation of glycolysis (Simpson et al. 2006). 
1.1.1 HAT is a debilitating disease 
The Trypanosoma brucei species encompasses three morphologically indistinct 
sub-species; T. b. rhodesiense, T. b. gambiense and T. b. brucei, all of which 
cause a form of Trypanosomiasis. Transmission primarily occurs via the bite of an 
infected Tsetse fly (genus Glossina; Kennedy 2013; Steverding 2008), though 
there are reports of transmission across the placenta and via sexual activity 
(Olowe 1975; Rocha et al. 2004). T. b. gambiense and T. b. rhodesiense are the 
aetiological agents of Human African Trypanosomiasis (HAT), with over 98% of 
cases being caused by the more common species T. b. gambiense over the last 
10 years (found in 24 countries across West and Central Africa 
http://www.who.int/mediacentre/factsheets/fs259/en/). T. b. gambiense 
causes a chronic infection, though two sub-groups of T. b. gambiense exist 
(Group 1 and Group 2), which differ in their ability to resist lysis by human 
serum (Capewell et al. 2011). T. b. rhodesiense causes an acute form of the 
disease and accounts for the remaining reported cases, in an estimated 13 
countries across East and Southern Africa (e.g Malawi; Franco et al. 2014). 
Overlap of the sub-species was reported in Uganda (Picozzi et al. 2005) and a 
map of HAT distribution is shown in Figure.1-1. 
The third subspecies, T. b. brucei, is not human infective due to the presence of 
a high density lipoprotein (HDL) in the serum, which this subspecies cannot resist 
(reviewed by Stephens et al. 2012).Instead, T. b. brucei causes Nagana, which 
manifests as a severe wasting disease in domestic livestock such as cattle 
(genus; Bos taurus). Nagana represents a huge economic burden, with millions of 
cattle at risk (Steverding 2008). In indigenous species (including wildebeast, 
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buffalo and other native bovids such as the genus Bos indicus) the disease is 
often mild. 
 
Figure  1-1: HAT distribution in Africa 
(A) The distribution of T. b. gambiense (left) and T. b. rhodesiense (right) in Africa as of 
2014. The highest number of cases (3206) reported in 2014 were in the Democratic Republic 
of Congo (marked by a black star). The black arrow indicates Uganda, the country in which 
both T. b. gambiense and T. b. rhodesiense can be found. Map images were accessed in 
July 2016 and adapted from 
http://gamapserver.who.int/mapLibrary/Files/Maps/HAT_rh_2014.png and 
http://gamapserver.who.int/mapLibrary/Files/Maps/HAT_ga_2014.png WHO ©. (B) A sufferer 
of HAT in Uganda; (C) The effect of Nagana on livestock. Images were provided by the 
Wellcome trust library. Image reference numbers: V0029100 (B) and L0049104 (C) 
http://wellcomeimages.org/. WHO (all rights reserved). Used with permission. 
Chronic HAT can persist with mild symptoms for years, in contrast to the acute 
form, which can be fatal in under a year from the initial infection (Franco et al. 
2014; Kennedy 2013); both are normally lethal if left untreated. Asymptomatic 
carriers have been reported and may act as a reservoir of the disease (Sudarshi 
et al. 2014).Two distinct stages of HAT exist. The primary (Haematolymphatic) 
stage has no defining symptoms, making it hard to diagnose; patients often 
present with periodic fevers and fatigue for up to 7 days. Occasionally, a rash on 
the body can be observed. Here, the parasites predominantly reside 
extracellularly in the bloodstream and lymphatic fluids. Non-specific symptoms 
such as headaches, drowsiness and anorexia have been reported (Kennedy 2013). 
Parasite migration occurs from the initial site of infection to further areas of the 
body, including the large organs such as the liver, adipose tissue and the skin 
(Trindade et al. 2016; Capewell et al. 2016), which may act as a parasite 
reservoir. The second, late stage (Meningoencephalitic stage) begins with 
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parasite migration into the Cerebral-Spinal Fluid (CSF) and across the Blood 
Brain Barrier (BBB; Kennedy 2013). A defining feature of this progression is the 
appearance of neurological complications, in particular the characteristic 
disruption of normal sleeping patterns. Patients can develop severe fatigue, 
seizures, confusion and may become aggressive. Within months to years 
(Kennedy 2013) the patient can reach a comatose state, resulting in death, 
though there are reports of survival amongst humans (Sudarshi et al. 2014). 
What factors govern survival are currently unknown. 
Recently, the incidence of HAT has significantly reduced due to increased 
awareness, surveillance, effective case management and persisting vector 
control, with < 4000 cases being reported in 2014, though the disease is still 
endemic in 36 sub-saharan African countries (Franco et al. 2014). Due to the 
disproportional effect of this disease on poor, rural areas, an estimated 70 
million people over 1.55 million km2 remain at risk of infection (Steverding 
2008). Furthermore, in combination with potentially non-symptomatic human 
carriers, the disease is also zoonotic. T. b. rhodesiense can be found in wild and 
domestic animals, including antelope, buffalo, cattle and sheep, which persist as 
a reservoir for human infections and continue to impose a huge economic burden 
on the country. T. b. gambiense has been reported to reside in pigs, though 
these parasites were shown to be genotypically different from T. b. gambiense 
found in humans (Simo et al. 2006). 
Due to the falling number of cases, HAT has been targeted for elimination as a 
public health concern, alongside diseases such as leprosy, Chagas Disease and 
lymphatic filariasis by 2020 (NTD RoadMap 2012 
[http://www.who.int/neglected_diseases/NTD_RoadMap_2012_Fullversion.pdf])
. However, continual monitoring of the parasite may be required to ensure 
resurgence of the disease does not occur. 
1.1.1.1 Current HAT treatment options 
Currently, the treatment of HAT relies solely on four single drugs and a 
combination therapy (summarised in Table 1-1 below; reviewed by Kennedy 
2013). Each drug or drug combination has recognised side effects and require 
prolonged or invasive delivery regimes. Novel drugs with fewer, more acceptable 
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side-effects may be needed. Ideally, such drugs would be administered orally to 
help reduce the reliance on medically trained individuals being required for 
treatment, specifically in rural regions Africa, where there is neither the training 
nor funding available to provide such a service. 
 
Table  1-1: Current HAT treatment options 
Information obtained from the following sources: (A) (Pépin et al. 1995) (B) (Burri & Brun 
2003) (C) (Bacchi et al. 1983). (D) (Wegner & Rohwedder 1972). (E) (Janssens & De Muynck 
1977). (F) (Priotto et al. 2007) (G) (Doua et al. 1996). (H) (Jennings et al. 1983). General 
treatment review by (Kennedy 2013). 
1.2 The lifecycle of T. brucei; a dixenous parasite 
The lifecycle of T. brucei is complex, as the parasite cycles between a 
mammalian host and the Tsetse fly vector (a dixenous lifestyle; see Figure 1-2). 
Additionally, extensive morphological and metabolic changes occur during 
development within both hosts (more so within the vector), providing a survival 
advantages at multiple points. 




Figure  1-2: The lifecycle of T. brucei 
A simplified depiction of the T. brucei parasite lifecycle. The lifecycle stages are discussed 
in the text. CNS (Central Nervous System). Figure adapted from (Langousis & Hill 2014)© with 
permission (Licence number: 3900680426952) and Casas-Sánchez and Acosta-Serrano, 
2016 (Casas-Sánchez & Acosta-Serrano 2016). 
T. brucei is transmitted when an infected Tsetse fly (~0.1 % of which harbour 
transmissible T. b. gambiense; (Jamonneau et al,. 2004) bites a suitable 
mammalian host. During feeding, non-proliferative metacyclic form (MCF) cells 
(from the fly’s salivary glands) are transmitted into the subcutaneous tissue 
surrounding the bite. The trypanosomes then migrate to the hosts’ bloodstream 
via the lymphatic fluid. Here, MCF parasites rapidly differentiate into replicative 
long slender blood stream form (BSF) cells; a highly mobile, free-living form also 
found in tissues (Langousis & Hill 2014). In addition to inhabiting the 
bloodstream, recent studies have also demonstrated the presence of parasites 
persisting in the dermis (and other regions) of the skin (Capewell et al. 2016; 
Caljon et al. 2016) and within the adipose tissue of mice (Trindade et al. 2016). 
These ‘tissue’ forms may represent components of the lifecycle (dashed box, 
Figure 1-2) which have not been previously described. Furthermore, the 
presence of trypanosomes in these locations may, in part, explain the presence 
of asymptomatic carriers; the Macleod group were able to infect Tsetse flies 
with the skin derived parasites (Capewell et al. 2016). 
Chapter  1  34 
 
 
The BSF lifecycle stage harbours an additional organelle (the glycosome) for the 
sole purpose of glycolysis. The single BSF mitochondrion is relatively 
metabolically inactive. BSF cells are covered with a dense coat of proteins 
known as the Variant Surface Glycoprotein (or VSG), which protect the cells 
from complement mediated lysis and the humoral immune response, permitting 
a prolonged, chronic infection in the mammalian host (Horn & McCulloch 2010; 
Section 1.4). Proliferation of the long slender BSF continues until a critical 
population density is reached (MacGregor et al. 2012; Mony et al. 2014), 
resulting in accumulation of a Stumpy Induction Factor (SIF; still to be 
identified) which triggers differentiation from the long slender to non-replicative 
short stumpy BSFs. Short stumpy BSFs do not undergo antigenic variation (see 
below) and are controlled by the host humoral immune response (surviving ~72 
hrs in the bloodstream; Langousis & Hill 2014). Short stumpy BSFs are pre-
adapted to life inside the vector and when taken up during a blood meal they 
differentiate into the replicative Procyclic Form cell (PCF). This lifecycle form is 
distinct from the BSF; the cell is elongated, the kDNA repositions and the 
mitochondrion becomes metabolically active to circumvent glucose starvation 
and utilise the abundance of proline in the fly midgut. The most notable change 
is the surface coat. Early stage PCF cells (within the first week of infection) 
express a coat of Procyclins comprised of pentapeptide repeats called GPEET. 
The early stage PCF cells have been shown to undergo a form of Social Motility 
(Imhof et al. 2014), making them behaviourally distinct from the late stage 
PCFs, which additionally only express the EP procyclin dipeptide (Acosta-Serrano 
et al. 2001). Late stage PCFs migrate to the salivary glands of the fly and further 
differentiate into an intermediate stage, before becoming the Epimastigote form 
which embeds in the salivary gland wall. Again the surface coat alters and 
expression of alanine rich proteins, called BARPs, occurs (Urwyler et al. 2007). 
Sexual exchange can occur, though this may not always be required (Peacock et 
al. 2011). Parasite differentiation proceeds in the Tsetse salivary gland lumen 
and the MCF stage primed for the infection of the mammalian host emerges. To 
survive the initial host infection, the MCF is coated in VSGs specific to this stage 
(mVSGs; Barry et al. 1998; Ginger et al. 2002) and of a limited repertoire 
relative to BSF cells. Overall passage through the Tsetse fly takes approximately 
30 days (MacGregor et al. 2012), whereas the parasite can live for years in the 
mammal. To date the longest recorded infection with T. b. gambiense in a 
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human is 29 years (Sudarshi et al. 2014). These above lifecycle stages are 
specific to the T. brucei species; the life cycles of other species, such as T. vivax 
and T. congolense, vary (are not discussed further). 
1.3 T. brucei: molecular biology 
1.3.1 The cell body and cell cycle 
T. brucei is typically elongated in shape due to an organized arrangement of 
highly polarised sub-pellicular microtubules running from the anterior to the 
posterior of the cell (Figure 1-33 A). At the posterior end, a small invagination of 
the cell membrane occurs to form the flagellar pocket (FP), the only site of 
endo- and exocytosis on the surface (see section 1.4.1.4). From here, a single 
flagellum (with a typical 9+2 axonemal arrangement Langousis & Hill 2014) 
protrudes, initiating from the basal body (BB), which is directly attached to the 
single kinetoplast by the tripartite attachment complex (TAC). The flagellum is 
attached laterally along the full length of the cell (reviewed by Field & 
Carrington 2009) by the flagellar attachment zone (FAZ), and plays a role in both 
cellular division and motility. 
T. brucei cells have a single copy of several organelles: the mitochondrion, the 
golgi, the kinetoplast, the basal body and the nucleus (Figure 1-3 B). During cell 
division, these organelles are localised to the posterior and central regions of 
the parasite, producing a defined and organized assembly of organelles within 
the cell, though re-positioning of the kinetoplast occurs between lifecycle 
stages. This makes progression of the cell cycle readily examinable by 
microscopy, for instance by chromatin staining using DAPI (Woodward & Gull 
1990). 




Figure  1-3: Trypanosome cell body structure 
(A) SEM image of a BSF trypanosome cell (T. brucei). FP = Flagellar pocket. Image captured 
by L. Lemgruber-Soares for use in this thesis. (B) Internal trypanosome cell structure. Refer 
to image legend for details. Image adapted from (Matthews 2005); The Company of 
Biologists Limited 2005©. Used with permission (License ID: 3906400295096). 
The trypanosome cell cycle, like a typical eukaryotic cell cycle, occurs in four 
stages, G0/G1, S, G2 and M (followed by cytokinesis; illustrated in Figure 1-4). 
Cell cycle progression is co-ordinated by a series of incompletely understood 
kinase cascades (Hammarton 2007) and, though largely conserved, a number of 
trypanosomatid-specific processes occur. The cell cycle can be monitored by 
DAPI staining cells to reveal their n-and kDNA. Uniquely, trypanosomes have 
evolved two separate S-phases; kDNA replication begins prior to nDNA 
replication, with the former S-phase being shorter; in addition, kDNA segregation 
occurs before the beginning of nDNA mitosis. As such, the G2-phase for the 
kinetoplast begins before S-phase is completed for the nDNA, and the 
kinetoplasts separate during nuclear G2-phase (Figure 1-4 B). Observing the 
relative number of kinetoplasts (K) to nuclei (N) permits an estimate of which 
cell cycle stage an individual cell is found in (McKean 2003; Hammarton 2007). 
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During nuclear G1 (1N1K cells), maturation and duplication of the BB complex 
occurs, promoting the generation of a new flagellum. The point at which the 
new flagellum exits the membrane generates a new FP. The golgi complex is 
then duplicated. The new flagellum is physically attached to the old flagellum, 
using its structure as a template on which to extend and develop through S-
phase (Farr & Gull 2012). When the cells enter later G1/ S-phase, the kDNA 
becomes ‘elongated’ (1N1eK). Separation of the basal body initiates division of 
the kinetoplast, giving rise to cells possessing a single nucleus and two 
kinetoplasts (1N2K), which are in nuclear G2 phase. Following the onset of 
mitosis, the chromosomes segregate and the nucleus divides, producing a cell 
with two kinetoplasts and two nuclei (2N2K); cytokinesis has yet to occur. T. 
brucei, like other ‘lower’ eukaryotes (such as yeast) undergoes a ‘closed’ mitosis 
in which the nuclear membrane does not breakdown and re-form. Instead, 
materials required for replication are trafficked through the nuclear membrane 
via nuclear pore complexes (NPCs; Daniels et al. 2010). Cytokinesis begins when 
the new flagellum reaches the anterior end of the old flagellum (a process which 
occurs throughout the cell cycle). Here, a cleavage furrow forms along the 
length of the cell, beginning at the anterior end of the cell (though an 
additional, posterior to anterior form of cytokinesis has been shown to occur 
Zhou et al. 2016). Now each cell harbours a full set of organelles and can finally 
separate by abscission into two individual cells by the enzyme spastin (in BSF 
cells; Benz et al. 2012). 




Figure  1-4: The BSF cell cycle 
(A) Schematic illustration of the BSF trypanosome cell cycle. Red = new flagellum, Green = 
old flagellum. Images on the right show DAPI stained nDNA and kDNA configurations of 
BSF cells. Images were captured on an Axioskop 2. (B) Schematic representation of nDNA 
and kDNA division timing. D = kDNA division, A- kDNA anaphase, M- nuclear mitosis, C- 
cytokinesis. Figure kindly provided by C.Marques (University of Dundee) and adapted for 
this thesis. 
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1.4 Avoiding host clearance 
Colonisation of complex multicellular organisms by other species can be 
mutually beneficial; on one hand the host organism provides a rich and fertile 
environment in which the other species can thrive and, on the other, the 
colonising organism can provide a service for the host in exchange. A commonly 
cited example of this is the complex (symbiont) relationship between the 
intestinal microflora and the host; the microflora appears to influence the host 
immune system (O’Hara & Shanahan 2006).In the case of parasitic organisms, 
colonisation and nurture is at the expense of the host, often producing nutrient 
deficits which can result in a disease state. Parasitic organisms range in size 
from viral particles to bacteria, protozoans and up to larger, multicellular 
organisms such as helminths and invertebrates. In order for any parasite to 
survive in (and on) the host without being expelled, they have evolved several 
strategies to combat clearance. However for the purposes of this thesis, the 
focus of this section will be specifically on immune evasion by true antigenic 
variation3. 
Once inhabiting a host organism, a parasite faces several challenges, notably the 
innate and adaptive immune responses. Although the initial innate response 
must be overcome (to do this, pathogens have evolved multiple strategies; 
reviewed by Chai et al. 2009; Hornef et al. 2002; Deitsch et al. 2009; Melo et al. 
2011; Stijlemans et al. 2016), surviving the ongoing adaptive immune response is 
critical for the maintenance of a long term infection. Antigenic variation (as 
defined by Deitsch et al. 2009) is: 
“…the capacity of an infecting organism to systematically alter the 
proteins displayed to the host immune system, such that the host is 
confronted with a continually changing population that is difficult or 
impossible to eliminate…” 
Antigenic variation relies on the adaptive immune response requiring time to 
generate a response against a particular antigen. The parasite exploits this time 
requirement to generate an antigenically distinct variant and express it; 
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parasites harbouring the ‘old’ variant(s) are cleared by the immune response, 
while those expressing new variants survive. Thus infections by organisms that 
use antigenic variation frequently manifest as waves of bacteraemia or 
parasitaemia over a long period of time. The success of this method of survival is 
highlighted by its presence across numerous different lineages throughout 
evolution. For example, the aetiological agent of malaria (Plasmodium 
falciparum), is able to switch the erythrocyte membrane protein 1 (EMP1) 
displayed on the red blood cell surface by transcriptionally switching its 
repertoire of 60 var genes. In the case of the bacteria Borrelia burgdoferi, both 
its Major Surface Protein 2 (MSP2) and a lipoprotein VlsE undergo antigenic 
variation through a process of gene recombination (Palmer et al. 2009). 
For the purpose of this thesis, the focus will be on T. brucei antigenic variation, 
which appears to be a uniquely complex set of mechanisms that rely on a vast 
‘library’ of genes it can access for this sole purpose. T. brucei antigenic 
variation is facilitated by both the parasite’s unusual genome architecture and 
its dense surface coat: the VSG coat. 
1.4.1.1 The VSG Coat 
Approximately 95% of the BSF parasite’s surface is densely coated in a monolayer 
of VSGs (Figure 1-5; ~ 2 x107 VSG proteins anchored to the cell surface; Mugnier 
et al. 2016), which ‘shield’ any invariant surface antigens (for example, 
invariant surface glycoproteins, or ISG). However, this ‘shielding’ effect is under 
debate due to the discovery of an ISG that is predicted to protrude past the VSG 
on the parasite surface (Ziegelbauer & Overath 1993; Higgins et al. 2013). The 
VSG protein is homodimeric in structure and approximately 15 nm in size (~400 
amino acids long). It is affixed to the membrane by a C-terminal 
Glycosylphosphatidlyinositol (GPI) anchor (Schwede et al. 2011). The N-terminus 
is exposed to the immune system; this is the hyper-variable region. Antigenic 
variation is mediated by stochastic switching of the VSG coat (at a rate of 10-3 
switches/cell/division; (Turner & Barry 1989); reviewed by (Morrison et al. 2009; 
McCulloch et al. 2015; Horn & McCulloch 2010; Glover, Hutchinson, et al. 2013; 
Günzl et al. 2015)  




Figure  1-5: The structure of the VSG 
(Dashed box) TEM image of the dense BSF T.brucei surface coat; image captured by 
L.Lemgruber-Soares for use in this thesis. (Solid box) The structure of the N-terminal 
domain of the VSG antigen Lister 427-2 (vsg1). Image adapted from (Hall 2012). 
1.4.1.2 T. brucei genome is unusually arranged 
The genome of T. brucei (927 TREU strain) has 11 diploid Megabase 
chromosomes (MBC) approximately 0.9 - > 6 Mb in size and annotated from one 
(the smallest) to eleven (the largest; chromosome size is strain dependent; (El-
Sayed et al. 2000). Interestingly, the chromosomes across the different 
kinetoplastid organisms show a high level of synteny (El-Sayed et al. 2005). In 
addition to the MBCs, T. brucei has between one to five ‘intermediate’ 
chromosomes (~150-900 kbp) and 100s of ‘mini-chromosomes’ (50-150 kbp). Over 
9000 genes are estimated to be encoded by the T. brucei nuclear genome 
(Berriman et al. 2005); around 20% of the genes (~2500, though estimates are 
imprecise) are thought to be VSGs, most of which (~80%) are VSG pseudogenes 
and are primarily found in subtelomeric arrays (Berriman et al. 2005; Marcello & 
Barry 2007; Callejas et al. 2006). The intermediate and minichromosomes appear 
only to encode VSG and VSG-associated genes (Wickstead et al. 2004). 
The MBCs are organised with ‘house-keeping’ genes clustered towards the 
chromosomes’ centre. Most of these genes are transcribed by RNA Pol II, though 
PolI transcribes rRNA and procyclin genes within the interior in a small number 
of loci, while tRNA genes are transcribed by RNA PolIII from a few loci (Daniels 
et al. 2010). The subtelomeric regions harbouring extensive VSG arrays and 
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pseuodgenes flank the housekeeping core, appear highly dynamic and are largely 
untranscribed (Berriman et al. 2005; Wickstead et al. 2004; El-Sayed et al. 
2000). Proximal to the telomeres are specialised regions for VSG expression 
(some are also found on ‘intermediate’ chromosomes). These sites are called 
Expression Sites (ES) of which ~15 are predicted in the Lister 427 strain and used 
in BSF cells (BES). More truncated ES (MES) are used to express MCF VSGs 
(discussed below). 
Transcription of the genome is also unusual in all kinetoplastids; most genes are 
arranged as large polycistronic transcriptional units (or directional gene clusters) 
containing potentially 100s of open reading frames (Figure 1-6; reviewed by 
Daniels et al. 2010). The transcription units are separated by strand switch 
regions (SSRs); which can be divergent, convergent or head-to-tail. Despite the 
obvious lack of Pol II promoters, transcription is initiated from each SSR, 
resulting in transcription of a polycistronic RNA from which mRNAs arise by 
trans-splicing and polyadenylation (reviewed by Michaeli 2011; Preußer et al. 
2012). SSRs are marked by chromatin modifications. For example, enrichment of 
histone H4 acetylated at lysine 10 (H4K10ac), histone H3 trimethylated at lysine 
4 (H3K4me3) and histone variants H2Z and H2BZ (Siegel et al. 2009) occurs at 
transcription initiation sites. Termination appears to occur at sites enriched with 
H4V and H3V histone variants, and the modified thymidine, Base J (Reynolds et 
al. 2014). 
 
Figure  1-6: The structure of the T. brucei genome 
The typical structures of T. brucei chromosomes; labels are provided in the diagram. The 
dashed box illustrates the organisation of the ‘housekeeping’ genes (labelled CDS on the 
diagram) into polycistronic units (blue arrows). The black arrow indicates a convergent 
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SSR, the green arrow indicates ‘head-to-tail’ SSR and the pink arrow a divergent SSR.T2AG2 
repeats are found to cap all T. brucei chromosomes. Diagram adapted from (Tiengwe et al. 
2014; Glover, Hutchinson, et al. 2013). Not to scale 
In addition to intermediate and minichromosomes, T. brucei also harbours extra 
chromosomal elements (‘NR-elements’, as described by Alsford et al. 2003), 
potentially linked to recombination at the telomeres. 
1.4.1.2.1 BESs 
The MBCs and some intermediate chromosomes harbour BESs, which show a 
defined structural organisation (as illustrated in Figure 1-7). In MCFs, metacyclic 
expression sites (MES) are required for expression of the mVSGs in a manner 
similar to the BESs, despite differences in the promoter (Ginger et al. 2002). 
Here, only the single VSG gene is transcribed from the PolI promoter, making 
MES the only examples of single gene expression units in the genome (Ginger et 
al. 2002). In contrast, VSGs in all BES are transcribed in combination with 
expression site associated genes (ESAGs). Only one BES from the larger 
repertoire is fully transcribed at one time; this process is known as monoallelic 
expression (Günzl et al. 2015). BES, like MES and procyclins, are transcribed by 
RNA PolI (Günzl et al. 2003). BES are the only sites for expression of the VSG 
protein and the active BES is associated with an RNA PolI-containing structure 
known and the Expression Site Body (ESB), which is required for monoallelic 
expression and  located outwith the nucleolus (Navarro & Gull 2001). 
 
Figure  1-7: Generalised schematic of BES architecture 
Upstream of the BES PolI promoter is a region of 50 bp repeats (grey box), of unknown 
function. Downstream of the promoter sits multiple ESAG genes (purple boxes) thought to 
facilitate parasite survival across a number of host environments (Cordon-Obras et al. 2013; 
Pays et al. 2001). Further downstream is an array of 70 bp repeat sequences (green box), 
utilised to facilitate homology directed VSG switching (Alsford et al. 2009). The same repeats 
are found proximal to over 90% of VSGs in the subtelomeric arrays (Marcello & Barry 2007). 
The VSG gene (pink box) is located proximal to the telomere. Not to scale. 
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1.4.1.3 VSG switching 
Broadly, VSG switching can occur transcriptionally (section 1.4.1.3.1) or by gene 
recombination (section 1.4.1.3.2). 
1.4.1.3.1 Monoallelic expression and transcriptional switching 
Though VSG expression is monoallelic, meaning a single VSG is transcribed, 
translated and surface expressed, it is not the case that silent BESs are entirely 
transcriptionally ‘silent’. In fact, it appears transcription is initiated from the 
promoter, but at a low level and extending for only a small distance into the BES 
(reviewed by Günzl et al. 2015). Activation of a ‘silent’ BES and silencing of the 
‘active’ BES appears to be a coordinated process, as simultaneous expression of 
two or more BES is normally not seen (Chaves et al. 1999). How switching occurs 
remains not understood fully, though mutation of one chromatin modifier, 
DOT1B, has been shown to delay the active to silent BES transition (Figueiredo et 
al. 2008; Batram et al. 2014). 
More is understood about the factors that mediate BES silencing. From studies in 
other eukaryotes, genes in close proximity to the telomeres are often subject to 
Telomere Position Effect (TPE). Here, the telomere exerts a ‘silencing’ effect 
due to spread of protection of the telomere ends mediated by the Shelterin 
complex (the Shelterin complex is reviewed by Palm & de Lange 2008), which is 
essential and required to prevent activation of a damage response due to the 
presence of incompletely replicated DNA ends at the telomere. Loss of T. brucei 
shelterin factors (TbRAP1, TbTRF) causes expression from silent BES (Yang et al. 
2009; Pandya et al. 2013; Sanaa E. Jehi et al. 2014). In addition, the core origin 
recognition complex factor, ORC1/CDC6, has been shown to bind telomeres and 
RNAi affects VSG transcription and switching (Benmerzouga et al. 2013). 
Somewhat paradoxically, loss of two other telomeres factors have different 
impacts: loss of TbTIF2 (Jehi et al. 2016; Sanaa E Jehi et al. 2014) has been 
linked to VSG switching, but not silencing of BESs; and mutation of Ku80 (a 
component of the heterodimeric Ku complex with functions during DNA repair) 
impairs telomere length but does not detectably affect monoallelic VSG 
expression (Conway et al. 2002; Janzen et al. 2004).It has also been 
demonstrated that although a PolI promoter can be silenced by a telomere, this 
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only occurs when in close proximity (Glover & Horn 2006). Taken together, the 
significance of TPE for VSG control remains open. Recently, ectopic expression 
of a second VSG was shown to attenuate the active ES, with silencing appearing 
to spread from telomere towards the promoter due to DOT1B action (Batram et 
al. 2014). Most recently, a novel active BES factor, VEX1, has been uncovered 
whose loss activates silent BES and may act via homology (possibly VSG)-
mediated silencing (Glover et al. 2016). 
Beyond DOT1B, which generates the H3 methylated lysine 76 histone variant, 
RNAi of a number of further chromatin modifiers alleviates VSG silencing. These 
include an FACT subunit (Denninger et al. 2010; Denninger & Rudenko 2014), the 
linker histone H1 (Povelones et al. 2012), two histone chaperones (Alsford & 
Horn 2012) and an HMG factor (Narayanan & Rudenko 2013). RNAi of nuclear 
envelope lamina proteins also appears to play a role, since RNAi of two 
interacting but functionally and spatially distinct components, TbNUP-1 and 
TbNUP-2 (DuBois et al. 2012; Maishman et al. 2016), results in de-repression of 
the silent BES. Intriguingly, while loss of TbNUP1 results in new VSG on the BSF 
cell surface, suggestive of switching, loss of TbNUP-2 appears not to have the 
same effect. Nonetheless, these effects may indicate a role for the nuclear 
envelope in maintaining VSG silencing and thus monoallelic expression; indeed, 
the nuclear envelope has been implicated in gene silencing in other eukaryotes 
(reviewed by Towbin et al. 2009). 
Maintaining expression of the active VSG BES has also been considered, with a 
number of factors emerging, including cohesin (Landeira et al. 2009). Beyond 
this, RNA PolI BES expression appears, at least in part, to be mediated by the 
class I transcription factor A (CITFA) complex, which is accumulated at the 
active BES promoter to a higher level than in the silent BESs (Nguyen et al. 
2014). Finally, though the composition of the ESB remains surprisingly unclear, 
SUMOylation has been found to accumulate in the active, but not inactive, BES 
and impairment of this modification leads to loss of VSG expression (Lopez-
Farfan et al. 2014). A simplified model of transcriptional switching is shown 
below in Figure 1-8. 




Figure  1-8: Transcriptional switching 
Transcription of ‘active’ BES (with the pink VSG gene) is repressed and transcription of an 
‘inactive’ BES (with the black VSG gene) is turned on; this BES is now the ‘active’ BES. 
Dashed arrow indicates transcription occurring. Not to scale. 
1.4.1.3.2 Recombinational switching 
Switching transcriptionally cannot sustain a long term infection. With ~15 BESs in 
the Lister 427 strain, only 15 different VSG variants are available. To this end, T. 
brucei more frequently utilises recombinational switching to facilitate antigenic 
variation. To generate a recombinational switch, a VSG from the silent archive, 
spread across the silent BES, the subtelomeric arrays, intermediate 
chromosomes and minichromosomes must be ‘moved’ into an active BES and is 
subsequently expressed. Unlike transcriptional switching, recombinational 
switches occur by several different pathways; gene conversion (GC ;Bernards et 
al. 1981), telomere crossover (TC; likely a rare event; De Lange et al. 1983) or 
by generating novel, mosaic VSG genes (as reviewed by McCulloch et al. 2015 
and summarised in Figure 1-9). 




Figure  1-9: Recombination switching 
(A) VSG switching by telomere crossover. The telomere of the ‘active’ BES (pink box) is 
exchanged for a ‘silent’ VSG (black box). The ‘pink’ VSG still retained in the silent BES as a 
silent VSG gene. (B) VSG switching by gene conversion. An intact VSG from the silent 
archive is duplicated into the ‘active’ BES and replaces the currently expressed VSG gene. 
Homology can be used from the 70 bp repeats or (if the VSG is telomeric) the telomere can 
be used as a point of homology (referred to as telomeric conversion), as can the ESAGs 
(purple boxes). (C) VSG switching using multiple VSG genes or pseudogenes. A novel, 
intact (mosaic) VSG is generated by segmental gene conversion from fragments of other 
VSG genes; either intact or from pseudogenes. Unlike the process above, this reaction 
relies on intra-VSG ORF homology. This process is thought to predominate in late in the 
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infections (Hall et al. 2013; Marcello & Barry 2007). Not to scale. Figure generated based on 
data from (Devlin 2015). 
A common feature associated with over 90% of VSG genes is the presence of a 
variable 70 bp repeats (array VSG genes typically harbour only small numbers, 
while in BES-associated VSGs up to 100 repeat sequences have been reported; 
Alsford et al. 2009). The role of the 70 bp repeats remains a subject of 
investigation. They may be limited to facilitating homology between archival 
VSGs and the VSG in the active BES. Alternatively, the repeats may actively 
promote recombination, perhaps via unusual base pairing properties (Ohshima et 
al. 1996) due to their sequence content (which comprises of TAA/TAA-like 
tandem repeats at the 5’ region, and conserved TA repeats at the 3’ region 
(Hovel-Miner et al. 2016). However, the available data on such a role is unclear, 
since though one study suggested DNA breaks localise to the 70 bp repeats in the 
active BES (Boothroyd et al. 2009), others did not (Glover, Alsford, et al. 2013; 
Jehi et al. 2014); in addition, two reports have indicated that removal of the 70 
bp repeats from the active BES does not impair VSG switching (McCulloch et al. 
1997; Boothroyd et al. 2009), while one suggests such a deletion activates the 
reaction (Hovel-Miner et al. 2016). 
What is clear, is that recombinational switching, of at least intact VSGs, exploits 
the homologous recombination (HR) pathway of DNA repair (and perhaps uses 
sub-pathways, including synthesis-dependent strand annealing [SDSA] and break 
induced repair [BIR]) to facilitate these switches (Borst et al. 1996; David Barry 
& McCulloch 2001). HR is reviewed by Krejci et al. 2012 and summarised in 
Figure 1-10 below. Other repair pathways, including single strand annealing 
(SSA) and microhomology mediated end joining (MMEJ), have also been shown to 
occur in T. brucei (Conway et al. 2002; Burton et al. 2007; Glover et al. 2011), 
but their enzymology is less clear. HR proteins are well documented to be 
involved in mediating VSG switching. For example, knockouts of TbBRCA2, the 
TbRAD51-3 paralogue and the core HR catalyst, TbRAD51, severely reduced VSG 
switching rates (McCulloch & Barry 1999; Dobson et al. 2011; Proudfoot & 
McCulloch 2006; Hartley & McCulloch 2008). Conversely, other HR factors, such 
as a topoisomerase TbTOPO 3α, TbRMI1 and TbRECQ2, (Kim & Cross 2011; Devlin 
et al. 2016) increase the rate of switching when mutated. Nonetheless, some 
specialisation of VSG HR switching may occur, since mutation of other TbRAD51 
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paralogues and a component of the MRN complex (which is recruited to a double 
stranded break [DSB] lesion in an ataxia telangiectasia mutated (ATM)-
dependent manner; ATM and HR are discussed in detail below and in chapter 6 
respectively; Shiloh & Ziv 2013; Krejci et al. 2012) do not affect VSG switching. 
 
Figure  1-10: Generalised schematic of HR and HR sub-pathways in eukaryotes 
Generally, the presence of a double stranded break (DSB) is detected by the Meiotic 
Recombination Protein 11/Rad50/Nijmegan Breakage Syndrome 1 (MRN) complex. The MRN 
complex, which harbours exonuclease (5’ to 3’) activity, resects the break ends to generate 
3’ overhangs of ssDNA. A second exonuclease (Exo1) further resects these regions. 
Replication Protein A (RPA) proteins then decorate the ssDNA strand to prevent further 
damage to this strand. The RPA is replaced by the RAD51 protein, which is loaded onto 
ssDNA by the breast cancer 2 (BRCA2) protein forming a RAD51-nucleofilament. After, 
strand invasion (of an undamaged strand) can occur catalysed by RAD51 to form a ‘D-loop’. 
The invading strand is then used as a template for repair of the 3’ resected DSB region. 
Repair proceeds either by gene conversion, BIR or SDSA. Here, Holliday junctions (HJs) 
form between strands. Strand exchange can occur (resulting in genetic material transfer 
from the template) and the HJs are resolved. BIR is used when one 3’ strand invades to form 
a D-loop. The D-loop can remodel into a replication fork and replication can continue 
downstream over a long region of DNA. SDSA involves formation of a D-loop, priming DNA 
synthesis then removing the invading strand and annealing it to the other complementary 
DSB strand. 
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Considering the involvement of HR it was hypothesised that a DNA lesion is 
responsible for initiating VSG switching. Some work has suggested that DSBs 
could trigger VSG switching. Boothroyd et al (Boothroyd et al. 2009) 
demonstrated that directly generating a DSB in The active BES, using an 
inducible meganuclease, drastically increases the rate of VSG switching. 
Furthermore, they demonstrated this effect was dependent on the position of 
the DSB relative to the 70 bp repeats (Boothroyd et al. 2009). Additionally, they 
detected breaks around the 70 bp repeats. Later, Glover et al (2013) confirmed 
these findings, showing that a meganuclease –induced break only triggered 
switching when sited between the 70 bp repeats and VSG in the active BES, not 
elsewhere in the active BES or in an inactive BES. 
Another potential explanation for the trigger of HR- mediated repair has 
emerged from studying replication timing of the BES. Some studies have 
speculated that the 70 bp repeats might cause an increased predisposition to 
stalling replication forks (Kim & Cross 2011). Fork collapse can trigger HR-
mediated repair following the formation of single stranded DNA (ssDNA) at the 
lesion site. Commonly, such ssDNA is detected in an ATM-Rad3 related (ATR)-
dependent manner (Zeman & Cimprich 2014; as discussed in chapter 6). Indeed, 
replicative lesions have been insinuated to facilitate recombination in the both 
the yeast S. pombe (Doe & Whitby 2004) and the bacterium Neisseria (here 
through the formation of DNA-RNA hybrids or ‘R-loops’; (Cahoon & Seifert 2009). 
Now, recent evidence in T. brucei supports this theory. Despite T. brucei cells 
lacking the DNA helicase REQ2 (RecQ helicases are involved in genome 
maintenance; reviewed by Croteau et al. 2014) being defective in DSB repair, 
they harbour elevated VSG switching rates by recombination at their telomeres. 
Additionally, DSBs within the active BES were inefficiently repaired in such 
mutants, arguing against a direct DSB being the VSG switch trigger. Instead, 
Devlin et al were able to demonstrate that the active BES, alone amongst the 15 
BES, replicates early, which could establish conditions that produce stalled 
replication forks. Though further work is required to scrutinise this model in 
more depth, the data provides the first indication that replicative lesions may 
trigger VSG switching by recombination (Devlin et al. 2016). 
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One area of mechanistic uncertainty in T. brucei antigenic variation rests on 
mosaic VSG formation by segmental gene conversion. It is clear from numerous 
studies that the huge number of VSG pseudogenes are used as recombination 
substrates, with considerable reaction flexibility that potentially generates 
millions of novel VSGs (Mugnier et al. 2015; Hall et al. 2013; McCulloch & Field 
2015). However, the machinery which catalyses the reaction, the potential 
trigger(s) and the location of mosaic assembly remain unknown. 
1.4.1.4 Endocytosis as a method of immune evasion in T. brucei 
The stochastic switching of the VSG antigen permits evasion of the host humoral 
response. However, during the early infection stages, both complement and less-
specific IgM antibodies can become attached to the parasite surface. To 
overcome these issues, BSF trypanosomes utilise their endocytic pathway to 
internalise (via hydrodynamic forces; Engstler et al. 2007) and dispense with any 
attached immune factors during surface coat recycling. 
Surface VSGs are first transported in Rab5A-positive vesicles to the early 
endosome then rapidly recycled to the surface by Rab11-positive vesicles. ISGs, 
in contrast, are thought to be trafficked by Rab5B vesicles, though can 
potentially be trafficked to the surface again by Rab11-positive vesicles 
mediated by the protein RME-8 (Koumandou et al. 2013), or they can enter the 
endosome system and progress into the late endosome system in a Rab28-
mediated manner (endocytosis in T. brucei is reviewed by Field & Carrington 
2009). 
The available evidence suggests BSF T. brucei require a highly efficient 
endocytosis system for VSG recycling and antibody clearance. This process 
appears to be clathrin-mediated, and does not rely on an AP2 complex, 
suggesting T. brucei has streamlined its endocytosis pathway to maximise 
clearance and recycling of the VSG (Manna et al. 2013). Most likely this is a 
further mechanism of immune evasion. 
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1.5 Kinases and phosphorylation: Co-ordination of 
cellular communication 
Protein kinases (PKs), through their ability to transfer protons via 
phosphorylation, provide a means of cellular communication. De-regulation of 
this process can be catastrophic, though severity depends upon the pathway in 
which an individual PK operates. Nonetheless, a large proportion of human PKs 
have been directly linked to the onset of disease following de-regulation (for 
example, in a recent review, ~ 50 PKs were found to contribute to 67 diseases 
associated with aberrant kinase activity; referred to as ‘kinasopathies’; (Lahiry 
et al. 2010). 
Phosphorylation is a post-translational modification, which involves transferring 
the γ-phosphate of one ATP molecule to the OH- group on a targeted protein at 
either a serine (S), threonine (T) or tyrosine (Y) residue. The phosphate transfer 
can then regulate protein activity, for instance through conformational changes 
or allosterically. 
1.5.1 The human kinome; eukaryotic kinases and atypical kinases 
The human kinome was published in 2002 (Manning et al. 2002) marking the 
expansion of the kinase biology field. Over 500 PKs have been identified in the 
human genome, accounting for ~2% of all human genes. PKscan be further 
grouped into either eukaryotic protein kinases (ePKs) or atypical protein kinases 
(aPKs), as discussed below. 
1.5.1.1 Eukaryotic Protein Kinases (ePKs) 
Over 90% of human kinases are ePKs, all sharing a common protein configuration. 
ePKs transfer the phosphate to either a serine or a threonine (S/T kinases), a 
tyrosine (tyrosine kinases) or to a serine, threonine or tyrosine (dual specificity 
kinases). In addition, PKs able to phosphorylate histidine and other amino acids 
have been identified, for example histidine (Puttick et al. 2008). The members 
of the ePK group of kinases are first classified based on 12 highly conserved 
subdomains throughout the PK structure (Hanks & Hunter 1995), then further 
classified into eight PK ‘families’ based on conserved sequence motifs in their 
catalytic region: Tyrosine Kinases (TKs), Tyrosine Kinase Like kinases (TKLs), 
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Calcium and Calmodulin-regulated kinases (CAMKs) , CDK-like Kinases (CMGCs), 
Receptor Guanylate Kinases (RGCs), Protein Kinases A, G and C (AGC), Casein 
Kinase 1 (CK1) and Homologs of yeast Sterile 7, Sterile 11, Sterile 20 (STE) 
kinases. Despite these groupings, members of the different PK ‘families’ do not 
strictly adhere to interactions with members of their own group; many often 
require activation by PKs from other groups or share a common substrate; for 
instance, the Mitogen Activated Protein Kinases (MAPKs; family CMGC) can be 
activated by STE kinases (family STE; Ahn et al. 1999). 
The highly conserved structure of the ePKs was first observed in the 1990s 
following the publication of the crystal structure of protein kinase PKA (a cAMP 
dependent PK; Knighton et al. 1991). A generalised schematic of a typical ePK 
structure and domain organisation is shown in Figure 1-11 below. 
 
Figure  1-11: Conserved ePK domains 
The position of each subdomain within the two lobes is shown schematically (above) and by 
theor approximate position (below) in the structure of the typical ePK, ABL. The role of each 
subdomain is detailed in Table 1-2 (below) and in the text. Figure adapted from N.Jones and 
(Dixit & Verkhivker 2009). Not to scale. 
ePKs are composed of two ‘lobes’: an N-terminal lobe and a C-terminal lobe. 
The active site residues required for ATP binding are located in a cleft within 
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the region linking the two lobes. Subdomains and their functions are shown in 
Table 2 and discussed below. 
 
Table  1-2: ePKs have 12 conserved subdomains 
The known function(s) of each domain are as detailed in the above table. The information 
used to generate this table was extracted from (Taylor & Kornev 2011). 
The N-terminal ‘lobe’ (or C-helix) is comprised of 5 β –sheets and one α-helix 
domain. This lobe is both the smaller and more mobile and encompasses 
subdomains I-IV (reviewed by Taylor & Kornev 2011; see table 1-3). The lobe is 
primarily required for co-ordinating the orientation of both the phosphate and 
the magnesium ion relative to the active site. The lobes are connected in a 
hinge-like fashion by a beta sheet (within the N-terminal lobe) and an alpha 
helix (within the C-terminal lobe). Additionally, the hinge region can also 
contribute to peptide binding specificity. Subdomains VI -XI are located in the 
larger C-terminal lobe, which is composed mostly of α-helices (seven) and four 
β-strands. Subdomains IV to VIIA primarily contribute to stability of the core 
kinase structure. Overall, the C-terminal lobe is required for binding the 
required peptide substrate and facilitating the transfer of the phosphate onto 
the substrate; for optimal kinase activity, the orientation of the phosphate 
within the active site is critical. 
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1.5.1.2 Atypical Protein kinases (aPKs) and Protein Kinase Like (PKL) 
kinases 
aPKs lack the conserved subdomain structure of a typical ePKs but have been 
reported to harbour kinase activity or show structural homology to other kinases. 
Currently, four aPK kinase ‘groups’ are recognised (Duong-Ly & Peterson 2013): 
pyruvate dehydrogenase kinases (PDHKs), nucleoside diphosphate kinases 
(NDKs), pyruvate kinase (PyK) and structurally atypical putative PKs (SAPPKs; for 
example, bromodomain containing kinases; Devaiah et al. 2012). 
Recently, many aPKs were re-classified into a family of ePKs known as the PKL 
kinases; these kinases harbour similarities to ePKs in the catalytic domain region 
and their activation mechanism, yet still lack many of the other conserved 
features of ePKs. This group encompasses the following kinase groups; ABC1 
domain containing kinases, Alpha kinases, phosphatidyl inositol kinases (PIKs), 
RIO kinases, Phosphatidly Inositol phosphate kinases (PIPKs), AGPHD1 kinases, 
golgi associated kinases (GASKs) and phosphatidyl inositol 3’ kinase-related 
kinases (PIKKs). A subset of ‘other’ PKL kinases exist, which are highly diverged 
in sequence (Kannan et al. 2007). 
1.5.1.3 Pseudokinases: just a dead kinase? 
In addition to PKs, ~10% of the human kinome are in fact pseudokinases, which 
are enzymes that appear to lack any catalytic activity based on their protein 
sequence. Though they lack critical residues required for kinase activity, this 
does not mean they are incapable of signalling and interactions, even via 
phosphate transfer, though often their modes of action remain highly elusive 
(Boudeau et al. 2006; Reiterer et al. 2014; Zeqiraj & van Aalten 2010; Zhang et 
al. 2012). Instead of acting as kinases, they function as structural elements able 
to tether incoming substrates (perhaps as part of a kinase signalling pathway), 
substrate competitors, protein modulators, or act in a manner to allow different 
signalling pathways access to each other (as suggested by Reiterer et al. 2014). 
Pseudokinases typically show loss of three core conserved motifs found in 
kinases: the HRD motif (His-Arg-Asp), the DFG motif (Asp-Phe-Gly) and the VAIK 
motif (Val-Ala-IIe-Lys; required for ATP orientation). The origins of these 
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pseudoenzymes (as discussed by (Zhang et al. 2012; Zeqiraj & van Aalten 2010; 
Reiterer et al. 2014) are unknown. 
Several pseudokinases have now been linked to disease states in vertebrate 
organisms. For example loss of Kinase suppressor of ras1,KSR1, results in 
modulation of Ras signalling depending upon the level of KSR1 expression 
(mutations in Ras proteins themselves are associated with the oncogenic effects 
in cells; reviewed by Downward 2003). 
1.5.1.4 Pseudokinases in parasitic organisms 
Pseudokinases in protozoan organisms are increasingly becoming of interest. For 
example, the causative agent of Giardiasis (Giardia lamblia) has ~50% of their 
predicted kinome as pseudokinases. Interestingly, of the 195 NEK kinases (an 
expanded family of kinases), an estimated 139 (or 71%) may be pseudokinases 
(Manning et al. 2011). The expansion of this family and the roles of these 
pseudokinases are still under investigation. To date, only that action of two 
active NEK kinases in G. lamblia (GlNek1 and GlNek2) have been reported as 
important regulators of the cell cycle and parasite excystation (Smith et al. 
2012). 
The obligate intracellular parasite Toxoplasma gondii has a predicted 51 
pseudokinases from a total kinome of 159 proteins (Peixoto et al. 2010). One 
pseudokinase (ROP5) is important for the phosphorylation of the rhoptry protein 
ROP18 (see Dlugonska 2008 for a review on the organelles in T. gondii), which is 
involved in the inactivation of IRG proteins (which are required for resistance of 
cells to T. gondii invasion). Deletion of ROP5 reverted a highly virulent T. gondii 
strain to an avirulent form, highlighting the importance this pseudokinase plays 
in the establishment of a T. gondii infection (Sibley et al. 2009 for a review of 
rhoptry proteins; Lim et al. 2012; Fleckenstein et al. 2012). 
1.5.2 The T. brucei kinome 
With the publication of the T. brucei genome in 2005, the kinome of this 
parasite could comprehensively be investigated (Parsons et al. 2005). 
Approximately 2% of the genome of T. brucei (a similar complement to that of 
the human genome) is dedicated to protein kinases, of which there are 158 
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ePKs, 20 aPKs and an estimated 12 pseudokinases. Figure 1-12 shows a stylised 
map of the trypanosome kinome detailing only the ePKs. To date, no receptor 
tyrosine kinases (TKs) or tyrosine kinase like kinases (TKL) have been identified. 
However, tyrosine phosphorylation occurs in T. brucei, though further work is 
required to identify the PKs responsible (Parsons et al. 1991). 
 
Figure  1-12: The T. brucei kinome 
Branch lengths are simply representative of family groupings and do not reflect any 
phylogenetic observations. Red nodes indicate RNAi targeting of the PK affects BSF 
proliferation in vitro from the data presented by (Jones et al. 2014). Families are defined 
based on protein sequence characteristics. Tree represents 156 ePKs from T.brucei. Figure 
adapted from (Jones et al. 2014). 
Contractions and expansions of several PK families have occurred in T. brucei. 
CMGC kinases, STE kinases and NEK kinases show expansion relative to the 
human kinome, while CAMK kinases and AGC kinases are underrepresented. 
Expansion of PK families is not a unique feature of trypanosomatid parasites; 
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over 70% of the Giardia lamblia kinome is comprised of NEK kinases (Manning et 
al. 2011); in humans there are only 11 NEK kinases (Fry et al. 2012) and in T. 
brucei 21 (Parsons et al. 2005; Jones et al. 2014). 
Overall, an estimated 22% of the T. brucei kinome is required for BSF 
proliferation, of which ~30% of these kinases produce severe phenotypes when 
targeted by RNAi (Jones et al. 2014). For example, depletion of the kinase RDK2 
(family: NEK Kinase; Tb927.4.5310) results in differentiation from BSF to PCF 
both in vitro and in vivo (Jones et al. 2014); the parasite population ceases 
proliferation ~72 hours post RNAi induction when cultured in HMI-11 BSF medium 
(data not shown). Studies like the aforementioned and others (Mackey et al. 
2011) highlight the importance of protein kinase activity in these parasites. 
1.5.2.1 Pseudokinases in T. brucei 
Of the 190 predicted protein kinases of T. brucei an estimated 6% (12) are 
thought to be pseudokinases; this could be an underestimation due to potential 
miss-annotation of the reference genomes (Lister 427 or TREU 927; TriTrypDB). 
Furthermore, of the 12 predicted pseudokinases of T. brucei, nine have been 
shown (by kinome-wide screening with minimal follow up validation) to be 
required for full parasite viability in vitro (Jones et al. 2014). However, to date, 
there is no known role for any pseudokinase in T. brucei or any other 
kinetoplastid. 
1.6 DNA Repair and Damage 
Genomic integrity can be challenged at any moment; from endogenous sources 
of damage such as replicative lesions and metabolic by-products, to exogenous 
sources including mutagenic chemicals and radiation. To add further complexity, 
a variety of lesions can form, including double-stranded breaks (DSBs), single 
stranded breaks (SSBs), replication forks (RF) stalls, cross-linking of DNA strands 
(intra-or inter), DNA base modifications (such as methylation) or mismatching of 
DNA bases during replication. Due to the myriad of routes by which genome 
integrity can be challenged, cells have evolved an extensive array of pathways 
to repair (or tolerate) any potential lesion which may arise (Figure 1-13). 
Collectively, these diverse responses are known as the DNA damage response 
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(DDR). The DDR has been extensively reviewed (Chang & Cimprich 2009; 
Cimprich & Cortez 2008a; Guleria & Chandna 2015; Kondo et al. 2010; Larsen & 
Stucki 2015; Nogueira et al. 2011; Podhorecka et al. 2011; Shiloh & Ziv 2013; 
Zeman & Cimprich 2014) and hence will be briefly discussed below and 
elaborated on when required in the appropriate chapters. 
When a lesion arises, several clear ‘signals’ can form. For example, the MRN 
complex or Ku heterodimer localises to DSBs; ssDNA activates members of the 
poly (ADP ribose) polymerase (PARP) family (as reviewed by Ciccia & Elledge 
2010; Cohen-Armon 2007), such as PARP-1, or can be bound by ATRIP (a protein 
complexed to an atypical PK). Additionally, the phosphorylated histone variant 
H2A(X) can also arise in response to several lesions (as reviewed by Mah et al. 
2010; Kuo & Yang 2008; Dickey et al. 2009), though it does not directly 
contribute to repair of all damage. Once lesions are then ‘sensed’ by the above 
proteins, the signal is further amplified by ‘mediator’ proteins. For example, 
MDC1 (Mediator of DNA Damage Checkpoint Protein 1) acts to retain the MRN 
complex and the Ataxia Telangiectasia Mutated [ATM] PK at DSBs. The signal is 
then further amplified by ‘transducer’ proteins. For example, the PIKK kinases 
ATM and DNA-PKcs (the DNA-dependent kinase catalytic subunit) are activated 
via MRN and Ku, respectively, on DSBs. A further PIKK kinase, AT-and Rad3 
Related (ATR), is activated via ATRIP on some ssDNAs, and MAPK kinase signalling 
occurs following PARP-1 activation on other ssDNA lesions (Ciccia & Elledge 
2010). The specific PK activated predominantly determines which DNA repair 
pathway is pursued to resolve the lesion. Failure to resolve a DNA lesion, in 
particular a DSB, is often fatal for the cell (DSB repair is reviewed by 
(Kakarougkas & Jeggo 2014) and so cell cycle checkpoints can be activated, 
resulting in stalling of the cell cycle progression to allow time for lesion repair 
by ‘effector’ proteins, such as and RAD51 during HR. A description of how each 
repair pathway operates is beyond the scope of this thesis, but is reviewed in 
kinetoplastids by (Passos-Silva et al. 2010; Genois et al. 2014). A generalised 
schematic of known DDR pathways is shown in Figure 1-13. 




Figure  1-13: The diverse range of DNA lesions and their corresponding DNA repair 
pathways 
The schematic above represents both the diversity of lesions which can form, the source by 
which they are generated and the myriad of routes required to resolve the lesions. IR 
(Ionizing radiation), ROS (reactive oxygen species), ssDNA (single stranded DNA), UV (ultra 
violet), ISC (Inter/intra strand cross links), DSB (double stranded break), HR (homologous 
recombination), NHEJ (non-homologous end joining) SSA (single strand annealing), TLS 
(translesion synthesis) and BIR (break induced repair). Adapted from (Genois et al. 2014) 
with permission. 
1.6.1.1 Replicative stress 
As mentioned in section 1.4, recent evidence suggests the involvement of 
replication-derived lesions to initiate VSG switching. In addition, in any cell 
lesions that halt replication are the most deleterious to life. As such, replicative 
stress will be discussed in more detail below. 
Replicative stress is a broad term, which encompasses lesions derived from 
replicative processes predominantly associated with either the slowing, stalling 
or halting of replication fork progression. A replication fork is a complex 
structure of many replication proteins (the replisome), which collectively 
unwind the DNA, synthesis new DNA and remove torsional stress (reviewed by 
Ciccia & Elledge 2010; Zeman & Cimprich 2014). Replicative stress can arise in 
many ways. For example, at regions of repetitive sequences, at mismatched 
base sites, following the activation of oncogenes (like c-myc; as reviewed by 
Rohban & Campaner 2015), where DNA-RNA hybrid structures (R-loops) form, 
due to dormant origin firing, at collisions with protein complexes, most notably 
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transcription, and when the replication machinery encounters ‘fragile’ sites. 
Little work has examined the replication stresses encountered in the T. brucei 
genome, though mapping replication dynamics revealed slowed replication 
progression due to head-on encounters with multigenic transcription (Tiengwe et 
al. 2012). More speculatively, the BESs appear a rich source of such stress: the 
VSG is immediately adjacent to the shelterin-bound telomere, the BES harbour 
70 bp repetitive sequences, and early replication of the active BES site suggests 
clashes with transcription. In this regard, the recently described ‘early 
replicating fragile sites’ (which are GC-rich) have been postulated to activate 
the ATR kinase following lesion formation (Mortusewicz et al. 2013). 
Predominantly, DNA lesions such as DSBs and ssDNA arise from stalled replication 
and subsequently activate pathways which mediate their resolution. Routinely, 
two outcomes are possible following the stalling of a replication fork; replication 
fork resolution or replication fork collapse. Though these processes still require 
further investigation, forks that are able to restart are predominantly assisted by 
ATR, whereas forks that fail to resolve may produce a DSB causing activation of 
ATM (Trenz et al. 2006 as reviewed by Allen et al. 2011). More detail on the 
roles of TbATR and TbATM in these processes is provided in chapter 6. 
1.6.2 DNA Repair in T. brucei 
Extensive work has detailed the action of a wide range of DNA repair pathways 
in kinetoplastids, including T. brucei, revealing that most pathways are generally 
conserved and active. However, some clear divergences are apparent. 
Accumulating evidence, based initially on homology searches and later on 
experimental analyses (Glover et al. 2008; Glover et al. 2011; Burton et al. 
2007; Zhang & Matlashewski 2015; Peng et al. 2015), suggests that kinetoplastids 
do not utilise NHEJ repair, but instead repair of DSBs is dominated by the HR 
pathway and MMEJ (or SSA; Glover et al. 2008; Glover et al. 2011). NER also 
appears highly diverged, with a focus on repair of transcription-blocking lesions 
by an altered NER machinery, perhaps due to the presence of multigenic 
transcription (Machado et al. 2014). Mismatch repair appears to be required for 
dealing with oxidative derived lesions in both T. brucei and T. cruzi (Grazielle-
Silva et al. 2015). Even HR has been adapted to the needs of the parasites: the 
core HR mediator, BRCA2, has undergone structural reorganisation in T. brucei 
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(Hartley & McCulloch 2008; Trenaman et al. 2013), perhaps due to the demands 
of VSG switching; T. cruzi is highly radiation resistant, a process that requires HR 
(Grynberg et al. 2012; Vieira et al. 2014; Passos-Silva et al. 2010; Regis-da-Silva 
et al. 2006); and the huge genome plasticity of Leishmania is, at least in part, 
catalysed by HR activities (Laffitte et al. 2016; Genois et al. 2014). Finally, 
recent work has shown that function of at least one damage sensing complex, 
the 9-1-1 complex, acts divergently in Leishmania (Damasceno et al. 2013; 
Damasceno et al. 2016). Indeed, another divergence of the T. brucei DDR from 
other eukaryotes is seen in phosphorylation of H2A after damage, generating the 
γH2A signal. In all other eukaryotes, phosphorylation of H2A(X) occurs on a 
Serine, but in T. brucei phosphorylation is on a Threonine (130; γH2AThr130) 
within poorly conserved surrounding residues (Glover&Horn 2012). 
How the above described differences in repair pathways and proteins affect, and 
influence, the interconnected DDR of these kinetoplastids parasites remains 
largely unknown. A striking deficit in our knowledge is in the role of PKs 
associated with DNA repair. Many components of the DDR undergo PK-mediated 
phosphorylation during repair in other eukaryotes, including, for example, the 
HR factors RAD51 (Flott et al. 2011), BRCA2 (Kim et al. 2008) and RAD51 paralogs 
(Suwaki et al. 2011; Niu et al. 2009). In addition, PK-mediated phosphorylation is 
a central component of the cascade of protein recruitment and activation during 
replication. Despite this, little work has examined such modifications in the 
kinetoplastids. In Leishmania KU70 appears to be a target for CRK3 -mediated 
phosphorylation (Maity et al. 2011), though the purpose of this phosphorylation 
is currently unknown. In Plasmodium, the origin replication complex is regulated 
by PfPK5 phosphorylation (Deshmukh et al. 2015), though this has not been 
described in kinetoplastids. Considering the vital roles PKs play in the eukaryotic 
DDR, and in genome maintenance generally, this is an area in need of 
investigation. Any insight may reveal novel functions in the regulation and 
execution of crucial processes, such as T. brucei antigenic variation. 
1.7 Project Objectives 
The aim of this project was to biologically validate two independently performed 
RITseq screens that were designed to identify PKs with DNA repair-associated 
roles in BSF T. brucei parasites. Specifically, the screens searched for those 
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factors, including PKs, required for survival in the presence of MMS. One chapter 
reveals validation and deeper exploration of the MMS sensitivity of several 
candidate PKs recovered in the screens. The following three chapters examine 




2 Materials and Methods 
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2.1 General Bioinformatics 
2.1.1 Sequence retrieval and examination 
Kinetoplastid protein and DNA sequences were retrieved from TriTrypDB (current 
version. 28; http://tritrypdb.org/tritrypdb/; Aslett et al. 2010). For RNAseq 
analysis, the whole genome sequence of T. brucei brucei Lister 427 was 
retrieved from TriTryp DB (v.28; May 2016). Protein sequences from other 
organisms were retrieved from the NCBI database 
(http://www.ncbi.nlm.nih.gov/). All sequences were input into CLC genomics 
Workbench 7 (Qiagen) for further examination. This software was also used for 
the plasmid map construction, primer design, restriction digest design, sequence 
analyses, plasmid sequencing analysis and sequence alignments. 
2.1.2 Homology searching, protein domain analysis and structure 
prediction 
Homology searches were performed using the NCBI database Basic Local 
Alignment Tool (BLAST; Altschul et al. 1990; 
http://blast.ncbi.nlm.nih.gov/Blast.cg). The standard (BLOSUM 62) blastp 
settings were used to BLAST against all non-redundant (nr) protein sequences 
available in the database. The SmartBLAST feature (standard settings; 
http://blast.ncbi.nlm.nih.gov/smartblast/?LINK_LOC=BlastHomeLink) was used 
for a more concise and optimised analysis. Features of this software are 
available here: 
http://blast.ncbi.nlm.nih.gov/smartblast/smartBlast.cgi?CMD=Web&PAGE_TYPE
=BlastDocs). For protein domain analysis, several web bases programs were used: 
NCBI BLAST (as above) and InterPro (https://www.ebi.ac.uk/interpro/). For 
generation of structural homology models and protein structure predictions, the 
RaptorX platform was used (http://raptorx.uchicago.edu/). 
2.1.3 General Statistics 
All statistical analysis was performed using GraphPad Prism 5 
(http://www.graphpad.com/scientific-software/prism/). The appropriate tests 
were conducted following advice from J.Wilkes and are as detailed in the 
corresponding figure legends. 
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2.2 Molecular Techniques 
2.2.1 Genomic DNA extraction and preparation 
Cells were harvested as per section 2.7.6 and genomic DNA (gDNA) extracted 
using the Qiagen Blood and Tissue extraction kit (Qiagen) as per manufacturer’s 
instruction. gDNA was eluted in 50 µl ddH20 and stored at 4 
oC. 
2.2.2 Agarose Gel 
Routinely 0.8-1 % (w/v) agarose (UltraPureTM Agarose; Invitrogen) was melted in 
1 x TAE buffer (40 mM Tris Base, 19 mM acetic acid, 1 mM EDTA). For DNA 
visualisation, 3 µl- 6 µl of a DNA stain (SYBR® Safe DNA Stain; Life Technologies) 
was added. For gel loading, 1 x type III DNA Gel-loading buffer was added to the 
DNA. For fragment size estimation, 1 Kb Plus ladder (Invitrogen) was also loaded. 
Gels were run between 60-120V (size dependant) 1 x TAE buffer. Gels were 
visualised using a GelDocTM XR+ system (BioRad) or myECL™ imager 
(ThermoFisher Scientific). The software provided was used for gel image 
capture. 
2.2.3 General Primer design 
Primers were designed based on the TREU927 sequence using the in-built primer 
design feature of CLC Genomics Workbench 7.and synthesised as ‘unmodified 
DNA oligos’ by Eurofins Genomics (http://www.eurofins.com/). The lyophilised 
primer was reconstituted in ddH20 upon arrival to give a final primer 
concentration of 100 pM/μl and stored at -20 oC. Primers were used at a working 
concentration of 10 pM/μl in a 50 μl PCR reaction. 
2.2.4 Polymerase Chain Reaction (PCR) 
For diagnostic PCR analysis, NEB Taq DNA polymerase (NEB) was used as per 
manufacturer’s instructions. Typically, for a 50 µl reaction, the following 
reaction was set up: 1 µl 1 mM dNTP mix (Promega), 10 µl 10 x ThermoPol® 
Buffer, 2.5 µl Primer 1 (10 pmol stock), 2.5 µl Primer 2, 4 µl gDNA, 0.5 µl 
Phusion® and 29.5 µl ddH20. For PCR products required for plasmid construction, 
Phusion® High-Fidelity DNA polymerase (NEB) was used as per manufacturer’s 
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instructions. Phusion® harbours proof-reading activity for amplification of a high 
fidelity product. Typically, for a 50 µl PCR reaction for cloning, the following 
reaction was set up: 1 µl 1 mM dNTP mix (Promega), 5 µl 5 x HF Buffer, 2.5 µl 
Primer 1 (10 pmol stock), 2.5 µl Primer 2, 4 µl gDNA, 0.5 µl Phusion® and 29.5 µl 
ddH20. The following basic program was used for amplification (a variety of 
thermocycler machines were used throughout this project): 
 98 oC 3 mins (1 cycle ; Phusion®) or 95 oC 5 mins (1 cycle ; NEB Taq DNA 
polymerase) 
 98 oC 15 sec (1 cycle ; Phusion®) or 95 oC 30 sec (1 cycle ; NEB Taq DNA 
polymerase) 
 54-60 oC 30 sec (30 cycles; both polymerases; temperature was primer 
dependent) 
 72 oC 30 sec to 1 min (1 cycle; Phusion®; time was fragment size 
specific)or 68 oC (1 cycle; time was fragment size specific; NEB Taq DNA 
polymerase) 
 72 oC 10 mins (1 cycle Phusion®)or 68 oC 10 mins (1 cycle; NEB Taq DNA 
polymerase) 
Resultant fragments were analysed on an agarose gel (section 2.2.2). 
2.2.5 DNA fragment purification 
For purification of DNA fragments from agarose gels, the appropriate bands were 
excised using a sterile scalpel blade and purified using the QIAquick Gel 
purification kit (Qiagen) as per manufacturer’s instructions. Purified fragments 
were eluted in 15-22 µl ddH20 and stored at 4 
oC. 
2.2.6 Restriction Digest 
Generally, the required PCR fragment was digested with the appropriate 
restriction enzyme (detailed alongside the primers in the appropriate tables 
below). The vector backbone was also prepared in this manner. For PCR 
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fragment digests, 30 µl reactions were set up as follows: 22 µl gel extracted PCR 
fragment, 3 µl 10 x digest buffer (enzyme dependent), 1 µl enzyme 1, 1 µl 
enzyme 2 and 3 µl ddH20. For vector backbone digests, 30 µl reactions were set 
up as follows: 3 μl of the appropriate vector, 3 µl 10 x digest buffer (enzyme 
dependent), 1 µl enzyme 1, 1 µl enzyme 2 and 22 µl ddH20. Reactions were 
incubated at 37 oC for 1 hour. Digested products were resolved on an agarose gel 
(section 2.2.2) and extracted (section 2.2.5). Digested products were stored at 
4oC. 
2.2.7 Fragment Ligation 
Digested PCR products were ligated into the appropriate vector backbone using 
T4 DNA ligase (NEB) as per manufacturer’s instructions. 10 μl reactions were set 
up as follows: 1 μl 1 x ligation buffer, 0.5 μl T4 DNA ligase, 2 μl digested vector, 
6.5 μl digested PCR product (1:2 ratios; vector: PCR product). Reactions were 
left overnight at 16 oC. 
2.2.8 Transformation of E. coli 
Chemically competent DH5 α E. coli bacteria (in house) were thawed on ice (5 
mins) then 50 μl of bacteria were transformed with 3 μl ligation mix (1 μl for 
plasmid re-transformation). The cells incubated on ice for 30 mins then ‘heat-
shocked’ at 42 oC for 45 secs then immediately on ice for 5 mins. 1 ml of SOC 
media (5 g yeast extract, 20 g tryptone, 0.5 g NaCl, 10 ml 1M MgCl2, 10 ml 2M 
glucose, 10 ml 1M MgS04 /L) was added to the cells which were subsequently 
incubated (with agitation) at 37 oC for 1 hour after which the cells were pelleted 
by gentle centrifugation (10,000 rpm for 1 min) and the pellet re-suspended in 
~50 ul of the remaining supernatant. The cells spread onto Luria-Bertani (LB) 
broth agar plates ([5 g yeast extract, 10 g tryptone, 10 g NaCl /1L ddH20; pH 7.0] 
and 20 g agar) which were supplemented with 100 µg ml ampicillin (suitable for 
all plasmids generated for this study). Plates were incubated at 37 oC for ~18 
hours. 
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2.2.9 Construct retrieval and confirmation 
2.2.9.1 Plasmid DNA extraction from bacteria 
A 5 ml overnight culture of LB broth (supplemented with 100 µg ml amplicillin; 
Sigma-Aldridch) was inoculated with a colony containing the required plasmid 
DNA and left to grow for ~18-24 hrs. 800 µl of the liquid culture was stored in a 
50:50 ‘peptone-glycerol’ mix for long term storage at -80 oC. Bacteria were 
harvested by centrifugation at 2000x g for 10 mins and the plasmid DNA 
extracted using a QIAprep Spin Miniprep Kit (Qiagen) as per the enclosed 
instruction manual. A Nanodrop 1000 (Thermo Scientific) was used to determine 
the concentration of plasmid DNA after extraction (routinely 200-300 ng/µl). 
2.2.9.2 Plasmid confirmation by sequencing and restriction digest analysis 
The extracted plasmids were subject to restriction digest analysis (section 2.2.6) 
using appropriate restriction enzymes and resolved on an agarose gel (section 
2.2.2). If the correct fragment sizes were observed, the plasmid was then sent 
for sequencing (service provided by Eurofins Genomics) using the primers 
detailed in Table 2-1. The sequence results were examined in CLC Genomic 
Workbench 7 by comparing the plasmid map with the returned sequence. 
 
Table  2-1: Primers required for the sequencing of all construct in this thesis 
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2.3 Gateway® Cloning 
For Gateway© cloning, the following protocol was utilised (as designed and 
implemented by Jones et al. 2014).An RNAi target fragment and corresponding 
primers were identified using the TrypanoFAN RNAit software 
(http://trypanofan.bioc.cam.ac.uk/software/RNAit.html). A detailed protocol 
and the primers used for Gateway® cloning are shown in chapter 8 (section 
8.1.1). 
2.4 Construct Design 
2.4.1.1 Endogenous tagging 
The following primers were used for the endogenous tagging of genes of interest 
(Table 2-2). 
 
Table  2-2: Primers required for endogenous tagging 
Primer sequence reads 5’-3’. ORF (open reading frame) and UTR (untranslated region). 
2.4.1.1.1 C-terminal 
For C-terminal endogenous tagging, the vector pNATx12myc (as described in 
Alsford & Horn 2008; kind gift R.Devlin) was used. This construct permits C-
terminal tagging with 12 copies of the myc epitope (12myc) and contains a 
Blasticidin (BSD) resistance cassette for positive selection following 
transformation. A generic plasmid map is shown in Figure 2-1 alongside the 
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tagging strategy. Primers which specifically amplify a region of the 3’ region of 
the ORF excluding the stop were designed (Table 2-2). Cloning was performed as 
described in section 2.2. 
 
Figure  2-1: C-terminal tagging strategy 
(A) Generic plasmid vector map of the construct harbouring an insert (labelled C-terminal 
ORF region). Routinely, fragments were cloned in between HindIII and XbaI sites (unless 
otherwise indicated in Table 2-2). To ensure expression of RNA transcripts tubulin (for 
transplicing) and actin (for polyadenylation) intergenic regions (IR) were present flanking 
the blasticidin (BSD) gene (green) in the plasmid. (B) Endogenous tagging strategy. The 
linearised plasmid was transformed into cells and integrated into the genome by HR (black 
cross) using the region homologous (black line hashed green box) to the endogenous ORF 
(green) to permit fusion of the myc tag to the 3’ region of the endogenous locus. Not to 
scale. 
2.4.1.1.2 N-terminal tagging 
For N-terminal endogenous tagging, the vector pEnT6B (modified from Kelly et 
al. 2007; kind gift R.Devlin) was used. This construct permits N-terminal tagging 
with 12 copies of the myc epitope (12myc) and contains a Blasticidin (BSD) 
resistance cassette for positive selection following transformation. The BSD 
resistance cassette is flanked by aldolase and actin processing sequences (at the 
5’ and 3’ respectively). A generic plasmid map is shown in Figure 2-2, below 
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which is the tagging strategy employed. Primers were designed to amplify the 5’ 
region of the ORF (excluding the start codon) and the 3’ region of the 5’ UTR 
upstream of the ORF (primer sequences are detailed in Table 2-2) thus the 
fragment resides downstream of the 12 myc tag. Both fragments are required for 
HR directed integration following linearization of the construct using KpnI. The 
5’UTR fragment does not integrate endogenously into the locus due to trans-
splicing of the RNA upstream of the BSD resistance cassette. 
 
Figure  2-2: N-terminal tagging strategy 
(A) Generic plasmid vector map of the construct harbouring inserts (labelled geneORF and 
gene 5’UTR). The ORF fragment (lacking the ATG start codon) was inserted into the vector 
using SpeI and KpnI sites. The 5’UTR fragment up to but not including the start codon was 
cloned between BamHI and KpnI sites. To ensure expression of RNA transcripts, aldolase 
(ALD; for transplicing) and actin (ACT; for polyadenylation) UTRs were included in the 
plasmid. These transcripts also flanked the blasticidin gene (BSD; green) in the plasmid. (B) 
Endogenous tagging strategy. The linearised plasmid (using KpnI) was transformed into 
cells and integrated into the genome by HR (black cross) using the region homologous 
(black line hashed green or red boxes) to the endogenous ORF (green) and the endogenous 
5’UTR (red) to permit fusion of the myc tag to the 5’ region of the endogenous locus. Dark 
blue boxes = actin 5’ and 3’ flanking regions respectively. Not to scale. 
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2.4.1.2 KO constructs 
Two constructs were required to generate a KO mutant cell line by replacing 
each endogenous locus with an antibiotic selection marker for positive selection 
following transformation. Both vectors were modified from the pmtl23 vector 
(Devlin et al. 2016; kind gift R.Devlin). These constructs are termed ΔORF::NEO 
and ΔORF::BSD. A generic plasmid map is shown in Figure 2-3, below which is the 
KO strategy employed. Primers were designed to amplify the 3’ region of the 5’ 
UTR upstream and the 5’ region of the 3’ UTR downstream of the desired gene 
to facilitate HR directed insertion. In some cases, a proportion of the ORF was 
used. In addition to harbouring the antibiotic resistance cassette, the parental 
vector also contained two intergenic sequences derived from T. brucei Actin and 
T. brucei β/αTubulin (upstream and downstream of the BSD or NEO respectively) 
to facilitate trans-splicing and polyadenylation required for mRNA transcription 
(a generalised schematic of the knockout plasmids is shown in Figure 2-3). 
The primer sequences are detailed in Table 2-3. Cloning was performed as 
described in section. The 5’UTR fragment was inserted first followed by the 
3’UTR. The final resulting plasmids were confirmed by sequencing and analysis 
by restriction digest (section 2.2.6). Approximately 10 µg of the appropriate 
plasmid DNA was linearised by NotI and concentrated (as per 2.2.6 and 2.2.9). 
Transformation of the T. brucei cells was was performed as per section 2.7.4. 
 
Table  2-3: Primers required for KO construct generation 
Primer sequence reads 5’ to 3’. 




Figure  2-3: KO strategy 
(A) Generic plasmid vector map of the construct harbouring inserts (labelled 5’UTR/ORF 
and 3’UTR/ORF). The 5’UTR/ORF fragment was inserted in using HindII and Xbal restriction 
sites. The 3’UTR/ORF fragment was inserted in using ClaI and SacI restriction sites. To 
ensure expression of RNA transcripts, tubulin (for transplicing) and actin (for 
polyadenylation) intergenic regions were included in the plasmid. These transcripts flanked 
the blasticidin gene (BSD.NEO; orange) in the plasmid to ensure the correct processing of 
the selection antibiotic transcript. (B) KO strategy. The linearised plasmid (using NotI) was 
transformed into cells and integrated into the genome by HR (black cross) using the region 
homologous (black line pruple or red boxes) to the endogenous ORF (green) to facilitate 
deletion of the endogenous locus. Tub = tubulin, BSD = blasticidin, NEO = neomycin, 
‘target’ refers to the regions of homology used for HR. Not to scale. 
2.4.1.3 RxP constructs 
For gene re-expression, a modified version of the pGL2070 vector (kind gift, 
R.Devlin) was used. R.Devlin made the following modifications: the blasticidin 
resistance gene was replaced with a hygromycin resistance gene and the 6HA tag 
removed and replaced with a multiple cloning site composed of NheI and Xbal to 
facilitate insertion of the desired ORF for re-expression. The final construct is 
integrated into the T. brucei βα tubulin locus by replacing an endogenous α 
tubulin ORF. A generic RxP plasmid is shown in Figure 2-4. The primers used for 
cloning are shown in Table 2-4 below. 




Figure  2-4: Generic RxP construct 
The entire ORF of the required gene is cloned into the vector using the NheI and XbaI 
restriction sites. The whole ORF is flanked at the 5’UTR by an actin IR and at the 3’UTR by a 
βα tubulin IR region. The resistance cassette gene (HYG) is also flanked in this manner. The 
βα tubulin regions flanking the ORF permit HR mediated integration of the construct into the 
βα tubulin array from which the whole ORF can then be expressed. NheI and XbaI produce 
compatible ends when digested. RxP (re-expression), UTR (untranslated region), IR 
(intergenic region), HYG (hygromycin), ORF (open reading frame). 
 
Table  2-4: Primers required for RxP construct generation 
Primer sequence reads 5’ to 3’. 
2.5 RNA protocols 
2.5.1 RNA extraction 
For general use, total RNA was extracted from 3 x 107 BSF cells using the RNeasy 
Mini kit (Qiagen) using the manufacturer’s protocol entitled “Purification of 
Total RNA from Animal Cells using Spin Technology”. Off-column DNase I (RNase 
Free DNase set, Qiagen) was performed after RNA extraction (30 min 
incubation). The RNA was ‘cleaned-up’ after DNase digestion as per 
manufacturer’s protocol. The concentration of total RNA was assessed using a 
NanoDrop 1000TM Spectrophotometer (Thermo Scientific). 
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For RNA required for RNAseq analysis, 5 x107 cells were harvested and RNA 
extracted as described above. For accurate concentration analysis, total RNA 
samples were analysed using a Qubit® 3.0 Fluorometer (ThermoFisher) as per 
the manufacturer’s guidelines. Total RNA was stored at -80 oC until required. 
2.5.2 Complementary DNA (cDNA) Preparation 
1 µg of total RNA from each sample was converted to cDNA using the 
SuperScriptTM III Reverse Transcriptase Kit (Invitrogen) as per manufacturer’s 
instructions (“First Strand cDNA Synthesis” protocol). Random primers were used 
for amplification. In all cases, duplicate reactions were set up lacking the 
reverse transcriptase enzyme to control for gDNA contamination. cDNA was 
stored at -80 oC until required. 
2.5.3 qRT-PCR analysis 
2.5.3.1 qRT-PCR Primer design 
Primers (shown in Table 2-5 below) required for qRT-PCR were designed using 
the Primer Express® 3.0 software supplied (Applied Biosystems). 
 
Table  2-5: Primers used for qRT-PCR analysis 
Primer sequence reads 5’ to 3’. CT_OL primers were designed by C.Tiengwe. N/A = no 
number assigned to this primer. 




To assess RNA levels, the following experiment was set up using the required 
primers as detailed in Table 2-5. Each sample set was performed as a technical 
triplicate. The master mix was prepared as follows at4 oC (but not in direct 
contact with ice): 12.5 µl SYBR® Green PCR Master Mix (Applied Biosystems), 5 
µl RNase free ddH20 (Qiagen), 2.5 µl of each primer (300 nM stock) and 2.5 µl of 
the appropriate cDNA (section). The master mix was pipette into a MicroAmp® 
Optical 96-well reaction plate (Thermo Fisher). Actin (primers x) were used as 
an endogenous control and ddH20 (RNase free) was used as a negative control.  
The AB 7500 RT PCR system thermocycler conditions for all reactions were 50oC 
for 2 min (x 1), 95oC for 10 min (x 1), 95oC for 15 sec followed by 60oC for 1 min 
(x 40) then a dissociation step was added as follows, 95 oC for 15 secs, 60oC for 1 
min, 95oC for 15 secs and finally 60oC for 15 secs (x 1). The data was processed 
as detailed in the AB manual. 
2.6 RNAseq Analysis 
2.6.1 Sample preparation and sequencing conditions for RNAseq 
Total RNA samples were transported on dry ice to the Glasgow Polyomics facility 
(University of Glasgow). The sample quality was confirmed on an Agilent 2100 
Bioanalyzer (Agilent Technologies) prior to the preparation of a stranded RNAseq 
library using the TruSeq Stranded mRNA Sample Prep kit (Illumina). Samples 
were sequenced on an Illumina NextSeq 500 (Illumina). All quality control steps 
prior to and post RNAseq library preparation and the subsequent sequencing of 
the library was performed at Glasgow Polyomics by J.Gilbraith. 
2.6.2 Bioinformatics analysis workflow 
Analysis of the RNAseq reads was performed on a console server using the PUTTY 
client (http://www.putty.org/) and the data analysed and assembled in R-Studio 
(https://www.rstudio.com/). All script used in the analysis was kindly written by 
N.Dickens. Analysis of the data was overseen and contributed to by N.Dickens. 
Figure 2-5 below details the workflow for this analysis. 




Figure  2-5: RNAseq workflow schematic 
A complete explanation of the above schematic is provided in the accompanying text. 
The raw sequence reads were provided by Glasgow Polyomics as ‘.fasta’ files. 
The quality of the reads was subsequently assessed using FASTQC 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). The illumina 
sequence adaptors were trimmed off the sequence reads using the program 
TrimGalore (http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/; 
settings: Q 20 and L 20; rest of the settings were as default). The quality of the 
reads was then assessed in FASTQC as before. Prior to read alignment to the 
reference genome, the required reference genome was retrieved from TriTrypDB 
(V28). For this analysis the Lister 427 genome (Tb427 version 4; v4 and the 
Tb427_telo version 2; v2) were used. The ‘.gff’ file (which encompasses the 
gene annotations) was formatted to produce a ‘.gtf’ file using the program 
gffread (http://ccb.jhu.edu/software/stringtie/gff.shtml) using standard 
settings. The genome was indexed using HiSat2 ‘-build’ command (standard 
settings; https://ccb.jhu.edu/software/hisat2/index.shtml). The sample 
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sequence reads were then aligned to the indexed reference genome using HiSat2 
(standard settings), the alignment quality examined (in FASTQC and using the 
program IGV) and the subsequently generated files indexed in samtools 
(http://samtools.sourceforge.net/) to generate ‘.bam’ files. The quality of each 
replicate was assessed in samtools using the ‘Flagstat’ command. The abundance 
of each read was then calculated using the CuffQuant program (http://cole-
trapnell-lab.github.io/cufflinks/; a component of the CuffLinks program set; 
settings as standard with library type set to ‘fr-firstrand’). The process was 
repeated for each individual replicate within each time point (Figure 2-5A). The 
FPKM for each read and the subsequent comparison of the reads between each 
replicate (of which there are three) was performed using the CuffDiff program 
(standard settings). For obtaining genes differentially expressed across all 
replicates, the files were imported into and analysed in R studio using the 
CummerBund R package (http://compbio.mit.edu/cummeRbund/; Bioanalyzer). 
Here the quality of the data was also examined for both time points and for each 
replicate and various plots generated using the included graphical software 
(Figure 2-5B). 
2.7 Trypanosome strains and culture 
2.7.1 Strains 
T. brucei brucei Lister 427 cells (Rudenko et al. 1996; McCulloch et al. 1997) 
were used4. This strain is monomorphic remaining as LSBSF cells in vitro with a 
doubling time of ~8 hrs (Proudfoot & McCulloch 2006). For studies requiring RNAi 
cell lines, a genetically modified strain, termed the 2T1 strain5, was utilised 
(Alsford et al. 2005). The doubling time of this line is approximately 6 hours. 
                                         
4
 The Lister 427 strain is derived from a strain known as MITat (Molteno Institute T. brucei antigenic 
type 1.2 clone 221a). 
5
 This strain is ultimately derived from the Lister 427 strain. 
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2.7.2 Medium and Maintenance of BSF Trypanosome growth in 
vitro 
For BSF culturing (Lister 427 and genetically altered Lister 427 cell lines) in 
vitro, ‘complete’ HMI -9 medium was used (Hirumi & Hirumi 1989). ‘Incomplete’ 
HMI-9 was generated using the following recipe (for 4 Litres of culture media): 
 Pre-formulated HMI-9 powder (Gibco) 
 200 μM β-mercaptoethanol 
 3 % w/v NaHCO3 
‘Incomplete’ HMI-9 was filter sterilised with a 0.22 μM bottle top filter unit 
(Millipore) and stored until required at 4 oC. To ‘complete’ HMI-9 for culture 
use, 20 % v/v heat inactivated foetal calf serum (FCS) and 1% penicillin-
streptomycin solution (10 U.ml-1 stock solution) and the ‘completed’ HMI-9 
medium was filter sterilised again. Cell lines derived from 2T1 were cultured in 
HMI-11. To make ‘complete’ HMI-11, ‘incomplete’ HMI-9 was supplemented with 
10 % (v/v) heat inactivated tetracycline free FCS and 1% penicillin-streptomycin 
solution (stock as previously described) and again re-filtered as previously 
descried. ‘Complete’ HMI-9 and HMI-11 were stored at 37°C. Selective drugs 
were added to cultures containing genetically modified parasites. Table 2-6 
details the drugs and concentrations used in this study6. 
 
Table  2-6: Antibiotic concentrations for BSF cells 
Selective drugs purchased from InvivoGen. 
                                         
6
 All knockout cell lines were maintained in the absence of selective drugs as it was found that in 
the presence of NEO, cell lines carrying the resistance gene still appeared to be susceptible to 
the effects of the drug as seen by a slowing in growth in the presence of the drug (data not 
shown). 
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In vitro, BSF trypanosomes were cultured in vented flasks or tissue culture plates 
at 37°C in 5 % CO2 humidified incubator. To maintain cultures, cells were sub-
cultured below a maximum of 1.5 x 106 cells.ml-1. For experimental use, cells 
were seeded at either 1 x 104 or 1x105 cells.ml-1 and were collected between 6 
x105 and 1 x 106 cells.ml-1. Population density was measured using a Neubauer 
improved haemocytometer (Marienfeld-Superior, Germany) as follows; 10 μl of 
the culture was loaded onto the haemocytometer and parasites in a 1 mm square 
region were counted. To determine the number of parasites in the culture 
(cells.ml-1), the number obtain was multiplied by 104. 
2.7.3 Preparation and stabilates revival  
Cultures were grown to a maximum density of 1 x 106 cell.ml-1. In a 1.8 ml 
cryovial, 800 μl of the trypanosome culture and 200 μl of a 50:50 solution of 
glycerol and the appropriate media for maintaining the cell line were added. 
The stabilate tube was then labelled with an identification number in the 
following format (TRY_X; X referring to a sequential number), wrapped in cotton 
wool and stored at -80°C for ~24 hrs. For long term storage, the stabilate was 
transferred to a liquid N2 storage tank (information available in the Freezerworks 
database [http://www.freezerworks.com/] as requested by the WTCMP). For 
revival, cryovials were thawed at room temperature before the entire contents 
added to 9 mls of the appropriate BSF medium (lacking drugs). If required, 
selective drugs were added 24 hrs later and the cells were maintained as 
described in the section above. 
2.7.4 Calculating population doubling times 
Population doubling times were calculated as described in the equation below: 
𝐶𝑒𝑙𝑙 𝑑𝑜𝑢𝑏𝑙𝑖𝑛𝑔 𝑝𝑒𝑟 ℎ𝑜𝑢𝑟 (𝐾)  =
(𝑙𝑜𝑔10 𝑜𝑓 𝑡ℎ𝑒 𝑐𝑒𝑙𝑙 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑎𝑡 48ℎ𝑟𝑠)−(𝑙𝑜𝑔10 𝑜𝑓 𝑡ℎ𝑒 𝑐𝑒𝑙𝑙 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑎𝑡 0 ℎ𝑟)
(0.301 𝑥 48 ℎ𝑟𝑠)   
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2.7.5 Transformation of BSF trypanosomes 
For stable transfection of T. brucei BSF cells, 3 x 107 cells (~1 x 106 cells.ml-1) 
were collected by centrifugation (1620 x g for 10 mins; RT). The pellet was re-
suspended in remaining media, transferred to a 1.5 ml Eppendorf tube and re-
spun at 665 x g for 3 mins. Immediately after, the pellet was re-suspended in 
100 μl of Amaxa Human T Cell Nucleofactor Solution (Lonza) and transferred to 
an electroporation cuvette containing 5 μg of the linearized plasmid (as per 
section 2.2.6). For electroporation, the programme X-001 pre-programmed onto 
an Amaxa Nucleofactor II transfection machine (Lonza). Following 
electroporation, cells were immediately transferred into 30 mls of either HMI-9 
or HMI-11 medium (drug free). To achieve clonal populations, two further serial 
dilutions (1:10) were performed resulting in 3 tubes at 3 concentrations; 1 x 106 
cells.ml-1 (A), 1 x 105 cells.ml-1 (B) and finally 1 x 104 cells.ml-1 (C). Tubes were 
inverted to mix contents evenly. Each tube was plate out separately onto 24 
well plates (1 ml/well) and the cells were left to recover for 24 hrs before the 
addition of antibiotics for selection. The concentration required for each drug is 
detailed in Table 2-6. Transformants were selected after 7 days following 
selection antibiotic addition. Plates were examined by light microscopy and the 
number of well containing live trypanosomes were counted and scored. 
Routinely, between 6 and10 wells were selected for further analysis if fewer 
than 80 % of the wells contained live parasites. 
2.7.6 Re-cloning of polyclonal BSF trypanosome populations 
To re-clone out cells cultures recovered from transfection, cultures were set up 
at 0.5x101 cells.ml-1 (5 cells.ml-1) in an appropriate volume of appropriate media 
containing the required selection drugs. At this concentration, one cell should be 
present in each well. Cultures were mixed well and 200 µl of cells from these 
cultures were plate out onto a 96 well plate using a multichannel pipette. After 
~5-7 days, 6 positive wells were expanded for further analysis. 
2.7.7 Preparation and retrieval of BSF trypanosomes for 
molecular biology procedures 
For gDNA and RNA extraction and preparing cells for western blot analysis, an 
appropriate number of cells were harvested by centrifugation (405 x g for 10 
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mins). The supernatant was removed and the pellet either immediately frozen 
(at -20 oC for gDNA and – 80oC for RNA) or re-suspended in protein loading buffer 
(section 2.1.2.1.1). Samples were stored until required. 
2.8 BSF trypanosomes cell assays 
2.8.1 Growth analysis of RNAi cell lines 
For growth analysis, RNAi cell lines were set up at a concentration of 6.25 x 102 
cells.ml-1 in an appropriate volume of HMI-11 medium (tet free) containing the 
required selective antibiotics (Table 2-6). Cells were left to grow overnight to a 
density of 1 x 104 cells.ml-1. The following day, the culture was divided into two 
flasks. Tetracycline (at a concentration of 1 µg ml) was added to one flask (tet+) 
and 1.2 mls of each flask was pipette into a 24 well plate and left to grow at 
37oC (5 % CO2) for 72-96hr (unless otherwise stated). Growth was monitored by 
counting as described in section 2.7.2. 
For assessment of growth under genotoxic stress conditions, cells were set up as 
described however the culture was split into four flasks. Two were induced and 
to one of these a source of damage was added. Of the remaining two (both non-
induced) a source of damage was added to one. In the case of UV exposure, the 
cells were set up as described above. After 24 hrs induction, 1.2 ml of each flask 
was pipette into a separate 12 well dish; one for each UV exposure required 
harbouring both the induced and non-induced cells. The cells were UV irradiated 
using a Stratagene Stratalinker UV Crosslinker 2400. After exposure, each well 
was transferred onto a new 24 well plate and left to grow as above. 
The following damaging agent concentrations or exposures were used unless 
stated otherwise: MMS (0.0003 %), UV (1500 J/m3), HU (0.06 mM) and PHL (0.1 
µg.ml-1). Damaging agent stocks were prepared as follows: MMS in medium, HU 
in ddH20 and PHL in medium. 
2.8.2 Growth analysis of other cell lines 
For growth analysis of all other cell lines, cells were set up at a concentration of 
1.25 x 103 cells.ml-1 in an appropriate volume of HMI-9 medium containing the 
appropriate selective antibiotics (if required; Table 2-6). Cells were left to grow 
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overnight to a density of 1 x 104 cells.ml-1. The following day, 1.2 ml of the flask 
was pipette into a 24 well plate, left to grow and assessed as described in the 
section above. If a source of damage was required, the culture was split in two 
and to one flask, damage was added. As no induction was required, UV exposure 
was performed immediately. The concentrations of damage used are as detailed 
in the section above. 
2.8.3 Cell cycle analysis by DAPI 
For cell analysis of all cell lines, cells were set up at a concentration of either 
6.25 x 102 cells.ml-1 (RNAi cell lines) or 1.25 x 103 cells.ml-1 (WT cell lines) in an 
appropriate volume of HMI-9 medium containing the appropriate selective 
antibiotics (if required; Table 2-6). Cells were left to grow overnight to a density 
of 1 x 104 cells.ml-1. The culture was split in two (or four if MMS damage was 
required; MMS was used at a concentration of 0.0003 % [v/v] for this analysis) 
and 1 µg.ml-1 tetracycline added to one (or two) of the cultures. Cultures were 
left and the cells harvested by centrifugation (405 x g for 10 mins) at the 
required time points post induction. If RNAi induction was not required, the cells 
were set up at 1 x105 cells.ml-1 and left for 24 hours before harvesting as 
described. The pellet was then washed in 1x PBS by centrifugation. Cells were 
then prepared and stain with DAPI as described in section 2.11.1. 
2.8.4 Flow cytometry 
For flow cytometry, ~2.5 x106 cells were collected by centrifugation (405 xg for 
10 mins) and washed once in 1x PBS by centrifugation (405 xg for 3 mins). The 
supernatant was removed and the pellet re-suspended in 1ml 1 % FA in 1x PBS 
for 10 mins at room temperature. The cells were then washed in 1 ml 1x PBS at 
405 xg for 3 mins. The supernatant was removed and if required, the pellet was 
re-suspended and stored in 1 x PBS at 4 oC for up to 1 month. The PBS was 
removed and the pellet re-suspended in 2.5 M glycine. The cells were then 
incubated on ice for 15 mins. The cells were then pelleted (405 xg for 10 mins), 
the supernatant removed and the pellet re-suspended in 1x PBS 0.01 % Triton-x 
100. The samples were then incubated on ice for 30 mins. The cells were 
pelleted (405 x g for 10 mins) and washed in 1x PBS by centrifugation as 
described. The supernatant was removed, the pellet re-suspended in 1x PBS 
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containing 100 µg.ml-1 RNaseA (Qiagen) and the samples incubated at 37 oC for 
30 mins. To stain the DNA, propidium iodide (Sigma) to a final concentration of 
10 µg.ml-1 was added to each sample and the samples filtered through a fine 
mesh gauze prior to flow cytometry analysis. 
2.9 Antibody and Dye concentrations 
2.9.1 Immunofluorescence Analysis 
The following antisera concentrations were used for all indirect IF and other 
microscopy protocols (Table 2-7). 
 
Table  2-7: Antisera concentrations used for microscopy procedures 
2.9.2 Western blotting 
The following antisera concentrations were used for all western blotting 
protocols (Table 2-8). 




Table  2-8: Antibody concentrations used for western blot analysis 
Abbreviations: EF1-α (Elongation factor 1- alpha), H2A (Histone 2 A), VSG (Variant surface 
glycoprotein) and HRP (Horseradish peroxidase). 
2.10 Telo-FISH analysis 
Approximately 5x 106 cells were harvested and washed by centrifugation (3000 
rpm for 3 mins). The supernatant was removed and the pellet re-suspended in 
4%FA in 1x PBS. The cells were then spread onto a poly-L-lysine treated slide and 
left to settle and fix for 20 mins (room temperature). The cells were then 
pelleted and washed by centrifugation (x 3). The supernatant was removed and 
the cells permeabilised with 0.1 % TritonX-100 in 1x PBS for 5 mins then washed 
as before. The cells were then dehydrated with pre-chilled ethanol in ascending 
concentrations (70-90-100 %) for 5 mins each concentration. The slide was then 
left to dry. The telomere-specific probe (as purchased from DAKO.com 
[Telomere PNA FISH Kit/FITC]) was then heated at 85 oC (in water bath) in 
hybridisation solution (50 % Formamida, 10 % Dextran, 2x SSPE buffer [1x SSPE: 
0.18 M NaCl, 10 mM NaH2P04, 1 mM EDTA, pH 7.7: use buffer at pH 7.9]). Ten 
microliters of the probe were dilute in 60 µl hybridisation solution (per sample). 
After heating the probe, the solution was added to the slide, the slide sealed 
and heated at 95 oC for 5 mins in a water bath (the slide was placed in a falcon 
filled with ddH20). After, the slide was then placed at 37
oC for 16hrs. The slide 
was then washed for 30 mins with 2 x SSC (Thermo Fisher)/50 % Formamide at 
37oC, then for 60 mins at 50 oC in 0.2 x SSC and finally for 10 mins at room 
temperature in 4 x SSC. The supernatant was then removed and the slide stained 
with DAPI as per section 2.11.1. 
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2.11 Microscopy techniques 
2.11.1 DAPI staining 
All solutions required were filtered prior to use. Approximately 2x 106 cells were 
harvested by centrifugation (405x g for 10 mins). The pellet was washed in 1x 
PBS by centrifugation (405x g for 3 mins), the supernatant removed and the 
pellet re-suspended in ~50 µl 1xPBS. The cells were settled for 5 mins on a 12 
well glass (Menzel-Gläser) slide treated with Poly-L-Lysine (Sigma). A wax barrier 
was drawn around the wells using a PAP pen (Life Technologies). The 
supernatant was removed and 25 µl 4 % formaldehyde (FA) was added for 4 mins. 
The FA was removed and the cells washed 3 x in 50 µl 1x PBS for 5 mins. To each 
well, 5 µl of DAPI (SouthernBiotech) was added and incubated at room 
temperature for 4 mins. A coverslip was then added and sealed with nail varnish. 
Slides were stored in the dark at 4 oC. 
2.11.2 Generic IF analysis protocol 
For IF analysis, cells were collected, washed and fixed as described above 
(section 2.11.1). For staining requiring permeabilisation, cells were 
permeabilised with 25 µl 1x PBS/Triton X-100 (Thermo Scientific) for 10 mins. To 
neutralise free -aldehyde groups, 100 mM glycine was added for 20 mins. The 
wells were then washed three times in 1x PBS for 5 mins. The wells were 
blocked for 1hr with 25 µl blocking solution (1 % BSA [Sigma], 0.2 % Tween-20 in 
1 x PBS) in a wet chamber. After, 25 µl of the required primary antiserum 
diluted in blocking solution was then added and incubated for 1hr in wet 
chamber. The wells were then washed 2 x with 1 x PBS for 5 mins. Twenty-five 
microliters of the appropriate secondary antisera were added to each well and 
then incubated for 1hr in a wet chamber. After which the cells were washed 
three times with 1x PBS for 5 mins. The cells were then DAPI stained and the 
slides stored as described above. 
For staining requiring KMX-1 antiserum, cells were harvested and fixed as per 
section 2.11.1. The cells were then washed three times in 1x PBS for 5 mins 
after which they were stained as described above with the following 
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modification; cells were blocked and the antibody diluted in 1 % BSA only. DAPI 
was added as above ad slides stored as above. 
2.11.3 Mitotracker® staining 
For Mitotracker© staining, ~1 x106 cells were collected in a 1.5 ml Eppendorf 
tube, pelleted by centrifugation at 405 xg for 10 mins. The pellet was re-
suspended in 1 ml of the appropriate medium in an Eppendorf. Mitotracker ® to 
a final concentration of 100 mM was added to the culture and the cells left for 
15 mins at 37 oC in the dark. After, the cells were harvested by centrifugation 
(405 xg for 10 mins), the supernatant removed and the cells washed by 
centrifugation in 1 x PBS. The cells were then processed for indirect IF analysis 
(section 2.11.2). 
2.11.4 VSG staining protocol 
For VSG staining, 500 µl cells were added to 500 µl 2 % FA in an Eppendorf and 
fixed for 1 hr at 4 oC. The cells were centrifuged at 6000 rpm for 1 min, washed 
in 1 ml 1 x PBS (2x; cold) by centrifugation as before. The supernatant was 
removed and the pellet re-suspended in 1 % BSA (1 x PBS; cold) then centrifuged 
as before. Most of the supernatant was removed and the cells re-suspended in ~ 
10 µl of the remaining supernatant and spread onto wells of a poly-L-lysine 
treated slide. The slides were left overnight to dry after which the wells were 
re-hydrated in 1x PBS (50 µl/well for 5 mins [3 x]). The cells were then blocked 
in 50 % FCS:PBS (50 µl) for 15 mins. The primary antibody (Table 2-7) diluted in 3 
% FCS:PBS was then added to the cells (25 µl/well) and incubated in a wet 
chamber for 1 hr. After which the antibody was removed and the wells were 
washed in 1x PBS as before. The secondary antibody (Table 2-7) diluted in 3 % 
FCS:PBS and added to the cells (25 µl/well) then incubated for 1 hr in a wet 
chamber. The wells were washed as before and the slide DAPI stained and 
mounted as per section 2.11.1. 
2.11.5 Cytoskeletal extraction protocol 
For cytoskeletal extracts, ~2 x106 cells were harvested by centrifugation (1000 
xg for 10 mins) then washed in 1xPBS. The supernatant was removed and the 
cells re-suspended in 25 µl 0.25 % NP40 in 100 mM PIPES (Sigma) with 1 mM MCl2 
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(Sigma) pH 6.8. The cells were settled onto a poly-L-lysine treated slide for 10 
mins. The supernatant was removed and the cells washed 2 x 5 mins in 100 mM 
PIPES with 1 mM MCl2 (pH 6.8). After the final wash, the supernatant was 
removed and the cells fixed in 3% FA (in 1x PBS) for 10 mins followed by 
neutralisation using 100 mM glycine for 5 mins (2x). The glycine was then 
removed and the cells washed in 1x PBS. The slides were then placed in a wet 
chamber and incubated with 25 µl/well of α BILBO1 antiserum in 1x PBS for 1 hr. 
After which the wells were washed 2 x for 5 mins in 1x PBS. The wells were then 
incubated with 25 µl/well of secondary α mouse 594 antiserum (Table 2-7) for 1 
hr in a wet chamber. The slides were processed for DAPI staining and storage as 
per section 2.11.1. Protocol kindly provided by D.Robinson (University of 
Bordeaux). 
2.11.6 Tomato Lectin staining 
For endocytosis assays requiring tomato lectin (TL), ~ 1.5 x 106 cells were 
collected by centrifugation at 500 xg for 5mins at 4oC. The pellet was re-
suspended in 1ml cold 1x PBS. The cells were washed once by centrifugation as 
above and re-suspended in 100 µl 1 x PBS. A poly-L-lysine slide was prepared as 
per section 2.11.1 on which the cells were settled for 10mins at 4oC. The 
supernatant was removed and 25 ul (per well) of TL:FITC conjugate (Sigma; in 1 
x PBS) was added. TL:FITC was prepared by diluting 17 µl of the stock solution in 
200 µl 1 x PBS for usage). The slides were incubated in the dark at 4oC for 45 
mins. After, the supernatant was removed and the wells washed 2 x with 1 x PBS 
(cold; performed at 4 oC). The cells were fixed at 4 oC for 30 mins in 3 % FA in 1x 
PBS. After, the wells were neutralised with 100 mM glycine (Sigma) then stained 
with DAPI as per section 2.11.1. Protocol kindly provided by A.Albisetti 
(University of Bordeaux). 
2.11.7 EM protocols 
All EM sample preparation following fixation and EM imaging was performed by 
L.Lemgruber-Soares. 




Approximately 5 x106 cells were fixed in 2.5 % glutaraldehyde and 4 % PFA in 0.1 
M phosphate buffer. Samples were stored in fixation solution at 4 oC until 
required. The cells were then settled on a poly-L-lysine cover slip then washed 
with 0.1 M phosphate buffer. The cells were then dehydrated in ascending 
ethanol solutions (from 30 % to 100 %) and critical point dried. After, the 
coverslips were metal coated (gold/palladium) and visualised on a Jeol 6400 
scanning electron microscope (Jeol, Japan). 
2.11.7.2 TEM 
Approximately 5 x106 cells were fixed in 2.5 % glutaraldehyde and 4 % PFA in 0.1 
M sodium cacodylate buffer (pH 7.2) then post-fixed for 45 mins in 1 % osmium 
tetroxide and 2.5 % potassium ferrocyanide (pH7.3) in 0.1 M sodium cacodylate 
buffer in the dark. The cells were washed several times with 0.1 M cacodilate 
buffer and the samples stained (en bloc) with 2 % aqueous uranyl acetate the 
dehydrated in acetone solutions (30, 50, 70, 90 and 100 %). The samples were 
then embedded in Epon resin and sectioned (ultrathin sectioning). The samples 
were visualised on a Tecnai T20 transmission electron microscope (FEI, 
Netherlands). 
2.11.7.3 Cryo-immunolabelling 
Approximately 5x 106 cells were fixed in 4 % PFA and 0.2 % glutaraldehyde in 0.1 
M phosphate buffer (pH 7.2). The samples were then infiltrated in 2.1 M sucrose 
overnight then rapidly frozen (by immersion) in liquid nitrogen. Cryosections 
were prepared at -100 oC using an Ultracut cryo-ultramicrotome (Leica). 
Cryosections were then blocked in 3 % BSA in phosphate buffer then incubated 
with the primary antibody (Table 2-7; diluted in blocking buffer) for 1 hr. The 
cryosections were then washed several times in blocking buffer then incubated 
for 1 hr with 10 nM gold-labelled antiserum (Table 2-7) diluted in blocking 
buffer. 
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2.11.8 Image Analysis and preparation 
2.11.8.1 Image Capture 
For images captured on an Axioskop 2 (Zeiss) fluorescence microscope, the 63 x 
DC magnification lens was used to acquire images using the provided ZEN 
software package (Zeiss; http://www.zeiss.com/corporate/en_de/home.html). 
All EM images were captured as stated above. DeltaVision images were captured 
on an Olympus IX71 DeltaVision Core System (Applied Precision, GW) using a 
1.40/100 x lens were acquired using the SoftWoRx suite 2.0 software (Applied 
Precision, GE). Z-stacks were acquired of varying thickness (no more than 10 µm) 
and the images de-convolved (conservative ratio; 1024x1024 resolution) by the 
SoftWoRx software. High resolution images were captured on an Elyra PS.1 super 
resolution microscope (Zeiss) using the structure illuminated microscopy 
technique. For all images, the 1.4/63 x lens was used. Z-stacks were captured 
using ZEN software. 
Differential interference contrast (DC) imaging was used to visualise the whole 
cell (Axioskop2) and a UV filter was used to visualise DAPI. Alexa Fluor 488 
conjugate antibodies were visualised using a fluorescein isothiocyanate (FITC) 
filter (520 nm). Alexa Fluor 594 conjugate antibodies were visualised using a 
rhodamine filter (673 nm). 
2.11.8.2 Image preparation 
All images captured on an Elyra microscope as described above were processed 
initially by L.Lemgruber-Soares. The raw images were acquired using the 
provided ZEN Black Edition Imaging Software tool (Zeiss). The images were then 
aligned to the channel alignment files generated on the day of imaging using the 
aforementioned software. All images were processed in ImageJ/Fiji 
(http://fiji.sc/Fiji; Schindelin et al. 2012). For most images, excluding the ones 
used for quantification of the DAPI signal, both the contrast and brightness of 
the DAPI signal was enhanced to improve visualisation. For all images, the 
background was subtracted and suitable false colours were assigned to the 
fluorescence channels. All EM images were processed by L.Lemgruber-Soares. 
The 3D video shown in chapter 5 was generated using a combination of EM 
images (processed by L.Lemgruber-Soares) captured in chronological order. 
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FIB/TEM (focused ion beam/transmission electron microscopy; Medeiros et al. 
2012) was performed on a single Tb6560 -/- cell (see chapter 5). The alignment 
of the images was performed in Jmod (Kremer et al. 1996) and the 3D images 
were generated using the IMARIS software 
(http://www.bitplane.com/imaris/imaris; V.8.2). All images are at the same 
scale. Scale bar =100 nm. 
2.11.8.3 Quantification of signal intensity 
For fluorescence intensity measurements (of DAPI, γH2A and myc) a region of 
interest (ROI; 21x21 pixels) was drawn around individual cell nuclei. The 
background was then subtracted with a radius of 50 pixels. The mean pixel 
intensity and the fold change calculated in MS Excel (Microsoft®). 
2.12 Protein Protocols 
2.12.1 Western Blotting 
2.12.1.1 Sample preparation 
Routinely 1 x106-2.5 x106 cells were harvested by centrifugation 1620 xg for 10 
mins at room temperature. The supernatant was removed and the pellets re-
suspended in 10 μl 1x protein loading buffer (PLB: 250 μl 4x NuPAGE® LDS 
sample buffer [Invitrogen], 750 μl 1x PBS and 25 μl β-mercaptoethanol) and de-
natured at 100 oC for 10 mins. Samples were stored at -20 oC until required. For 
high molecular weight proteins, 20 μl 2x Roche cOmplete Mini protease inhibitor 
cocktail tablets was added to the loading buffer. 
2.12.1.2 Western blot protocol 
Whole cell lysates were separated by SDS-PAGE using the following NuPAGE® 
Novex® pre-cast gels: 4-12 % Bis-Tris, 10 % Bis-Tris, 12 % Bis-Tris and 3-8 % Tris-
acetate gels. The appropriate gel was selected based on protein size and is 
detailed in the accompanying figure legend where appropriate. The gels were 
run as per the manufacturer’s instructions. 
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2.12.1.3 Transfer protocol 
For blotting on to the PVDF membrane, the proteins from the SDS-PAGE gel were 
transferred using a Mini Trans-Blot® Cell (Bio-Rad). The PVDF (Amersham Bio) 
membrane was immersed completely in 100 % methanol for 1 min prior to 
submersion in transfer buffer (25 mM Tri pH 8.3, 192 mM Glycine and 20 % [v/v] 
methanol). The filter paper, foam and the gel(s) were also equilibrated in 
transfer buffer for 10 mins before assembling the components into the tank. The 
components were assembled as follows: black side of the plastic cassette-2x 
foam-1x filter paper-gel-PDVF membrane-1x filter paper-1x foam. The plastic 
cassette was closed and placed in the tank alongside an ice block. The transfer 
was performed by electrophoresis at 100 V for 2hrs (most proteins) or for high 
molecular weight proteins at 400 mM for one hour followed by 90 mM overnight 
(performed at 4oC). The membrane after transfer was incubated for 10 mins in 
the dark with Ponceau-S solution (Sigma) to confirm transfer of proteins has 
occurred. 
2.12.1.4 Antibody detection 
After transfer, membranes were washed once in 1x PBST (PBS, 0.01 % Tween-20 
[Sigma]) for 10 mins on a rocker then the membrane was incubated for 1hr in 
blocking solution (1x PBST, 5 % Milk powder [Marvel]) or if required, overnight at 
4 oC. After, the membrane was rinsed once for 10 mins in 1x PBST then placed in 
blocking buffer containing the required primary antisera (Table 2-8) for one 
hour. The membrane was then rinsed once in 1x PBST for 20 mins then placed in 
blocking solution containing the appropriate secondary antisera (Table 2-8) for 
one hour. After, the membrane was washed in 1x PBST for 30 mins then the 
SuperSignal West Pico Chemiluminescent Substrate (Thermo-Fisher) or ECL Prime 
Western Blotting Detection Reagent (Amersham) were pipette evenly onto the 
membrane which was subsequently incubated in the dark for 5 mins. The 
membrane was then exposed to an X-ray film (Kodak) or an ECL Hyperfilm 
(Amersham) for ~one second to overnight and the film developed using a Kodak 
M-25-M X-omat processor. For westerns requiring quantification, see section 
2.12.5 for image capture. 
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PVDF membranes were stripped if required using the Restore Western Blot 
Stripping Buffer (Thermo-Fisher). The membrane was placed in the buffer on a 
shaker for 8 mins then washed with 1x PBST re-staining. 
2.12.2 Immunoprecipitation 
Approximately 50 μl of Dyna-beads® (M-280 Sheep α-mouse IgG, Novex®) were 
collected in a 2 ml Eppendorf then washed in 1 ml blocking solution (0.5 % BSA in 
1x PBS, pH 7.2). The beads were collected using a DnyaMagTM-2 magnet (Life 
Technology) and the supernatant removed. The previous step was repeated 
twice then the beads finally re-suspended in 125 μl blocking solution and 5 μg α-
myc antiserum (α-mouse clone 4A6; Millipore). The beads were left rotating 
overnight at 4 oC. After 24 hrs and prior to addition of the cells, the bead were 
washed with blocking solution 3 x and re-suspended in 50 μl blocking solution. 
For IP analysis, between 2–3x 108 cells were harvested from a culture of BSF cells 
at a concentration of ~ 8x 105 cells ml by centrifugation at 1620x g for 10 mins. 
The cell pellet was washed in 1x PBS by centrifugation. Approximately 2.5 x 106 
cells were re-suspended in PLB (section 2.12.1) as a pre-lysis (PL) sample and 
stored at -20 oC. The pellet was re-suspended in 1 ml whole cell extract buffer 
(WCE: 50 mM Hepes pH 7.55, 100 mM NaCl, 1 mM EDTA pH 8.0, 1 mM EGTA pH 
8.0, 10 % glycerol, 1 % Triton X-100, 1 mM DTT and 2x complete protease and 
phosphatase inhibitor cocktail; Roche) and lysed at 4 oC for 30 mins. The lysate 
was centrifuged for 30 mins at 4 oC (15 000 xg). Approximately 30 μl of the 
supernatant was re-suspended in 10 μl 4x PLB and stored at -20 oC (Input 
sample). The remaining supernatant (~ 900 μl) was added to the 50 μl magnetic 
beads and incubated at 4 oC for 2hrs. After which the beads were collected using 
the magnet as previously described and 30 μl of the supernatant was collected, 
added to 10 μl 4 x PLB and stored at – 20 oC (Flowthrough sample). The 
remaining supernatant was discarded and the beads washed 3x using cold wash 
buffer (WB: 50 mM Hepes pH 7.55, 100 mM NaCl, 1 mM EDTA pH 8.0, 1 mM EGTA 
pH 8.0, 10 % glycerol, 0.1 % Triton X-100, and 2x complete protease and 
phosphatase inhibitor cocktail; Roche) by placing the Eppendorf on the magnet, 
removing the WB and gently re-suspending the beads by swirling the tube. After 
the final wash step, the samples were centrifuged at 1000 x g for 3 mins at 4 oC, 
placed again on the magnet and the supernatant discarded. The beads were re-
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suspended in 15 μl 1x PLB, incubated at 70 oC for 10 mins and then centrifuged 
(room temperature) at 15 000 xg for 1 min. The beads were then placed on the 
magnet and the supernatant collected and re-suspended in 15 μl 1 x PLB (Eluate 
sample). 1 μl was added to 9 μl 1 x PLB for running on an SDS-PAGE gel (as 
described in section 2.12.1.2. 
2.12.2.1 Specific amendments 
The WCE buffer for the IP performed in chapter 5, section 5.7, did not contain 
Phosphatase inhibitors. 
2.12.3 Nanoflow HPLC Electrospray Tandem Mass 
Spectrometry (nLC-ESIMS/MS) 
nLC-ESIMS/MS analysis was performed at Glasgow Polyomics (University of 
Glasgow). The following protocol was used (kindly provided by R.Burchmore). 
Peptides were solubilised in 2% acetonitrile and 0.1 % trifluoreacetic acid then 
fractionated on a nanoflow uHPLC system (Thermo RSLC nano). The results were 
analysed by electrospray ionisation (ESI) mass spectrometry using an Amazon 
Speed ion trap MS/MS (Bruker Daltonics). A Pepmap C18 reversed phase column 
(LC Packings) was used to separate the peptides which were subsequently 
desalted and concentrated (4 mins) then exposed to an acetonitrile gradient 
(0.1% [v/v] formic acid, 3.2-32% [v/v] 4-27 mins, 32- 80% [v/v] 27-36 mins, held 
at 80 % [v/v] 36 – 41 mins then re-equilibrated at 3.2 %). This was performed for 
a total of 45 mins. For the analytical column, a solvent flow rate of 0.3 µl.min-1 
was used, for the trap column solvent a flow rate of 25 µl.min-1 was used. 
Solvent flow used: 2% acetonitrile with 0.1 % (v/v) trifluoracetic acid. For 
analysis, the most abundant peptides were examined. The data was assessed 
using the Data Analysis software (Bruker) and the Matric Sceince Mascot Daemon 
server (v2.4.1). The annotated protein database from TriTrypDB was used to 
identify proteins from which the peptides were produced. 
2.12.4 Sypro Ruby® staining of SDS-PAGE gels 
For protein gel staining, the gel was fixed in a polypropylene container on a 
shaker in 100 ml 7 % (v/v) Acetic Acid and 50 % (v/v) Methanol diluted in MilliQ 
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water for 2 x 30 mins. The fixation solution was discarded and 60 ml SYPRO® 
Ruby gel stain (Molecular ProbesTM, Life Technologies) was added and left 
overnight on a shaker at room temperature. The following day, the gel was 
transferred to a new polypropylene container and washed on a shaker for 30 
mins in 7 % (v/v) Acetic Acid and 10% (v/v) Methanol diluted in MilliQ water. The 
wash solution discarded and the gel washed twice on a shaker for 5 mins with 
MilliQ water. The gel was imaged using a Typhoon 8600 Variable Mode Imager 
(Amersham Biosciences) using the 457 mm Blue I and Blue II emission filters. 
2.12.5 Quantification of relative protein levels 
Protein levels were quantified from western blots performed as detailed in 
section 2.12.1. The image was captured on a myECLTM Imager (ThermoFisher 
Scientific) system using the ‘Interactive Chemi-luminescence’ feature of the 
installed software. Using this software prevented over exposure of the signal. 
The digital file was input into ImageJ and the intensity of each band was 
measured by first highlighting the loading control lane (using 
>analyse>gels>select first lane). The lanes were then plotted, a line drawn 
across the base of each peak and the peaks labelled. This was repeated for the 
sample lanes. The intensity was calculated by normalising each sample to the 
loading control and calculating the relative fold change to the control sample. 
The data analysis was performed in MS Excel (Microsoft®). 
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3 Identifying novel DNA repair-associated protein 
kinases using RITseq screening 
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3.1 High throughput RNAi screening 
High-throughput (HT) screens combine a forward genetic approach, to examine a 
large number of genes at once, with assays for phenotypic effects of gene loss. 
Reverse genetic techniques, such as RNAi mediated gene knockdown (sometimes 
exploiting an inducible RNAi system; such as Zuber et al. 2011 RNAi is reviewed 
by Wilson & Doudna 2013, provide a rapid, potentially genome-wide approach to 
tackle such screens (Carpenter & Sabatini 2004; Echeverri & Perrimon 2006; 
Zuber et al. 2011). Furthermore, when combined with next generation DNA 
sequencing (NGS; a review of NGS technology is presented by Liu et al. 2012), 
the loss of each gene can be assessed relative to another, providing quantifiable 
categories of phenotype severity with greater sensitivity and coverage than, for 
example, a microarray-based screen (Sims et al. 2011; Bassik et al. 2009). 
3.1.1 HT-RNAi screening of T. brucei 
HT-screens provide a wealth of data and, since the discovery of RNAi in T. brucei 
in 1998 (Ngô et al. 1998), screens exploiting this system have been developed (as 
reviewed by (Kolev et al. 2011). Indeed, given that other members of the 
kinetoplastid family either lack a functional RNAi pathway (including L. major) 
or are less amenable to genetic manipulation (including other members of the 
Leishmania spp. and T. cruzi7), exploitation of RNAi could be argued to make T. 
brucei a model for biological discovery in the kinetoplastids. Considerable effort 
was undertaken to develop tetracycline inducible systems for RNAi (such as 
described in (Alsford et al. 2005)), but it was the generation of a genome-wide 
RNAi fragment library (Morris et al. 2002) that allowed HT screening in T. brucei 
to became feasible. 
The first genome wide RNAi screen performed in trypanosomes was conducted by 
generating a large ‘pooled’ culture of PCF parasites, in which each parasite 
carried a random RNAi target sequence (Morris et al. 2002). This approach was 
used to link the EP procyclin surface coat and the process of glycolysis in 
mediating changes to the surface coat. Later, harnessing of ISceI-mediated DNA 
                                         
7
 T. cruzi, T. congolense and L. braziliensis are all known to contain functional RNAi systems 
however the ability of these systems to be exploited to the same extent to that of T. brucei is 
difficult (Inoue et al. 2002; DaRocha et al. 2004; Lye et al. 2010). 
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cleavage to enormously increase transformation efficiency allowed two parallel 
screens to be performed, which additionally used NGS to map gene-specific 
effects; this has been termed RNAi targeted sequencing or ‘RITseq’. Alsford and 
colleagues (2011) successfully used RITseq to examine the genome as a whole, 
by looking for genes required for growth in vitro and for BSF to PCF 
differentiation (Alsford et al. 2011). In another early RITseq screen (Baker et al. 
2011), growth in the presence of Nifurtimox or Eflornithine revealed that RNAi 
loss of nitroreductase (NTR) and an amino acid transporter (AAT6) were required 
for resistance to Nifurtimox or Eflornithine respectively (in BSF cells). Other 
studies have since used such positive selection during RITseq to examine 
resistance to a wider range of anti-trypanosome compounds(Gould et al. 2013; 
Alsford et al. 2012), as well to examine quorum sensing during differentiation 
(Mony et al. 2014) and innate immune response-associated proteins (Alsford et 
al. 2014). 
3.1.1.1 T. brucei kinome screening 
Screening a whole genome using siRNA methods allows comprehensive coverage, 
but may be limited by depth of sequencing and the need for a clear phenotypic 
screen. Another approach has been to examine a smaller number of genes in a 
pathway, or to focus on a specific group of proteins. Numerous studies have 
been undertaken to examine the kinase complement (the ‘kinome’) of an 
organism using siRNA libraries (e.g. Morgan-Lappe et al. 2006; Arora et al. 2010; 
Prudêncio et al. 2008). One motivation is the availability of inhibitor libraries, as 
well as innate interest in these proteins stemming from their ability to co-
ordinate many cellular reactions. In 2014, Jones and colleagues examined the 
kinome of T. brucei BSF cells to identify protein kinases (PKs) involved in co-
ordinating the cell cycle. Briefly, a library of cell lines was generated, each 
conditionally expressing an RNAi target fragment recognising one of the 190 PKs 
of T. brucei. Each RNAi effect was examined individually, screening for loss of 
growth and then performing more detailed examination of cell cycle defects for 
a selection of PKs. When compared with the RITseq screen performed by Alsford 
et al (2011), ~70% of PKs produced similar growth impairments in the kinome 
screen. 
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3.1.2 Using RNAi screens to de-convolve DNA damage-
associated pathways 
HT- RNAi screening approaches to identify proteins involved in the DNA damage 
response (DDR) have provided unprecedented insight into both the DDR and the 
oncogenic transformation of cell lines (reviewed by Diehl et al. 2014). Using 
whole genome RNAi libraries, genes required for cell survival to methyl 
methanesulfonate (MMS; Chang et al. 2002; Ravi et al. 2009; Rooney et al. 
2009), hydroxyurea (HU; Kavanaugh et al. 2015), oxidative stress (Nagaoka-
Yasuda et al. 2007), replicative stress (Kotov et al. 2014; Kavanaugh et al. 2015) 
and other therapeutic agents, such as Gemcitabine (Smith et al. 2014), have 
been identified and characterised. However, the predominant methodology has 
not included NGS to identify the target genes, with most approaches examining 
growth or factor localisation in individual RNAi clones. To date, few examples 
are available of kinome-focused RNAi screens to identify kinase which act in DDR 
pathways. Arora and colleagues (Arora et al. 2010) used an siRNA library 
transformed into ovarian cancer cells and tested for PKs involved in modulating 
the response to cisplatin using a CellTitre-Glo luminescence assay; 55 PKs were 
identified, amongst which were MAPKs, PLKs, CHK1 and ATR. A second kinome 
screen identified PKs involved in phosphorylation of the histone variant H2AX 
following exposure to radiation; 46 PKs with indirect or direct roles were 
recovered (Benzina et al. 2015). 
In T. brucei no HT-RNAi screen has been performed to identify any gene, 
including PKs, with potential roles during the DDR. The closest any study has 
come to date has involved examining the transcriptional and proteomic changes 
in response to gamma radiation in T. cruzi, which have suggested protein 
phosphorylation is a central component of irradiation tolerance (Vieira et al. 
2014; Grynberg et al. 2012). 
3.2 Research Aims 
The aim of this chapter was to biologically validate two independently 
performed RITseq screens, one genome-wide and one kinome-wide, which 
sought to identify PKs and wider factors with roles in the response of BSF T. 
brucei to MMS exposure. Considering the central role of PKs in cell cycle control, 
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including after DNA damage, the work described here is focused on PKs and only 
a brief explanation of the (unpublished) screens is provided. For both screens, 
the Sn2 alkylating agent MMS was chosen as a source of genotoxic stress because 
of its wide-ranging effects. MMS is a chemical with both electrophilic and 
methylating properties and can interact with nucleophilic DNA bases 
(particularly guanine and adenine) to produce bulky methylated base adducts. 
These adducts can result in base mismatches, replication fork stalling, strand 
breaks and, ultimately, affect protein synthesis. Resolution of DNA lesions can 
occur through a variety of pathways such as direct adduct reversal, BER, NER, 
MMR, TLS and HR (reviewed by (Wyatt & Pittman 2006). Furthermore, genes 
required for cellular survival following MMS stress have been examined by HT 
screens in E. coli (Rooney et al. 2009), yeast (Chang et al. 2002) and Drosphila 
melanogaster (Ravi et al. 2009), thus allowing comparison between organisms. 
3.3 Results 
3.3.1 Screen workflow 
3.3.1.1 Genome wide RITseq screen 
The genome wide RITseq screen was performed as a single experiment (with 
technical duplicates) by S. Alsford (LSHTM), as outlined in Figure 3-1. Sequencing 
of RNAi targets PCR-amplified from RNAi induced and MMS treated or untreated 
cells was performed at Glasgow Polyomics using IonTorrent semiconductor 
technology (ThermoFisher) and the sequence analysed by J. Wilkes (University of 
Glasgow). Biological validation was performed by the author, unless stated 
otherwise. 




Figure  3-1: Schematic illustration of the genome wide MMS RITseq screen in BSF cells 
The constructs and cell lines were generated as described (Glover et al. 2015). RNAi was 
induced (with tetracycline, Tet) in the transformed parasites for 24hrs and gDNA was 
prepared. The culture were then each split in four and MMS (0.0003% v/v) was added to two 
induced cultures, but omitted from the two others All cells were grown for four days (5 days 
total RNAi induction), gDNA was prepared, a limited-cycle PCR performed (by G. Hamilton), 
the products fragmented, a library prepared and sequenced using IonTorrent semi-
conductor technology. Sequence reads were mapped to the TREU927 reference genome 
and genes with greater loss of reads following RNAi induction (Tet+) in the presence of 
MMS (Tet+MMS+) than in RNAi uninduced, untreated cells were identified. 
3.3.1.2 Kinome wide RITseq screen 
The kinome wide RITseq screen was performed by T.Donatelli-Serafim (now NIH, 
Washington) using a pooled culture (generated by F.Fernandes-Cortez) 
containing all BSF cell lines that individually target all T. brucei PKs (Jones et al. 
2014), and thus accounting for the kinome. In this RITseq approach (Figure 3-2), 
cells were grown in two concentrations of MMS, with (Tet+) and without (Tet-) 
RNAi, and samples were prepared every 24 hr for 4 days. After PCR amplification 
of the RNAi inserts, the products were sequenced by Eurofins Genomics 
(Germany) on an Illumina NextSeq 500 platform (Illumina) and relative 
abundance determined by mapping to the genome. 




Figure  3-2: Schematic illustration of the kinome wide MMS RITseq screen in BSF cells 
181 individual RNAi cell lines representing 190 PKs were pooled into one culture, passaged 
once and split in two; tetracycline was added to one culture to induce RNAi knockdown. 
After 24 hrs, gDNA was collected and each culture split in three; 0.0002 % MMS (v/v) or 
0.0003 % MMS (v/v) was added to two cultures, and one was grown without damage. gDNA 
was harvested at 24, 48, 72 and 96 hrs subsequently and the RNAi fragments amplified by 
limited cycle PCR using an RNAi target cassette specific primer (sequence 5’- 
TAATGCCAACTTTGTACAAA-3’; F.Fernandes-Cortez, T.Donatelli Serafim and N.Jones). An 
Illumina adapted library was prepared from each PCR and sequenced using Illumina 
technology. Sequence reads were mapped to a reference genome comprising the PK genes 
and genes with a loss of reads following RNAi induction (Tet+) in the presence of MMS 
(Tet+MMS+) were identified relative to the undamaged controls. 
3.3.2 Bioinformatics analysis 
Processing of the raw sequence read data and the subsequent mapping analyses 
of both RITseq screens was performed by J. Wilkes, R. McCulloch and T. 
Donatelli-Serafim. Normalised sequence reads, including the read mapping ratios 
and gene identifications are available in the accompanying CD; these data are 
being archived on TriTrypDB.org. As the aim of this thesis was to examine PKs 
with potential DNA repair associated roles, the discussion of the bioinformatics 
analysis presented here is limited to this. A wider range of pathways identified 
using the genome-wide RITseq approach is being prepared for publication. 
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3.3.2.1 Bioinformatics analysis of the genome wide RITseq screen 
In contrast to the RNAi target amplification by semi-specific PCR described by 
Alsford et al (2011), the approach here performed limited cycle PCR 
amplification using primers common to all inserts described by Baker et al 
(2011). In addition, sequence reads were mapped to a ‘minimal’ genome 
artificially generated from the T. brucei TREU 927 reference genome. Included 
within this ‘minimal genome’ was 9849 protein and RNA coding sequences (CDS) 
and the surrounding CDS regions including a random 30 bp sequence between 
each transcript to minimise inaccurate mapping to the ‘minimal’ genome. Non-
conding sequences were excluded from the analysis. Despite these differences, 
when read depth for every gene was compared in the fifth and six day RNAi 
induced samples from this RITseq screen and that of Alsford et al. (2012) 
respectively, the profiles were comparable (Figure 3-3). 
 
Figure  3-3: Comparison of the total sequence reads across two independent RITseq screens 
The total number of sequence reads which mapped to the minimal T. brucei genome were 
compared at day six (Alsford et al. 2012) and day five (this study) post-RNAi induction. The 
coefficient of determination is shown. The axes are shown as a log scale on which the total 
number of sequence reads for both screens are plotted.The plot was generated by J.Wilkes. 
To identify genes important for BSF T. brucei survival in the presence of MMS 
following RNAi the reads for each gene, normalised relative to total reads and 
the CDS length and averaged from the repeats, was determined. The resulting 
value was then compared in the MMS-treated and untreated data and expressed 
as an MMS+/MMS- ratio (all values are shown in the accompanying CD; see folder 
labelled Chapter3RITseqtables and the subsequently enclosed tables labelled 
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TableS1-S4; the raw genome wide RITseq reads are encompassed in the folder 
within entitled RawRITseqreads). MMS+/MMS- ratios were calculated as follows; 
the sequence reads which mapped to all annotated genes were obtained. These 
reads were then normalised both relative to the length of the coding sequence 
of each gene and to the total number of reads in the library. The resulting 
values were averaged for both the duplicate induced (Tet+), MMS- samples and 
the induced (Tet+) MMS+ samples. The MMS+/MMS- ratios were then calculated 
by determining the ratio of reads from the Tet+MMS+ samples relative to the 
Tet+MMS- samples. In principle, all genes of <1 MMS+/MMS- are genes whose 
RNAi results in impaired growth in the presence of damage, and thus are 
potential ‘hits’ for further validation. All MMS+/MMS- ratios were plotted on a 
scatter plot relative to the chromosomal location of the gene within the T. 
brucei genome (Figure 3-4). Applying an MMS+/MMS- cutoff of 0.5 revealed 274 
genes (including 44 VSGs, which are likely artefacts), amongst which nine PKs 
were recovered (Table 3-1 and Figure 3-4; chapter 8, section 8.3, Figure 8-1 
A&B). When the predicted GO terms were analysed for these 230 genes an 
enrichment of protein kinase activity was observed (~2-fold increase; see 
chapter 8, section 8.2, Figure 8-1 C for GOterms), potentially highlighting the 
importance of kinases following exposure to MMS stress. The 8 PKs represent ~ 4 
% of the kinome, but other PKs with known roles in the DDR in other organisms 
were not recovered. Notably, neither the predicted T. brucei homologs of ATR 
(TbATR; Tb927.11.14680; ratio: 1.875) and ATM (TbATM; Tb927.2.2260; ratio: 
1.17), the commonly cited ‘master-regulators’ of the DDR were identified as 
candidates, and nor was TbWEE1 (T. brucei homolog: Tb927.4.3420; ratio: 1.64), 
which is phosphorylated in response to genotoxic stress in an ATR-dependent 
manner (WEE1 activity and function is reviewed by Matheson et al. 2016). 
Four different kinase families were represented in the eight PKs with 
MMS+/MMS- ratios <0.5: CAMK (Tb927.2.1820 [TbCAMK/KL] not shown in Figure 
3.4; see legend] and Tb927.2.5230), CMGC (Tb927.10.7780 [TbKFR1], 
Tb927.6.4220 and Tb927.8.5390), Other (Tb927.3.3920 [TbAUK2] and 
Tb927.9.6560) and STE (Tb927.8.5950). Identification of the eight PKs provided a 
means to validate the MMS RITseq screen. As only one gene in this cohort 
(TbAUK2 [Tb927.3.3920]; chapter 4) had been implicated in genome 
maintenance previously, two other repair candidate PKs, the tousled kinases 
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[TbTLK1 and 2], were also examined further, despite both not having a ratio of 
<0.5 (Tb927.8.7220 [TbTLK2], 0.68; Tb927.4.5180 [TbTLK1], 1.15). These PKs 
were chosen due to their important roles in metazoans and yeasts in DNA repair 
and genome maintenance (Benedetti 2012). In addition, TLKs are known 
interaction partners of ATR, ATM, RAD9 (a component of the 9-1-1 complex) and 
aurora kinases (as reviewed by Benedetti 2012). TbTLK1 in T. brucei is required 
for the maintenance of genome integrity in BSF cells (Li et al. 2007), but 
evidence of a role in the T. brucei DDR has been yet to be examined. The roles 
of TbATR and TbATM are examined in chapter 6. 
 
Table  3-1: Eight PK candidates identified by the genome wide MMS RITseq screen 
The table details the 8 PKs identified along with their Gene ID (TriTrypDB v28), the 
corresponding annotation (if present) and the averaged MMS+/MMS- ratio. 
 
Figure  3-4: The average MMS+/MMS- ratios of T. brucei genes mapped relative to their 
position in the genome. 
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The MMS+/MMS- ratio of each gene (grey dot) was plotted on a scatter plot relative to the 
genomic location of the gene across the 11 megabase chromosomes (lower bar) of T. 
brucei. A ratio of 1 = no change (solid black line), >0.5 suggests increased resistance to 
MMS (higher dashed line), <0.5 suggests increased sensitivity to MMS (lower dashed line). 
All protein kinases (Pks) are highlighted in red and the candidate PKs examined further are 
indicated by a black arrow. CAMK (Tb927.2.1820) could not be mapped due an MMS+/MMS – 
ratio of <0.1. 
3.3.2.2 Bioinformatics analysis of the kinome wide RITseq screen 
The bioinformatics analysis of the kinome-focused RITseq screen was performed 
using a similar pipeline to the genome-wide RITseq, but reads were mapped only 
to the PK genes. This approach permitted quantitative monitoring of loss of 
individual PKs with time and in the presence of both a low (0.0002 %) and high 
(0.0003 %) concentration of MMS. In addition, the loss of PKs in the presence of 
MMS could be compared against loss without damage, allowing identification of 
essential PKs whose loss is accelerated by MMS. In this approach, reads were 
normalised between the barcoded groups and the 10 lowest read counts were 
excluded from each repeat, reducing variability. All read depth data and 
MMS+/MMS- ratios for each PK are displayed in the accompanying CD (see folder 
labelled Chapter3RITseqtables and the subsequently enclosed table TableS4). 
Approximately 98 % of the kinome was identified across the experimental 
replicates; the remaining 2 % could not be mapped in any sample, suggesting 
they were lost during growth. 
In total, over the course of the experiment (from 48 to 120 hrs growth), 23 PKs 
were revealed as being important for survival in the presence of MMS. Eight of 
these genes had MMS+/MMS- ratios which gradually reduced at both MMS 
concentrations but showed no change in abundance in the RNAi-induced, 
undamaged samples relative to the uninduced, undamaged cells. These PKs were 
considered non-essential. 15 PK genes showed loss of reads in the RNAi-induced, 
undamaged samples relative to the uninduced, undamaged cells, indicating they 
are important for growth (essential), but showed increased loss of reads in the 
presence of MMS damage after RNAi. These data are summarised in Table 3-2 
below. 




Figure  3-5: A heatmap summary of the MMS+/MMS- ratios for each putative MMS damage 
response kinase at each time point post induction from two different concentrations of MMS 
The heatmap shows data from two independent experiments for each concentration of MMS 
at each timepoint. To illustrate which genes are important for cell survival in the absence of 
MMS, the reads from the Tet+ samples were set relative to the corresponding Tet- samples 
for each timepoint. The colours range from black (an MMS+/MMS- ratio of 0) to red (an 
MMS+/MMS- ratio of > 2). The kinases represented by the heatmap are arranged into three 
categories; no loss of fitness, loss of fitness and weak evidence for a role during the MMS 
damage response. The kinases are referred to on the left of the heatmap by their gene ID, 
the kinase class to which they belong and their name (if annotated in the reference 
genome). Genes highlighted in bold red were absent from the genome wide RITseq screen 
but were validated (see section 3.3.4.2). Those highlighted in red were common to both the 
genome wide screen and the kinome wide screen and those highlighted in pink are thought 
to act in other eukaryotes during the repair of MMS induced damage. Heatmap generated by 
J.Wilkes and assembled by R.McCulloch for use in this thesis. 
Three of these PKs (Tb927.2.1820 [TbCAMK/KL], Tb927.3.3920 [TbAUK2] and 
Tb927.8.5950) were common to both screens. In addition, both TbATR and 
TbATM had MMS+/MMS- ratios < 0.5 (0.382 and 0.430 respectively) at 120 hrs 
post induction in the kinome RITseq screen. Furthermore, TbTLK1/2 (as a double 
knockdown RNAi lined was used) appeared amongst the essential candidates, 
with a particularly severe loss of reads after RNAi. Finally, TbTOR4 was 
highlighted, consistent with a role for TOR signalling in response to MMS 
treatment in other eukaryotes (Ravi et al. 2009). 
3.3.3 Biological validation of candidates 
Validation and characterisation of the PK candidates identified from both RITseq 
screens was achieved by examining: 1) growth in the presence or absence of 
genotoxic stress after RNAi; 2) cell cycle progression after RNAi and damage; 3) 
expression of γH2A (a marker of genotoxic stress) and 4) localisation of each 
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protein. The sections below provide these data for nine PK genes that showed 
evidence of a role in damage repair. However, in total, nine genome-wide 
candidates and seven kinome-wide candidates were examined for growth, and 
RNAi against seven of these genes (four from the whole-genome screen and 
three from the kinome screen) showed no preliminary evidence for increased 
sensitivity to MMS (data provided in chapter 8, section 8.2, Table 8-2 and Figure 
8-3); as these were considered to be false positives, no further phenotypes were 
examined. 
3.3.3.1 RNAi cell lines used for validation 
RNAi lines (generated as described in chapter 2, section 2.3 and chapter 8, 
section 8.1.1) were kindly provided by E.Brown (University of York), N.Jones 
(University of York) and A.Hamilton (University of Glasgow). The table (Table 3-
3) below describes the RNAi cell lines examined in depth. The RNAi cell line 
termed TbTLK1/2 targets both Tb927.8.7220 (TbTLK2) and Tb927.4.5180 
(TbTLK1). The parental RNAi cell line (2T1; kind gift S.Alsford) was examined to 
ensure no phenotypes could be attributed simply to addition of tetracycline 
(data shown in chapter 8, section 8.2, Figure 8-2). 
 
Table  3-2: RNAi cell lines examined 
Details of the cell lines used for all PK candidates. The STL number refers to the stabilate 
number, according to the Mottram laboratory system for labelling. The plasmid number 
(pTL) numbered as according to the Mottram plasmid repository. Puromycin sensitivity was 
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examined prior to freezing as recommended by S.Alsford. Orange (genome wide 
candidates), blue (kinome wide candidates). 
3.3.3.2 Generation of C-terminal endogenously tagged RNAi lines 
To assess the efficiency of gene silencing in the RNAi cell lines and to explore 
the sub cellular localisation of each PK, endogenous tagging in the corresponding 
RNAi cell line was undertaken for each candidate. Tagging with 12 copies of the 
myc epitope was chosen due to the wide availability of commercial antibodies 
for detection. C-terminal tagging constructs were generated as per section 
2.4.1.1.1; only Tb927.11.1180 was N-terminally tagged, using the strategy 
detailed in section 2.4.1.1.2. For the TbTLK1/2 RNAi cell line, no attempt was 
made to tag either gene; localisation of both has been described nuclear (Li et 
al. 2007) and the growth effects of RNAi are documented. 
3.3.3.3 Construct generation and endogenously tagged RNAi cell line 
generation 
The constructs were named as follows: Tb927.9.656012myc, Tb927.10.778012myc, 
Tb927.2.182012myc, Tb927.3.392012myc, Tb927.10.514012myc, Tb927.7.96012myc, 
Tb927.6.311012myc and 12mycTb927.11.1180. Primers used for cloning are detailed 
(section 2.4.1.1) and all, with the exception of one (Tb927.9.656012myc), were 
confirmed by Sanger sequencing (section 2.2.9.2). One non-synonymous 
mutation (T1720S) was observed in the Tb927.9.656012myc construct, but multiple 
PCR amplifications yielded the same mutation, suggesting the amino acid may be 
miss-annotated in the reference genome sequence or the parasite strain used 
here harbours this mutation. As serine and threonine are similar with regards to 
the structure of their sidechain extensions and, furthermore, can both be 
phosphorylated on their hydroxyl group the function of the endogenous protein is 
not expected to be compromised by integration of the tagging construct. 
Each endogenous tagging construct was transformed into the appropriate RNAi 
cell line and transformants selected as described in section 2.7.4. Routinely, six 
to ten clones were expanded for further analysis and confirmed as described 
below. 
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3.3.3.4 Confirmation of endogenously tagged RNAi cell lines by western blot 
analysis 
Though multiple transformants were readily recovered from each transfection, 
surprisingly few showed expression of the 12myc tag in some cases by western 
blot analysis (performed as per section 2.12.1; Figure 3-5), for reasons unknown. 
Nonetheless, in all cases clones expressing proteins of the approximate size for 
each tagged PK were recovered, with one exception: endogenously tagged 
Tb927.11.1180 (TbCRK6) resolved at a lower than expected size (~25 kDa rather 
than the predicted ~51.1 kDa). This is discussed further in section 3.4.3. One 
myc-tagged clone was taken forward in each case. 
 
Figure  3-6: Confirmation of endogenously tagged RNAi candidate cell lines 
Western blot analysis of whole cell extracts from myc-tagging transformants, as indicted by 
gene IDs. The ladder shows the size in kDa. Wild type (WT427) cells were used as a negative 
control. Protein was resolved on a 10% BT gel (in the case of Tb927.11.1180 [TbCRK6], a 12 
% gel was used). The following sizes refer to the predicted molecular weight (MW) of the 
protein (from TriTrypDB) + the MW of the 12myc tag (14.4 kDa): Tb927.3.3920 TbAUK2; 56.5 
kDa), Tb927.9.6560 (94.6 kDa), Tb927.10.7780 (TbKFR1; 53.8 kDa), Tb927.2.1820 
(TbCAMK’KL; 84.9 kDa), Tb927.6.3110 (TbCRK11; 63.3 kDa), Tb927.7.960 (107.6 kDa), 
Tb927.10.5140 (TbMPK2; 64.1 kDa) and Tb927.11.1180 (TbCRK6; 51.1 kDa). Ladder used: 
Novex® Sharp Pre-Stained Protein Standard (ThermoFisher) or Spectra
TM
 multicolor broad 
range protein ladder (Thermofisher). 
3.3.4 Growth analysis of RITseq screen candidates 
Growth of each PK candidate was monitored by examining cellular proliferation 
in the presence or absence of 0.0003 % MMS, with or without RNAi induction. 
This assay was performed as described in section 2.8.1. 
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3.3.4.1 The genome wide candidates 
Of the five RNAi cell lines examined, double knockdown of TbTLK1/2 was the 
only RNAi that showed a severe impairment of cell proliferation in the absence 
of MMS from 24 hrs post induction (Figure 3-6). At 96 hrs post induction, very 
few cells remained in culture and all harboured aberrant morphology (below). 
This growth reduction is in keeping with the phenotypes observed by (Li et al. 
2007). The other four genes did not appear to be required for proliferation as 
proliferation continued following RNAi knockdown. 
 
Figure  3-7: In vitro growth analysis of the genome wide candidates 
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Growth analysis of each genome wide PK candidate with (Tet+) or without (Tet-) RNAi 
induction and with (MMS+) or without (MMS-) exposure to MMS (0.0003%). Error bars 
represent ± SEM, n=3. For statistical analysis, tet - cells in the presence of MMS (dashed 
black line) were compared with the tet + cells in the presence of MMS (dashed orange line) 
at each time point. (*) = p<0.05 as determined by a Mann Whitney U test. The western blots 
show whole cell extracts after 24 or 48 hrs growth with (+) or without (-) RNA induction, 
probed with α myc or α EF1α (as a loading control) antiserum. White space indicates images 
aligned from the same or different images. 
Two cell lines Tb927.10.7780 [TbKFR1] and Tb927.9.6560; Figure 3-6) showed a 
slight impediment in growth after RNAi (between 48-96 hrs post induction. 
Indeed, this reduced proliferation for both cell lines is consistent with data 
reported by Jones and colleagues (Jones et al. 2014). From 48 hr post induction, 
loss of TbKFR1 and Tb927.9.6560 was associated with the appearance of 
morphologically aberrant cells, which were predominantly ‘rounded’ in 
appearance in the latter case. RNAi against the two remaining PKs 
(Tb927.2.1820, [TbCAMK/KL]; and Tb927.3.3920, TbAUK2) had no clear growth 
perturbation. Consistent with this, RNAi knockdown of TbAUK2 has been 
previously investigated in both BSF and PCF cells and no growth effect has been 
reported (Tu et al. 2006). Western blots showed that RNAi induced loss of the 
cognate myc-tagged protein in all cases. 
Following RNAi induction in the presence of MMS, the growth of each cell line 
was significantly reduced relative to the induced population in the absence of 
MMS and was reduced relative the uninduced, MMS-treated cells, suggesting each 
gene is required for survival under MMS stress conditions. These data, combined 
with the RITseq data (an MMS+/MMS- ratio of <0.5), provide the first 
demonstration of any T. brucei kinase with a role in BSF trypanosomes’ response 
to MMS exposure. 
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3.3.4.2 The kinome RITseq candidates 
 
Figure  3-8: In vitro growth of the kinome wide PK candidates 
Growth analysis of each kinome wide candidate following RNAi knockdown and following 
exposure to MMS (0.0003%). The error bars represent ± SEM, n=3. For statistical analysis, 
tet - cells in the presence of MMS (dashed black line) were compared with the tet + cells in 
the presence of MMS (dashed orange line) at each time point. (*) = p<0.05 and (**) = p<0.005 
as determined by a Mann Whitney U test. The western blots shown confirm protein 
knockdown using the endogenously tagged RNAi cell lines (generated in section 3.3.3.2. 
The endogenously tagged protein (~ sizes of each are annotated in Figure 3-5) was detected 
using α myc antiserum and EF1α was used as a loading control (due to the size of 
Tb927.11.1180, γH2A was used as a loading control [14.2 kDa in size; (Glover & Horn 2012). 
In each, by 48 hrs the protein signal was lost in the induced cells. Western blots were 
exposed between 1 min to 30 mins (for Tb927.11.1180). The growth curve for Tb927.7.960 
was performed by T.Donatelli-Serafim (in duplicate). White space indicates images aligned 
from the same blot. 
Following RNAi knockdown of Tb927.10.5140 (TbMPK2; Figure 3-7), a severe 
reduction of growth from 24 hrs was observed, suggesting this gene is essential 
for in vitro BSF survival, a phenotype closely resembling that reported by Jones 
and colleagues (Jones et al. 2014). Additionally, gross morphological changes 
could be observed after RNAi, with the cells notably larger than a non-induced 
BSF cell. RNAi against two PKs (Tb927.6.3110 [TbCRK11] and Tb927.11.1180 
[TbCRK6]) showed little to no effect on cell growth following RNAi induction, in 
contrast with the report of a slight slowing of the growth after TbCRK6 RNAi by 
Jones et al. 2014. Though TbCRK11 show no loss of fitness after RNAi, from 24 
hrs post induction, some cells in the population harboured aberrant, rounded 
morphology. RNAi against Tb927.7.960 produced a very mild growth effect at 24 
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and 48 hrs post induction, but the cells reached the same final density as 
uninduced. 
When the RNAi was induced in the presence of MMS, a significant reduction in 
the growth was again observed (relative to all controls) for each PK, confirming 
that loss of each gene sensitised the cells to MMS. 
3.3.5 Cell cycle analysis 
To examine whether the nine PKs play a role during cell cycle progression, an 
analysis of the DNA content was undertaken after RNAi with and without MMS 
exposure. Cells were prepared for analysis and DAPI stained (to visualise the 
nDNA and kDNA) as detailed in section 2.8.3 and section 2.11.1. The cells were 
categorised according to their ratio of kDNA to nDNA to give an estimation of the 
cell cycle stage of each individual cell (as described by Benmerzouga et al. 2013) 
with ‘1N1K’ corresponding to G1/S phase (~ 80 % of cells), ‘1N2K’ to S/G2 phase 
(~ 10% of cells) and ‘2N2K’ to M phase (~ 5 % of cells). Any cell unable to be 
identified under these categories was considered as ‘other’. These data are 
shown in Figures 3-9 (genome wide candidates) and 3-11 (kinome candidates). 
3.3.5.1 Genome wide RITseq candidates 
Of the five RNAi lines analysed, only the double knockdown of TbTLK1/2 had a 
clear effect on cell cycle progression (Figure 3-8). From as early as 24 hrs post 
induction >10% of the population lacked any detectable nucleus (1K0N; ‘zoids’) 
and at 48 hrs the number of zoids increased to ~ 25 % of the population. 
Additionally, over 25% of the population were classified as ‘other’; these cells 
possessed enlarged, aberrant nuclei, suggesting a block during nuclear division. 
However, no significant increase in 1N2K cells were detected following 
induction, suggesting nuclear S-phase was not significantly affected or was a 
G2/M arrest affected. Overall, the lack of an S-phase stall and the production of 
‘zoid’ cells suggest a defect in the checkpoint(s) monitoring nuclear S-M phase 
transition. 




Figure  3-9: In vitro cell cycle analysis of the genome wide PK candidates 
Cells were collected from tetracycline induced (1 μg/ml
-1
) or uninduced cultures at 24 abnd 
48 hrs. Cells were also harvested from cultures induced or uninduced in the presence of 
0.0003 % MMS (v/v). Cells were fixed as per section 2.11.1 and stained with DAPI. The 
number of 1N1K, 1N2K, 2N2K and ‘other’ (including 0N1K, zoid) cells were counted and 
expressed as a percentage of the total population. The error bars represent ±SEM (n = 3, > 
200 cells counted per experiment). Significance was calculated by comparing ‘other’ cells 
from the non-induced individually with ‘other’ cells from the induced cells using a Mann 
Whitney U test (one tailed). (*) = p<0.05. Cells were counted on an Axioskop 2. 
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For the other four RNAi lines examined, very little disruption of the cell cycle 
was observed (Figure 3-8), though in all cases, at ~48 hrs post induction, a small 
increase in ‘other’ cells were noted (TbKFR1 [~13 % on average], Tb927.9.6560 
[~21 % on average], TbAUK2 [~12 % on average] and TbCAMK/KL [~9 % on 
average]). Examples of aberrant cells from each induced RNAi cell line at this 
time point is shown in Figure 3-9. For Tb927.9.6560, the nDNA appeared smaller 
in size after RNAi and, in a few cells the kDNA appeared undetectable or 
indistinguishable from the nuclear signal. In addition, for Tb927.9.6560 the 
typical morphology of a trypomastigote cells was lost and a ‘rounded’ or 
‘clumped’ cell morphologies began to appear (investigated in chapter 5). In 
contrast for TbKFR1 and TbAUK2, aberrant cells appeared to have increased DNA 
content, though this was not significant in the case of TbKFR1. 
 
Figure  3-10: Morphology of the genome wide candidates after 48 hrs RNAi induction 
Images of cells post induction for each candidate. DAPI was used to visualise nDNA and 
kDNA (blue) and DIC imaging was used to view the cell body. In the black dashed box are 
representative images of cells in the absence of tetracycline induction (images taken from 
the Tb927.2.1820 cell line). White arrow indicated cells with ‘other’ phenotypes. Images were 
captured on an Axioskop2 (Zeiss) and processed in ImageJ (as per section 2.11.8). Scale 
bar = 10 μm. No images of TbTLK1/2 are shown. 
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When TbAUK2 was knocked down, a transient increase in 1N2K cells was 
observed at 24 hrs (on average 21 % of the cells were 1N2K post induction 
compared to the 12 % observed in the uninduced culture), indicating a potential 
stall during nuclear S-or G2 phase that was not maintained until at 48 hrs, when 
aberrant cells appeared (which are further characterised in chapter 4). Overall, 
the main observable effects are linked to the nucleus (lesser so to kDNA 
changes) suggesting that these PKs may be involved in maintaining some aspect 
of the BSF nucleus; perhaps with RNAi disrupting nuclear mitosis. 
The cell cycle was also examined post RNAi induction under MMS stress to test if 
exposure to MMS revealed an increased, specific defect during cell cycle 
progression. Cells were exposed to 0.0003 % MMS (v/v) and collected as 
described in section 2.8.3 and section 2.11.1. In all cases, no significant 
difference was seen after RNAi induction when compared with the pronounced 
cell cycle defects MMS caused to uninduced cells. Consistently, after 12 hrs 
(data available in chapter 8, section 8.2, Figure 8-4) exposure to MMS (regardless 
of induction status), a large increase (~ 30 % of the population) in 1N2K cells 
became apparent, suggesting MMS induces a stall during nuclear S/G2 phase. At 
later time points the number of 1N2K cells reduced dramatically and instead a 
large increase (~50 % of the population at 24 hrs, and ~70 % at 48 hrs) in 
aberrant ‘other’ cells were detected. These data suggest that BSF cells exposed 
to MMS simply continue replication (after a transient stall during S-phase) and, 
unlike human cells (for example as shown by Cliby et al. 1998), may fail to 
monitor nuclear damage as stringently resulting in the appearance of aberrant 
cells. 
3.3.5.2 Kinome wide RITseq candidates 
For the kinome wide RITseq candidates, a similar analysis was undertaken 
(conducted as described in the sections above), though the effect of RNAi 
knockdown on the cell cycle was not examined in the presence of MMS (Figure 3-
10). Knockdown of TbCRK11 (Tb927.6.3110) produced no changes in the cell 
cycle relative to the control, consistent with the lack of any measurable 
disruption in growth Figure 3-10). RNAi of both TbCRK6 (Tb927.11.1180) and 
Tb927.7.960, after 48 hrs, caused a small increase in aberrant cells (though only 
for Tb927.7.960 was this significant). For TbCRK6, the RNAi induced cells 
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adopted a clear rounded morphology (Figure 3-10), though further 
characterisation was not undertaken. 
 
Figure  3-11: In vitro cell cycle analysis of the kinome wide candidate 
Cells were collected from tetracycline induced (1 μg/ml-1) or uninduced cultures at 24 and 
48 hrs. Cells were also harvested from cultures induced or uninduced in the presence of 
0.0003% MMS (v/v). Cells were fixed as per section 2.11.1 and or stained with DAPI. The 
number of 1N1K, 1N2K, 2N2K and ‘other’ (including 0N1K, zoid) cells were counted and 
expressed as a percentage of the total population. The error bars represent ±SEM (n=3, 
>200 cells counted per experiment). Significance was calculated by comparing ‘other’ cells 
from the non-induced individually with ‘other’ cells from the induced cells using a Mann 
Whitney U test (one tailed). (*) = p<0.05. Cells were counted on an Axioskop 2. 
In the case of TbMPK2 (Tb927.10.5140), from 24 hrs post induction (Figure 3-10), 
a significant increase in aberrant (‘other’) cells was observed (~20 % of the 
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population, which increased to over ~70 % at 48 hrs). Morphologically (Figure 3-
10), the cells produced a variety of phenotypes ranging from rounded, 
abnormally shaped (but unable to categorise) or clumped. It is unclear as to the 
origin of these defects. 
 
Figure  3-12: Morphology of the kinome wide candidates after 48 hrs RNAi induction 
Images of cells post induction for each candidate. DAPI was used to visualise nDNA and 
kDNA (blue) and DC imaging was used to view the cell body. In the black dashed box are 
representative images of cells in the absence of tetracycline induction (images taken from 
the Tb927.10.5140 cell line). White arrows indicate cells with ‘other’ phenotypes. Images 
were captured on an Axioskop2 (Zeiss) and processed in ImageJ (as per section 2.11.8). 
Scale bar = 10 μm. 
3.3.6 Analysis of the expression of γH2A in the RNAi cell lines in 
vitro 
As discussed in chapter 1 (section 1.6), one of the earliest signals of DNA damage 
(such as DSBs), is the phosphorylation of the core histone H2A or the histone 
variant H2AX, generating γH2A(X). In T. brucei this variant histone is referred to 
as H2A (γH2AThr130 or γH2A when phosphorylated) and is expressed after a range 
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of damage (Glover & Horn 2012), In mammals ~ 46 PKs have been implicated in 
this phosphorylation, the ATM and ATR kinases are best understood (Benzina et 
al. 2015). In T. brucei the PK(s) that phosphorylate H2A, using a non-canonical 
threonine, has yet to be determined. Here, we tested whether loss of the PKs 
induced γH2A, or abolished the response after MMS treatment. 
As shown in Figure 3-12, the 2T1 parental cell line produces little expression of 
γH2A under standard culture conditions, with the low level of expression 
perhaps explained by the antiserum cross reacting with the unphosphorylated 
H2A. When the 2T1 cells were exposed to genotoxic stress (by the addition of 
0.0003 % MMS for 24 hrs), expression levels of γH2A radically increased (Figure 3-
12), consistent with previous findings. 
3.3.6.1 The genome wide candidates 
Of the five candidates recovered from the genome wide screen, only one showed 
clear changes in the expression of γH2A (Figure 3-12). All cell lysates were 
collected at 48 hrs post RNAi induction. MMS was added after 24 hrs RNAi 
induction at a concentration of 0.0003 %. Knockdown of Tb927.9.6560 or 
Tb927.2.1820 did not result in an observable increase in the expression of γH2A, 
while RNAi of Tb927.10.7780 (TbKFR1) or Tb927.3.3920 (TbAUK2) caused, at 
most, only a slight increase (this expression was not quantified). Furthermore, in 
all cases following MMS induction, increased expression of γH2A could be seen to 
the same extent in the induced and uninduced cells. Overall, from this analysis, 
none of the PKs play a major role in H2A phosphorylation. In fact, Tb927.9.6560 
appears to be a pseudokinase, and so may not have the capacity to 
phosphorylate any substrate (see chapter 4). As RNAi of Tb927.10.7780 (TbKFR1) 
and Tb927.9.6560 both produced an observable defect growth defect, the level 
of γH2A generated may not always directly correlate with a slow growth 
phenotype, meaning this pattern of growth may not always be due to nuclear 
defects that cause DNA damage. 




Figure  3-13: Examination of γH2A expression in the genome wide PK candidates 
Cells were induced (with 1 μg/ml-1 tetracycline) or left uninduced for 24 hrs. At 24 hrs, MMS 
(to a concentration of 0.0003% [v/v]) was added to an induced and an uninduced culture. 
Whole cell lysates were collected as described in section 2.12.1. Whole cell extracts were 
separated on 15 % BT gels, blotted and γH2A was detected using α γH2A antiserum and α 
EF1α was used as a loading control. Westerns were performed by T.Donatelli-Serafim. 
In the case of the double knockdown of TbTLK1/2, an increased level of γH2A 
expression was observed even in the absence of MMS, suggesting loss of 
TbTLK1/2 results in the accumulation of DNA lesions, which is perhaps in keeping 
with the severe nuclear abnormalities observed after RNAi. However, the level 
of γH2A did not alter after MMS exposure and RNAi. 
3.3.6.2 The kinome wide candidates 
The kinome wide PK candidates were next analysed as above. Only TbCRK11 
(Tb927.6.3110) showed an increased expression of γH2A in the absence of MMS 
damage and after RNAi (Figure 3-13). This was unexpected, as neither an effect 
on cell growth or cell cycle could be detected and reinforces the suggestion that 
accumulation of the histone variant is not merely a reflection of growth 
impairment. Consistent with this, knockdown of TbMPK2 (Tb927.10.5140), which 
profoundly impairs growth from as early as 24 hrs post induction; Figure 3-7), did 
not result in an increased expression of γH2A. Equally, RNAi of Tb927.7.690 or 
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TbCRK6 (Tb927.11.1180), which moderately affect growth, caused no observable 
increase in γH2A expression. 
 
Figure  3-14: Examination of γH2A expression in the kinome wide candidates 
Cells were induced (with 1 μg/ml-1 tetracycline) or left uninduced for 24 hrs. At 24 hrs, MMS 
(to a concentration of 0.0003% [v/v]) was added to an induced and an uninduced culture. 
Whole cell lysates were collected as described in section 2.12.2. Whole cell extracts were 
separated on 15 % BT gels, blotted and γH2A was detected using α γH2A antiserum (T. 
Donatelli-Serafim) and α EF1α was used as a loading control. Exposure: 1-30 seconds. 
As for the genome-wide PKs, loss of none of the kinome PK candidates resulted 
in altered levels of γH2A in the presence of MMS relative to the uninduced cells 
therefore it is unlikely any of these kinases is the major enzyme contributing to 
the phosphorylation of H2A. 
3.3.7 Localisation of endogenously myc-tagged kinases 
Determining the sub-cellular localisation of each PK may provide further insight 
into their role in T. brucei. To this end, cells expressing the myc-tagged PK 
variants were prepared for indirect IFA as described in section 2.11.1 and 
section 2.11.2 and stained with α-mouse α-myc FITC-conjugated antibody; 
additionally, nDNA and kDNA were stained with DAPI. 2T1 cells were used as a 
control to account for background fluorescence. Routinely, two tagged clones 
were selected for analysis though data is only shown for one as no observable 
differences were noted between any clones. As only one allele was endogenously 
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tagged, it is unclear whether the endogenous tagged allele is functional, with 
the exception of Tb927.10.7780 (TbKFR1; chapter 8, section 8.2, Figure 8-5, 
Tb927.9.6560 (chapter 5) and Tb927.3.3920 (TbAUK2; chapter 4). 
3.3.7.1 Genome wide RITseq candidate localisation 
No attempt was made to examine the localisation of either TbTLK1 or TbTLK2, 
as this has been previously assessed (Li et al. 2007; both are nuclear). Amongst 
the genome-wide PK candidates, Tb927.9.6560 localised in close proximity to 
the kDNA, and Tb927.3.3920 localised to the nucleus, as detailed in chapter 5 
and chapter 4, respectively. Localisation of Tb927.10.7780 will be discussed 
further below. No distinct signal could be seen for Tb927.2.1820 (data not 
shown). WT cells were also endogenously tagged using the same construct, with 
the same results, though a faint cytoplasmic signal could be observed. It is 
possible that this kinase localises diffusely throughout the cytoplasm. As loss of 
this PK resulted in sensitisation of the cells to MMS, an attempt to localise the 
protein after growth of the tagged cells for 18 hrs in MMS (0.0003 %); however, 
as before, no distinct signal could be identified; instead a faint cytoplasmic 
signal was observed. 
Unfortunately, unlike the genome-wide candidates, no discrete localisation 
could be clearly ascertained for any of the kinome-wide candidates by indirect IF 
analysis. All the PKs appeared to stain diffusely throughout the cytoplasm of the 
cell (chapter 8, section 8.2, Figure 8-7). As for Tb927.2.1820, localisation of 
each PK was also tested after exposure to MMS, but no MMS-induced localisation 
was revealed (chapter 8, section 8.2, Figure 8-7). 
3.3.7.1.1 Localisation of Tb927.10.7780 (TbKFR1) 
The subcellular localisation of Tb927.10.7780 (TbKFR1) has not been reported in 
T. brucei. However, the L. mexicana ortholog (56 % sequence identity to 
TbKFR1), when expressed from an episome as a C-terminal GFP fusion, was 
shown to localise diffusely throughout the cytoplasm of promastigote cells (M. 
Wiese, personal communication). 




Figure  3-15: Sub-cellular localisation of Tb927.10.7780 
(A) Representative field of view image of Tb927.10.7780-myc localisation in BSF cells. Cells 
were harvested, fixed and stained with DAPI (to visualise nDNA and kDNA; magenta) and α-
myc antiserum (to visualise the endogenous myc tag; green). DC imaging was used to 
visualise the cell body. White arrows indicate cells harbouring Tb927.10.7780 localisation. 
(B) Close up images corresponding to the blue and orange boxes shown in (A). (C) 
Representative field of view image of Tb927.10.7780 localisation in BSF cell following 48 hrs 
RNAi induction. Cells were prepared as above. Scale bar = 10 μm. Images of 
Tb927.10.7780
12myc
 RNAi CL1 were captured on an Axioskop2 and processed in ImageJ as 
per section 2.11.8. 
Unexpectedly, the localisation of the endogenously myc- tagged Tb927.10.7780 
(TbKFR1) did not match the pattern described in Leishmania. Instead, no distinct 
signal could be observed in ~90 % of BSF T. brucei cells, regardless of their cell 
cycle stage status (Figure 3-15). Instead a faint cytoplasmic signal was observed 
in these cells. However, in ~10 % of cells a small, and in addition to a faint 
cytoplasmic signal, a single focus could be seen in at the posterior end of the 
cell in close proximity to the kDNA (though it did not appear to co-localise with 
the kDNA; Figure 3-15 B). This localisation pattern could only be observed in 
1N1K cells (G1 phase). To confirm this localisation was not simply an artefact, 
RNAi knockdown was induced in the endogenously tagged RNAi cell line for 48 
hrs and indirect IF performed again. Here, the faint cytoplasmic signal could not 
be detected and no foci could be observed in any cell (Figure 3-15 C), suggesting 
the discrete signal localisation and the faint cytoplasmic signal are indeed due to 
the presence of the PK. Localisation of TbKFR1-myc did not differ following MMS 
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exposure (for 18 hrs; 0.0003 %; chapter 8, section 8.2, Figure 8-6). As ~80 % of 
cells are in G1 (1N1K; Benmerzouga et al. 2013), it is unclear why small 
percentage of 1N1K cells show this discrete localisation. Potentially, these cells 
could be within a specific stage of G1. Why such localisation is not seen in 
Leishmania is unclear. 
3.4 Discussion 
3.4.1 RITseq screening for DDR associated PKs in BSF T. brucei 
parasites 
Kinase signalling is vital for the co-ordination of the DDR in most eukaryotes and 
acts from the initial detection of a DNA lesion by atypical PKs like ATR and ATM, 
to signal amplification via PKs like CHK1 and CHK2 (as reviewed by Marechal & 
Zou 2013), and subsequent downstream control of the cell cycle by PKs like 
WEE1 (as reviewed by Matheson et al. 2016), CDKs (as reviewed by Duursma & 
Cimprich 2010) and AUKB (Mackay & Ullman 2015). The range of PKs that 
contribute to DDR signalling has only to date been explored in mammals, where 
screening suggests a wide network acts. At least 55 PKs (~10 % of the human 
kinome), acting across a number of pathways, modulate sensitivity of ovarian 
cancer cells to the therapeutic agent cisplatin (Arora et al. 2010). In addition, a 
range of mammalian PKs have been identified that contribute to γH2AX 
phosphorylation (Benzina et al. 2015). 
To date, there has been no description of a PK with a role in the DDR of T. 
brucei, or any related parasite. In the case of T. brucei, PKs involved in the 
regulation of the DDR may be of specific interest considering a recent report 
which links DSBs and the likely presence of replicative lesions during the process 
of VSG switching (Devlin et al. 2016). In fact, the only kinase implicated in the 
VSG switching process, phosphatidylinositol 5-kinase (TbPIP5K), is not implicated 
in the phosphorylation of proteins, as it is a component of the inositol phosphate 
pathway and is predicted to phosphorylate phosphatidylinositols. Therefore 
TbPIP5K is unlikely to act directly on the genome (Cestari & Stuart 2015). 
Searching for genes with DNA repair associated roles has been performed in a 
variety of organisms (for example as detailed in Ravi et al. 2009; Rooney et al. 
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2009; Pan et al. 2012), revealing the network of pathways required to respond to 
the large variety of lesions encountered. The work detailed in this chapter 
represents the first attempt to perform such a screen in a protozoan parasite to 
look for genes whose loss sensitises T. brucei BSF cells to MMS. From a genome-
wide RNAi screen, a total of eight PK candidates were initially identified and 
nine PKs tested further. Five of the PKs were validated in vitro as being involved 
in cellular survival following MMS treatment; homologs of two of these PKs 
(TbTLK1/2 and TbAUK2) have been previously implicated in the DDR in other 
organisms (Benedetti 2012; Vader & Lens 2008; Carmena et al. 2009), but not in 
T. brucei; the four other PKs are novel in all organisms. Additionally, a kinome 
focused screen was performed (using a previously established library of RNAi cell 
lines; Jones et al. 2014). This approach revealed 23 PK candidates, including 
three seen in the whole genome screen, and TbTLK1/2. From the 19 new 
candidates, eight were examined further, and four were validated; after RNAi 
induction, their loss sensitised BSF cells to MMS in vitro. In addition to the nine 
PKs now validated, TbATR and TbATM were detected in the kinome MMS screen. 
Considering their well-characterised roles (in other eukaryotes) as ‘master-
regulators’ of the DDR (Marechal & Zou 2013), both should be considered as 
putative damage response PKs in T. brucei. In total, across both screens, there 
are at least 11 PKs in BSF T. brucei parasites whose loss is associated with 
increased sensitivity to MMS; these PKs may act during the DDR. In addition to 
these validated candidates, preliminary data suggested eight PKs (of the 28 PKs 
predicted across both screens), may in fact be false positive ‘hits’. However, it 
is still possible more DNA repair associated PKs are present within the remaining 
untested genes. Further work would be required to analyse these remaining 
candidates. If T. brucei does indeed require a similar proportion of its kinome to 
DNA damage signalling compared with the complement of PKs revealed by 
limited studies in mammals, it is possible PKs additional to those discussed here 
are present. 
More PKs were identified using the kinome wide screening approach as opposed 
to the genome wide screen, perhaps for several reasons. Foremost, the data 
from the genome-wide screen was collected from a single time point (5 days) 
following RNAi induction, and only after 4 days growth in one concentration of 
MMS. In contrast, the data from the kinome wide screen was collected as a time 
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course ranging from 24 hrs to 120 hrs post induction in the presence of two MMS 
concentrations, hence allowing the effect of PK depletion to be assessed 
progressively and with greater sensitivity. An added complication is the potential 
for RNAi cell lines, particularly those targeting essential genes, to revert 
following induction over a period of time, for instance becoming insensitive to 
tetracycline. This effect may explain why TbATR failed to be identified as a 
candidate in the genome wide screen. At 72-96 hrs post RNAi induction, TbATR 
appears to revert and recover proliferation (chapter 6). Indeed, it is notable that 
none of the essential PK candidates in the kinome screen were detected in the 
whole genome screen. Finally, the much greater read depth provided by the 
kinome screen is likely to allow detection of genes with minor roles, where small 
changes in MMS/MMS ratio could be detected. 
From the kinome wide screen, a range of sensitivities to MMS could be detected 
after RNAi of the PKs identified. For some (for example, Tb927.7.960), a 
prolonged exposure to MMS resulted in a reduced MMS+/MMS- ratio. Others (for 
example Tb927.1.1930) showed a rapid reduction. It is possible these differences 
may be explained by differing levels of RNAi knockdown. However, it is equally 
possible that these differences perhaps reveal PKs which act either at early or 
late stages in the response to MMS. Whether they act within a single pathway or 
within multiple is unclear at this stage. Another interesting consideration is as to 
why some of the PKs examined by RNAi are essential for survival following MMS 
stress and others are perhaps dispensable. This may support a role for the 
requirement of multiple pathways to facilitate BSF survival following MMS 
exposure (see below). Though only TbATR and TbATM were investigated further 
in chapter 6, other PKs with known roles in the DDR of other eukaryotes were 
also identified, including a polo-like kinase (TbPLK; Tb927.7.6310; MMS+/MMS-: 
1.397), the aurora kinase 1 (TbAUK1; Tb927.11.8220; MMS+/MMS-: 1.528), the 
Nima related kinases (NEK) TbNRKA/B (a dual targeting RNAi line was used; 
Tb927.4.5390/Tb927.8.6930; MMS+/MMS-: 0.717) and the target of rapamycin-4 
(TOR4) kinase (Tb927.1.1930; MMS+/MMS-: 0.744). Though none of these were 
examined further, investigation of these PKs may shed further light on the 
parasites response to MMS exposure. 
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When comparing the genome-wide screens for DNA damage response factors in 
yeast (Chang et al. 2002), Drosophila (Ravi et al. 2009)and E. coli (Rooney et al. 
2009), it is clear that a reasonably conserved network for MMS survival operates; 
DDR pathways associated with the repair of base adducts were enriched 
(generally). Such pathways include NER, BER and MMR. Additionally, genes 
associated with DNA replication and HR were also enriched in these screens. As 
previously eluded to, the PKs identified in these screens may operate within 
several pathways activated in response to MMS. Of course a key remaining 
question is if and how these PKs interact with common or specific elements of 
these pathways, many of which have been characterised (Genois et al. 2014). 
3.4.2 Candidate validation: growth and cell cycle analysis 
Chapters 4 and 5 provide in depth analysis of the functions of two of the PK 
candidates: Tb927.9.6560 and Tb927.3.3920 (TbAUK2). Below I discuss what is 
known about the other validated PKs. 
3.4.2.1 Genome wide candidates 
Loss of TbTLK1/2 resulted in a drastic reduction in cell growth and the formation 
of ‘zoid’ cells, though as this cell line targets both PKs, the phenotype could 
result from lack of either or both. However, data produced by Li and colleagues, 
using RNAi cell lines targeting each PK independently, suggest the drastic 
reduction in growth is due to the loss of TbTLK1. TbTLK1 RNAi results in an 
accumulation of cells in S-phase of the cell cycle and abnormal segregation of 
chromosomes and spindle machinery (Li et al. 2007) in both the PCF (2007) and 
BSF (Z. Li, Umeyama, et al. 2008) of the cell. In our hands, the phenotype of the 
double RNAi closely resembles these findings. BSF cells forming ‘zoids’ after 
RNAi have been described, including following loss of ORC1/CDC6 (Marques et al. 
2016). This may be in keeping with a role for TbTLK1/2 during DNA replication, 
which may explain the increased MMS sensitivity. Nonetheless, further work will 
be needed to determine whether TbTLK1/2 directly interact with replication 
factors, in addition to described interaction of TbTLK1 with TbAUK1 and histone 
modifiers (Li et al. 2007). Aside from this, previous research has linked TLKs to 
genome maintenance (as reviewed by Benedetti 2012), which is in keeping with 
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the role of TbTLK1/2 in response to MMS, though to date such activities have 
been thought to largely be metazoan-specific. 
Tb927.10.7780 (TbKFR1) is regarded as an essential gene (Hua & Wang 1997), 
since attempts to delete the ORF (in PCF cells) were unsuccessful. Indeed, a 
knockout of this gene was attempted in WT BSF cells, and despite transformants 
being recovered, there was evidence of gene duplication resulting in retention 
of a gene copy (data not shown). Despite this, the recovered transformants 
appeared to be sensitive to MMS stress (data not shown). In contrast, though 
LmMPK1 has been shown to be required to form skin lesions in vivo (Wiese 1998) 
the gene can be knocked out in vitro, suggesting a less critical role in L. 
mexicana. Though the function of this PK (TbKFR1/Tb927.10.7780) in the T. 
brucei cell is unclear, further investigation of the localisation may provide a 
greater insight into its role. 
No growth effect after RNAi induction, nor disruption of the cell cycle, was seen 
when Tb927.2.1820 (CAMK/KL) was targeted. There are no reports in the 
literature on the function of this kinase. When analysed by BLASTp (data not 
shown) the protein did not appear to show homology to any human PK; instead 
the PK was most homologous to calcineurin B-like (CBL)-interacting S/T kinases 
in plants (Arabidopsis and Glycine). Interestingly, these calcium activated 
kinases are thought to be important for sensing environmental stress signals. 
Furthermore, the plant PKs interact with a multigene family (the CBL proteins) 
to transduce an extracellular ionic salt signals into an intracellular 
phosphorylation signal (reviewed by Luan 2009). Such functions in sensing 
extracellular stress could be in keeping with a role for Tb927.2.1820 in the 
detection of MMS stress. 
3.4.2.2 Kinome wide candidates 
From the kinome wide candidates, only one PK (Tb927.10.5140; TbMPK2) was 
essential for BSF proliferation, though its loss did not appear to affect 
progression of the cell cycle; instead, aberrant cells began to accumulate shortly 
after RNAi induction. This PK (under the name TbMAPK6) has been functionally 
examined in PCF and BSF cells (Wei & Li 2014). In BSF cells, Wei and Li report 
similar defects to those described in this thesis, and suggest a role during BSF 
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cytokinesis. The process of cytokinesis is intimately linked to DDR processes in 
other organisms, and many damage-associated PKs, like the aurora kinases, have 
both repair and cell division functions (Pan et al. 2012; Fry et al. 2012; Carmena 
et al. 2012; Fu et al. 2007; Goldenson & Crispino 2015). As MAPK kinases are 
components of signal transduction pathways in T. brucei (Wei & Li 2014), it is 
possible that this acts in such a pathway to signal damage. In fact, activation of 
MAPKs has been shown to occur following PARP-1 activation, an early DDR signal 
(Cohen-Armon 2007). 
For the other candidates, growth did not appear to be affected nor were any 
defects in cell cycle progression observed. In contrast, when TbCRK6 
(Tb927.11.1180) was knocked down by Jones et al (2014), growth was slowed; 
furthermore, growth defects in PCF cells are seen following TbCRK6 knockdown 
(Tu & Wang 2004). Interestingly, when TbCRK6 was knocked down, cells with a 
‘rounded; appearance (akin to those observed following the knockdown of 
Tb927.9.6560; see chapter 5) were seen, perhaps suggesting a common role in 
endocytosis and/or trafficking. It is interesting that, in addition to TbCRK6, a 
second cdc2-related kinases (TbCRK11) were identified and validated as having a 
role in the response to MMS exposure. CRKs (or cdc2-related kinases) in T. 
brucei, when paired with a cyclin (CYC), have been shown to regulate the 
transitions between cell cycles stages (for example, CYC2-CRK3 may be required 
for the G1-S phase transition; Hammarton et al. 2003). Indeed, control and 
regulation of the cell cycle is a key process following DDR activation. It is 
possible that these PKs mediate DNA damage associated cell cycle checkpoints. 
The final candidate (Tb927.7.960) shows sequence homology to a serine rich PK 
(SRPK; family: CMGC). Interestingly, in P. faciparum, the kinase PfSRPK1 (also an 
SRPK) was shown to be involved in mRNA trans-splicing regulation. Furthermore, 
in other eukaryotes, the functions of SRPKs range from mRNA processing to the 
mediation of import into the nucleus (Dixit et al. 2010). This may be of interest 
due to T. brucei’s need to regulate gene expression post-transcriptionally and 
may suggested the PK controls gene expression in response to MMS stress. 
Intriguingly, this PK was identified in a RITseq screen designed to identify PKs 
required for survival in vivo (Fernandes-Cortez et al. in preparation). 
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3.4.2.3 False positive hits 
As expected, several ‘false-positive’ candidates were identified from both 
screens (chapter 8, section 8.2, Figure 8-3). Despite showing MMS+/MMS- ratios 
of <0.5, when examined in vitro, no sensitivity to MMS could be detected 
relative to the controls. Surprisingly, several NEK kinases were detected and 
examined (including TbNEK19 and TbNRKA/B) though none, when targeted by 
RNAi, showed increased sensitivity to MMS. NEK kinases are an expanded family 
of PKs in T. brucei with known roles in the DDR in other eukaryotes (Moniz et al. 
2011). It is therefore perhaps surprising that no NEK kinase examined showed 
increased sensitivity to MMS stress. TbNRKA and TbNRKB are instead 
hypothesised to have a potential role in differentiation from BSF to PCF (Gale & 
Parsons 1993; Gale et al. 1994; Jones et al. 2014). As the level of knockdown for 
each false positive hit was not assessed, it is possible that some of the cell lines 
failed to produce adequate gene knockdown. 
3.4.3 Candidate Localisation 
Of the eight candidates endogenously tagged, localisation could only be clearly 
determined for three: Tb927.10.77880 (TbKFR1), Tb927.3.3920 (TbAUK2; see 
chapter 4) and Tb927.9.6560 (Tb6560, see chapter 5). Interestingly, only one 
(TbAUK2) was nuclear; the other two localised in close proximity to the kDNA. 
For Tb927.10.7780, the endogenous tagging construct was transformed into WT 
cells and the other allele deleted in order to confirm functionality of the tag (as 
describe in section 2.4.1.2). This was undertaken due to the unusual localisation 
exhibited by this PK; indeed, the tag appeared to be functional and the 
population appeared to be clonal. Additionally, super resolution images were 
captured, clearly demonstrating the PK forms a particular structure within the 
cell near the kDNA. It is possible this PK may be associated with the FP, since 
the signal did not co-localise with the kDNA. However, the detailed spatial 
position of this kinase and the very limited cell cycle stage during which it 
localises is unclear. However, TbKFR1 is also a MAPK family member, and 
therefore putatively part of a signalling cascade. Perhaps TbKFR1 is recruited to 
its discrete region in response to an incoming stimulus, perhaps via the FP. 
TbKFR1 shows strong sequence homology to kinases within a MAPK signalling 
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cascade controlling a mating pathway in S. cerevisiae: the KSS1, FUS3 and ERK1 
kinases (KSS1FUS3 Related Kinase 1 or KFR1). In addition, TbKFR1 appears to be 
lifecycle regulated, with more protein activity being observed in the BSF relative 
to the PCF (Hua & Wang 1994; Hua & Wang 1997). Perhaps within this 
circumstantial evidence are clues to understand the function of TbKFR1. 
No distinct localisation could be determined for any of the kinome-wide 
candidates however it is possible that these kinases may localise diffusely 
throughout the cytoplasm of the cell; further analysis is required to confirm this 
statement. Conversly, it is possible that epitope tagging the PKs interrupts 
function and the kinases are unable to correctly localise within the cell ; due to 
time constraints, functionality of each tagged variant could not be confirmed. 
However, TbMAPK6 (Tb927.10.5140/TbMPK2) has been previously been shown to 
localise diffusely throughout the cell across all cell cycle stages in T. brucei BSF 
and PCF cells (Wei & Li 2014). In addition, an SRPK kinase in P. falciparum has 
been reported to be cytosolic (Dixit et al. 2010). 
Neither CRK could be localised, despite other members of this family being 
visualised by endogenous tagging. For example, TbCRK9 (a CRK involved in pre-
mRNA transplicing; Badjatia et al. 2016) localises diffusely throughout the 
nucleus (Gourguechon & Wang 2009). Endogenously tagging Tb927.11.1180 
(TbCRK6) proved challenging and was finally achieved by N-terminally tagging 
the gene. However, when examined by western blot, the size at which the 
protein resolved and the predicted MW were different; the endogenously tagged 
gene was ~50% smaller than the expected size. The reason for this is unknown; 
potentially the ORF could be miss-annotated, or perhaps the kinase is post-
transcriptionally processed (i.e cleaved upon, for example, following a 
phosphorylation event) which may explain the reduced size. Nonetheless, when 
knockdown of the gene was induced in the tagged RNAi cell line, the signal was 
lost, suggesting the correct gene was endogenously tagged. Further work would 
be required to determine the reason behind this size difference. 
134 
 
4 Dissecting the function of TbAUK2 in 
bloodstream form T. brucei 
  




4.1.1 Aurora Kinases 
Aurora kinases (AUKs) maintain normal cellular proliferation, with functions 
ranging from chromosomal duplication, DNA checkpoint signalling, chromosome 
segregation, and overseeing and co-ordinating the processes of mitosis and 
meiosis. Defects or deregulation of AUKs in mammals commonly manifest as 
cancer; e.g. over expression of AUKs is observed in breast cancer, ovarian cancer 
and leukaemia (as reviewed by D’Assoro, Haddad, & Galanis, 2015; Mountzios, 
Terpos, & Dimopoulos, 2008). With such crucial roles AUKs provide vast potential 
as anticancer targets, and are at the forefront of drug discovery programmes. 
The AUK family of serine/threonine kinases (family ACG) is conserved across the 
eukaryotic kingdom and the first AUK was identified in the budding yeast S. 
cerevisiae (Chan & Botstein 1993). All yeasts only have one AUK, which is a 
homolog of AUKB (below) and is termed IPI1p in S. cerevisiae and Ark1 in S. 
pombe. Most multicellular eukaryotes have two AUKs, termed AUKA and AUKB in 
vertebrates; (Carmena & Earnshaw 2003)8. A third aurora kinase (AUKC) is found 
in mammals only (Sasai et al. 2004; Kimmins et al. 2007). 
The three human AUKs are similar at their C-termini, which host the catalytic 
domain. AUKA, B and C share ~70% sequence homology in this region. The N-
terminal regions are notably varied, perhaps due to the functional divergence 
shown by each kinase; in addition, the N-terminus contains several important 
regulatory domains (discussed below). Though characterisation of the roles of 
the AUKs in a typical multicellular eukaryotic cell is ongoing, it appears that 
each AUK plays vitally different roles and act distinctly during nuclear division, 
though functional overlap can be observed (Sasai et al. 2004; Fu et al. 2007). 
Numerous interaction partners for AUKs have also been described (Samudio & 
Vélez 2015). A summary of the dynamic localisation of each human AUK is 
                                         
8
 C. elegans, D. melanograster and X. laevis each only have two (AUKA and AUKB). A. thaliana 
has three, which are classified into two distinct groups and appear to have diverged functions 
from AUKs of other eukaryotes (reviewed by Weimer, Demidov, Lermontova, Beeckman, & Van 
Damme, 2016). 
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illustrated in Figure 4-1, and a summary of function for each is presented below.
 
Figure  4-1 ; AUKs localise dynamically throughout mitosis 
AUKA (green circles) localises to the centromere throughout mitosis. During metaphase 
and anaphase, AUKA moves to the spindle poles. Both AUKA and AUKB protein levels are 
highly reduced during G1 phase of the cell cycle due to degradation (for AUKC this is 
unknown; (Stewart & Fang 2005). AUKB and AUKC (red circles) are both associated with the 
chromosomal passenger complex CPC at kinetochores. During anaphase the kinases move 
to the centre spindle (red rectangle), after which they it progress to the contractile ring 
during cytokinesis. Figure adapted from (Giet et al. 2005). 
4.1.1.1 AUKA 
Overexpression of AUKA is a common hallmark of cancers (reviewed by D’Assoro 
et al., 2015; Vader & Lens, 2008). Furthermore, cells with high levels of AUKA 
continue cellular proliferation in the presence of DNA damage (such as Cisplatin 
or X-rays), due to de-regulation of the DDR, since excess AUKA over-rides the 
spindle assembly checkpoint (Krystyniak et al. 2006; Katayama et al. 2012; Sun 
et al. 2014). Conversely, the loss of AUKA is required for normal cellular 
proliferation and ablation of only a single allele is associated with tumour 
development in mice9. The precise regulation of AUKA is therefore critical to 
maintaining normal cell proliferation. 
AUKA has numerous interaction partners (Figure 4-2). Mainly, AUKA (in human 
cells) aids centrosome maturation, the initiation of mitosis (through 
phosphorylation of the polo-like kinase PLK110; reviewed by(Asteriti, De Mattia, 
& Guarguaglini, 2015; Carmena, Ruchaud, & Earnshaw, 2009; Lindqvist, 
                                         
9
 Embryos of mice lacking AUKA do not progress past the 16 cell stage. Mice which are 
heterozygote at the locus encoding for the AUKA gene have an increased rate of tumour 
development (up to 3 fold increase; Lu et al., 2008). 
10
 PLK1 is phosphorylated (in human cells) on a threonine at position 210 (T210) by AUKA (Asteriti 
et al. 2015). 
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Rodríguez-Bravo, & Medema, 2009 and Samudio & Vélez, 2015), re-entry to 
mitosis following cell cycle arrest, and formation of the spindle poles (when 
associated with a microtubule binding protein known as TPX2). AUKA is also 
required for cytokinesis (during abscission).
 
Figure  4-2: A summary of the interaction partners of AUKA 
AUKA has numerous interaction partners depending on the role the kinase is required to 
perform. For example, when AUKA is overexpressed, it represses RAD51 function, which in 
turn represses homologous recombination (Sourisseau et al. 2010). Figure adapted from 
(Samudio & Vélez 2015). 
Following the observation that AUKA can interact with spindle microtubules 
during mitosis, Ritchey and Chakrabarti (Ritchey & Chakrabarti 2014) showed 
AUKA is also important for modulation of the actin cytoskeleton, via Cofilin (an 
actin depolymerising protein; Ritchey & Chakrabarti, 2014) and other 
cytoskeleton-associated proteins. This is consistent with separation of 
centrosomes requiring the cell’s actin cytoskeleton. The diverse roles of AUKA 
throughout mitosis are reflected in its dynamic localisation (Figure 4-1). 
Regulation of AUKA activity is mediated by its interaction partners (Figure 4-2) 
and by irreversible ubiquitin-directed degradation (Crane, Kloepfer, & 
Ruderman, 2004 and reviewed by Lindon, Grant, & Min, 2016). 




Overexpression of AUKB, like AUKA, has been implicated in cancer (Smith et al. 
2005; Falchook et al. 2015). However, a direct role of AUKB in oncogenesis is 
unclear. Instead, the interaction partners (such as the tumour suppressor protein 
p53; Gully et al., 2012) of AUKB may influence the development of carcinomas. 
AUKB activation, unlike AUKA, is associated with the Chromosomal Passenger 
Complex (CPC; other members of this complex include INCENP, Survivin and 
Borealin; the functions of the CPC are reviewed by Carmena, Wheelock, 
Funabiki, & Earnshaw, 2012). Additional interaction partners of AUKB are 
summarised in Figure 4-3. 
 
Figure  4-3: A Summary of the interaction partners of AUKB 
AUKB also had a wide range of interaction partners. For example, AUKB forms a complex 
with Borealin (Dasra), INCENP and survivin known as the chromosomal passenger complex. 
This complex is required to co-ordinate functions such as the alignment of chromosomes 
and cytokinesis. In addition, this complex modulates the kinase activity of AUKB (reviewed 
by (Vader et al. 2006; Carmena et al. 2012). Figure adapted from (Samudio & Vélez 2015). 
As part of the CPC, AUKB monitors and co-ordinates spindle formation, 
chromosome segregation and cytokinesis (reviewed by Afonso, Figueiredo, & 
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Maiato, 2016; Carmena et al., 2009; Samudio & Vélez, 2015). AUKB is required 
during sister chromatid bi-orientation and cohesion at the spindle mid-zone. 
AUKB can phosphorylate (and regulate) several protein components of the 
kinetochore to correct miss-orientation of sister chromatids. AUKB is physically 
moved from its substrates, thereby reducing its activity (Maresca & Salmon 2009; 
Carmena et al. 2012; Lampson & Cheeseman 2011) and stabilising the 
kinetochores with the correct sister chromatid orientation at the spindle mid-
zone. The dynamic localisation of AUKB throughout mitosis is mostly distinct 
from AUKA, highlighting the functional divergence of these kinases (Figure 4-1). 
Several proteins influence AUKB activation, notably INCENP, TLK-1 (Riefler et al. 
2008) and CHK1 (Petsalaki & Zachos 2013), the latter of which; acts in response 
to stimulation from the atypical kinase ATR (Liu et al. 2000), providing a direct 
link to the DDR. As for AUKA, regulation of AUKB activity can be mediated by 
irreversible ubiquitin-directed degradation (Crane et al., 2004 and reviewed by 
Lindon et al., 2016). 
4.1.1.3 AUKC 
AUKC defects are associated with infertility and AUKC expression, unlike A and 
B, is limited to germ cells (Sasai et al. 2004; Kimmins et al. 2007). Like AUKB, 
AUKC comprises part of the CPC, localising at the centromeres during early 
meiosis and subsequently re-localising as meiosis progresses to the spindle mid-
zone. AUKC, primarily, is important for chromosome segregation and cytokinesis 
(much like AUKB). In oocytes and spermatocytes deficiencies and deletions in 
the AUKC gene results in polyploid cells (Dieterich et al. 2007; Balboula & 
Schindler 2014) highlighting the role this kinase plays in the co-ordination of 
meiosis. 
4.2 Aurora Kinases in T. brucei; what do we know? 
Remarkably for a protozoan, T. brucei has three aurora kinases (TbAUK1 
[Tb927.11.8220], TbAUK2 [Tb927.3.3920] and TbAUK3 [Tb927.9.1670]) and AUKs 
are of interest as drug targets in T. brucei, given the range of inhibitors 
available. Indeed, TbAUK1 is at the forefront of a drive towards ‘drug 
repurposing’ for the treatment of neglected tropical diseases (Ochiana et al. 
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2013). The L. donovani AUK LdAIRK has also been suggested to be a potential 
drug target (Chhajer et al. 2016). 
Functional characterisation for each AUK has been undertaken, though with a 
primary focus on TbAUK1 (a potential homology of AUKB), across both lifecycle 
stages. TbAUK1 is essential (as shown by RNAi; Tu et al. 2006) for cell 
proliferation in both PCF and BSF T. brucei cells (Li & Wang, 2006), though it 
exhibits some life cycle stage specific functions. In PCF cells knockdown of 
TbAUK1 prevents entry into both nuclear and kinetoplast S phase; the converse 
effect is observed in BSF cells, where the nucleus and kinetoplast continued to 
replicate generating cells with large, polypoid nuclei and multikinetoplasts. In 
addition, the morphology of the BSF becomes grossly affected, with the cells 
adopting a ‘rounded’ appearance, possibly linking TbAUK1 to the control of 
microtubules; again, this effect is not observed in PCF cells (Li, Umeyama, & 
Wang, 2009). 
TbAUK1, like AUKB, localises to the centromeres and, as mitosis progresses, the 
kinase re-localises to the spindle mid-zone, both observations consistent with 
TbAUK1 being required for the movement of the CPC11 during mitosis and 
cytokinesis, and for the transition from metaphase to anaphase (Li et al. 2009). 
Recently TbAUK1 has been shown to regulate Polo-like Kinase (TbPLK1) during 
cytokinesis via a trypanosomatid specific protein known as TbCIF1; TbCIF1 
permits the recruitment of TbAUK1 to the new FAZ, allowing TbAUK1 to drive 
the initiation of cytokinesis (similar to the roles both AUKA and AUKB play in 
human cells; see sections 4.1.1.1 and 4.1.1.2 above). In the absence of TbCIF1, 
cytokinesis proceeds in the opposite direction (‘reverse cytokinesis’). 
Identification of a specific trypanosomatid AUK binding factor highlights the 
potential functional divergence of the T. brucei AUKs from those of vertebrate 
eukaryotes (Zhou et al. 2016). 
Strikingly, no phenotypes were initially observed for either TbAUK2 or TbAUK3 in 
the PCF stage after RNAi induction (Tu et al. 2006). Later, one report (Jones et 
                                         
11
 Interestingly, divergence of the CPC appears to have occurred with T. brucei, which has two 
proteins termed TbCPC1 and TbCPC2 that are distinct from the three originally described CPC 
proteins (Li et al., 2008). 
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al. 2014) suggested BSF knockdown of TbAUK3 results in a slow growth 
phenotype with arrest during mitosis and cytokinesis (an effect reproduced as 
part of a kinome RITseq screen; D.Paape and J.Stortz, unpublished). 
TbAUK2 was identified in the screen detailed in chapter 3 to have a potential 
role in cellular survival to MMS stress and in an kinome wide RITseq screen as a 
kinase potentially required for survival in mice in vivo (Fernandes-Cortez et al. 
2016, in preparation). These observations represent the first description of any 
roles for TbAUK2 in BSF T. brucei. 
4.3 Research Aims 
RNAi Knockdown of TbAUK2 did not significantly alter cell proliferation except 
following exposure to MMS. The aim of this chapter was to further probe the 
function of TbAUK2 by generating knockout mutants in BSF cells and localising 
the protein. 
4.4 Results 
4.4.1 Bioinformatics analysis 
TbAUK2 is encoded for by the gene Tb927.9.3920 (TritrypDB v.28), predicting a 
protein of ~42.1 kDa (380 amino acids). TbAUK2 orthologs can be found across 
the kinetoplastid phylum, as ascertained from the genomes available in 
TriTrypDB (v.28). 
4.4.1.1 BLAST analysis of TbAUK2 
TbAUK1 is considered the homolog of the human aurora kinase AUKB (Tu et al. 
2006).To identify genes with potential homology to TbAUK2, the protein 
sequence of TbAUK2 was used as a query sequence and analysed using the 
BLASTp algorithm (BLOSUM62; version; BLASTp 2.3.1; 
http://blast.ncbi.nlm.nih.gov/Blast.cgi). The sequence was compared against  
all non-redundant (nr) protein sequences available in the NCBI database (Li et 
al. 2013) and analysed using the ‘SmartBLAST’ feature (NCBI; currently under 
development) as described in section 2.1.2. 
Chapter  4  142 
 
 
The top five ‘hits’ (in addition to the original reference sequence) identified are 
indicated in Table 4-1 (a list of additional hits from the SmartBLAST analysis are 
summarised in chapter 8, section 8.3, Table 8-4). TbAUK2 is conserved across 
the kinetoplastid phylum. One of the top hits beyond the kinetoplastids was H. 
sapiens AUKA (NP_003591.2; E-value = 6e-53), suggesting TbAUK2 may be 
homologous to this AUK. In support of this, TbAUK2 also showed highest levels of 
sequence homology to aurora A kinases in other eukaryotes, for example to 
AUKA (36%) in the Mus musculus (5e-52; NP_001278114.1) and Aurora A (36%) in 
the D. melanogaster (1e-51; NP476749.1). In contrast, homology to AUKB and 
AUKC homologues was slightly lower.
 
Table  4-1: Top five SmartBLAST ‘hits’ for TbAUK2 in the NCBI database 
(http://www.ncbi.nlm.nih.gov/). All data was recovered in June 2016. 
4.4.1.2 TbAUK2 harbours kinase specific motifs 
Protein kinases have several sequence motifs required to facilitate their kinase 
activity (as discussed in section 1.5).To ask if TbAUK2 harbours these conserved 
motifs, the TbAUK2 protein sequence was aligned against a human kinase (c-Src) 
using the Kinase Sequence Database (http://sequoia.ucsf.edu/ksd/) and against 
human AUKA (as an example of a typical aurora kinase). The resulting alignment 
was viewed using CLC genomic Workbench 7 (chapter 8, section 8.3, Figure 8-8). 
TbAUK2 contains most typical features of a protein kinase, though the GxGxxG 
motif lacks the final ‘G’ (G170; replaced with an S). Such non-canonical GxGxxG 
motifs have been reported in several other kinases, such as human TLK1 and 
TLK2 (Silljé et al. 1999) and in the MAP Kinase (LF4) in Chlamydomonas 
reinhardtii (Berman, Wilson, Haas 2003). Since all such proteins have kinase 
activity, the motif divergence does not necessarily infer compromised kinase 
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function in TbAUK2. The activation loop of all three T. brucei AUKs was 
predominantly conserved (chapter 8, section 8.3, Figure 8-8 and Figure 4-4), 
though in the case of TbAUK2, a conserved motif associated with aurora kinases 
is lacking. 
AUKs in other eukaryotes harbour specific conserved sequence motifs required 
for regulation of their activity (Fu et al. 2007; Lindon et al. 2016).To look for 
these conserved motifs in all T. brucei AUKs, their protein sequences were 
retrieved from TriTrypDB (v.28; TbAUK1 [Tb927.11.8220], TbAUK2 
[Tb927.3.3920] and TbAUK3 [Tb927.9.1670]) and compared with the protein 
sequences for each human AUK (retrieved from the NCBI database; AUKA 
[NP_003591.2], AUKB [NP_001300879.1] and AUKC [NP_003151.2]). The aligned 
sequences were examined in CLC genomics Workbench 7 and a summary of the 
motifs that were sought and their conservation is provided in Figure 4-4. 
The ‘DAD-box’ is a type of ‘A-box’ motif required to control AUKA degradation 
during late M-G1 (Castro et al. 2002). Degradation of AUKA additionally requires 
a C-terminally located ‘D-box’, without an associated ‘KEN’ motif (Crane et al. 
2004). In contrast, AUKB requires both a KEN motif and an A-box in order to be 
degraded during M-G1 (though the timing of this differs from AUKA; (Stewart & 
Fang 2005; Lindon et al. 2016). The requirements and pathways to degrade AUKC 
are as yet unpublished. All AUKs of T. brucei were missing several of these 
motifs. No KEN motif could be detected, and nor could a DAD-box or A box be 
identified, in any TbAUK. Only a D-box motif could be identified, and in each 
TbAUK. However, the mode of action of this motif for regulating AUK expression 
usually requires an additional N-terminal motif (the A-box or DAD box motif; 
Lindon et al., 2016), which is a feature the T. brucei aurora kinases lack 
(discussed below). 




Figure  4-4: T. brucei aurora kinases lack sequence motifs typical of eukaryotic AUKs 
(A) The conserved regulatory motifs of aurora kinases in H. sapiens, their consensus 
sequence and in which aurora kinase the motif is present, and their likely conservation in T. 
brucei AUKs.  (B) An illustration of the approximate location of sequence motifs identified in 
human (Black box) and trypanosomatid AUKs (below), and their position relative to the 
conserved kinase domain (red box). Not to scale. 
4.4.1.3 The T. brucei Aurora Kinases 
TbAUK2 has ~31% sequence identity to TbAUK1 (E-value = 4e-38) and ~32% to 
TbAUK3 (E-value = 2e-33). From the simplified alignment in Figure 4-5 (a detailed 
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alignment is available in chapter8, section 8.3, Figure 8-9), the three T. brucei 
AUKs show a similar pattern of conservation to the human AUKs, with notable 
homology across most of the length. However, TbAUK3 appears to have an 
extended C-terminal region with little to no homology to the other T. brucei 
AUKs, consistent with this protein being the largest (with a predicted size of 
~72.3 kDa; TbAUK1 is ~35.5 kDa). The potential function of the C-terminal 
extension in TbAUK3, which is not seen in any of human AUKs, is unknown. 
 
Figure  4-5: A simplified alignment of the three T. brucei aurora kinases 
The amino acid sequences for each kinase (retrieved from TriTrypDB.org, V 28) were 
aligned in CLC Genomics Workbench 7. The solid black lines represent regions of 
alignment. The lower bar shows the level of sequence conservation in that particular region. 
Conservation is illustrated as a gradient; the brightest red colour reflects 100% 
conservation and the blue colour represents 0% conservation. 
4.5 Generation of TbAUK2 null mutant cell lines 
Aurora kinases in other organisms are required for cell viability (Vader & Lens 
2008). In contrast, RNAi of TbAUK2 suggests this gene is not required for survival 
under in vitro conditions. To test this, mutants lacking the TbAUK2 gene were 
generated. The constructs and strategy applied to generate knockout cell lines is 
detailed in chapter 2 section 2.4.1.2. Briefly, the majority of the ORF was 
replaced with antibiotic resistance cassettes by integration of knockout 
constructs by homologous recombination following transformation. Figure 4-6 
illustrates the regions used for homology driven recombination of TbAUK2 
knockout constructs after transformation. 
 
Figure  4-6: Schematic illustration of homology regions required for TbAUK2 knockout 
A region of the 5’UTR (including part of the Open Reading Frame (ORF) and a region of the 
3’UTR (Untranslated Region, and including part of the ORF) were amplified by PCR (black 
arrows show primer positions in the genome). The primer numbers are highlighted in 
brackets beside the expected fragment sizes for the two PCR products; bp (base pairs). The 
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amplified regions were cloned into knockout vectors (as per section 2.2). Primer sequences 
are available in section 2.4.1.2. Not to scale. 
4.5.1 Gene knockout strategy 
Disruption of the TbAUK2 ORF (deleting 834 bp, from amino acids 75 to 353) was 
achieved sequentially through two rounds of transformation into wild type (WT) 
BSF T. brucei Lister 427 cells. WT cells were first transformed with the construct 
ΔAUK2::BSD to produce putative heterozygote cell lines (+/-).One validated 
clone (TbAUK2+/-) was chosen for a second round of transformation with the 
construct ΔAUK2::NEO and neomycin clonal transformants selected (using G418). 
At this stage, the selective antibiotics were removed from the media due to the 
slowing of growth observed in the presence of G418 (data now shown). 
4.5.2 Integration of knockout constructs and confirmation of 
knockout clones using PCR analysis 
To confirm the generation of TbAUK2+/- and TbAUK2-/- cell lines, putative +/-and 
-/- clones were harvested and their gDNA extracted. PCR analysis was performed 
to confirm absence of the ORF and the correct integration of both knockout 
constructs. Figure 4-7 shows the PCR strategy and agarose gels of PCR on the 
clones examined. As the +/- cell line was generated by integration of the 
ΔAUK2::BSD construct, diagnostic PCR amplification was seen for this construct 
but not for  the ΔAUK2::NEO construct, and PCR amplification of the TbAUK2 
ORF was seen. No PCR amplification of the TbAUK2 ORF was detected in the 
putative -/- clones, whereas diagnostic PCR amplification of both integrated 
constructs was observed, suggesting the expected deletion of the TbAUK2 ORF 
had occurred. The white arrows indicate the two -/- clones chosen for further 
analysis (referred to as TbAUK2-/- CL1 and TbAUK2-/- CL2). 




Figure  4-7: PCR analysis of putative TbAUK2 null mutant and heterozygote clones 
(Top) Schematic illustration of expected fragment sizes amplified by PCR (bp), diagnostic 
primers used (black arrows) and their position in the genome. Primer sequences are 
available in Table 2-3 section. Not to scale. (Below) Agarose gels of diagnostic integration 
PCRs, which were performed using the primer pairs detailed in A (testing for integration of 
NEO or BSD, or testing for the presence of intact ORF) using gDNA from five -/- clones (B1-
B3, B5 and B6), wild type (WT) cells, heterozygote +/- cells, or using double distilled water 
(ddH2O) as a negative control. All PCRs were performed on the same gDNA samples. NEO 
(Neomycin), BSD (Blasticidin), B/α tub (Beta/Alpha Tubulin), Actin IR (Actin intergenic 
region), gDNA (genomic DNA). For each gel, size markers are shown (bp). White arrows 
indicated clones used for further analysis (B3 referred to as CL1 and B6 referred to as CL2 
in the remainder of this chapter). 
4.5.3 Confirmation of knockout clones using qRT-PCR analysis 
To test for loss of TbAUK2 expression in both knockout clones, qRT-PCR and PCR 
analyses were performed on cDNA prepared as described in chapter 2 section 
2.5. Relative to the WT cells (where the level of RNA was arbitrarily set to 100 
%; Figure 4-8), the TbAUK2+/- cell line had ~50 % less RNA transcript, whereas in 
both knockout clones, no RNA transcript could be detected. To test this further, 
end-point RT-PCR was used to attempt to PCR amplify a region of the ORF (~280 
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bp) (Figure 4-8, right panel). This region of the ORF failed to PCR amplify from 
cDNA from either knockout clone, but PCR amplified from both WT and 
TbAUK2+/- cells. To confirm the presence of cDNA, a control PCR (which 
amplified a region of the Tb927.9.6560 gene) was performed and PCR 
amplification occurred in the knockout cDNAs. PCR from samples treated in the 
same way but lacking RT enzyme showed the PCR products were derived from 
cDNA and not gDNA. 
 
Figure  4-8: Confirmation of AUK2 knockout clones by qRT-PCR and RT-PCR analysis 
RNA from each cell line was prepared from which cDNA was generated. qRT-PCR (results 
shown on the left graph) was performed to examine expression level of TbAUK2 in WT, 
heterozygote (+/-) and knockout (-/-) cell lines using primers AUK2RTFW2 and AUK2RTRV1 
(Table 2-5 detailed in section 2.5.3.1. Expression of TbAUK2 in the WT was arbitrarily set to 
100% expression. The agarose gel image on the right shows end-point RT-PCR performed 
on the same cDNA. An RT- (-) control was included to control for gDNA contamination. A 
control PCR was performed to confirm validity of the cDNA (top image). The primers used 
are detailed beside the gel image, including the expected fragment size. White space 
between images represents images from different sections of the gel aligned. Sizes shown 
(kb plus ladder, bp). cDNA (complementary DNA), qRT-PCR (quantitative real time PCR), rt – 
(reverse transcriptase negative), n=2 (except for TbAUK2-/- CL1, n = 1). 
4.5.4 Phenotypic analysis of TbAUK2 -/- knockout mutant 
4.5.4.1 Growth analysis and cell cycle analysis by DAPI in vitro 
To ask whether loss of TbAUK2 was detrimental to cell survival, growth of both 
TbAUK2-/- clones (CL1 and CL2) was assessed relative to WT and TbAUK2+/- cells. 
Growth curves were performed as per section 2.8.1 and are shown in Figure 4-9 
A. No antibiotics were added to the media to ensure any effect on growth could 
not simply be attributed to the presence of a selective drug. 




Figure  4-9: Growth and cell cycle analysis of TbAUK2 knockout clones 
(A) Growth of TbAUK2 knockout clones (CL1 shown by a dashed blue line [top graph]; CL2 
shown by a dashed orange line [bottom graph]) was assessed by counting every 24 hours 
for 72 hours and plotted on a logarithmic scale alongside the growth of WT (solid black line) 
and TbAUK2 +/- cells (solid blue line [top graph] or solid orange line [bottom graph]). Error 
bars indicate ± SEM (n=3). (*) = p<0.05, (**) = p<0.005. Significance was assessed using a 
Mann Whitney U test (B) Cell cycle analysis. Cells were fixed and stained with DAPI, each 
cell type counted and plotted as a percentage of the total number of cells (n= >200 
cells/experiment; n=3). Error bars represent ± SEM. Aberrant cells were classified as ‘other’ 
based on DAPI content alone. (*) = p<0.05, (**) = p<0.005, WT cells at each time point 
compared with the TbAUK2 -/- clone; Mann Whitney U test. (C) Representative images of 
cells from the TbAUK2 -/- CL1 cell line. Cells were fixed and stained with DAPI (see section 
2.11.1 and 2.11.2; cyan) and α-KMX1 antiserum (to detect tubulin; magenta). Highlighted in 
the box are cells conforming to the normal 1N1K, 1N2K or 2N2K categories. Below are cells 
representative of the range of ‘others’ observed. Images captured on a DeltaVision 
microscope, de-convolved and processed as per section 2.11.8. Scale bar = 5 μm. 
The TbAUK2+/- cell line showed no significant effect on growth when compared 
with WT cells. However, in contrast to the results of the TbAUK2 RNAi 
knockdown (chapter 3), both TbAUK2-/- clones showed a significant reduction 
(p<0.05) in growth relative to WT. In the time frame of these experiments the -
/- cells did not reach the same maximal density seen for WT cells, and the slope 
of the growth curves indicated increased population doubling times (with an 
approximate doubling time of 10 – 11 hrs for both clones compared to 7 – 8 hrs 
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for the parental WT427 cell line; see section 2.7.4 for the mathematical 
formula). 
Loss of aurora kinases is also associated with cell cycle arrest in other organisms 
(Vader & Lens 2008).To ask whether the above growth impairment may be 
explained by an altered cell cycle in the -/- mutants, cells were prepared for 
indirect IF (as described in section 2.11.1 and 2.11.2) and stained with DAPI (to 
visualise the nDNA and the kDNA) and α-KMX1 antiserum (to visualise tubulin and 
thus the cell body). The cell cycle stage of individual cells in the population was 
assessed as described in chapter 3 section 3.3.5, and the data is represented in 
Figure 4-9 B. Any cell that did not conform to normal cell cycle stages with 1n1k, 
1N2K or 2N2K DNA content, as detected by DAPI, (section 2.11.1) were classified 
as ‘other’. No significant change in the proportion of the population that were 
either 1N2K or 2N2K cells was observed, suggesting progression into S phase and 
through mitosis was unchanged. However, a pronounced loss of 1N1K cells was 
observed that correlated with a significant increase in the number of cells with 
aberrant DNA content. Approximately 30 % of the cells (consistent in both 
clones) had aberrant nDNA and kDNA ratios, such as 0N1K or 1N0K. In addition, 
cells with observably aberrant nDNA staining were seen, perhaps suggesting 
abnormal division of the nucleus. Several nDNA aberrancies manifested: nuclear 
‘blebs’ (see below), one nuclei appearing smaller than the other (in 2N2K cells), 
cells with enlarged, misshapen nuclei, or cells with faintly stained, small nuclei. 
In addition, cell ‘clumps’ could be observed (discussed in section 4.10.2; see 
Figure 4—C for examples of aberrant cell types), where it was difficult to discern 
nDNA and kDNA content. Taken together, the diverse, predominantly nuclear-
focused phenotypes of the aberrant cells appear to indicate important, 
potentially widespread nuclear functions for TbAUK1. As the mutants appear 
unperturbed during progress from G1-S-G2 (based on the DAPI cell cycle data), 
the phenotypes indicate mitotic deficiency. Furthermore, the presence of cells 
with aberrant DNA suggests cytokinesis can occur even with inaccurate genome 
segregation, suggesting the absence of a G2/M or M/cytokinesis checkpoint. 
However, the identification of cell clumps may suggest activation of a 
checkpoint at cytokinesis in some circumstances. 
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Based on the above analysis, the role of TbAUK2 appears to overlap (at least in 
part) with the functions of TbAUK1. For example, RNAi of TbAUK1 in BSF cells 
predominantly results in multinucleated and multi kinetoplast cells (Li & Wang 
2006); these cells can be observed in the absence of TbAUK2, though multi-
kinetoplast cells were not predominant. However, as TbAUK2-/- mutants are 
viable, TbAUK2 may be subservient to TbAUK1 or required for different purposes 
during the cell cycle. In this regard, why a small population of -/- cells display 
abnormalities is unclear. 
4.5.4.2 Analysis of the nucleus by DAPI counting and Electron microscopy 
Loss of TbAUK2 results in ~30 % of the total cell population having aberrant 
nuclear content. Two different methods of imaging were performed to 
investigate this observation further. First, transmission electron microscopy 
(TEM) was performed to examine the nuclear ultrastructure of WT, TbAUK2+/- 
and TbAUK2-/- cells (CL2 was used for this analysis). The samples were harvested 
and fixed as described in section 2.11.7.2. Figure 4-10 depicts representative 
images from this analysis (additional images are available in chapter 8, section 
8.3, Figure 8-10, including cells whose structure was difficult to interpret: 
‘unclear phenotype’) and the results of this comparison are summarised in Table 
4-2. 
 
Table  4-2: TEM imaging of cells lacking TbAUK2 reveals nuclear defects 
Nuclei of cells imaged by TEM were examined and categorised depending upon the extent 
of the nuclear defect, n=1. 
The majority of the WT cells (~89 %) had no observable nuclear defect except in 
the case of two cells; one cell had large electron dense vesicles in its nucleus 
and the other presented an unusual arrangement of membranes within the 
nucleus. In the TbAUK2-/- cell line, ~48 % of the cells had no observable nuclear 
defect, meaning 52 % were aberrant. ~6 % of these cells (2) could not be 
classified, due to extensive morphological divergence from the WT cells; indeed, 
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no clear nucleus could be observed in one of these cells. Approximately 19% of 
the cells had observable nuclear defects, including intra-nuclear membranes, 
the presence of electron dense vesicles in the nucleus and, potentially, cells 
with nuclei of differing sizes. In ~27 % of cells nuclear ‘blebbing’ could be seen 
(see below for further analysis). 




Figure  4-10: Representative examples of nuclei imaged by TEM from TbAUK2 -/- cells 
Representative example of nuclei from WT (top left), TbAUK2+/- (top right) and TbAUK2 -/- 
CL2 cells (lower two images). Highlighted in the black boxes are close up images of a 
nucleus with an unusual arrangement of nuclear membranes (lower left), or with a nuclear 
‘bleb’ (lower right). Scale bar sizes are indicated on each image. Further processing and 
imaging of the samples was kindly conducted by L.Lemgruber Soares. 
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A higher percentage of aberrant nuclei were imaged by TEM in the knockout 
cells than were detected in the cell cycle analysis. This could potentially be 
attributed to two factors. Firstly, a smaller data set was available for the EM 
analysis; over 200 cells were imaged for the cell cycle analysis, in contrast to 31 
imaged by TEM. Secondly, DAPI staining might not reveal the presence of all 
defects within the nucleus, such as nuclear membrane defects 
To examine further the proposed nuclear blebbing in the -/- mutants, since this 
was potentially a predominant phenotype, high resolution images of the nuclei 
from WT, TbAUK2 +/- and both TbAUK2 -/- clones were captured on a DeltaVision 
microscope. To quantify the extent to which blebs form in the cells, over 200 
images were examined in each case. Here, only cells with discernible nuclear 
blebs were considered: cells with aberrant nuclei but no apparent nuclear blebs 
were placed in the ‘no-bleb’ category, which also included cells with apparently 
normal nuclei. These data are graphed in Figure 4-11, which also provides a 
representative image of a nuclear bleb (Figure 4-11 below the graph). 




Figure  4-11: Loss of TbAUK2 is associated with nuclear ‘blebbing’ 
Over 250 cells were imaged and examined for the presence of nuclear ‘blebs’. Cells were 
scored either as ‘bleb’ or as having ‘no bleb’. Each category is expressed as a percentage of 
the total cell count (n=1). Outlined in the black box are representative examples of the two 
cell categories (DAPI; cyan). Images were captures on a DeltaVision microscope, de-
convolved and processed as per section 2.11.8. Scale bar = 5 μm. 
Cells with nuclear blebs were rare in the WT cells, amounting to only ~2 % of 
those examined. Cells with nuclear blebs were around 10-fold more common in 
the TbAUK2 -/- cells, accounting for 20-23 % of the population. Intriguingly, ~12 % 
of TbAUK2 +/- cells appeared to have nuclear blebs, indicating loss of one allele 
may be detrimental. These data appear consistent with the TEM data, though 
whether the blebs indicate simply loss of nuclear membrane integrity or reflect 
underlying changes in chromosome content is unclear. 
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4.5.4.3 Loss of TbAUK2 is associated with loss of mitotic spindle formation 
Mammalian AUKA and AUKB are implicated in formation of the mitotic spindle 
(Asteriti et al. 2015; Mountzios et al. 2008). To ask if the phenotypes above may 
derive from altered mitotic spindles in TbAUK2-/- cell lines, indirect IF analysis 
was performed as per section 2.11.2. WT, TbAUK2+/- and both TbAUK2 -/- clones 
were stained with DAPI (to visualise the nDNA and kDNA) and α KMX-1 (to 
visualise the spindle). Images were captured on a DeltaVision microscope and 
the number of 1N2K cells with/without a spindle were counted and expressed as 
a percentage of the total population. This data is represented in the graph 
below (Figure 4-12 A). Representative images of a mitotic spindle (in WT cells) 
and of a TbAUK2 -/- CL1 cell lacking a detectable mitotic spindle (despite 
elongation of the nucleus) are shown in the black box (Figure 4-12 B). 




Figure  4-12: Loss of TbAUK2 is associated with loss of the mitotic spindle 
(A) Analysis of the mitotic spindle of 1N2K cells in WT, TbAUK2+/- and TbAUK2-/- cells. 
Images of 1N2K cells were captured as per section 2.11.2 and 2.11.8 and categorised 
depending upon the presence (spindle) or absence of (no spindle) of a mitotic spindle by 
staining with α KMX-1 antiserum. The counts were represented as a percentage of the total 
cells examined (n=1). The number of cells counted per cell line is indicated above the 
corresponding bars. (B) Representative images of a WT cell with an intact mitotic spindle 
(indicated by the white arrow) and a TbAUK2-/- cells without a detectable spindle (upper 
panel) and with a detectable spindle (lower panel; indicated by a white arrow). The nDNA 
and kDNA were visualised by DAPI (magenta) and the mitotic spindle using α KMX-1 
antibody (green). Scale bar = 5 μm. Images captured on a DeltaVision microscope, de-
convolved and processed as per section 2.11.8. 
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In previous work, approximately 50% of 1N2K WT cells have a clear oval-shaped 
nuclear spindle (Tu et al. 2006), which is comparable with ~44% of WT 1N2K cells 
in this experiment. The relative number of cells with and without detectable 
spindles appeared unchanged in the TbAUK2+/- cell line. However, in both 
TbAUK2 -/- clones only ~20-25% of 1N2K cells had an observable mitotic spindle, 
with the majority of cells not staining for this structure. The ~50% reduction in -
/- cells with a spindle relative to WT and TbAUK2+/- cells is in keeping with a 
potential role for TbAUK2 during nDNA mitosis, and may account for the 
appearance of aberrant nuclei; lack of a mitotic spindle may result in miss-
division of the chromosomes during mitosis. 
4.5.4.4 Morphological analysis of the TbAUK2 -/- knockout mutants 
In cell lines lacking aurora kinases, cell morphology routinely becomes distorted 
(Huck et al. 2010; Tao et al. 2008; King 2008; Ritchey & Chakrabarti 2014). 
Here, a proportion of the TbAUK2-/- cells appeared to have lost typical 
trypomastigote morphology, manifesting as either rounded cells (akin to those 
described for TbAUK1 (Li & Wang, 2006), multinucleated clumps, or cells which 
did not present with a specific classifiable morphology (‘aberrant’). To examine 
this further, morphology of the knockout cells was compared with WT and 
TbAUK2+/- cells, evaluating cells shape by DIC imaging. These data are graphed 
in Figures 4-13 A and B (original cell numbers available in the accompanying CD 
in the excel file labelled Cellcountmasterspreadsheet.xls; this spreadsheet 
encompasses all the raw counts from each chapter). 
Only approximately 4 % of WT cells could be classified as morphologically 
defective, a proportion that appeared to increase to ~8 % of the TbAUK2+/- cells. 
Strikingly, in both knockout clones ~33-39 % of the population was 
morphologically defective, a similar proportion to those observed with aberrant 
DNA content (see above; Figure 4-13 A). To further understand these 
morphological defects, the aberrant cells in each cell line were further classified 
into three categories (‘rounded’, ‘multinucleated clumps’ and ‘aberrant’), 
depending on their visual appearance (Figure 4-13 B). Figure 4-13 C depicts a 
representative field of view image from TbAUK2 -/- CL2 and, below, a 
representative image for each category. The predominant morphological defect 
present in WT cells were those with an unclassifiable morphology (‘aberrant’, 
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~85 %). These cells also predominated the morphologically defective TbAUK2+/- 
cells. In the knockout cell lines again a further significant increase in cells with a 
‘rounded’ morphology were observed (~35-36 %), though the predominant 
morphological defect remained aberrant cells. 




Figure  4-13: Loss of TbAUK2 is associated with aberrant cell morphology 
(A) Cells were examined and any with morphology which did not conform to the 
trypomastigote shape were considered as having morphological defects (expressed as a 
percentage of the total cell counts; n=3). Over 200 cells/experiment were counted for this 
analysis. Error bars represent ± SEM. Significance was assessed by a Mann Whitney U test 
(B) Cells with morphological defects were further classified into three categories depending 
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upon their appearance; rounded, clumps or aberrant. Each category is shown as percentage 
of the total number of cells with morphological defects, as shown in (A). Over 200 
cells/experiment were counted for this analysis (n=3). (**) = p<0.005; rounded cells from WT 
and the appropriate TbAUK2 -/- clone were examined by a Mann Whitney U test. Error bars 
represent ± SEM. (C) Representative field of view of DAPI (to visualise nDNA and kDNA; 
cyan) and αKMX-1 (to visualise βtubulin; magenta) stained cells from the TbAUK2 -/- CL2 
cell line. In the black box is a representative example of the typical trypomastigote shape. 
Below are representative images from each aberrant morphology categories. Scale bar = 
5μm. Images were captured on an Axioskop2 microscope (Zeiss) and processed in ImageJ 
(as per section 2.11.8). 
From this analysis, loss of TbAUK2 affects cellular morphology at a level 
consistent with the percentage of DNA defects observed, perhaps suggesting that 
cells with aberrant nuclear DNA account for the cells with aberrant morphology. 
Why loss of TbAUK2 results in increased levels of notably rounded cells is 
unclear, but, in addition to loss of the mitotic spindle, TbAUK2 deficient cells 
might potentially lose other structural filaments, since aurora kinases have been 
linked to maintenance of cell structure via interactions with microtubules 
(Ritchey & Chakrabarti 2014). 
4.6 Analysis of the sensitivity of the TbAUK2 -/- knockout 
clones to DNA damaging 
Loss of aurora kinases is associated with increased sensitivity to genotoxic agents 
(Wang, Liu, Jin, Fan, & Zhan, 2006). In human cells, downregulation of AUKA (by 
RNAi) sensitises the cells to genotoxic agents such as UV, cisplatin (Wang et al., 
2006) and IR (Tao et al. 2007).RNAi knockdown of TbAUK2 sensitised BSF T. 
brucei cells to MMS (chapter 3). Here, we asked whether sensitivity to MMS, and 
wider DNA damage, is also seen in the knockout cell lines. Furthermore, the 
presence of known markers of DNA damage (γH2A and RAD51) was examined. 
4.6.1 Growth analysis under DNA damage stress 
To determine whether loss of TbAUK2 sensitised the cells to a variety of DNA 
damage sources, the knockout cell lines were exposed to MMS, PHL, UV and HU 
in turn. Growth of the cells was measured and compared with WT and TbAUK2+/- 
cells. Growth curves were performed as described in section 2.8.2 and cultures 
were set up as described in section 2.8.2. The data for WT and -/- mutants at 
single doses of damage are represented in Figure 14.4; data for the TbAUK2 +/- 
cells is available in chapter 8, section 8.3, Figure 8-11. 
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Both knockout clones showed an increased sensitivity, relative to the WT, to all 
of the genotoxic agents, suggesting a wide range of damage impairs growth in 
the absence of TbAUK2; in contrast, no significant reduction in growth following 
exposure to any damage source was observed in the TbAUK2+/- cells (chapter 8, 
section 8.3, Figure 8-11). 




Figure  4-14: In vitro growth of TbAUK2 -/- cell lines following treatment with DNA damaging 
agents 
(A) Growth analysis of TbAUK2 -/- CL1 under a variety of genotoxic stress sources. MMS 
(0.0003%), UV (1500 J/m2), PHL (0.1 ug/ml) and HU (0.06mM). The data is plotted on a 
logarithmic scale. The error bars represent ± SEM. For statistical analysis, WT cells under 
genotoxic stress at the appropriate time point were compared with TbAUK2 -/- cells. (*)= 
p<0.05, (**) = p<0.005; Mann Whitney U test. (B) Growth analysis of TbAUK2 -/- CL2 under a 
variety of genotoxic stress sources. MMS (0.0003%), UV (1500 J/m2), PHL (0.1 ug/ml) and HU 
(0.06mM). The data is plotted on a logarithmic scale. The error bars represent ± SEM. For 
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statistical analysis, WT cells under genotoxic stress at the appropriate time point were 
compared with TbAUK2 -/- cells. (*)= p<0.05, (**) = p<0.005; Mann Whitney U test. 
4.6.2 Analysis of γH2A expression by IFA and western blot 
analysis 
Overexpression of AUKA in human cells may de-regulate the DDR by reducing the 
formation of γH2AX foci in cells exposed to genotoxic agents (Sun et al. 2014). 
Conversely, blocking AUKA activity resulted in an increase in γH2AX fluorescence 
(Moretti et al., 2011) whereas overexpressing AUKA under non-genotoxic 
conditions did not appear to alter γH2AX foci formation (Sourisseau et al. 2010). 
Overall, AUKA appears to regulate γH2AX expression in human cells. To ask 
whether the loss of TbAUK2 was associated with the accumulation, or conversely 
the loss of of γH2A, expression of this chromatin modification was examined by 
indirect IF (as described in section 2.11.2) and western blot analysis (as 
described in section 2.12.1). In all cases WT, TbAUK2 +/- and TbAUK2 -/- CL1 and 
CL2 whole cell extracts or slides were probed with α-γH2A antiserum (kind gift; 
T.Donatelli Serafim) in the absence of exposure to DNA damage. From Figure 4-
15 A and B an increase in the number of cells with detectable anti-γH2A signal 
was seen in both knockout clones, and the cells with such signal were frequently 
morphologically aberrant. The α-γH2A signal appeared mainly as diffuse signal 
throughout the nucleus, without clear nuclear foci, such as seen after induced 
damage (Glover and Horn, 2012). Indeed, occasionally such a signal was seen in 
WT cells. Western blot analysis confirmed the increased signal in the IF, with a 
notably more abundant putative γH2A band of ~14.2 kDa in the -/- mutants. The 
fold change was calculated relative to the level in WT cells, revealing that 
expression of γH2A was ~3 fold higher in CL1 and ~7 fold higher in CL2, with 
little evidence for accumulation of γH2A in the +/- cells (Figure 4-15 C). Loss of 
TbAUK2 therefore appears to result increased nuclear DNA damage, or extended 
accumulation of unrepaired damage. 




Figure  4-15: Loss of TbAUK2 is associated with increased γH2A expression 
(A) Representative field of view images from WT (black box) and TbAUK2 -/- (below) cells 
stained with DAPI (to visualise the nDNA and kDNA; cyan) and γH2A (to visualise 
phosphorylated H2A; red). Scale bars = 10 μm. Images captured on an Axioskop2 and 
processed in Image J as per section 2.12.5. (B) Representative western blot of whole cell 
extracts from WT, TbAUK2+/- and TbAUK2 -/- cell lines. The membrane was probed with 
γH2A antibody to detect phosphorylated H2A. EF1α was used as a loading control. White 
space denotes images from different areas of the same blot re-aligned. (C) Quantification of 
western blot signal using ImageJ (as per section 2.11.8.3) and expressed as the fold change 
relative to WT cells. Error bars represent ±SEM, n=2. 
4.6.3 Analysis of RAD51 foci formation 
To evaluate further the nature of the increased nuclear DNA damage in the 
TbAUK2-/- cells, localisation of RAD51 was next examined. Overexpression of 
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AUKA in human cells blocks RAD51 recruitment in the presence of a DSB; a 
function that AUKA performs in addition to its role during the cell cycle 
(Sourisseau et al. 2010; Y. Wang et al. 2014; Katsha et al. 2015). To investigate 
RAD51 localisation in the absence of TbAUK2, indirect IF analysis was performed 
on WT cells, TbAUK2 +/- cells and both TbAUK2 -/- clones. In addition, WT cells 
were treated for 18 hrs with PHL to induce DNA damage, as a positive control for 
the formation of RAD51 subnuclear foci, as has been described previously (Devlin 
et al. 2016). The cells were probed with an anti-RAD51 antiserum, which 
predominantly produces a diffuse signal throughout the cell in the absence of 
induced damage (Figure 4-16 B). In only ~1% of WT cells could subnuclear RAD51 
foci be observed, as scored by counting the number of cells in the population 
with one or more discrete, punctate spots in their nucleus (Figure 4-16 A). 
Treatment with PHL increased the number of WT cells with RAD51 foci to ~23% 
of the population, consistent with previous work (Dobson et al. 2011; Hartley & 
McCulloch 2008). 




Figure  4-16: Loss of TbAUK2 is associated RAD51 foci formation 
(A) RAD51 foci formation. Over 200 cells were counted for each cell line. The numbers of 
cells with RAD51 foci in their nuclei are shown expressed as a percentage of the total cell 
population. Error bars represent ± SEM (n=3). (*) = p<0.05, (**) = p<0.005 (Mann Whitney U 
test). (B) Representative images of cells with RAD51 foci. Cells were fixed and probed with α 
RAD51 antiserum (red). nDNA and kDNA were visualised by DAPI (cyan). Images were 
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captured on a DeltaVision confocal microscope, de-convolved and processed in ImageJ as 
per section 2.11.8. Representative -/- cells lacking TbAUK2 are shown in the panel below the 
black box. In the black box are WT cells grown in the absence of PHL (top images) or the 
presence of PHL (lower set; control). Scale bar = 5 um. White arrow indicated RAD51 foci 
formation. 
No change in the proportion of TbAUK2 +/- cells with RAD51 foci was observed. 
However, in the knockout cells, up to~9% of the population had RAD51 foci, 
suggesting the absence of TbAUK2 results in pronounced accumulation of nuclear 
damage to which RAD51 localises. Notably, in some cases RAD51 foci were seen 
where clear nuclear DAPI staining was absent, suggesting these cells may 
harbour aberrant nuclei. 
4.7 Localisation of TbAUK2 
Aurora kinases in other organisms show dynamic patterns of localisation in the 
nucleus (section 4.1.1). To examine this in T. brucei, TbAUK2 was endogenously 
epitope tagged and the functionality of the tagged protein evaluated. 
4.7.1 Generation of a TbAUK2+/-12myc cell line 
The construct Tb927.3.392012myc (generated as per section 2.4.1.1.1) was first 
transformed into WT cells. The knockout construct (ΔAUK2::NEO; section 
2.4.1.2) was subsequently transformed into putative endogenously tagged cells. 
Both constructs were prepared for transformation as described (section 2.2.9). 
Putative heterozygote tagged clones were selected for described in section 
2.7.4. 
4.7.2 Confirmation of a TbAUK2+/-12myc cell line 
To confirm deletion of one allele and retention of the endogenously tagged 
allele, the putative TbAUK2+/-12myc clones were analysed by, first, western blot 
analysis (as per section 2.12.1). As shown in Figure 4-17 B all clones still 
expressed a protein of ~ ~56 kDa that is recognised by anti-myc antiserum. This 
size is consistent with myc-tagged TbAUK2 (14.4 kDa myc epitope + 42.1 kDa 
Tb927.3.3920). Secondly, integration of the ΔAUK2::NEO construct was 
undertaken by PCR analysis (as detailed in Figure 14-17 A). Five of the six 
transformants examined expressed putative myc-tagged TbAUK2 and had 
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correctly integrated the knockout construct (Figure 4-17 C). Two clones were 
chosen further analysis (TbAUK2+/-12myc CL1 and TbAUK2+/-12myc CL2). 
 
Figure  4-17: Confirmation of TbAUK2 heterozygote endogenously tagged cell lines 
(A) Schematic illustration of the PCR analysis performed on putative heterozygote tagged 
clones. Primer position in the genome is indicated by a black arrow, primer number is 
shown in brackets beside the expected fragment size. Not to scale. (B) Western blot 
analysis of putative heterozygote tagged clones. Western blot analysis was performed on 
whole cell lysates. Lysates from WT cells and the original endogenously tagged cell line 
were run as – and + controls, respectively. The membrane was probed with α myc antibody. 
EF1 α was used as a loading control. Two clones were chosen for further analysis (indicated 
by the white arrows). (C) Agarose gel showing the PCR analysis testing for integration of 
the ΔAUK2::NEO construct into the genome of putative heterozygote tagged cell lines. 
Double distilled water was used as a negative control. All PCRs were performed on the 
same gDNA sample. NEO (Neomycin), B/α tub (Beta/Alpha Tubulin), Actin IR (Actin 
intergenic region), WT (Wild type), gDNA (genomic DNA), ddH20 (double distilled water). (+/-
) TbAUK2+/- cell line, (+/+12myc) original endogenous tag cell line. Sizes shown (kb plus 
ladder; bp). 
4.7.3 Confirmation of C-terminal tag functionality by assessment 
of growth in vitro 
To ask whether C-terminal tagging of TbAUK2 disrupted function, growth of both 
the TbAUK2+/-12myc clones was examined and compared to WT and TbAUK2+/- 
cells. In addition, growth was assessed under MMS stress conditions. If gene 
function was interrupted, it was hypothesised that the TbAUK2+/-12myc cell line 
would show a similar growth phenotype to the knockout cell lines, assuming that 
only the tagged allele is present. This analysis was performed as detailed in 
section 2.8.2. As depicted in Figure 4-18, growth of the TbAUK2+/-12myc clones in 
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the absence or presence of MMS was not significantly affected in comparison to 
the WT cells, suggesting the epitope tag does not interrupt function. 
 
Figure  4-18: In vitro growth analysis of TbAUK2
+/-12myc
 cell lines 
(A) Growth analysis of TbAUK2+/-12myc cell lines. Growth was compared to WT, TbAUK2+/- 
and TbAUK2+/+12myc cells. (B) Growth analysis of TbAUK2+/- 12myc cell lines in the 
presence of MMS. Growth was compared to WT, TbAUK2+/- and TbAUK2+/+12myc cells in 
the presence of MMS (0.0003 %). Cell density was plotted on a log scale and represents data 
from one experiment. 
4.7.4 TbAUK2 is a cell cycle regulated nuclear kinase 
To evaluate the pattern of TbAUK2 localisation, indirect IF analysis was 
performed on both TbAUK2+/-12myc clones (as per section 2.11.2). WT cells were 
fixed and used as a control to account for any non-specific antibody binding or 
background fluorescence (chapter 8, section 8.3, Figure 8-12). The cells were 
stained with DAPI (to visualise the nDNA and the kDNA) and with an α-myc::FITC 
conjugated antibody (to visualise the myc epitope). DC imaging was used to 
visualise the cell body. The IF images shown in Figure 4-19 are representative 
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images from one clone (TbAUK2+/-12myc CL1; no observable differences were 
noted between clones).  
 
Figure  4-19: TbAUK2 localises to the nucleus of BSF cells 
Representative images of cells from each cell cycle stage fixed and stained with α myc to 
visualise the myc tagged TbAUK2 (green). The nDNA and kDNA were stained with DAPI 
(magenta). The cell body was visualised by DC imaging. Images were captured on an 
Axioskop 2 and processed in ImageJ as per section 2.11.8. Scale bars = 5μm. Images 
captured of TbAUK2 
+/-12myc
 CL2. 
Anti-myc signal was observed diffusely within the nucleus of all cell cycle stages 
(Figure 4-20). However, in ~10% of 1N1K cells no signal was detected (as shown 
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by the graph in chapter 8, section 8.3, Figure 8-13). This pattern of localisation 
was also observed in the PCF cells when TbAUK2 was C-terminally tagged with 
YFP (unpublished data, personal correspondence B.Akiyoshi, University of 
Oxford).Furthermore, as the cell cycle progressed, the intensity of the staining 
appeared to increase, with a greater intensity in 1N2K cells relative to 1N1K. To 
quantify this, the signal intensity for DAPI (nuclear staining) and FITC (the 
endogenous tag) was measured in Image J as per section 2.11.8.3. TbAUK2 +/-
12myc CL1 was chosen for this analysis. Based on the DAPI intensity plot, the 
tagged cells progress through the cell cycle as expected, since a significant 
increase in the DAPI signal was observed in 1N2K cells (S-phase; Figure 4-20 A) 
and this reduced in each nucleus of 2N2K cells (M) to the levels seen in 1N1K 
cells (G1). Consistent with the intensity increase of the DAPI signal during S-
phase, the signal intensity of TbAUK2 also peaked in 1N2K cells (p<0.005; n= 
253; Figure 4-20 B). Due to the weak signal of TbAUK2, several cells fell below 
background levels (this was an average of 179.6 pixels in WT cells). These cells 
were not excluded from this analysis and are thus represented in the group of 
cells showing signal lower than that of the WT background. 
 
Figure  4-20: Dynamics of TbAUK2 throughout the cell cycle 
(A) Intensity of DAPI (nDNA) was measured using ImageJ. A region of interest (21x21 pixels) 
was drawn around each nucleus and the mean pixel intensity recorded (represented by a 
‘dot’ on the graph). The error bars represent the median value and the interquartile range. 
Significance was assessed using the Kruskal-Wallis non parametric test. (*) p<0.05, (**) 
p<0.005 and (***) p<0.0005. n=253 cells, n=1. Results are shown from one experiment. (B) 
Intensity of myc was measured as described for (A). The data was plotted as per (A) and the 
statistical analysis performed as per (A). Clone used: TbAUK2
+/-12myc 
CL1. Background 
intensity in the FITC channel was found to be an average of 179.6 pixels in WT427 cells. 
The above data provide evidence for cell cycle changes in TbAUK2 expression or 
localisation, perhaps indicating regulation. The identity of the small number of 
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1N1K cells without detectable TbAUK2 staining are unknown, but they could be 
in an early stage of G1, given that none appeared to have elongated kinetoplasts 
(the cell stage which marks the entry into nuclear S-phase). Increased signal for 
TbAUK2 in 1N2K cells appears to mirror the increased quantity of nuclear DNA 
during replication. Human aurora kinases also show a cell cycle regulated 
pattern of localisation and, indeed, the localisation pattern of TbAUK2 is 
potentially most like that of AUKA in human cells, since the centralised 
localisation of AUKB and AUKC during anaphase was not detected (Figure 4-1). 
However, from the immunolocalisation to date, no discrete subnuclear TbAUK2 
localisation could be revealed. 
4.7.5 Super resolution analysis of TbAUK2 localisation and 3D 
reconstruction of localisation 
To ask if TbAUK2 adopts discrete subnuclear localisation, structure-illuminated 
super-resolution imaging (SIM) was performed. Indirect IF staining was 
performed as detailed in the section above. Images were captured on a Zeiss 
Elyra Super Resolution Microscope. WT cells were used as a control (chapter 8, 
section 8.3, Figure 8-14). 




Figure  4-21: Super resolution and 3D imaging of TbAUK2 localisation 
(A) Super resolution images of TbAUK2 localisation in BSF cells. The graphs show 
fluorescence intensity (arbitrary units; AU) plotted for both the DAPI (blue) and anti-myc 
(green) signal. The white box represents the area from which the fluorescence intensity was 
measured (using ImageJ) to generate the graph. Fluorescence intensity (as AU) is plotted 
(X-axis) over distance (μm; Y-axis). Scale bar = 5 μm. (B) 3D reconstructions of TbAUK2 
localisation. The images were generated from super resolution stack images captured on an 
Elyra (Zeiss) super resolution microscope. 3D images were generated using the IMARIS 
software (http://www.bitplane.com/imaris/imaris; V.8.2). Image on the left (scale bar = 0.1 
μm). Image on the right (scale bar = 1 μm). Images are of TbAUK2
+/-12myc
 CL2 cells. . The 
images captured and the 3D reconstructions shown in Figure 4-21 B were prepared under 
the supervision of L. Lemgruber Soares. 
Localisation of TbAUK2 in 2N2K cells could not be imaged successfully using SIM; 
as signal was detected by confocal microscopy in this population of cells, it is 
possible TbAUK2 localises diffusely in this cell cycle stage. In contrast, in 1N1K 
and 1N2K cells, a punctate pattern was observed in all cells with localisation. In 
1N1K cells, the anti-myc signal appeared as spots throughout the nucleus, while 
in 1N2K cells the localisation appeared to shift towards the centre of the 
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nucleus. These data suggest TbAUK2 is not stationary in the nucleus, but instead 
moves to different regions during the cell cycle. Despite this, TbAUK2 appears 
not re- localise as dynamically as TbAUK1, which shows a similar pattern of 
localisation to human AUKB (Carmena et al. 2009). TbAUK1 localises diffusely in 
the nucleus during interphase before progressing to the mitotic spindle during 
anaphase. TbAUK1 finally re-localises to the flagellar attachment zone prior to 
cytokinesis (Tu et al. 2006; Zhou et al. 2016). 
4.7.6 Localisation of TbAUK2 following exposure to DNA 
damaging agents 
Given the sensitivity of TbAUK2 mutants to several DNA damage sources, super 
resolution images of the localisation of TbAUK2 were next captured under MMS 
stress. Before indirect IF was performed (as per section 2.11.2), the cells were 
first exposed to PHL, MMS and UV as detailed in section 2.8.1. As no difference 
in the localisation could be detected following the generation of DNA damage by 
any of the three sources, IF images of representative localisation are only shown 
following MMS treatment in Figures 4-22 and 4-23 (using TbAUK2+/-12myc CL2; 
localisation after other sources of damage are available in chapter 8, section 
8.3, Figure 8-15). Cells were fixed and stained as per section 2.11.2. Images 
were first captured on an Axioskop 2 and processed in ImageJ as per section 
2.11.8. WT cells were used to as a control for background levels of fluorescence 
or to account for any non-specific binding of the α myc antibody. 
 
Figure  4-22: Localisation of TbAUK2 after MMS exposure 
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The cells were exposed to 0.0003 % (v/v) MMS for 18 hours before fixation and IF analysis. 
WT cells (top panel) were used as a control. The myc tag (green) was visualised using α 
myc:FITC conjugate antibody. The nDNA and kDNA were stained with DAPI (magenta). 
Scale bar = 10 μm. 
No clearly observable changes in localisation were observed following MMS 
exposure (Figure 4-22), and regions of more intense anti-myc signal appeared to 
correspond with higher DAPI staining, perhaps due to chromatin changes after 
damage. However, preliminary SIM images (Figure 4-23) appeared to suggest 
TbAUK2 forms a greater number of puncta throughout the nucleus after MMS 
treatment. Further analysis would be required to explore this observation in 
more detail. 
 
Figure  4-23: Super resolution images of TbAUK2 localisation after MMS exposure 
(A) Cells were fixed and stained as per section 2.11.2 following 18 hrs exposure to MMS 
(0.0003 % [v/v]). Cells were imaged on an Elyra (Zeiss) microscope by structure illuminated 
microscopy. The nDNA and kDNA were visualised by DAPI (blue) and the endogenous tag 
detected by α myc antibody (green). Scale bar = 5 μm. (B) 3D reconstruction of TbAUK2 
localisation following 18 hrs MMS exposure. 3D reconstruction was generated using IMARIS 
software (V8.2) as described in the figure legend above. Scale bar = 0.5 μm. Images in (A) 
and (B) are of TbAUK2
+/-12myc
 CL2. 
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4.8 Identification of potential interaction partners by 
immunoprecipitation 
Aurora kinases in other eukaryotes have a wealth of interaction partners to 
facilitate their functions within a proliferating cell (see section 4.1.1). To 
attempt to identify potential interaction partners of TbAUK2 an 
immunoprecipitation (IP) was performed as described in section 2.12.2 with anti-
myc antiserum using the myc tagged TbAUK2+/-12myc cell line. The protocol is as 
detailed in section 2.12.2; all modifications are as detailed in section 2.12.2. To 
control for non-specific binding of proteins to the Dyna beads (as prepared in 
section 2.12.2), WT cells were used as a negative control. No attempt was made 
to perform this IP after DNA damage due to the difficulty in harvesting the 
required cell number for this analysis. To allow for identification of interaction 
partners visually and by mass spectroscopy, an IP was performed. The final 
eluate of one IP (S1) was separated on a 10% BT gel by SDS-PAGE and stained 
with SYPRO® Ruby before imaging on a Typhoon (section 2.12.4). No clear 
differences were observed between the eluate of TbAUK2+/-12myc cells and WT 
cells. Nor could a band corresponding to TbAUK2+/-12myc was seen (Figure 4-24 A). 
A second eluate sample (S2) from both cells was sent for mass spectroscopy 
analysis (section 2.12.3; Glasgow Polyomics Facility; the WT sample was run 
first) and a western blot was performed (section 2.12.1 and 2.12.2), verifying 
that TbAUK212myc could only be detected (as indicated by the black arrow; Figure 
4-24 B) in the eluate of the TbAUK2+/-12myc sample. Described below are the 
proteins identified (summarised in Table 4-3) from MS analysis, which are 
proteins only detected in the experimental and not control (WT) IPs (see the file 
supplied on the accompanying CD entitled MSdataTb6560andTbAUK22016.xls for 
all proteins identified in both samples). TbAUK2 could not be identified in either 
the IP from the TbAUK2+/-12myc cells or from the WT cells. The reason for this is 
unknown; however, as the whole eluate was send for MS, it is possible the weak 
expression of the tagged protein was masked by more abundant peptides from 
other proteins. 
It is important to note that none of the putative interaction partners have been 
verified by further analysis (such as performing a repeat IP, directed co-IP or 
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reciprocal IP) and therefore all hits presented here must be treated as 
preliminary. 
 
Figure  4-24: Immunoprecipitation of TbAUK2+/-12myc cell line 
(A) Sypro Ruby stained SDS-PAGE gel showing the eluate fractions from WT and TbAUK2+/-
12myc (S1) cell lines. The dark bands in line with the (*) indicate the heavy and light chains 
of the myc antibody. Protein Standard (Novex ® Sharp Pre-Stained protein ladder; 
ThermoFisher). (B) Western blot analysis on all fractions of the IP from TbAUK2 +/- 12myc 
S2. The antibody chains were not detected by this western. WT (Wild Type), A (TbAUK2+/- 
12myc CL1), PL (Pre-lysis), I (Input/Lysate), F (Flowthrough), E (Eluate). The black arrows 
show the position of the endogenously tagged protein and to the loading control EF1α. S2 
eluate was send for Mass Spectroscopy (MS) analysis. Gel image captured on a Typhoon 
9400. 
Table 4-3 details the proteins identified from the IP that were absent in the WT 
sample and, in addition, were not detected in an anti-myc IP performed 
independently by another researcher in the lab (unpublished data, A.C. Zurita-
Leal) using BSF cells expressing a putatively unrelated myc-tagged protein. 
 
Table  4-3: Potential interaction partners identified by Mass Spectroscopy analysis 
‘Hits’ shown were only present in the endogenously tagged cell line. Any protein identified 
in the WT sample was excluded from this analysis. Samples were analysed using MASCOT 
software. Protein sequence for each ‘hit’ was analysed by BLASTp using the SmartBLAST 
feature. Displayed in the table are the potential corresponding human homologs. Pale red 
(kinetoplastid specific), pale orange (potential DNA repair related function). 
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Two factors may be of interest, but would require validation as true interactors 
of TbAUK2. The first was a RuvB- like helicase; members of the RuvB family, first 
identified in prokaryotes, are important for Holliday junction formation and in 
overcoming replication fork stalling (Baharoglu et al. 2006). In addition, a 
hypothetical protein with a Zn finger containing ubiquitin ligase like domain was 
identified. Aurora kinases have been shown to be negatively regulated by 
ubiquitination (as reviewed by Lindon et al., 2016) and, additionally, Zn finger 
domains can bind DNA (Krishna et al. 2003). 
4.9 Re-expression of TbAUK2 in TbAUK2-/- knockouts 
To determine whether the phenotypic effects observed in the TbAUK2-/- cells are 
attributed simply to loss of TbAUK2 gene or if they result from secondary 
effects, mutant cells re-expressing TbAUK2 gene were generated. 
4.9.1 Generation of the re-expresser construct 
To strategy for gene re-expression and the methodology used to generate the re-
expresser constructs is as described in section 2.4.1.3. Figure 4-25 illustrates the 
position of the primers used for PCR amplification of the complete TbAUK2 ORF, 
which was inserted into a plasmid (TbAUK2::RXP) that allow integration of the 
gene into the tubulin locus, with mRNA processing provided by non-endogenous 
sequences. 




Figure  4-25: Schematic of the TbAUK2 re-expression plasmid AUK2::RXP 
(A) Schematic representation of the region PCR amplified for re-expression. The whole ORF 
(including the start and stop codons) was required for re-expression. The primers required 
are indicated in brackets beside the expected PCR fragment size. The primer positions in 
the genome are indicated by black arrows. (B) A representative illustration of the 
AUK2::RXP construct. The PCR fragment was cloned in using NheI and Xbal restriction 
sites. AUK2::RXP was linearised with PacI prior to transformation into BSF cells. Schematic 
generated by CLC Genomics Workbench 7. Not to scale. 
4.9.2 Generation of TbAUK2-/-/+ cell lines 
To re-express the TbAUK2 gene, the TbAUK2-/- CL2 cell line was transformed 
with the PacI digested TbAUK2::RXP construct. Transformants were selected for 
as per section 2.7.4. Only a few transformants were recovered, potentially due 
to poor growth of the TbAUK2-/- cell lines or perhaps indicative of a role in for 
TbAUK2 in recombination. Two clones were chosen and expanded for further 
analysis. 
4.9.3 Confirmation of TbAUK2 re-expression by PCR and qRT-
PCR analysis 
To confirm re-expression of TbAUK2 in the putative re-expresser clones two 
analyses were undertaken. First, correct integration of the TbAUK2::RXP 
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construct into the genome was examined by PCR, as depicted in Figure 4-26 
A&B. 
 
Figure  4-26: Confirmation of TbAUK2 re-expressing cell lines 
(A) Schematic illustration of expected fragment size amplified by PCR (bp), diagnostic 
primers used (black arrows) and their position in the genome. Primer sequences are 
available in Table 2-3 and Table 2-1. Not to scale. (B) Agarose gels of diagnostic integration 
PCR, performed using the primer pairs detailed in A (testing for integration of the RxP 
construct using gDNA from two -/-/+ clones (RxP CL1 and RxP CL2), wild type (WT) cells, 
heterozygote +/- cells, TbAUK2-/- cells (CL2) or using double distilled water (ddH2O) as a 
negative control. All PCRs were performed on the same gDNA samples. B/α tub (Beta/Alpha 
Tubulin), Actin IR (Actin intergenic region), gDNA (genomic DNA), ORF (open reading 
frame). For each gel, size markers are shown (bp). (C) RNA from each cell line was prepared 
from which cDNA was generated. qRT-PCR was performed to examine expression level of 
TbAUK2 in WT, heterozygote (+/-), knockout (-/-) and both re-expressor (-/-/+) cell lines using 
primers AUK2RTFW2 and AUK2RTRV1 (Table 2-5 detailed in section 2.5.3.1). Expression of 
TbAUK2 in the WT was arbitrarily set to 100% expression. A low level of gDNA 
contamination could be detected in the WT and heterozygote samples (data not shown). 
From the PCR, the construct appeared to have correctly integrated in both 
clones. Secondly, expression of TbAUK2 RNA was examined by qRT-PCR. RNA was 
extracted from the re-expresser clones and cDNA was generated as per section 
2.5. qRT-PCR was performed to determine the level of expression relative to the 
WT cells (as a control), the TbAUK2+/- cells and the knockout clone used for the 
original transformation (TbAUK2-/- CL2).The confirmed re-expresser clones are 
referred to as TbAUK2-/-/+ CL1 and TbAUK2-/-/+ CL2 in this thesis. 
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4.9.4 Characterisation of TbAUK2 re-expresser cell lines 
4.9.4.1 Growth analysis in the absence and presence of MMS in vitro 
Loss of TbAUK2 significantly reduced proliferation in vitro. To determine if re-
expression of the TbAUK2 gene restored growth to a WT level, the growth of two 
re-expresser cells was compared to WT andTbAUK2-/- CL2 cells in the absence of 
any antibiotic selection. The growth assay was set up and monitored as 
described in section 2.8.2. The growth in vitro of both TbAUK2-/-/+ clones 
appeared more comparable to WT cells than the -/- mutants (Figure 4-26 A). 
 
Figure  4-27: In vitro growth of TbAUK2 re-expresser clones 
(A) Growth of re-expresser clones was examined in vitro and compared to WT and the 
parental TbAUK2 knockout clone. The data is plotted on a logarithmic scale. The error bars 
represent ± SEM (n=2). (B) Growth of re-expresser clones in vitro following exposure to 
MMS. Cells were exposed to 0.0003% MMS and growth assessed as per section 2.8.2. The 
data is plotted on a logarithmic scale. The error bars represent ± SEM, n=2. 
To test the effect of TbAUK2 re-expression further, growth (Figure 4-26 B) of the 
TbAUK2-/-/+ cells were monitored and compared to TbAUK2-/- CL2 and WT cells in 
the presence of MMS (0.0003 %). The cells were set up and growth monitored as 
per section 2.8.2. Beyond 24 hrs post exposure to MMS, no cells could be 
recorded for the TbAUK2-/- CL2 cell line, reflecting its sensitivity to genotoxic 
stress conditions (Figure 4-26 B). Conversely, the growth of both re-expresser 
clones was more comparable to growth of the WT cells in the presence of MMS, 
though one clone appeared to be more sensitive than the other, for reasons that 
are unclear. Taken together, these data suggest re-expression of TbAUK2 in -/- 
mutants is able to complement at least two phenotypic impairments. 




The purpose of this chapter was to examine the role of TbAUK2 in BSF T. brucei 
cells, in particular pertaining to a potential role in DNA repair. As little 
characterisation of TbAUK2 has been undertaken, the data detailed in this 
chapter represent the first insights into TbAUK2 function in the BSF lifecycle 
stage of T. brucei. Discussed below is how the data presented here relates to 
the biology of other aurora kinases and to the parasite. 
4.10.1 Insights from the bioinformatics analysis 
Aurora kinases (universally found in the Eukarya) are required to co-ordinate 
numerous aspects of cell proliferation (Goldenson & Crispino 2015) and though 
these kinases are well studied across this kingdom, their evolutionary origin has 
yet to be deciphered. As such, insights from early branching eukaryotes like the 
trypanosome may further our understanding of these critical enzymes. The AUK 
family is conventionally considered to have expanded in line with increasing 
eukaryote complexity. For example, in yeasts and the amoeboid Dictyostelium 
discoideum (both single celled organism), only one AUK has been described. In 
‘lower’ metazoans, such as D. melanogaster, typically two AUKs (AUKA and 
AUKB) are found, while in mammals, three are present (AUKA, AUKB and 
AUKC).In keeping with this proposed progression, the single AUK in yeast and D. 
discoideum appears able to perform the functions of both AUKA and AUKB (Li et 
al. 2008), which display differing localisation and possess distinct interaction 
partners in humans. Indeed, human AUKC appears to have evolved specifically 
for aspects of gametocyte function. If correct, this evolutionary scenario raises 
an obvious question; why do the kinetoplastids require three AUKs? The data 
provided here on T. brucei AUK2 suggests distinct functions from AUK1, the best 
characterised kinetoplastid AUK to date (discussed below; Li & Wang, 2006; Tu 
et al., 2006). Such diversification raises the question of what aspects of 
kinetoplastid biology requires these extra layers of complexity. 
In the context of the above discussion, it is worth mentioning the divergence of 
aurora kinases is also seen within plants. In some plants, three AUKs have arisen 
and are found in two subgroups: the α-group (comprising AUK1 and AUK2) and β-
group (comprising AUK3). In contrast, some other plants only possess two α-
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group AUKs (Weimer et al. 2016). These data may indicate further specialisation 
of roles, but AUK characterisation in plants is still in its early stages. 
Nonetheless, the aurora kinases appear very ‘adaptable’ to the needs of an 
individual organism. In addition, aurora kinase redundancy has yet to be 
reported, perhaps suggesting organisms evolve as many AUKs as they require. 
TbAUK1 appears to be the kinetoplastid homolog of AUKB, based on functional 
studies. Assigning potential orthology of TbAUK2 and TbAUK3 based on sequence 
homology is not simple. While TbAUK3 has a C-terminal extension that 
distinguishes it from the two other kinetoplastid AUKs, TbAUK1 and TbAUK2 are 
of similar size and share similar levels of homology to all three of the human 
AUKs. In addition, one of the defining features of AUKA (the DAD/A box) is not 
present in any T. brucei AUK, suggesting each may be more closely related to 
AUKB in terms of regulation. However, the top ‘hits’ from a BLAST analysis using 
the sequence of TbAUK2 are predominantly annotated as the AUKA kinases, 
despite the absence of conserved DAD/A box or KEN motifs. As these motifs are 
required for degradation by ubiquitination, it is possible all the T. brucei AUKs 
are subjected to distinct regulation from their human homologs, and hence 
sequence identity may be a poor predictor of AUKA homology. Interestingly, 
though yeast Ark1 has a KEN box motif, it does not appear to play a role in Ark1 
degradation (Leverson et al. 2002). Indeed, Ark1 levels do not appear to be 
regulated throughout the cell cycle, as AUKs are observed to do in human cells. 
As T. brucei AUKs appear to have diverged earlier than most eukaryotic aurora 
kinases (as indicated by phylogenetic analysis performed by Li et al. 2008), it is 
possible that the KEN, A and/or DAD box motifs arose later and have come to act 
in expression regulation only in some circumstances. In this regard, it is notable 
that AUKC also does not possess either a KEN motif or an A-box/DAD-box, but 
localises dynamically throughout the cell cycle. All the T. brucei AUKs do, 
however, contain a D-box domain (section 4.4.1.2) in their C-termini, suggesting 
their activity is regulated in some manner. 
Overall, the evolutionary history of AUK kinases remains unclear and assigning a 
human homolog of TbAUK2 (and indeed TbAUK3) based on sequence comparisons 
may be premature. Instead, functional analysis may be the clearest route to 
assign functional homology. Indeed, understanding why trypanosomatids require 
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three AUKs will require functional analysis of TbAUK3. It is worth noting that 
further protein kinase family expansions are seen in trypanosomatids (Parsons et 
al. 2005). For example, the NEK (NimA related kinase) kinases are an expanded 
family (22 members in T. brucei compared with 11 members in H. sapiens), 
though not all appear to have a functional role or their roles are trypanosome-
specific (Jones et al. 2014). 
4.10.2 TbAUK2 acts in aspects of mitosis, spindle formation 
and cellular morphology 
4.10.2.1 Loss of TbAUK2 affects cell morphology 
Phenotypic analysis of TbAUK2 null mutants reveals that this AUK plays a role in 
co-ordinating nuclear division in BSF parasites. Loss of TbAUK2 significantly 
reduces cell proliferation, which is associated with nuclear and morphological 
aberrancies. In terms of morphology, ~30% of the total population lost the 
typical trypomatigote shape, either manifesting as ‘rounded’ cells (~35%), 
‘clumps’ (~10%) or simply that appeared large and distorted in shape 
(‘aberrant’; ~55%).Following RNAi of TbAUK1 in BSF cells, such morphological 
defects can also be observed, but appeared to be less pronounced, perhaps 
related to the fact that RNAi of TbAUK2 in the absence of genotoxic stress had 
little effect on in vitro growth. A clear explanation for the ‘rounded’ appearance 
of the TbAUK2 -/- cells remains elusive, though chemical inhibition of the L. 
donovani putative AUKB homologue (LdAIRK) was shown to produce cells with a 
rounded and distorted shape (Chhajer et al. 2016). Potentially, therefore, aurora 
kinases in kinetoplastids may play a role in cell morphology. In human cells, loss 
of morphology (as the result of defective cytokinesis) has been commonly 
reported following knockdown of AUKs. siRNA targeting AUKA results in large and 
distorted HCT116 cell, and the same is true following addition of an AUKA 
inhibitor MLN8054 (Huck et al. 2010). This affect was also observed following 
siRNA targeting AUKB in HeLa cells (Delaval et al. 2004). To date, several groups 
have now shown that aurora kinases are directly involved in regulating 
microtubules, cytokinesis and, recently, the actin cytoskeleton (Delaval et al. 
2004; Giet et al. 2002; Marumoto et al. 2003; Ritchey & Chakrabarti 2014). 
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RNAi of TbAUK1 in BSF cells is lethal and leads to the generation of potentially 
the same rounded cells seen in the TbAUK2-/- mutants. Whether this 
commonality indicates overlapping roles of TbAUK1 and TbAUK2, or even the 
proteins acting together, is unclear. However, loss of TbAUK2 is not lethal, 
meaning it may be subservient to TbAUK1 or that TbAUK1 may compensate for 
TbAUK2 loss. In addition to spindle microtubules, the subpellicular microtubule 
corset of the parasite is responsible for maintaining the highly polarised shape of 
the trypomastigote and is required for cytokinesis to occur. Some of the first 
steps of cytokinesis utilise newly synthesised microtubules as a ‘guide’ on which 
to direct cell separation. Furthermore, rather than all subpellicular microtubules 
being synthesised anew for the daughter cell, a series of (semi-) inheritance 
events occur in which some subpellicular microtubules from the mother cell are 
incorporated into the daughter cell (as shown by Wheeler, Scheumann, 
Wickstead, Gull, & Vaughan, 2013). Hence, microtubules and their co-ordination 
are not only required for mitosis but also to facilitate cytokinesis, meaning 
aberrant morphology, mitosis and cytokinesis may be linked through microtubule 
TbAUK functions. Indeed, the importance of TbAUK1 during cytokinesis was show 
recently by Zhou and colleagues (Zhou et al. 2016). T. brucei’s mechanism of 
cytokinesis occurs in the absence of an actomyosin contractile ring (Zhou et al. 
2016) and shows considerable divergence from the last common ancestor of 
eukaryotes, implying T. brucei may utilise an ancient method of cytokinesis. If 
both TbAUK1 and TbAUK2 activity is required to facilitate cytokinesis, an ancient 
evolutionary link between cytokinesis and aurora kinases is revealed (Zhou et al. 
2016), raising the question of why some eukaryotes evolved to conduct this 
central process with only one AUK. 
4.10.2.2 Loss of TbAUK2 affects spindle formation and mitosis 
When nDNA and kDNA content were examined in TbAUK2 -/- cells, ~30 % of the 
population had an aberrant nuclear content; a similar percentage to cells with 
morphological defects. Furthermore, a corresponding loss of 1N1K cells was 
associated with an increase in aberrant cells. In particular, the presence of 
‘intra-nuclear’ membranes and nuclear ‘blebs’ (~20-27 % of a population) was 
noted, suggesting miss-segregation of nDNA occurs in these cells. In support of 
this, when the cells were stained for KMX-1 to visualise the mitotic spindle, it 
was found that the number of 1N2K cells (cells in S-phase) with a mitotic spindle 
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was reduced by ~50 %. Failing to effectively form a mitotic spindle may account 
for this miss-division of nuclei during mitosis. RNAi-mediated loss of TbAUK1 also 
abolished nuclear spindle formation in BSF cells (Li & Wang, 2006), reinforcing 
the overlap between the two AUKs. The accumulation of cells with aberrant 
nDNA and kDNA ratios, including absence of both genomes, suggests cytokinesis 
may continue in the TbAUK2-/- mutants, despite impaired mitosis. As large, 
multinucleated cells also formed in the mutants, it is possible that loss of 
TbAUK2 impairs signalling a cytokinesis checkpoint, but that other factors can 
perform some such signalling in its absence. No apparent effect on kDNA was 
observed (as was the case following the loss of TbAUK1; Li & Wang, 2006), 
indicating both TbAUKs provide nuclear functions. 
Loss of AUKs in other eukaryotes also results in mitotic spindle defects and miss-
segregation of sister chromatids (Mountzios et al. 2008; Vader & Lens 2008; Tao 
et al. 2008), amongst other mitosis wide defects. In germline cells, loss of AUKA 
or AUKB is lethal as the mitotic spindle is defective (Lu et al. 2008; Balboula & 
Schindler 2014; Hoar et al. 2007). Furthermore, loss of AUKA results in 
chromosome miss-alignment, which is sensed and the cells are halted in mitosis; 
however, such cells can bypass the stall and continue through the cell cycle, 
resulting in aberrant nuclear segregation (Fu et al. 2007; Goldenson & Crispino 
2015). In these circumstances the tumour suppressor protein p53 can arrest cells 
in G1, but since p53 has not been identified in trypanosomatids, this additional 
control measure cannot be implemented and cells with potential nuclear 
aberrancies enter a new cell cycle. In the case of AUKB (and AUKC) mutants, the 
primary phenotype manifests as a failure to segregate chromosomes (as 
reviewed by Goldenson & Crispino, 2015). 
AUKA and AUKB have been shown to co-ordinate aspects of the nuclear envelope 
with chromosome condensation and mitotic spindle formation (Mora-Bermúdez 
et al. 2007). In HeLa cells, inhibiting AUKB during anaphase has little effect on 
nuclear structure (the envelope), but inhibition during early mitosis results in 
slower dissociation of the nuclear envelope from chromosomes, suggesting AUKB 
is required for the breakdown of the nuclear envelope during mitosis. Such an 
‘open’ mitosis in which the nuclear envelope is disassembled before separation 
of sister chromatids is not seen in the trypanosomatids. T. brucei, like yeast, 
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undergoes a ‘closed’ mitosis in which the nuclear pores permit entry and exit of 
materials required for mitosis (as reviewed by Daniels, Gull, & Wickstead, 2010; 
DuBois et al., 2012). In the TbAUK2-/- mutants a link between miss-segregation 
of nuclear DNA and the nuclear envelope is seen in that the blebs appear to 
contain genetic material (as shown by DAPI staining). As mentioned above, 
TbAUK1 is required for the formation of the mitotic spindle and movements of 
the spindle during mitosis (Tu et al. 2006). However, TbAUK1 does not appear to 
regulate spindle assembly through the centrosome. Potentially, therefore, 
TbAUK2 may play a role in how the spindle of T. brucei is arranged to permit an 
‘even’ division of genetic material between the two developing daughter cells. 
As little is known about how T. brucei actively co-ordinates this aspect of 
division, these data may provide the first indication that nuclear envelope 
maintenance, growth or division during mitosis is, in part, regulated by an 
aurora kinase. Moreover, this is the first indication of distinct functions for 
TbAUK1 and TbAUK2. 
4.10.3 Loss of TbAUK2 is associated with increased sensitivity to 
genotoxic stress 
Aurora kinases in humans are intimately linked to the development of cancer 
(Vader & Lens 2008; Fu et al. 2007; Goldenson & Crispino 2015). For example, 
activity of AUKA must be finely tuned to prevent over- or under expression of 
AUKA, since both scenarios are detrimental to cells. AUKA is considered as a DNA 
repair-associated kinase, whereas AUKB’s role in cancer appears to be mediated 
through its interaction partners rather than directly by its activity (Y. Wang et 
al. 2014; Gully et al. 2012; Vader & Lens 2008). 
As seen in the RNAi cell line (which is sensitive to MMS on tetracycline 
induction), TbAUK2 -/- cell are sensitive to several sources of genotoxic stress, 
consistent with a potential role in monitoring the nucleus for DNA damage. In 
human cell lines, loss or de-regulation of AUKA sensitises cells to DNA damage12 
caused by UV, cisplatin (Wang et al., 2006), etoposide (a DSB agent; Krystyniak 
et al., 2006) and HU (Leontovich et al. 2013). Furthermore, it has been reported 
that knockdown of AUKA is associated with increased γH2AX (Moretti,et al. 2011; 
                                         
12
 This effect may be cell line specific (Wang et al., 2014). 
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in some cell lines) and RAD51 foci (Yang et al. 2010), phenotypes that closely 
mirror the effects on these DNA damage associated markers in T. brucei BSF 
cells lacking TbAUK2. Thus, TbAUK2’s functions may be analogous to those of 
human AUKA, though it should be noted these effects have not been examined in 
TbAUK1 depleted T. brucei cells. 
Numerous studies in other organisms have highlighted the role of the aurora 
kinases in the development of cancer, which arises predominantly as the result 
of defects during centrosome formation, chromosomal segregation or the 
inability to trigger a cell cycle check point. AUKA has been shown to 
phosphorylate and interact with proteins with well-established roles in the DDR. 
Notably, BRCA1 and BRCA2 have both been shown to interact with AUKA: AUKA 
binding to BRCA1 results in the loss of the G2/M checkpoint, while blocking AUKA 
activity results in increased BRCA2 repair foci following genotoxic stress. CHK1 
(a central kinase, which can be activated upon phosphorylation from the ATR 
kinase) activity is also affected when AUKA becomes de-regulated and, as a 
consequence, the HR response becomes defective (Sourisseau et al. 2010). To 
date, such roles for TbAUK1 or TbAUK2 have not been tested, but would be 
valuable, particularly as HR is the primary method used by T. brucei to deal with 
DSBs breaks (Glover et al. 2008). Indeed, HR is a critical mechanism for VSG 
switching (Glover, Alsford, et al. 2013), meaning testing TbAUK roles in this 
process would be valuable; to date, only silent VSG expression has been 
examined in the TbAUK2 -/- cells, with inconclusive results (chapter 8, section 
8.3, Figure 8-16). 
An attempt was made to overexpress TbAUK2 in BSF cells (chapter 8, section 
8.3, Figure 8-17), but did not result in increased tolerance to MMS stress (unlike 
overexpression of AUKA in human cells when exposed to cisplatin or UV; Wang et 
al., 2006) and no nuclear or morphological defects were observed. Though 
further tests are required, these data may suggest regulation of TbAUK2 levels. 
4.10.4 TbAUK2 shows a punctate nuclear localisation 
A hallmark of aurora kinases is their dynamic localisation throughout the cell 
cycle from late G2 to mitosis (Carmena et al., 2009; see section 4.1.1). In 
addition, the levels of AUKA and AUKB are much reduced in G1 cells (Lindon et 
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al. 2016). Dynamic localisation is also observed for TbAUK1, which begins as a 
diffuse signal in 1N1K and 1N2K cells and translocates to the midzone of in 2N2K 
cells, mimicking the localisation of AUKB in human cells (Li & Wang 2006; 
Carmena et al. 2009). Though dynamism of TbAUK2 may not be as pronounced, 
super resolution images show TbAUK2 localises in a punctate fashion throughout 
the nuclei of 1N1K cells and 1N2K cells. In 1N1K cells, localisation appeared 
throughout the nucleus, whereas in 1N2K cells the kinase appeared to localise 
towards the centre; potentially in the region of spindle mid-zone. This 
localisation is reminiscent of AUKA in human cells (see section 4.1.1). 
Localisation of TbAUK2 could not be observed by SIM in 2N2K cells, which could 
be due to the localisation becoming more diffuse, perhaps as it is no longer 
required to perform functions during this cell cycle stage. These data may be 
consistent with the observation that TbAUK2 appears absent in ~9-10% of the G1 
population. Potentially these cells could be in early G1, suggesting a more 
limited absence of AUKs from human G1 cells. Furthermore, in PCF cells, when 
TbAUK2 was endogenously tagged (C-terminally with YFP), the same absence of 
localisation was observed in a small percentage of cells (personal 
communication, B. Akiyoshi, University of Oxford). As cells progress through the 
cell cycle, the signal of TbAUK2 appears to peak significantly in 1N2K cells (cells 
which are entering into G2 and mitosis). Taken together, these data indicate 
TbAUK2 re-localises during the cell cycle in ways distinct from TbAUK1, 
providing further evidence for discrete functions. 
Under genotoxic stress, no obvious re-localisation of TbAUK2 occurred, though 
the pattern appeared to be more dispersed, suggesting TbAUK2 does not re-
localise to form specific foci in response to damage like RAD51, BRCA2 or γH2AX 
(Trenaman et al. 2013; Glover &Horn 2012; Dobson et al. 2011). However co-
localisation studies with these markers are required to test this inference. 
4.10.5 Identification of TbAUK2 interactors may guide 
functional analysis 
Aurora kinases have a plethora of distinct interaction partners (section 4.1.1;  as 
reviewed by Samudio & Vélez, 2015). To date, many common interaction 
partners of Aurora kinases have yet to be identified as interaction partners of 
TbAUK2, including TbATM, TbATR and TbBRCA2. Indeed, it is notable that 
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TbAUK1 interacts with two potentially novel factors in the CPC (Li et al., 2008). 
Here, we made a preliminary attempt to ask if common or novel factors interact 
with TbAUK2, using anti-myc IP from the TbAUK2+/-12myc cell line. No canonical 
interaction partners of aurora kinases were identified in a small sample of five 
of the proteins identified by mass spectroscopy. As no validation of interactions 
was performed, these must be treated with caution. Nevertheless, two proteins 
appeared to be connected with cellular metabolism and may be worthy of follow 
up analyses. 
RuvB helicases are members of the AAA+ family of ATPases. Humans have two: 
RuvBL1 (also known as Pontin; TIP49a) and RuvBL2 (also known as Reptin; 
TIP49b); T. brucei also appears to express two (Tb927.4.1270 and 
Tb927.4.2000), the latter of which is a candidate TbAUK2 interactor. No work 
has examined RuvB function in kinetoplastids. In human cells, RuvBL1 and 2 form 
a complex. Loss of RuvBL1 is fatal, with cells displaying chromosomal 
segregation abnormalities (Gentili et al. 2015), and loss of RuvBL2 is associated 
with decondensation of chromosomes after mitosis (Magalska et al. 2016). 
Recently, RuvBL1 was shown to co-localise with and be phosphorylated by the 
kinase PLK1 (Gentili et al. 2015), a prominent substrate of AUKA. Additionally, 
RuvBL1/2 shows a dynamic localisation: RuvBL1 translocates to the mitotic 
spindle and to intracellular bridges that form during cytokinesis, while RuvBL2 
localises at the midbody between cells and in the nucleus (Gentili et al. 2015). 
To date, no interaction of AUKs and RuvBL helicases has been shown, but our 
observation may suggest this occurs and could be conserved. The second protein 
shows homology to ubiquitin ligases (E3s) and possesses a Zinc finger domain. 
Regulation of aurora kinase activity through degradation by ubiquitination is 
extensively cited as the mechanism by which their cell cycle expression is 
controlled (as reviewed by Lindon et al., 2016). 
4.10.6 A preliminary model of TbAUK2 function in BSF cells 
Figures 4-27 and 4-28 provide a summary of the findings in this chapter, 
modelling the localisation and potential roles of TbAUK2 in BSF T. brucei. Firstly, 
TbAUK2 in a dividing cell appears to localise at S-G2 phases as potential foci 
distributed throughout the nucleus. When the cells enter into G2-M, the 
localisation appears to focus at the centre of the nucleus, though still as a 
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punctate pattern. When the cell enters mitosis, and proceeds to cytokinesis, the 
localisation becomes weaker, suggesting a reduced level of the kinase. Finally, 
just following cytokinesis, in the new ‘daughter’ cells (1N1K) localisation of 
TbAUK2 cannot be detected. 
 
Figure  4-28: Dynamic localisation of TbAUK2 in BSF cells 
A description of the figure is given in the accompanying text. Localisation of TbAUK2 is 
represented by green dots. Not to scale. 
Secondly, when TbAUK2 is absent, gross morphological defects arise in a 
subpopulation of cells. Why some cells appear normal remains unclear, but if 
loss of TbAUK2 can be compensated by another kinase some cells might form a 
spindle normally, segregate the genetic material and proceed to cytokinesis, 
generating two daughter cells that maintain the population. However, when a 
mutant BSF cell enters S-phase, potentially several defects can occur. If cells 
fail to form a spindle (or have spindle defects), the cells miss- segregate their 
chromosomes; this effect may be exacerbated if a mitotic spindle checkpoint 
fails to signal and nuclear aberrancies are not detected. When the aberrant cells 
enter G2/M, further abnormalities may develop, as suggested by the appearance 
of nuclear ‘blebs’, intra-nuclear membranes, incorrectly sizes nuclei and large, 
swollen multinucleated cells. Again, if there is mitosis checkpoint failure, 
aberrant nuclei and aberrant chromosome segregation may not be are detected, 
with cells arising from mitosis with abnormal nuclear DNA content and abnormal 
or absent nuclei. The fates of these defective cells are unknown, but it is likely 
most will die, though some may enter a new nuclear S-phase, accounting for 
multinucleated cells. 




Figure  4-29: Loss of TbAUK2 is associated with cell cycle defects 
An explanation of this figure is discussed in the text above. Question marks highlight areas 
of biology still to be uncovered. Not to scale. 
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5 Tb6560 is a pseudokinase that acts in 
bloodstream form endocytosis 
  




This chapter describes functional analysis of Tb927.9.6560, one of the protein 
kinases validated as displaying sensitivity to MMS in chapter 3. To provide 
context to the findings, an introduction to trypanosomatid endocytosis is 
provided below (see section 1.4.1.1), as is a discussion of pseudokinases (refer 
to section 1.5.2.1). Tb927.9.6560 is currently annotated as a NAK pseudokinase 
(Jones et al. 2014; Parsons et al. 2005) though additional sequence analysis will 
be described (section 5.3.1) that explored this annotation further. From herein, 
the protein was referred to as Tb6560 and all putative cell lines required for the 
analysis of this protein are named accordingly. 
5.1.1 Numb Associated Kinases (NAKs) 
The D. melanogaster NAK (the first described Numb Associated Kinase), is an S/T 
protein kinase (PK), which interacts with the protein Numb (Chien et al. 1998) 
via the Numb phosphotyrosine binding domain (PTB), ultimately mediating 
asymmetric division of Drosophila sensory cells (Frise et al. 1996). NAK also 
interacts with the α-adaptin subunit of the AP2 complex (Santolini et al. 2000; 
Peng et al. 2009) in human cells, permitting Numb to regulate Notch signalling 
(an evolutionary conserved method of cellular communication; reviewed by 
Bray, 2006; Guruharsha, Kankel, & Artavanis-Tsakonas, 2012). Thus, Notch 
signalling in one D. melanogaster daughter cell (Frise et al. 1996) is repressed 
and subsequently promotes asymmetric division. To date, Notch signalling has 
only been described in metazoans. 
5.1.1.1 The AP2 Complex and endocytosis 
The AP2 complex is a stable heterotetrameric adaptor complex found in most 
metazoans (Faini et al. 2013), which functions during clathrin mediated 
endocytosis (CME) internalisation of cargo via clathrin coated pits (CCPs) and 
clathrin coated vesicles (CCVs). The complex is comprised of four subunits, or 
‘adaptins’, linked by flexible polypeptide linkers known as ‘ear’ domains. 
Targeting of the complex is thought to occur first by an interaction between the 
α subunit and phosphoinositides from the membrane bilayer. Subsequently, the 
complex undergoes a significant conformational change (Collins et al. 2002; 
Jackson et al. 2010) and phosphorylation by a NAK kinase (section 5.1.1.2) to 
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permit the binding of specific peptide motifs (such as Yxxφ and [DE]xxxL[LIM]; 
Kelly et al. 2008,), which are expressed on incoming cargo (for example, the 
transmembrane transferrin receptor protein or the major histocompatibility 
complex class II). The AP2 complex performs a variety of functions to aid cargo 
internalisation via CCVs. The β2 subunit can directly bind the clathrin heavy 
chain, thus contributing to the assembly of CCVs and their internalisation. 
Clathrin and the AP2 complex also aid the development of CCP curvature and 
invagination (Figure 5-1). Once the cargo is secured in the CCP, the pit 
internalises and is separated (by scission) from the plasma membrane, a reaction 
often mediated by Dynamin (a large GTPase; Cocucci, Gaudin, & Kirchhausen, 
2014; Praefcke & McMahon, 2004). Next, the clathrin coat of the internalised 
vesicle is disassembled via the AP2 complex, which interacts with proteins 
including another NAK kinase known as GAK/Auxillin which in turn interacts with 
the heatshock protein 70 (Hsp70) required for CCV disassembly ((Umeda et al. 
2000). The complex is then removed by a dephosphorylation (by the 
aforementioned NAK kinase) reaction mediated by Rab5 (a small GTPase; 
(Semerdjieva et al. 2008) to permit progression of the CCV into the endocytic 
pathway. Now, the vesicle can enter the endosomal pathway, for example in the 
case of phosphoinositides (PI; important cellular signalling molecules (Shin et al. 
2005). 
Sorting of cargo by the endosome pathway is a multifaceted process relying on 
sorting signals in the form of pH gradients, geometry of endosomal vesicles, 
signals from the cargo itself and other post-translational modifications (reviewed 
by (Gruenberg 2001; Elkin et al. 2016). For example, early endosomes have a pH 
range of ~6.5-5.5 and are composed of either tubular-like structures (for 
recycling, ~pH 6.5) or larger, spherical vesicles (for degradation, ~ pH 5.5). 
Receptors from the cell surface often harbour ligands that are degraded at a 
higher pH and accumulate due to the large surface area of the tubular 
endosomes. Here, these proteins are then rapidly trafficked back to the cell 
surface for export. Ligands dissociating at lower pH are predominantly targeted 
for degradation in the lysosomes or targeted for further sorting and modification 
in the trans-golgi network (TGN). Other sorting signals, such as ubiquitinylated 
cargo, can be recognised and sorted via the endosomal sorting complexes 
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required for transport (ESCRT) machinery (reviewed by Henne, Buchkovich, & 
Emr, 2011). 
 
Figure  5-1: Internalisation of cargo mediated by the AP2 complex. 
Cargo (orange circle) is internalised by invagination of the lipid bilayer through the action of 
AAK1 (green rectangle) in conjunction with the AP2 complex (pale blue circle and a peptide 
signal (purple rectangle). A fuller description of this process is presented in the text, but 
internalisation leads to the cargo to the EE (Early Endosome), LE (Late Endosome) and TGN 
(trans-golgi Network). Diagram constructed based on data from (Gruenberg 2001; Elkin et al. 
2016). 
5.1.1.2 NAKs in humans 
Humans have four NAK kinases: adaptor associated kinase 1 (AAK1), BMP-2-
inducible kinase (BIKE/BMP2K), myristolyated and palmitoylated 
serine/threonine kinase 1 (MPSK1; also known as STK16, PKL12 and Krct) and 
cyclin G associated kinase (GAK, also auxillin 2; Smythe & Ayscough, 2003; 
Sorrell, Szklarz, Abdul Azeez, Elkins, & Knapp, 2016). These S/T kinases act 
primarily to control components of the endocytosis pathway. Generally, these 
kinases show little structural conservation outwith their kinase domain region; 
for example, AAK1 (accession number: NP_055726.3) shows ~ 76% identity within 
the N-terminal region harbouring the kinase domain to BMP-2 (accession number: 
NP_942595.1) though overall harbours only ~50% identity across the whole 
protein sequence. 
The roles of the NAKs in humans overlap. For example, BMP-2 was shown to both 
associate with CCVs (as determined by SILAC analysis) and co-localised with the 
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AP2 complex (Borner et al. 2012). GAK harbours a J-domain, which can interact 
and regulate 70 kDa heat shock proteins (Umeda et al. 2000; Walsh et al. 2004; 
Zhang et al. 2005), whose activity is linked to functions such as disassembly of 
the clathrin coat (reviewed by Eisenberg & Greene, 2007; Xing et al., 2010). 
Additionally, the GAK harbours a clathrin binding domain (Park et al. 2015) and 
may be required to facilitate assembly of both AP2 and accumulation at the 
plasma membrane and the Golgi (Korolchuk & Banting 2002; Zhang et al. 2005; 
Lee et al. 2005). MSPK1 is the least understood, only showing a distant 
relationship to the other NAK kinases. MSPK1 localises to the Golgi and may both 
regulate the activity of a GTPase (Eswaran et al. 2008) and aid during cargo 
sorting within the secretory network (Striz, Bernad, & Tuma, 2014). 
The final human NAK (AAK1) is a well-established co-ordinator of endocytosis 
(Smythe & Ayscough 2003) and regulator of Numb protein activity (Sorensen & 
Conner 2008). AAK1, which localises to CCPs, binds the AP2 complex and 
phosphorylates (in a clathrin modulated manner; Conner & Schmid, 2003) the μ2 
subunit to enhance AP2 affinity for membrane bound sorting signals and to 
promote signal tethering to CCPs (Jackson et al. 2003); without AAK1 
phosphorylation, uptake of molecules such as transferrin (Conner & Schmid 
2003) is blocked. In addition, uptake of the Flavivirus Hepatitis C (HCV) is also 
mediated by phosphorylation of the μ2 subunit by AAK1 (Neveu et al. 2015), 
further supporting the important role this kinase plays during endocytosis. 
5.1.2 Previous reports of Tb6560 in the literature 
In 2005, Tb6560 was identified as encoding a potential pseudokinase (Parsons et 
al. 2005) due to the presence of conserved pseudokinase-like motifs in the 
sequence (see section1.5.1.3 and section 1.5.2.1). In 2014, a kinome-wide RNAi 
screen demonstrated that downregulation of Tb6560 slowed cell proliferation of 
in vitro BSF parasites (Jones et al. 2014); no further characterisation was 
undertaken. In 2015, Tb6560 was identified as part of a screen aiming to identify 
protein components of stress granules (Fritz et al., 2015). Tb6560 was not found 
in stress granules but, upon serum starvation of in PCF cells, the protein 
(visualised by a C-terminal YFP tag) localised towards the posterior end of the 
parasite close to the flagellar pocket (FP); the functionality of the tagged 
variant was not confirmed nor was any further characterisation undertaken. 
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5.2 Research Aims 
Knockdown of Tb6560 in BSF cells affected cell proliferation and sensitivity to 
MMS (chapter 3). The aim of this chapter was to determine the role of Tb6560 by 
generating knockout mutants and by localising the protein in BSF parasites. 
5.3 Results 
5.3.1 Bioinformatics Analysis 
Differences in sequence were observed when the predicted protein sequences of 
Tb6560 from the sequenced strains of T. brucei (Lister 427 and TREU 927) were 
compared (as shown in chapter 8, section 8.4, Figure 8-18). The work in this 
chapter utilised the gene information from TREU 927 (accession number Tb6560; 
TriTrypDB.org, v28). This gene is predicted to encode a protein 80.2 kDa in size 
(726 amino acids). 
5.3.1.1 BLAST analysis of Tb6560 
To attempt to identify a potential homolog of the protein outwith the 
kinetoplastid phylum, the predicted protein sequence of Tb6560 was retrieved 
from TriTrypDB.org (V.28) and analysed using the BLASTp algorithm (BLOSUM62; 
version; BLASTp2.3.1; http://blast.ncbi.nlm.nih.gov/Blast.cgi). The sequence 
was ‘BLASTed’ against all non-redundant (nr) protein sequences available in the 
NCBI database (Li et al. 2013) and analysed using the ‘SmartBLAST’ feature 
(NCBI; currently under development) as described in section 2.1.2. 
The top ‘five’ hits (including the original reference sequence) are shown in 
Table 5-1. The top hits are specific to the kinetoplastid phylum, of which all 
were hypothetical proteins. A further protein of unknown function, but with 
much lower sequence similarity, was also identified in the amoeboid organism 
Dictyostelium discoideum. 




Table  5-1: Top five SmartBLAST ‘hits’ for Tb6560 in the NCBI database 
(http://www.ncbi.nlm.nih.gov/). All data was recovered in June 2016. 
When a wider range of BLASTp ‘hits’ were examined (Table 5-3), the Tb6560 
protein showed sequence similarity to AP2 associated proteins: H. sapiens AP2 
associated protein kinase 1 or AAK1 (30% identity; [E-value = 2e-24]), the Ppk29 
kinase in S. pombe (33% identity; [E-value = 1e-22]), a Numb associated kinase in 
D. melanogaster (28% identity; [E-value = 1e-20]) and to a group of protein 
kinases known as ‘NAKs’ in plants and yeasts (for example, the putative NAK 
protein kinase in Rhizopus microsporus; 30% identity; [E-value = 1e-22]). In all 
cases, the sequence homology revealed by SmartBLAST did not cover all the 
polypeptide and appeared instead to be predominantly within the N-terminal 
kinase domain region. 




Table  5-2: Additional SmartBLAST ‘hits’ for Tb6560. Several duplicate ‘hits’ were removed 
from this analysis. Accession numbers and the data above were correct as of June 2016 
when this data was collected. 
The predominance of predicted mouse AAK1 and BMP-2 proteins amongst the 
‘hits’ suggests Tb6560 does indeed encode a NAK-related kinase. Indeed, when 
the protein sequence of H. sapiens AAK1 (NP_055726.3) was analysed by the 
SmartBLAST function (following a BLASTp analysis), the hypothetical L. donovani 
protein (XP_003859605.1; table 5-1) was revealed (31% identity; E value = 8e-30), 
which is a likely kinetoplastid ortholog of Tb6560 (Table 5-1; see below). 
To examine the NAK homology further, the predicted protein sequence of 
Tb6560 was aligned to the protein sequences of H. sapiens AAK1 (NP_055726.3), 
M. musculus AP2 associated protein kinase isoform 1 (NP_j001035195.1) and S. 
pombe Ppk29 (NP_596027.1) in CLC genomics Workbench 7 (for a detailed 
alignment see chapter 8, section 8.4, Figure 8-19). Primarily, a higher degree of 
conservation was observed within the N-termini of each protein, where the 
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predicted kinase domain is located. The greatest conservation of the kinase 
domain is consistent with sequence comparisons of the human NAK kinases, 
where the C-termini are variable (Sorrell et al. 2016). 
Beyond the kinase domain, several important motifs can be identified in AP2 
associated protein kinases: a DPF motif (for α adaptin interactions; Owen et al., 
1999), a DLL motif (for clathrin binding; Morgan, Prasad, Hao, Augustine, & 
Lafer, 2000) and an NPF motif (for EH domain interactions; de Beer et al., 2000). 
All of these motifs potentially co-ordinate interactions required during clathrin-
mediated endocytosis. The protein sequence of Tb6560 was compared with AAK1 
(NP_055726.3) to test for the presence of each motif, though none were 
convincingly identified with the exception of a ‘DPF’ motif at position 719-721 in 
the C-terminus (Figure 5-2). Retention of the DPF motif may indicate Tb6560 
interacts with an adaptin-like protein (Owen et al. 1999), but whether the 
absence of the other motifs indicates divergence in wider interactions is 
unclear. AAK1 has a characteristic N-terminal G-rich region (of unknown 
function); this was also absent in the Tb6560 sequence. However, a C-terminal 
Q-rich region could be observed in the T. brucei sequence, in addition to a poly-
alanine motif. Both of these features can be seen in the human AAK1 protein 
sequence, though their biological significance is unknown. No additional domains 
could be identified using Interpro protein domain analysis, but the generalised 
schematic of motif and domain conservation between AAK1 and Tb6560 (Figure 
5-2) suggests broadly related functions. 
 
Figure  5-2: Schematic illustration of conserved motifs and domains in human AAK1 and 
Tb6560 
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The polypetide sequences of H. sapiens AAK1 and Tb6560 are shown in purple, and 
predicted numbers of amino acids (aa) indicated. Not to scale. Conserved sequence motifs 
of AAK1 are annotated as dotted triangles and coloured blocks, while the larger kinase 
domain is shown as a red block. Positions of the domain and motifs, and their potential 
conservation in Tb6560, were determined using Interpro (http://www.ebi.ac.uk/interpro/). 
The structure of Tb6560 was also predicted using the RaptorX protein structure 
and function predictor portal (Källberg et al. 2012). The results of this analysis 
are shown in Figure 5-3. The recently solved crystal structures of human AAK1 
and BMP-2 (Sorrell et al. 2016) were used to model the predicted protein 
structure of Tb6560 with high confidence (p = 5.54e-10 and p = 3.9 e -9), further 
supporting the hypothesis that Tb6560 may harbour similarities to these two NAK 
kinases. The mouse PK38 structure (p = 3.7e-9) was also used as a high 
confidence model in conjunction with the two NAK kinase models to predict the 
structure of this protein. The N-terminal region of Tb6560, including the 
predicted kinase domain, appears to be comprised predominantly of α helices 
with a small arrangement of β sheets towards the C-terminus. In contrast, the 
modelling suggests considerable disorder at the C-terminus, though whether this 
might adopt a more ordered structure when bound to interacting factors is 
unclear. 




Figure  5-3: Tb6560 shows structural similarity to two human NAK kinases 
(A+B) Predicted 3D structural model of the Tb6560 protein using the RaptorX web portal 
(http://raptorx.uchicago.edu/), as performed on the 28-6-2016, showing the complete protein 
(A) and the more ordered N-terminus (B). Structural prediction was modelled on the crystal 
structures of AAK1 (PDB ID: 514qA), BMP-2 (PDB ID: 4w9xA), and PK38 (M. musculus; PDB 
ID: 4bfmA) all of which are available in the PDB. The better template was 514qA, which was 
modelled with high confidence (5.54e-10). ~46% of the residues were modelled; the other 54 
% were predicted as regions of disorder (long tail in A). Yellow (β sheet), Pink+ Purple (α 
helix). (C) Schematic illustration of the 3D crystal structure of the human kinase AAK1 
complexed with an AAK1 dual inhibitor (LKB1; indicated by the black arrow; PDB ID: 5L4Q). 
(D) Schematic illustration of the 3D crystal structure of the human kinase BMP2K 
complexed with baricitinib (indicated by the black arrow; PDB ID: 4W9xA). (C+D) 3D 
structure images retrieved from the PDB. Crystal structure determined by (Sorrell et al. 2016) 
(C and D). Coloured according PDB colouring. Structures orientated from N-terminus to C-
terminus (left to right) where possible. 
5.3.1.2 Tb6560 is a pseudokinase 
When the sequence of Tb6560 was examined, several key kinase-associated 
motifs were absent. To illustrate this, the predicted sequence of Tb6560 was 
aligned against a canonical (and known active) protein human kinase (c-Src) 
using the Kinase Sequence Database (KSD). The alignment is shown in Figure 5-4 
(for a complete alignment refer to chapter 8, section 8.4, Figure 8-19). No 
GxGxxG motif, which is required for ATP binding, could be detected, and nor 
could an ‘HRD’ motif that is required to stabilise the orientation of ATP in the 
pocket; instead, the protein had an ‘HRN’ motif, suggesting a non-synonymous 
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mutation found in several pseudokinases (reviewed by Reiterer, Eyers, & Farhan, 
2014). Finally, the ‘DFG’ motif required for magnesium binding was also absent, 
and replaced with an ‘NFR’ motif. Only an APE motif (found at the end of kinase 
activation loops in eukaryotes) was identified. Taken together, and despite the 
generalised homology of Tb6560 with NAKs in the kinase domain, this analysis 
suggests it is unlikely Tb6560 could function as an active kinase, given the 
absence of so many core kinase functional motifs. 
 
Figure  5-4: Tb6560 lacks conserved kinase associated sequence motifs 
The protein sequences of Tb6560 (retrieved from TriTrypDB, v28; referred to as T.b.brucei 
on the diagram) and c-Src (GenBank ID 125711) were aligned in CLC Genomics Workbench 
7. The dashed triangles mark sequence motifs GxGxxG, HRD, DFG in c-SRC. 
The sequence of Tb6560 was next compared with related kinetoplastid proteins 
using the protein BLAST function available on TriTrypDB.org to examine whether 
its orthologues are also predicted pseudokinases, and indeed this was the case (a 
sequence alignment of the orthologues of Tb6560 in T. cruzi, L. mexicana, L. 
major and T. evansi is shown in chapter 8, section 8.4, Figure 8-20). All 
kinetoplastid proteins presented high sequence conservation in their N-terminal 
ends and highly divergent C-terminal regions. However, all kinetoplastid 
orthologues appeared to lack kinase specific motifs noted to be absent in 
Tb6560, suggesting the evolution of this protein as a pseudokinase arose in the 
ancestor of these parasites. 
5.3.2 Generation of Tb6560 knockout cell lines 
From 48 hours after RNAi, cells with reduced Tb6560 levels showed a small 
reduction in growth in vitro (chapter 3 in which this protein is referred to as 
Tb927.9.6560) and aberrant cells could also be observed in the population 
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(chapter 3 section 3.3.5.1). As RNAi-mediated loss of this gene product did not 
appear lethal, knockout cell lines (lacking both alleles of the gene) were 
generated to probe the role of this protein further. 
Figure 5-5 details the regions of Tb6560 used for homology-driven recombination 
required to generate disruption cell lines. 
 
Figure  5-5: Schematic illustration of homology regions required for Tb6560 knockout 
A region of the 5’UTR (including part of the Open Reading Frame (ORF) and a region of the 
3’UTR (Untranslated Region, and including part of the ORF) were amplified by PCR (black 
arrows show primer positions in the genome). The primer numbers are highlighted in 
brackets beside the expected fragment sizes for the two PCR products; bp (base pairs). The 
amplified regions were cloned into knockout vectors (as per section 2.4.1.2). Primer 
sequences are available in section 2.4.1.3. Not to scale. 
5.3.2.1 Gene knockout strategy 
Disruption of the Tb6560 ORF (deleting 1832 bp, from amino acids 50 to 610) was 
achieved sequentially through two rounds of transformation into wild type (WT) 
BSF T. brucei Lister 427 cells. Cells were first transformed with the construct 
Δ927.9.6560::NEO and G418 resistant clones selected (section 2.7.4) to produce 
putative heterozygote (+/-) cell lines. One validated clone (Tb6560+/-) was 
chosen for a second round of transformation with the construct 
Δ927.9.6560::BSD and blasticidin clonal transformants selected. At this stage, 
the selective antibiotics were removed from the media due to the slowing of 
growth observed in the presence of G418 (data not shown). 
5.3.2.2 Integration of knockout constructs and confirmation of knockout cell 
lines by PCR analysis 
Putative Tb6560-/- cell lines were confirmed by diagnostic PCR analysis using 
gDNA extracted from the transformants (section 2.2.1). The strategy employed 
and the agarose gels confirming integration are shown in Figure 5-6 (Putative +/- 
cell lines are shown in chapter 8, section 8.4, Figure 8-21). The analysis 
confirmed integration of both constructs into the knockout cell lines, since PCR 
products of the expected size were generated linking both antibiotic ORFs and 
flanking gene sequence. In addition, absence of the intact gene in the -/- clones 
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was demonstrated by the lack of amplification of a 337 bp fragment within the 
deleted portion of the Tb6560 ORF. Two -/- clones were analysed in all further 
analysis (referred to as Tb6560-/- CL1, and Tb6560-/- CL2). 
 
Figure  5-6: PCR analysis of putative Tb6560 null mutant clones 
(Top) Schematic illustration of expected fragment sizes amplified by PCR (bp), diagnostic 
primers used (black arrows) and their position in the genome. Primer sequences are 
available in section 2.4.1.2. Not to scale. (Below) Agarose gels of diagnostic integration 
PCRs, which were performed using the primer pairs detailed in A (testing for integration of 
NEO or BSD, or testing for the presence of intact ORF) using gDNA from two -/- clones (CL1, 
CL2), wild type (WT) cells, or using double distilled water (ddH2O) as a negative control.  All 
PCRs were performed on the same gDNA samples. NEO (Neomycin), BSD (Blasticidin), B/α 
tub (Beta/Alpha Tubulin), Actin IR (Actin intergenic region), gDNA (genomic DNA). For each 
gel, size markers are shown (bp). 
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5.3.2.3 Verification of knockout clones using qRT PCR analysis 
In addition to PCR analysis, qRT-PCR analysis was performed on cDNA to test for 
expression of Tb6560 RNA transcripts. Total RNA was extracted from WT, +/- and 
-/- cell lines as described in section 2.5.1 and cDNA generated as per section 
2.5.2. To control for the presence of undigested gDNA, a second reaction lacking 
the reverse transcriptase (-RT) enzyme was set up for each sample; gDNA 
contamination could not be detected in any of the samples by qRT-PCR analysis 
(data not shown). Primers suitable for qRT-PCR were designed and optimised as 
described in section 2.5.3.1 (primer sequences are available aforementioned 
section). The graph below (Figure 5-7) shows the RNA levels of the Tb6560 gene 
in each sample relative to the WT RNA levels (normalised to actin), expressed as 
a percentage. As partial recovery of some phenotypes was observed after 
prolonged passage of the knockout cell lines (see below), RNA was harvested at 
passage 2 (P2; ~1 week in culture after transformation) and passage 13 (P13; ~3 
weeks in culture) to ensure the recovery could not be attributed to outgrowth of 
non-mutants cells from a non-clonal population. Relative to WT cells, the 
Tb6560+/- cell line showed ~55% expression Tb65650 transcript, whereas in both 
knockout clones (and at both the early and late passage), no RNA transcript 
could be detected. 
 
Figure  5-7: Confirmation of Tb6560 knockout clones by qRT-PCR 
qRT-PCR analysis was performed as described in section 2.5.3.2. RNA transcript levels in 
both knockout clones (-/- CL1 and -/- CL2) and the Tb6560+/- cell line are shown as a 
percentage of RNA relative to the levels observed in wild type (WT) cells. The graph 
represents average data from one experiment, which was performed as a technical 
triplicate. 
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5.3.3 Phenotypic analysis of Tb6560 null mutant cell lines 
5.3.3.1 Growth and DAPI cell cycle analysis in vitro 
Since viable knockout mutants were generated, Tb6560 is not essential for the 
survival of BSF T.brucei cells in vitro. Nonetheless, following knockdown of 
Tb6560, the cells grew more slowly and a small population appeared 
morphologically aberrant (see chapter 3). To understand if these phenotypes are 
also seen in null mutants that lack all Tb6560 protein, the growth of both 
knockout clones was assessed relative to WT and Tb6560+/- cells (as described in 
section 2.8.2). This data is shown in Figure 5-8. No selective drugs were added 
to the medium to ensure any growth effects could not be attributed to the 
presence of antibiotic. 
Growth of the heterozygote cell line was not significantly affected when 
compared to WT cells. In contrast, a significant reduction in growth rate was 
observed in both knockout clones (Figure 5-8 A and B). Though both knockout 
clones reached approximately the same maximum cell density as WT and +/- 
cells, this was delayed (~72 hrs for the knockout clones, compared with ~48 hrs 
for WT cells), indicating increased population doubling times (with approximate 
doubling times of 9 - 10 hrs for Tb9650 CL1 and 8 – 9 hrs for Tb6560 CL2 
compared with 7 – 8 hrs for the WT427 parental cell line; calculated as described 
in section 2.7.4). When continually passaged in culture for over 3 weeks, the 
growth impediment appeared to recover, at least in part (data not shown). 
Given this, all subsequent assays were performed using cells within the 3 weeks 
from stabilate retrieval. 
To ask whether the reduced proliferation of the -/- cells could be attributed to 
disruption of the cell cycle, cells were prepared for indirect 
immunofluorescence (IF, as described in section 2.11.2) with α-KMX1 antiserum 
(to visualise tubulin) and stained with DAPI (to visualise nDNA and kDNA). DAPI 
staining allowed the cell cycle stage of individual cells within the cell 
populations to be assessed (as per section 2.8.3) and these data represented in 
Figure 5-8 C and representative images shown in Figure 5-8 D. Any cell that did 
not conform to the normal cell cycle categories (1N1K, 1N2K, 2N2K) was simply 
classified as ‘other’ for this analysis. In comparison to WT cells, no significant 
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difference in cell cycle distribution was observed in the +/-cell line; in both 
cases, only a very small percentage of aberrant cells were seen. For both 
knockout clones, a significant increase in ‘other’ cells was observed (~20 % of 
the population), which was associated with a decrease in the proportion of 1N1K 
and 1N2K cells; no obvious change in numbers of 2N2K cells was apparent. These 
‘other’ cells were classified as such based on their nuclear number alone. 
Generally, the nDNA stained by DAPI appeared smaller and less rounded than 
was observed in WT cells, and was also potentially fainter (as observed by eye), 
perhaps suggesting a lower content of nDNA or altered chromatin packing. 
Additionally, clearly defined kDNA signal appeared to be undetectable in some 
cells, either indicating that kDNA was absent or that the nDNA signal masked the 
kDNA signal as a result of shape distortion. Though these data may be 
interpreted as an altered cell cycle, the morphology of the -/- cells was also 
affected (this is further investigated in section 5.5 below) and in some rounded 
cells clear nDNA and kDNA signals could be discerned (Figure 5-8 D). Though the 
cells were simply stained with tubulin to determine the gross structure of the 
cell, it is clear that the typical trypomastigote shape has become lost in the 
absence of this protein; however, no clear loss of tubulin could be observed 
suggesting Tb6560 is unlikely to play a role in the formation of the parasite’s 
tubulin network. Based on the data presented below, it seems likely that the 
apparent changes in cell cycle suggested by the increased levels of ‘other’ cells 
may be most simply explained by wider changes in cell morphology, rather than 
by changes in nDNA or kDNA replication, meaning that loss of Tb6560 does not 
primarily affect the cell cycle. 




Figure  5-8: In vitro growth analysis of Tb6560 null mutant cell lines 
(A) In vitro growth curves. Error bars show ± SEM (n=3). Statistical significance was 
calculated to compare the density of WT cells at each individual time point to the 
corresponding null mutant clone (CL1 or CL2; A and B) using a Mann Whitney U test (one 
tailed); (*) = p<0.05. (B) Cell cycle analysis in vitro. Cells were stained with DAPI and the 
number of 1N1K, 1N2K, 2N2K and ‘other’ cells were counted and expressed as a percentage 
of the total population (for each cell line over 200 cells were counted per experiment). Error 
bars represent ±SEM (n=3). Significance was calculated by comparing ‘other’ cells from WT 
individually with ‘other’ cells from each knockout clone using a Mann Whitney U test (one 
tailed); (*) = p<0.05. (D) Representative IF images of -/- ‘other’ cells, as well as a cell with 
rounded morphology but discrete single nDNA and kDNA staining (arrowed). The cells were 
stained with DAPI (to visualise the nDNA and kDNA; magenta) and KMX-1 antiserum (to 
visualise β tubulin; cyan). A 1N1K WT cell is show as an example of the most frequent nDNA 
and kDNA configuration. Images were captured on an Axioskop2 (Zeiss) and processed as 
per section 2.11.8 in ImageJ. Scale bar = 5 µm. 
5.3.4 Localisation of Tb6560 
In previous work, Fritz et al., 2015) have shown that YFP-tagged Tb6560 localises 
to the posterior of PCF T. brucei cells. To ask if this is true also in BSF cells, and 
to investigate this localisation further, we set out to endogenously tag the 
protein in heterozygote cells, allowing the functionality of the tagged variant to 
be assessed. 
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5.3.4.1 Generation of a Tb6560+/-12myc cell line 
The endogenous tagging strategy employed is as described in section 2.4.1.1.1. 
The construct generated (Tb656012myc) permits C-terminal tagging of the 
endogenous gene with 12 copies of the myc epitope when transformed into WT 
cells (section 2.4.1.1.1). To evaluate functionality the knockout construct 
Δ927.9.6560::NEO was then transformed into putatively endogenously tagged 
cell lines, meaning the only expressed copy of the protein should be 12myc 
tagged. 
5.3.4.2 Confirmation of a Tb6560+/-12myc cell line 
To confirm the generation of a Tb6560+/-12myc cell line, gDNA was harvested from 
putative clones (section 2.2.1) and three independent PCRs performed to 
confirm integration of the Δ927.9.6560::NEO knockout construct into the 
genome; gDNA from WT cells and ddH20 were used as a controls to account for 
any contamination. Figure 5-9 A shows location of the primers in the genome, 
and the expected sizes of the PCRs. The integration PCRs are shown in Figure 5-9 
B below. Both constructs appeared to be correctly integrated into the parasite 
genome as evident from the presence of fragments of the expected size 
amplifying from each clone. 




Figure  5-9: Confirmation of Tb6560
+/-12myc
 clones 
(A) Schematic illustration of expected PCR fragment sizes in bold beside which the primers 
(for sequences refer to Table 2-3 used are detailed in brackets. Black arrows = primer 
localisation in the genome. Not to scale. (B) Integration PCRs. Images show integration of 
the Δ927.9.6560::NEO construct into endogenously tagged clones. PCRs were all performed 
on the same gDNA with ddH20 was used as a negative control. NEO (Neomycin), BSD 
(Blasticidin), B/α tub (Beta/Alpha Tubulin), Actin IR (Actin intergenic region), WT (Wild type), 
gDNA (genomic DNA), ddH20 (double distilled water). Sizes shown (kb plus ladder; bp). (C) 
Confirmation of endogenously tagged Tb6560
+/-12myc
 cell lines by western blot analysis. 
Whole cell extracts were separated by electrophoresis, blotted and the membranes probed 
with α myc antiserum (to detect the myc epitope) and α EF1α antiserum (as a loading 
control). The black arrows represent the two clones chosen for further analysis. 
All clones correctly integrated the knockout construct into the genomic locus. 
Furthermore, the Tb6560 ORF could still be detected in all clones. To test for 
expression of the 12myc tagged protein, whole cell extracts were prepared from 
each clone and a western blot analysis performed (section 2.12.1; Figure 5-9 C). 
A band of ~110 kDa was observed in each clone, which is a higher molecular 
weight than expected (the predicted size is 94.6 kDa; 80.2 kDa endogenous 
polypeptide + 14.4 kDa myc tag). However, the same size protein was seen in 
the Tb656012mycRNAi cells and when the RNAi against Tb6560 was induced, the 
signal on the western was ablated, arguing the protein detected is in fact 
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endogenously 12myc tagged Tb6560 (see section 3.3.3.4). Two clones were 
chosen and expanded for further experiments; Tb927.9.6560+/-12myc CL1 (C2A) 
and Tb927.9.6560+/-12myc CL2 (C2F). Both clones were derived from the original 
clone Tb6560+/-12myc C2. 
5.3.4.3 In vitro growth of the Tb6560+/- 12myc cell lines 
To confirm functionality of the tagged variant, the growth of both Tb6560+/-12myc 
clones was examined and compared with WT, Tb6560+/- and Tb6560-/- CL2 cells 
(section 2.8.2). As depicted in Figure 5-10, no significant proliferation defects, 
comparable with that seen for the -/- cells were observed in either clone 
relative to WT or Tb6560+/- cells, suggesting the endogenous tag does not hinder 
gene function. 
 
Figure  5-10: In vitro growth analysis of Tb6560
+/-12myc
 cell lines 
Growth of Tb6560
+/-12myc 
cell lines (CL1 and CL2) was assessed as described in section 
relative to WT, Tb6560+/- and the Tb6560-/- C2 No significant differences were observed 
relative to the WT cells. At 48 hours, the growth of the Tb6560-/- cell line was significantly 
reduced when compared to both Tb6560
+/-12myc
 CL1 and CL2 clones (p< 0.05, Mann-Whitney 
U test). Error bars represent ± SEM, n=3. 
5.3.4.4 Tb927.9.6560 localises to the posterior end of the parasite 
From the study performed by Fritz and colleagues, Tb6560-YFP was found to 
localise at the posterior end of PCF cells (Fritz et al. 2015) only under stress 
conditions. In contrast, the results presented here suggest constitutive 
localisation in BSF cells under routine in vitro culture conditions. 




Figure  5-11: Tb6560 localises to the posterior end of the parasite 
Cells were fixed as per section 2.11.2 and probed with α myc antiserum (to visualise the 
myc epitope; magenta) and DAPI (to visualise the nDNA and kDNA; cyan). The cell body was 
visualised by Differential interference contrast (DC) microscopy. Representative images of 
WT control cells (A) and of the localisation of Tb6560 in 1N1K, 1N1eK, 1N2K and 2N2K cells 
(B). Images were captured on an Axioskop2 (Zeiss) and images processed as per section 
2.11.8 using ImageJ. Scale bar represents 10 µm. Images are from Tb6560
+/-12myc
 CL1. 
To determine the localisation of 12myc-tagged Tb6560 indirect IF was performed 
as per section 2.11.2 using α-myc antiserum. To evaluate subcellular localisation 
through the cell cycle, nDNA and kDNA were visualised by DAPI and the cell body 
was visualised by DC imaging. Both tagged clones were examined in this manner 
with equivalent results, and so images are shown for just one clone (Figure 5-
11). In addition, WT cells were examined to control for any non-specific 
antibody binding and background fluorescence. Discrete anti-myc signal could be 
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localised in 100 % of cells and across all cell cycle stages (Figure 5-11). In all 
cases the signal was at the posterior end of the cell and was close to, but did not 
overlap with, the kDNA. Strikingly, the ‘focal’ signal followed the process of 
kDNA division. In cells in which the kDNA was replicated and dividing, but had 
not yet undergone segregation (1N1eK cells), two anti-myc foci could be 
detected around the kDNA. In 1N2K cells (where the kDNA has segregated but 
nuclear mitosis has not occurred), anti-myc signal was seen adjacent to each 
kDNA. Intriguingly, in both cases the anti-myc foci appeared to be unequal in 
size. Finally, in 2N2K cells that have undergone mitosis but not cytokinesis, two 
clear and perhaps more equally sized anti-myc foci were seen beside each kDNA. 
These data indicate a pronounced and discrete localisation of Tb6560 near the 
kDNA and, furthermore, suggest the protein associates with a structure (or 
structures) whose division precedes division of the kDNA and may develop 
unequally. As a result, the data may suggest the pseudokinase could be a 
component of the basal body, the flagellar pocket collar and/ or the flagellar 
pocket, each of which are found in this part of the cell. 
Attempts to co-localise Tb6560 with TbBIBLO-1 were undertaken, in order to 
begin to address the potential association of the pseuokinase with one of these 
structures (data not shown). However, this proved unsuccessful. TbBILBO-1 is 
embedded in the cytoskeleton as a core component of the FPC (Florimond et al. 
2015) and, as such, requires removal of the cell membrane for visualisation. In 
these conditions, Tb6560 localisation was lost (chapter 8, section 8.4, Figure 8-
22). Though the reasons for this finding were not tested further, it may suggest 
the protein membrane associated and may not be part of the FPC. 
5.3.4.5 Super resolution analysis and 3D reconstruction of Tb6560 
localisation 
To further analyse the localisation pattern of Tb6560, super resolution structural 
illuminated microscopy (SR-SIM) was undertaken and 3D images were generated. 
As most markers available for the FP and FPC required cytoskeletal extracts to 
be prepared, a dual staining was performed to detect the C-terminally 12myc 
tagged Tb6560 protein and the single mitochondrion of the cell in order to 
establish a more accurate localisation in the absence of such markers. Cells were 
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first labelled for 15 mins (at 37oC) with Mitotracker® (as per section 2.11.3) 
prior to fixation, and an IF with α-myc antiserum and staining with DAPI 
performed (as per section 2.11.2). Mitotracker® (in its reduced form) is taken up 
by actively respiring cells, in which the dye becomes oxidised and sequesters 
into the mitochondrion. Representative images are shown in Figure 5-12. 
SR-SIM revealed that the anti-myc foci observed previously adopted a more 
defined localisation in the cell, with the signal in 1N1K arranged in a ‘horse-
shoe’ like shape around the kDNA. In some cases, the signal appeared almost to 
be a ring with greater intensity at one side, whereas in other images it appeared 
to be an arrangement of foci at the anterior end of the kDNA. These data 
suggest localisation of Tb6560 may be more dynamic than static. Indeed, 
dynamic localisation was confirmed depending on the cell cycle stage and 
reflecting the earlier IF (Figure 5-11). Cells undergoing kinetoplastid S-phase 
(1N1eK) had two spatially distinct arrangements of the protein at either end of 
the dividing kinetoplast. In all cases, the anterior end of the kinetoplast 
appeared to harbour a larger concentration of the protein, where the ‘horse-
shoe’ shaped appearance could be seen. The other, posterior end appeared to 
harbour a lower (but still punctate) concentration of the protein. In cells that 
had divided the kinetoplast (1N2K cell), the signal reflected the protein 
localisation in 1N1eK cells, with a greater intensity and more pronounced 
horseshoe shape near one kDNA compared with the other. Once the nDNA and 
kDNA had both divided (2N2K cell), the protein localisation became a more 
defined ‘horse-shoe’ shape adjacent to each kDNA, with a more similar signal 
intensity at each (Figure 5-12 B), suggesting equalisation of the concentration of 
the protein in close proximity to the daughter kinetoplasts. 




Figure  5-12: Super resolution images of Tb6560 localisation 
(A) Tb6560
+/-12myc 
cells were stained with Mitotracker® prior to fixation. Top panel: nDNA and 
kDNA stained with DAPI (cyan). Second panel: Tb6560
+/-12myc 
stained with anti-myc 
(magenta). Third panel: mitochondrion stained with Mitotracker® (red). Bottom panel: 
Merged image of DAPI, myc and Mitotracker®. Scale bar represents 5 µm. (B) 3D 
reconstructions of Tb6560 localisation. The images were generated from super resolution 
stack images captured on an Elyra (Zeiss) super resolution microscope. 3D images were 
generated using IMARIS software (http://www.bitplane.com/imaris/imaris; V.8.2). Scale bars 
(from left to right) = 0.5 μm, 0.5 µm and 0.7 µm.). Image on the right (scale bar = 1 μm). 
Images are of Tb6560
+/-12myc
. The images above were captured under the supervision of L. 
Lemgruber Soares. 
Taken together, these data verify that Tb6560 has a dynamic, cell cycle-
dependent localisation. This dynamism appears distinct from that of TbBILBO-1 
(Florimond et al. 2015), suggesting the pseudokinase may not be a component of 
the FPC, but may instead be associated with the FP, the endosomal system or an 
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unanticipated structure. However, whether the protein accumulates in such 
regions in response to a particular signal, such as stress (Fritz et al. 2015), is not 
tested by this approach. 
5.3.4.6 ImmunoGold® labelling of Tb6560 
ImmunoGold® labelling was next performed on the Tb6560+/-12myc cell line to 
further probe the localisation pattern of the pseudokinase. Cells were fixed, 
stained with α myc antiserum and detected using serotype specific ImmunGold® 
particles (10 nm), and processed for TEM imaging (as per sections 2.11.72 and 
2.11.73). Representative images are shown in Figure 5-13 A and B. 
 
Figure  5-13: Localisation of endogenously tagged Tb6560 by ImmunoGold® labelling 
(A) Representative images of WT cells used as a control for non-specific localisation. Scale 
bars = 200 nm (left image) and 0.5 μm (middle and right image). (B) Representative images 
of Tb6560 localisation. 12myc-tagged protein was detected using ImmunoGold® particles in 
three Tb6560
+/-12myc 
CL1 cells (C) A representative image of Tb6560
+/-12myc
 localisation with an 
enlarged section highlighted by the black box. A vesicle associated ImmunoGold® particle 
is indicated by the white arrow. FP (Flagellar Pocket), F (Flagellum). Images were captured 
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on an Tecnai T20 EM microscope by TEM by L. Lemgruber-Soares. The scale bar was added 
in ImageJ =  0.2 μm for all images. 
Again, in these experiments most of the anti-myc signal localised to the 
posterior region of the cell, with a noted proximity to the FP. No clear ‘horse-
shoe’ shaped structure was observed. Instead, the signal appeared more 
dispersed, with many foci around the FP and with others more distal in the 
cytoplasm. In several cases where the signal was not at the FP membrane, co-
localisation could be detected with membrane-bound structures, some of which 
appeared to be vesicle-like (Figure 5-13 B). Additionally, localisation could 
occasionally be observed within the FP and on the flagellum itself. Further 
images are required for a more in depth analysis of Tb6560 localisation by 
immunolocalisation. 
To summarise, these EM data appear compatible with the indirect IF imaging of 
Tb6560, suggesting a dynamic localisation in the cell posterior and adjacent to 
the kDNA, which is often associated with both vesicle structures and the FP 
membrane. 
5.4 Loss of Tb6560 is associated with increased 
genotoxic stress sensitivity 
Knockdown of Tb6560 significantly increased cell sensitivity to MMS (see chapter 
3). To examine whether this sensitivity to MMS is also seen in the knockout 
mutants, and reflects wider sensitivity to other sources of genotoxic stress, the 
following section describes a series of experiments testing the predicted role of 
Tb6560 in the response to agents that cause DNA damage. 
5.4.1 Tb6560 knockout mutants are sensitised to genotoxic stress 
in vitro 
To ask if loss of Tb6560 sensitises T. brucei BSF cells to various sources of 
genotoxic stress, growth was analysed as per section 2.8.2. Cultures were set up 
(as per section 2.8.2) in media containing a single concentration of MMS, PHL or 
HU, as well as after exposure to a single dose of UV. Cell growth of the -/- 
mutants was measured with time and compared with WT and Tb6560+/- cells, 
and with cells grown in the absence of damage. For simplicity only the WT and -
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/- growth curves are shown in Figure 5-14 A and B, but data for the Tb6560+/- 
cell line is available in chapter 8, section 8.4, Figure 8-23. 
 
Figure  5-14: In vitro growth analysis of Tb6560-/- cells under genotoxic stress 
Growth analysis of Tb6560-/- CL1 (A, orange lines) and CL2 (B, pink lines) in the presence 
(dashed lines) or absence (solid lines) of a variety of genotoxic stress conditions:  MMS 
(0.0003 %), UV (1500 J/m
2
), PHL (0.1 μg/ml) and HU (0.06 mM). Black lines depict growth of 
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the WT cells. Error bars represent ± SEM; n=3. For statistical analysis, WT cells under 
genotoxic stress at each time point were compared with the corresponding Tb6560-/- cells; 
(*) = p<0.05 as determined by a Mann Whitney U test. 
When exposed each of the aforementioned sources of genotoxic stress, with the 
exception of UV, growth of the Tb6560-/- clones was significantly reduced. 
Moreover, and again with the exception of UV, the extent of the growth 
impairment in the presence of the genotoxic agents was more pronounced in the 
-/-cells than in WT, arguing that loss of Tb6560 results in increased sensitivity. 
Exposure to HU and PHL only exaggerated the growth phenotype already 
exhibited by the null mutant clones and proliferation continued. In contrast, 
when exposed to MMS growth notably stopped in the mutants for around 48 hrs 
before resuming, perhaps suggesting greater sensitivity to this treatment. The 
lack of increased sensitivity of the -/- mutants to UV, which has been shown to 
cause nuclear damage requiring DNA repair (Machado et al. 2014), indicates 
Tb6560 does not act in response to all genotoxic agents. In addition, cells 
exposed to these concentrations of UV, PHL and HU tend to retain recognisable 
trypomatigote morphology (Figure 5-16 and below). In the case of exposure to 
MMS treatment, though DNA lesions also form the architecture of the cell is 
more compromised (Figure 5-16). Given the non-nuclear localisation of the 
pseudokinase, which may be associated with the FP or the endosomal system, 
the greater sensitivity of the -/- mutants to MMS may be explained by a 
compromised ability to respond to damage outwith the nucleus. 
5.4.2 Loss of Tb6560 is not associated increased γH2A 
expression 
To test for the presence of genotoxic stress signalling, and to look for evidence 
of nuclear damage in the mutants, expression of γH2A was examined by indirect 
IF analysis. Tb6560-/- and WT cells were harvested at a density of ~5x105 
cells/ml, fixed and stained with DAPI (to visualise the nDNA and kDNA) and anti 
γH2A antiserum (as per section 2.11.2). Expression of γH2A was examined by 
measuring the fluorescence intensity of anti-γH2A signal in the nuclei of cells (as 
per section 2.11.8.3). However, when the fluorescence intensity was measured 
from each Tb6560-/- clone and calculated relative to the WT background level 
(Figure 5-15), no significant increase in γH2A levels could be determined 
(representative images are show in chapter 8, section 8.4, Figure 8-24). Though 
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γH2A can be considered as a general marker of genotoxic stress, primarily 
expression of γH2A is triggered in response to direct DNA lesions, such as double 
strand breaks (DSBs; Kuo & Yang, 2008). Thus, despite the demonstration that -
/- mutants display increased sensitivity to genotoxic stress (previous section), 
the negligible change in nuclear γH2A levels indicate it is unlikelyTb6560 plays a 
direct role in the nuclear response to DNA damage. 
 
Figure  5-15: Fluorescence intensity quantification of γH2A expression in Tb6560
-/-
 cell lines 
Fluorescence intensity from > 400 nuclei from WT, Tb6560-/-CL1 and Tb6560-/-CL2 cells was 
measured as per section 2.11.8.3 in ImageJ. The WT fluorescence was arbitrarily assigned a 
value of 1 and the fold change calculated for each knockout clone relative to the WT level. 
These values are expressed as arbitrary units (AU). Error bars represent ±SEM of 4 
independent experiments. No significance could be detected using a Wilcoxon matched 
pairs-signed rank test. 
5.4.3 Localisation of Tb6560 following genotoxic stress exposure 
To test further if Tb6560 does not play a role in the response to nuclear damage, 
localisation was examined following exposure to PHL, HU, UV or MMS, asking if 
the discrete localisation seen in undamaged cells changes, for instance by 
translocation of the protein to the nucleus. 




Figure  5-16: Tb6560
12myc
 localisation following DNA damage exposure 
WT427 cells (A) and Tb6560+/-12myc cells (B) were exposed to MMS (0.0003 %) or PHL (1 
µg.ml
-1
) for 18 hrs, fixed and stained as per section 2.11.2. Representative images are shown 
and were captured on an Axioskop2 (Zeiss) and processed as per section 2.11.8 using 
ImageJ. Untreated WT and -/- cells are shown for comparison. Scale bar represents 10 µm. 
Images shown are from Tb6560
+/-12myc
 CL1. 
Tb6560+/-12myc cells were exposed to 18 hours of a damaging agent, fixed and an 
indirect IF analysis was performed (section 2.11.2). The nDNA and kDNA were 
visualised by DAPI staining, the cell body visualise by DC imaging and the myc 
tag visualised by α myc antiserum. 
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Localisation of Tb6560-12myc did not appear to be affected following UV 
exposure or growth in the presence of HU (images shown in chapter 8, section 
8.4, Figure 8-25). Following PHL and MMS exposure, localisation of the anti-myc 
signal around the kDNA was also comparable to that of the untreated control 
cells, though after PHL exposure often a larger region of the posterior end of the 
parasite harboured the myc signal, sometimes appearing as a large focus 
particularly in 1N1K cells. In the later cell cycle stage, the localisation appeared 
more dispersed and punctate, though still within the posterior end of the 
parasite (Figure 5-16 B; middle panel) and not in the nucleus. After MMS 
exposure (Figure 5-16 B; lower panel), the anti-myc signal appeared more 
dispersed and disordered than the untreated cells. In some cells, the localisation 
was very punctate, in contrast to others in which localisation either could not be 
observed or an increased signal could be seen. Nonetheless, where signal was 
seen it remained around the kDNA and was not nuclear. Indeed, in cells 
harbouring multiple kinetoplasts, a focus of localisation could often be observed 
in close proximity to each kinetoplast. 
In summary, the anterior localisation of Tb6560 was normally still observed 
following exposure to genotoxic agents and appeared to remain associated with 
the FP/kDNA region of the cell. Thus, any pathway mediating recruitment to site 
of localisation was largely unaltered by such treatment and any putative 
function in mediating nuclear DNA repair is not reflected in detectable nuclear 
localisation. 
5.5 Morphological analysis of Tb6560 null mutants 
As indicated previously, loss of Tb6560 was associated with the appearance of 
cells with aberrant morphology (see chapter 3, section 3.3.5). This section 
describes experiments that explore this change in morphology in greater depth. 
5.5.1.1 Loss of Tb6560 affects cell morphology 
To examine cellular morphology, cells from the two knockout clones, and from 
the Tb6560+/- and WT lines, were harvested and indirect IF analysis was 
performed with α-KMX1 antiserum. The nDNA and kDNA were stained with DAPI 
and the cell body visualised by DC imaging. The population was visually 
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examined and cells that did not conform to a trypomatigote shape were counted 
and expressed as a percentage of the total population (as shown in Figure 5-17 A 
and B). Approximately 7 % of WT cells and 3 % of Tb6560+/- cells appeared 
visually aberrant, in contrast to ~44-46 % of cells from the Tb927.9.6560-/- lines. 
For further investigation, visually aberrant cells were further categorised 
depending upon the morphology observed. These categories were as follows: 
aberrant (cells which had no clearly definable defect), rounded (cells which 
appeared rounded in shape) and ‘BigEye’ (cells with what appeared to be 
enlarged FPs but were not rounded in shape; Allen, Goulding, & Field, 2003). 
Representative images of each category are shown in Figure 15-17 C. This 
categorisation revealed the increase in aberrant cells was primarily accounted 
for by a significant increase in ‘rounded’ cells (~20 % of all cells) in both Tb6560-
/- clones when compared to WT cells. In many cases, the flagellum could not be 
clearly observed, or appeared short in length. The next most common category 
was aberrant, but not clearly rounded, cells (> 20% of cells). Finally, a small 
increase in cells with the ‘BigEye’ phenotype was observed in both mutants (~ 5% 
of cells) relative to WT. When the ‘rounded’ cells were examined in more detail, 
two sub-categories could be detected. In around 30 % an enlarged vesicle-like 
structure was clearly discernible; for the remaining 70 % of ‘rounded’ cells, this 
was not the case (Figure 15-17 B). If the enlarged vesicle is the cause of cell 
rounding, why this should be absent in ~70 % of ‘rounded’ is unclear. However, 
as mentioned by Allen et al. 2003, cells with enlarged FPs are often fragile and 
fail to retain the structure following centrifugation. Thus, it is possible that 
many cells with these enlarged structures were lost during the indirect IF 
analysis here. ‘Rounded’ T. brucei cells have also be observed following clathrin 
knockdown (particularly PCF cells; Allen et al. 2003), and this effect has been 
attributed to the presence of a swollen FP (BSF) and internal vesicle pressure 
(PCF). Thus, some of the swollen cells in the Tb6560-/- mutants may not be 
attributed to an enlarged flagellar pocket; instead an increase in internal 
vesicles may account for this phenotype. Furthermore, the variation regarding 
the degree of ‘rounding’ could be attributed to differences in the level of 
vesicles present in each cell. 




Figure  5-17: Loss of Tb6560 affects BSF cell morphology 
(A) Cells were examined and the morphology categorised as detailed in the figure. The 
number of cells in each category is expressed as a percentage of the total cell counts. Over 
200 cells per experiment were counted. Error bars represent ± SEM; n=3. Significance was 
assessed by a Mann Whitney U test: (*) = p<0.05. (B) Cells with a ‘rounded’ morphology 
were further classified depending upon the presence or absence of a large swollen vacuole 
structure. Each category is shown as percentage of the total number of ‘rounded’ cells 
counted in (A). Over 200 cells per experiment were counted (n=3). Error bars represent ± 
SEM. (C) Representative images of DAPI (to visualise nDNA and kDNA; cyan) and αKMX-1 
(to visualise βtubulin; magenta) stained Tb6560-/- CL1 cells from each category. The cell 
body is visualised by DC. In the black dashed box is a representative WT cell. Scale bar = 10 
μm. Images were captured on an Axioskop2 (Zeiss) and processed in ImageJ (as per section 
2.11.8). 
5.5.1.2 High resolution morphological analysis using TEM 
To examine the swollen vesicle-like structure further and to potentially 
determine why this structure was absent in some morphologically aberrant cells, 
the internal structures of the cell were examined by TEM. The cells were fixed 
and imaged as per section 2.11.7.2. Representative images of WT cells are 
shown in Figure 5-18 and annotated for reference, while images of Tb6560-/- 
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mutants are shown in Figures 19 and 20. Images of Tb6560+/- cells are shown in 
chapter 8, section 8.4, Figure 8-26. 
 
Figure  5-18: Internal cellular architecture of wild type Lister 427 BSF T. brucei cells 
BSF T. brucei cells were fixed (section 2.11.7.2) and imaged by TEM. Important features of 
the cell posterior are annotated. The insert black box (left image) is an enlarged region of 
this image as highlighted. TGN (trans-golgi network), EV (endocytic vesicle), FA (flagellar 
axoneme), PBB (pro-basal body), FP (flagellar pocket) and kDNA (kinetoplast DNA). Images 
were captured on a Tecnai T20 trasmission electron microscope and processed in section 
2.11.7. Scale bars = 0.5 μm. 
Upon loss of Tb6560, significant and complex alterations, ranging in severity, 
were observed in the internal morphology. Representative images are shown in 
Figure 5-19. No clear kDNA-or nDNA defects could be observed. In one cell, the 
nuclear membrane appeared disrupted, but the phenotype of this cell was 
particularly severe and it is possible the general cell structure was breaking 
down (Figure 5-19 G). 
Of the 34 images captured from the Tb6560-/- CL1 cell line (Figure 5-19 A-I), 29 
cells examined had an enlarged FP. That the enlarged structure was the FP was 
based on several observed features: the presence of an electron dense coating 
on the inner surface of the membrane (most likely the VSG coat), a flagellum 
entry point (and the presence of a FAZ), and the presence of a glycan rich 
matrix within the enlarged FP. Routinely, the FP encompassed almost the entire 
cell volume (Figure 5-19 A-F). Interestingly, the FP did not retain a spherical 
shape, and instead the membrane was folded and misshapen, suggesting that 
membrane transport may be defective. Occasionally, densely coated objects 
could be observed within the FP (Figure 5-19 I). The remaining five cells 
examined did not harbour an enlarged FP; for two of the cells (Figure 5-19, 
G&H), no clear defects could be observed, whereas the remaining three 
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harboured multiple electron dense and electron light vesicles. In addition, 
defects in the endosomal and the trans-golgi network (TGN Figure 5-20) were 
observed (Figure 5-20 A&B), appearing as swollen ‘vesicle-like’ structures, some 
with internal cargo (occasionally very electron dense; Figure 5-20 C&D) and 
others lacking any clear contents (see Figure 5-19 A-F below). 
 
Figure  5-19: Loss of Tb6560 grossly affects structures associated with endocytosis and 
vesicular trafficking 
Representative images of the Tb6560-/- CL1 cell line. Cells were fixed as per x and imaged 
on a Tecnai T20 transmission electron microscope using TEM. The black boxes indicate 
areas enlarged in Figure 5-20 for clearer viewing. Images were processed in ImageJ and 
Adobe Photoshop. The top left image shows disruption of the nuclear membrane. Scale 
bars are as annotated on the images (between 1-0.5 μm). 




Figure  5-20: TEM images of abnormal cellular structures associated with Tb6560 loss 
Enlarged images of abnormal endosomal and golgi networks observed in Tb6560 knockout 
mutants. A. The image is annotated as follows: EV (endocytic vesicle), TGN (trans-golgi 
network), MVB (multi-vesicular body) and FP (flagellar pocket). B. An electron dense granule 
is shown by a solid white arrow (top right) and an abnormal vesicle-like structure 
highlighted by a solid black arrow (top right). C. A vesicle harbouring cargo is indicated by a 
solid white triangle. D. A large mass in the FP is indicated by a solid black arrow (bottom 
right). Scale bars = 0.5 μm (top panel) and 0.2 μm (bottom panel). Images of Tb6560-/- CL1 
were captured on a Tecnai T20 transmission electron microscope and processed in x. 
To determine whether FP swelling could be explained by a FPC defect, the point 
at which the flagellum entered the FP was examined in more detail in the 
mutants (Figure 5-21 shows representative images). However, no noticeable 
defects were observed, suggesting swelling is not due to a ‘loosening’ of the 
connection between the flagellum entry site and the FP membrane and thus an 
influx of extracellular material. Indeed, when the localisation of TbBILBO-1 was 
examined in the KO cell line (data shown in chapter 8, section 8.4, Figure 8-27), 
the protein did not appear to miss-localise, suggesting the absence of Tb6560 
does affects TbBILBO-1 in its role providing structural support to the FPC, 
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consistent with the EM data showing the entry point of the flagellum does not 
appear to be compromised. 
 
Figure  5-21: The enlarged FP is unlikely due to disruption at the flagellar entry point 
The entry point of the flagellum into the FP (via the FPC) was imaged by TEM as per section 
2.11.7.2. Enlarged images of the image indicated by the black box are shown below the 
corresponding picture. The images were captured on a Tecnai 20 transmission electron 
microscope and processed in ImageJ by L.Lemgruber-Soares. Images from Tb6560-/- CL1 
were shown. Scale bars = 0.5 μm. 
5.5.1.3 3D Video Reconstruction of the Tb6560 FP 
To visualise the 3D architecture of a BSF cell following the loss of Tb6560, 
focused ion beam/scanning electron microscopy (FIB/SEM) imaging was 
performed to generate a morphometric 3D reconstruction of a cell based on a 
robust statistical analysis. This technique has been used effectively to assess, for 
example, Plasmodium parasites within erythrocytes (Medeiros et al. 2012). The 
3D reconstruction was performed by L.Lemgruber-Soares (as detailed in the 
figure legend below). A video is provided as supplementary material 
(Accompanying CD; file entitled Tb6560videoreconstruction.mov). Still frame 
images from the video are presented in Figure 5-22 A-H. 




Figure  5-22: FIB/TEM analysis of Tb6560 knockout cells 
(A-H) Images from different stages of the video in chronological order captured for FIB/TEM 
analysis of a Tb927.9.6560-/- CL1 cell. The alignment of the images was performed in Jmod 
(Midas; Bouldor, Colorado; (Kremer et al. 1996) and the 3D images were generated using the 
IMARIS software (http://www.bitplane.com/imaris/imaris; V.8.2). All images are at the same 
scale. Scale bar =100 nm. Image capture and preparation was performed by L.Lemgruber-
Soares. 
From this analysis, it is clear that the FP occupies a vast proportion of the cell 
body. In addition, flagellum development does not appear impaired. 
Interestingly, enlargement of the FP predated cellular division in this cell as no 
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other nucleus could be detected in this cell, though no clear ‘daughter’ FP can 
be observed. Considering the flagellar pocket forms upon flagellum exit from the 
original ‘parental’ cell, it is possible that the process of FP formation is also 
disrupted in a dividing cell. In keeping with this hypothesis, no knockout cells 
with a ‘LittleEye’ phenotype (a ‘LittleEye’ phenotype indicates swelling of the 
developing flagellar pocket of the daughter cell) could be clearly observed, 
which would arise due to a swelling of the ‘daughter’ FP (Allen et al. 2003). 
In all, the EM images in section 5.5.1.2 and from the FIB/TEM analysis, confirm 
the swollen vacuole observed is the FP of the cell; perhaps explaining the 
morphology distortion. FP swelling may increase the internal pressure and 
eventually distort the subpellicular ‘corset’ of the parasites resulting in a 
‘rounded’ shape. In addition, some cells also harboured endosomal system and 
TGN defects suggesting that loss of Tb6560 not only affects bulk endocytosis but 
also the transport of internal cytoplasmic vesicles through the endosomal system 
and to the TGN. 
5.6 Tb6560 may be involved in BSF endocytosis and 
trafficking 
Loss of Tb6560 results in cells with enlarged FP, multiple internal vesicle-like 
structures and defects in both the endosomal system and the TGN (section 5.5). 
An explanation for this range of cellular changes is impaired endocytosis, 
perhaps including subsequent trafficking of internal vesicles. To test this 
hypothesis, an endocytosis assay was performed to assess the ability of the 
knockout cell lines to uptake tomato lectin (TL; Nolan, Geuskens, & Pays, 1999). 
The assay was performed as described in section 2.11.6 at 4 oC to examine TL 
uptake into primarily the FP and the early endosomal trafficking system. 
In WT and Tb6560+/-cells (representative images are shown in Figure 5-23 and 5-
24), TL was readily up taken into the FP and the early endosome system, as 
expected (Figure 5-23). A larger number of cells are shown in the images in 
chapter 8, section 8.4, Figure 8-28. 




Figure  5-23: Uptake of tomato lectin into the FP and the early endosome system of wild type 
BSF T. brucei 
Images are representative examples of wild type BSF T. brucei (WT427) cells showing 
uptake of FITC-conjugated tomato lectin (TL). The white arrow indicates TL in the early 
endosome system. The purple arrow indicates TL in the FP. Images were captured on an 
Axioskop2 and processed in ImageJ as per section 2.11.8. Scale bar = 10 μm. 
In contrast, the results from the knockout cells proved a challenge to interpret. 
Several different localisations of the lectin could be detected, representative 
images of which are shown in Figure 5-24. In most rounded cells lectin staining 
appeared diffusely throughout the cell but within this, more localised, intense 
accumulation of TL, potentially in the FP, was observed in many cells. In some 
other cells, including unrounded cells, small distinct foci of TL localisation could 
additionally be detected outwith the predicted region of the FP, and most likely 
within cytoplasmic vesicles. Finally, normal uptake of TL was also seen in a small 
population of cells, many of which were unrounded. 
The range of TL accumulation in the mutants, seemingly in both the FP and 
cytoplasmic vesicles of some cells, appears to mirror the abnormal morphology 
of the cells revealed by EM. Taken together, these data suggest that though 
endocytosis and internalisation of cargo is not blocked entirely, it is clearly 
impaired in the knockout cells. With such a diversity of TL distribution, it was 
difficult to decipher if a single stage of the endocytosis and trafficking pathway 
is lost in the mutants, perhaps suggesting Tb6560 operates at multiple points 
during this process. Additional assays are required to asses this phenotype. 




Figure  5-24: Cells lacking Tb6560 are defective in endocytosis 
(A) Representative images of FITC-conjugated tomato lectin (TL) uptake in Tb6560-/- 
knockout cells. The white arrows highlight internal vesicles also harbouring TL. (B) 
Enlarged examples of Tb6560 knockout cells showing uptake of TL into both the FP and 
internal vesicles. DC = differential interference contrast microscopy. Images captured on an 
Axioskop2 and processed in ImageJ as per section 2.11.8. Scale bar = 10 μm. 
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5.7 Identification of potential interacting partners of 
Tb6560 
If Tb927.9.6560 is involved in endocytosis, interaction partners could aid in 
deciphering a potential role for this protein in BSF T. brucei parasites. To this 
end, an immunoprecipitation (IP) was performed (as per section 2.12.2), using 
anti-myc antiserum to recover Tb6560-12myc from the Tb6560+/-12myc cell line. 
WT cells were used to control for any non-specific binding of proteins to the 
Dyna beads. To allow for identification of interaction partners visually and by 
mass spectroscopy, an IP was performed. The final eluate of one IP (S1) was 
separated on 4-12 % BT gel by SDS-PAGE and stained with SYPRO® Ruby before 
imaging on a Typhoon (section 2.12.4). One band was clearly unique to the 
Tb6560+/-12myc eluate, and was judged to be Tb6560+/-12myc based on size and 
clear identification of the protein by mass spectroscopy (Figure 5-25 A; section 
2.12.3). No other clear differences could be observed between the eluate of 
Tb6560+/-12myc cells and WT cells. 
 
Figure  5-25: Immunoprecipitation from a Tb6560
+/-12myc
 cell line using anti-myc antiserum 
(A) Image of a SyproRuby®-stained gel of eluate from an anti-myc immunoprecipitation (IP) 
from Tb6560
+/-12myc 
and wild type (WT427) cells (eluate S1). The (*) indicates C-terminally 
tagged Tb6560 (~94.6 kDa). Protein standard markers are shown (Novex® pre-stained 
protein standard ladder). (B) Western blot analysis confirming IP of Tb6560
+/-12myc
. The (*) 
marks both the heavy and light chain of the α myc antibody. E = eluate (S2), F = flow 
through, I = input, PL = pre lysis, W = WT427 and T = Tb6560
+/-12myc
. 
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A second eluate sample (S2) from both cells was sent for mass spectroscopy 
analysis (section 2.12.3; Glasgow Polyomics Facility; the WT sample was run 
first) and a western blot was performed (section 2.12.1), verifying that 
Tb656012myc could only be detected (Figure 5-25 B) in the eluate of the Tb6560+/-
12myc sample. Described below are the proteins identified (summarised in Table 
5-3) from MS analysis, which are proteins only detected in the experimental and 
not control (WT) IPs (Accompanying CD; see file entitled 
MSdataTb6560andTbAUK22016.xls for all proteins identified in both samples). 
Tb6560 was identified in the IP from the Tb6560+/-12myc cells and not WT, as 
expected. 
 
Table  5-3: Potential Tb6560 interaction partners identified by MS analysis 
Proteins shown were those proteins only present in an anti-myc IP from Tb6560
+/-12myc 
cells; 
all proteins also identified in IP from wild type cells were excluded. Samples were analysed 
using MASCOT software. Protein sequence for each ‘hit’ was analysed by BLASTp using the 
SmartBLAST feature and domains examined by Interpro analysis. Displayed above are also 
any potential corresponding human homologs. Hyp. Cons. = hypothetical conserved, MW = 
molecular weight. 
It should be noted that these data have not been verified by further analysis 
(e.g. repeat IP, directed co-IP or reciprocal IP), so must be treated as 
preliminary. Nonetheless, two proteins were revealed that may be consistent 
with the predicted endocytotic function of Tb6560. Most proteins were 
annotated as hypothetical and kinetoplastid specific. When analysed by BLASTp 
(section 2.1.2) and Interpro (section 2.1.2), no specific domains could be 
identified in most. However, one hypothetical protein (Tb927.8.1210) showed 
sequence homology to a cap-gly domain linker protein (54 % coverage, E-value 
2e-04, 27 % identity) in the helminth Ascaris suum, and very weak homology to a 
kinesin (Kin K39 from Moesziomyces antarcticus). Cap-gly domain containing 
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proteins may facilitate microtubule interactions (Wang et al. 2014). The protein 
was also predicted to possess a potential zinc binding site (a Gluzincin domain; 
this was not identified using the Interpro search and therefore may be a false 
identification). The second notable protein was the predicted heavy chain of 
dynein (Tb927.11.2430). To date, this protein has only been shown to be 
required for retrograde trafficking within the flagellum (Blisnick et al. 2014), so 
whether it is compatible with the function predicted here remains unclear. 
Three other proteins appear to be associated with the mitochondrion. 
Tb927.10.520 is a subunit of the F0F1-ATP synthase complex required for the 
production of energy for the mitochondrion (by generating ATP) in the PCF 
stage; loss of this gene reduces in vitro PCF cell growth and is required for the 
structural integrity of the ATPsynthase complex (Zíková et al. 2009). A role for 
this protein is still under investigation; though considering the increased activity 
of the PCF mitochondrion, it is a surprise as to why this would have been 
identified in this study due to the compartmentalisation of glycolysis in the BSF 
(the glycosome; Opperdoes & Borst, 1977) and the downstream respiratory chain 
not being required (reviewed by Coley, Dodson, Morris, & Morris, 2011). In 
addition, the second protein (Tb927.6.4520) was identified as harbouring a 
Trichohyalin-plectin-homology domain, potentially required for the tethering of 
the mitochondrion to the ER and to maintain its morphology (Cerqua et al. 
2010). The final protein (Tb927.8.5310) showed sequence homology to a 
Coenzyme Q binding protein, which in humans is involved in the respiratory 
chain of the mitochondrion (the importance of coenzyme Q is reviewed by 
(Hargreaves 2014). None of these proteins obviously fit with the data presented 
in this chapter, though the close proximity of Tb6560 localisation to the 
parasite’s mitochondrion may cause them to be pronounced contaminants. 
Indeed, no clear mitochondrial defects were observed by TEM (section 5.5.1.2). 
Further work is required to test any of these potential interactions. 
5.8 Discussion 
5.8.1 Tb6560 is likely a NAK pseudokinase 
Several interesting and surprising outcomes resulted from a fresh examination of 
the Tb6560 sequence. Though not specific to T. brucei or the kinetoplastids, 
several unusual features were observed when compared to the potential 
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homolog of this gene in H. sapiens. Firstly, the N-terminal region of Tb6560 is 
revealed to show clear sequence homology to the N-terminal region to H. 
sapiens AAK1 and to M. musculus BMP-2, both of which are part of the NAK 
kinase family, whose members predominantly function during endocytosis. The 
N-terminal region harbours the kinase domain of the NAKs and is highly 
conserved between members. Indeed, using protein structure prediction 
software (section), both the recently crystallised structures of AAK1 and BMP-2 
were used to produce a high confidence predicted model of Tb6560’s N-terminal 
region. In contrast, the C-terminal region (accounting for ~ 50 % of the protein 
sequence) of Tb6560 was predicted to be highly disordered. A common feature 
of NAK kinases is considerable variation between the C-terminal domains of 
family members, which may reflect divergence in the diverse roles of these 
kinases (Sorrell et al. 2016). Thus, the predicted disorder in the C-terminal 
region of Tb6560 may be consistent with lineage-specific roles of this part of 
NAKs. Though many AAK1-specific motifs were absent in Tb6560 and its 
kinetoplastid orthologues, a motif for α adaptin interaction could be identified 
within the C-terminal region of all of them. This motif is required for AAK1 to 
interact with the AP2 complex. The AP2 complex is found in both Leishmania 
and T. cruzi, but remains largely uncharacterised (Manna et al. 2013). As 
discussed in section 1.4.1.4, components of the AP2 complex are absent in T. 
brucei (Manna et al. 2013). Clearly, it would be interesting to investigate 
whether Tb6560 orthologs bind components of the kinetoplastid AP2 complex. 
A second notable observation from the sequence analysis of Tb6560 and its 
orthologues was the lack of conserved kinase residues; in all the kinetoplastids 
examined, the protein appeared to be a pseudokinase. A key function of AAK1 in 
H. sapiens is phosphorylation of the μ2 subunit of the AP2 complex to enhance 
the complex’s affinity for incoming cargo (Jackson et al. 2003) during CME. If 
Tb6560 does not have kinase activity, an adaptation of function is suggested, for 
reasons that remain unclear if it acts, like AAK1, in endocytosis. One possibility 
is that kinetoplastids possess a diverged AP2 system (or at least regulation 
mechanism). Indeed, it is striking that a potential lack of all AP2 complex 
subunits appears limited to T.brucei amongst the kinetoplastids, a loss that has 
been associated with the acquisition of the VSG coat in these parasites (Manna 
et al. 2013). It is however unclear whether Tb6560 ever harboured kinase 
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activity and could function in a similar role to AAK1 or if Tb6560 homologs were 
all initially pseudokinases and, perhaps driven by the need for a more complex 
endocytosis system, other eukaryotes required their homologs of Tb6560 to 
function as a kinase. 
In BSF T. brucei parasites the rate of endocytosis is very high to facilitate both 
recycling of the VSG and clearance of antibody-VSG complexes (Engstler et al. 
2007). The lack of AP2-mediated cargo sorting in T. brucei is thought to have 
‘streamlined’ this process to maximise VSG recycling to the cell surface (Manna 
et al. 2013). Indeed, endocytosis across synaptic vesicles also does not require 
an AP2 complex (Gu et al. 2008). However, the data here reveal a key kinase 
component of AP2-mediated endocytosis, which has evolved to be a 
pseudokinase in all kinetoplastids. This raises the obvious questions about the 
purpose of this protein in T. brucei and, more broadly, the regulation of the AP2 
complex in other kinetoplastids. As discussed below, Tb6560 is not essential, but 
its loss impairs BSF growth in vitro; why does T. brucei harbour a component of 
the eukaryotic AP2 complex if other components of the complex are absent? 
The involvement of a pseudokinase in an endocytosis pathway is not without 
precedent. In human cells, the Janus kinase, JAK2 (via its pseudokinase domain), 
can perform endocytic functions independent from its kinase activity (Putters et 
al. 2011). 
5.8.2 Loss of Tb6560 is associated with an enlarged FP and 
endosomal system defects 
This work suggests Tb6560 is a pseudokinase homolog of AAK1, or perhaps of the 
other related NAK kinases. Unlike endocytic components such as clathrin (Allen 
et al. 2003) and Rab5 GTPases (Hall et al. 2004), Tb6560 is not essential for BSF 
cell survival and does not appear to induce a cell cycle block, though cell 
proliferation is reduced and a variety of morphological defects arose associated 
with its loss. Over 40 % of the cells in the knockout cell lines were 
morphologically aberrant; ~30 % of these aberrancies could be attributed to a 
potential endocytosis defect and, indeed, by TEM (section 5.5.1.2) it was 
confirmed that some of these cells harboured enlarged FPs similar to that 
reported following clathrin, RAB5A and Rab5B knockdown (Allen et al. 2003; Hall 
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et al. 2004). This phenotype could be in fact be more severe as it is known that 
cells presenting with a ‘BigEye’ phenotype are fragile and can become destroyed 
following centrifugation; potentially the remaining rounded cells also harboured 
enlarged FPs (Allen et al. 2003). In all knockout cells examined with an enlarged 
FP, the spherical shape of the pocket was lost (it instead appeared folded or 
irregularly shaped), suggesting a potential defect in membrane trafficking or 
recycling (similar to that observed following Rab5A and B knockdown in BSF 
parasites; Hall et al., 2004) Cells with enlarged FPs were also shown to 
accumulate TL in the pocket. Taken together, these data suggest a role for 
Tb6560 during endocytosis. 
Loss of Tb6560 also produced cells with defective endosomal systems (multiple 
vesicles and unusual arrangements of endosomal structures) and, occasionally, 
TGN defects were also observed. These phenotypes are similar to that observed 
in PCF cells following clathrin knockdown, which has been attributed to a defect 
during endosomal trafficking: vesicles perhaps failing to fuse to their target. 
Tb6560 may therefore also support vesicular trafficking following endocytosis, 
possibly early in the process during, for example, surface coat recycling. In 
support of this, accumulation of TL could be observed in cytoplasmic vesicles in 
cells devoid of Tb6560. Again, however, the viability of Tb6560 mutants suggests 
any endocytic block is only partial. 
TL is up taken in a similar manner to type I transmembrane proteins like VSG, 
ISG and the transferrin receptor (Nolan et al. 1999). Lila Koumandou and 
colleagues have further demonstrated that in T. brucei, ISGs and transferrin 
appear to be differentially ‘sorted’ from the surface VSGs in a receptor-
mediated manner (directed by RME-8; Lila Koumandou, Boehm, Horder, & Field, 
2013). To date, it has yet to be confirmed whether other proteins can use the 
RME-8 signal to facilitate the initial uptake into the cell; loss of RME-8 does not 
produce an enlarged FP, suggesting it functions after cargo internalisation (Lila 
Koumandou et al. 2013). It has been assumed that the lack of an AP2 complex 
means this process of sorting is not required and, indeed, to manage the high 
turnover rate of the VSG coat this may in part be the case. However it is still 
possible that other proteins may require sorting before entry, though perhaps 
not as stringently as in higher eukaryotes. There is no doubt that that Rab5A/B 
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and 11 are required for trafficking of these proteins but, upon knockdown, the 
predominant phenotype is not an enlargement of the FP, suggesting again these 
proteins function after internalisation of cargo. Loss of Tb6560 appears to 
primarily produce an enlarged FP, suggesting it may act earlier in endocytosis 
that these GTPases, though the presence of internal vesicles may suggest it also 
functions to aid early endosomes too. Overall, the accumulation of TL into 
cytoplasmic vesicles and into the FP in Tb6560 mutants suggests two things: 1) 
some cargo becomes trapped within the FP; and 2) some cargo can enter the 
cell, perhaps reflecting the presence of two separate entry pathways. 
Two further observations of the Tb6560 mutants are worth noting, but have not 
been further investigated. First is the partial recovery observed following serial 
passaging in culture for over 3 weeks; the number of cells with visually 
observable aberrancies appear too reduced and growth improved. This may 
suggest the cells are able to compensate in part for the loss of this protein, or 
perhaps recycling of the surface coat proteome is somewhat reduced following 
serial passaging. The second, connected observation is that even though the -/- 
mutants should be devoid of Tb6560 protein, the phenotypes described are seen 
only in around half the population. Whether this indicates a response to growth 
conditions, or may be due to compensation during selection for the mutants, is 
unclear. 
5.8.3 The localisation and potential interaction partners of Tb6560 
supports a role during early endocytosis 
Localisation of Tb6560 in BSF cells is both complex and dynamic. Tb6560 is 
located at the posterior region of the cell between the kDNA and the nDNA, 
where other components of the polarised endosome system localise in T. brucei 
(Field & Carrington 2009). Occasionally, the protein appeared to localise to the 
flagellum itself, though this observation was limited to EM analysis. Though the 
protein adopts localisation within this region constitutively, it appears to move 
dynamically throughout the cell cycle, perhaps due to its close association with 
the FP and early endocytic vesicles (section 5.3.4.6). TbRab5A and B appear to 
localise closer to the nucleus than Tb6560, consistent with their role as part of 
the endosome system. Localisation of Tb6560 appears remarkably close to the 
FP, on occasion almost associating with the FP membrane, perhaps 
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strengthening the suggestion that Tb6560 may act during an early endocytosis 
event. By localising within this region, the protein has access to the FP 
membrane, potentially incoming vesicles and the flagellum. 
In keeping with a potential role in endocytosis and vesicular trafficking, two 
putative interaction partners were recovered by IP that have potential roles in 
these pathways. Recovery of the heavy chain of dynein and a potential cap-gly 
domain containing protein may suggestsTb6560 mediates the physical movement 
of intracellular vesicles. These potential interaction partners require validation 
by endogenously tagging each one and performing a co-immunoprecipitation 
experiment in the endogenously tagged Tb6560+/- cell line. Nonetheless, vesicles 
decorated with Rab5 are moved in a dynein mediated manner (Satoh et al. 2008) 
and, in Drosophila dendrites, this is thought to be co-ordinated by NAK (the D. 
melanogaster homolog of AAK1 (Yang et al. 2011). T. brucei utilises Rab5 
positive vesicles to traffic proteins like the transferrin receptor to the tubulated 
endosomes, though little is known about what is co-ordinating the movement of 
these vesicles. Indeed, AAK1 in humans is required for uptake and recycling of 
the transferrin receptor, though this activity utilises AAK1’s kinase activity, 
suggesting a difference from Tb6560 (Conner & Schmid, 2003; Ricotta, Conner, 
Schmid, Von Figura, & Höning, 2002). In T. brucei, TbCH2.2 mediates retrograde 
intraflagellar transport (Blisnick et al. 2014) and localises in a similar pattern to 
that of Tb6560. However, loss of TbCH2.2 does not result in an enlarged FP, nor 
were endosomal defects observed (Blisnick et al. 2014). It is possible flagellar 
defects were overlooked in the Tb6560 mutants, as no direct examination of this 
structure was undertaken. However, when a preliminary examination of the FAZ 
by indirect IF (data not shown) was undertaken, no clear defects were observed. 
Mutants with highly distorted morphology still harboured the FAZ and the 
flagellum appeared to run along the full length of the cell body. Furthermore, 
from the FIB/TEM analysis, the -/- cells examined appeared to generate two 
flagella of approximately similar lengths, suggesting that generation of the 
flagella is not impaired. In contrast, loss of TbDHC2.2 results in reduced flagellar 
lengths (Blisnick et al. 2014). Tentatively, therefore, it appears Tb6560 and 
TbCH2.2 provide distinct functions, though further investigation may be 
required. 
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5.8.4 Tb6560 is unlikely to be directly associated with DNA repair 
Despite significant growth reductions following exposure to different genotoxic 
agents, and a slightly elevated level of γH2A expression, it is unlikely that the 
primary role of Tb6560 is during the DNA damage response. The increased γH2A 
signal could be attributed to the morphological distortion observed in over 40 % 
of the cells, perhaps due to the nucleus becoming physically compressed due to 
the FP pocket expansion. Furthermore, the localisation of the protein suggests it 
is unlikely to influence repair of the nuclear or mitochondrial genomes. Indeed, 
the localisation was little changed by DNA damage exposure, suggesting re-
localisation of the protein (to for example the nucleus) does not occur. 
Furthermore, the sensitivity to chemical agents such as MMS could potentially be 
linked to defective endocytosis. During MMS stress, in addition to DNA lesions, 
cellular structures become compromised and require repair (plasma membrane 
repair is reviewed by Andrews, Almeida, & Corrotte, 2014). The repair following 
exposure to, for example, a chemical agent, is not solely limited to the repair of 
nuclear DNA lesions, damage also occurs to the cellular architecture and 
organelles; this must also be resolved for normal cellular proliferation to 
continue (Andrews et al. 2014). Furthermore, if the genotoxic chemical is still 
present in the environment, the cell may need to assume measures to limit 
further uptake (Shen et al. 2012). For example, reduced uptake of the drug 
Cisplatin (CP; a commonly used chemotherapeutic drug) is associated with 
reduced efficacy (Chauhan et al. 2003). The localisation of Tb6560 suggests a 
potential association with the FP and possibly the endosomal network and thus 
potentially involved in the trafficking of material into (and around) the cell. This 
process of renewal following cellular damage has yet to be examined in T. 
brucei. 
5.8.5 Summary 
Overall, the work in this chapter represents both the characterisation of a novel 
pseudokinase with a function during BSF endocytosis and, potentially, the 
identification of a new, minor ‘AP2-like’ trafficking pathway in these parasites. 
Potentially Tb6560 may function in the physical movement of vesicles within the 
cytoplasm to the endosome system, and perhaps also to the flagellum. 
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6 Analysis of the DNA repair-associated protein 
kinases TbATR and TbATM in bloodstream form 
T. brucei 
  




As discussed in chapter 1, control of a cell’s fate following the detection of a 
DNA lesion is mediated by the DNA damage response (DDR). At the centre of this 
response are atypical PKs (aPKs), notably ATR, ATM and DNA-PKcs. 
6.1.1 The PIKK family 
The members of the phosphatidyl inositol 3’ kinase-related kinase (PIKK) family 
(mTOR, ATR, ATM, DNA-PK, TTRAP and SMG-1; unabbreviated names are shown 
in Table 6-1) do not possess a typical eukaryotic PK (ePK) structure (section 1.5), 
though members of this family share several conserved domains (discussed 
below). The PIKK kinases are named after their apparent sequence similarity 
(within their kinase domain; KD) to a family of lipid kinases (phosphatidyl 
inositol-3 kinases; PI3Ks), though the PIKKs do not phosphorylate lipids, only 
proteins. Typically, these PKs are known for their ability to interact with 
nucleotides, their large molecular sizes (ranging from ~300 kDa to ~500 kDa; 
Baretić & Williams 2014), their S/T kinase activity (for example, ATR and ATM 
are thought to preferentially phosphorylate S/T residues in immediate proximity 
to a Q residue; for mTOR, this can be a Proline or another hydrophobic amino 
acid; (Hsu et al. 2011; Abraham 2001) and, finally, their requirement for an 
interacting protein to aid their activation and/or mediate their activity (see 
Table 6-1 below). One member, the transcription/transformation associated 
protein (TTRAP), does not appear to harbour phosphotransferase capabilities and 
thus is likely to lack kinase activity. TTRAP’s roles appear to be linked to 
regulation of histones (Cai et al. 2003), to the oncogenes c-MYC and E1A/E2F 
(both transcription factors; McMahon et al. 1998) and to the cell cycle-regulating 
kinase Wee1 (Calonge et al. 2010). 




Table  6-1: The members of the PIKK family, their localisation and their regulation 
Mammalian protein names are shown, with the S. cerevisiae homolog name in brackets. 
Table and information adapted from (Baretić‎&‎Williams‎2014). 
Structurally, the PIKKs show a high level of conservation and, with the 
publication of the crystal structures of most members (Wang et al. 2016 
[ATM/Tel1], Baretic et al. 2016 [TOR/mTOR], Melero et al. 2014 [SMG-1] and 
Sibanda et al. 2010 [DNA-PK]), it is clear there are several interesting features of 
this kinase family. A generalised schematic of the structure of each kinase is 
shown in Figure 6-1 alongside the crystal structure of Tel1, the S. cerevisiae 
homolog of ATM (Wang et al. 2016). 
 
Figure  6-1: The generalised structure of PIKKs 
(A) A generalised schematic of the structure of PIKKs from H. sapiens. Not to scale; size (in 
amino acids) is shown in brackets. (B) Architecture of a Tel1 monomer (the S. cerevisiae 
homolog of ATM). Model was fitted, colour coded and generated as described in (Wang et al. 
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2016). (A) Adapted from (Baretić‎&‎Williams‎2014). (B) Adapted from (Wang et al. 2016). All 
abbreviations in the diagram are explained in the text. 
Several domains and features are conserved between members; proposed 
functions are shown in Table 6-2. Typically, each PK has an extensive 
‘superhelix’, or α solenoid, which comprises HEAT repeat arrays (Perry & 
Kleckner 2003) and provides stability to the structure (Takai et al. 2007). 
Located at the C-terminal end of the N-terminal region is the FAT domain, which 
also harbours HEAT repeat domains and is associated with the C-terminal Kinase 
domain (KD). The KD (also known as the ‘head’ region) is highly conserved 
between PIKKs and harbours other conserved sub-domains, such as the LST8-
binding element (LBE), the FRB domain (absent from ATR and ATM) and, at the 
immediate C-terminal region, a PRD and a FATC domain. 
 
Table  6-2: Conserved PIKK domains and their potential functions 
Table generated based on data from (A) (Wang et al. 2016), (B) (Baretić‎&‎Williams‎2014), (C) 
(Schmelzle & Hall 2000), 2000, (D) (Yang et al. 2013), (E) (Lempiäinen & Halazonetis 2009). 
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6.1.2 The roles of ATR and ATM in other eukaryotes 
ATR was identified ~20 years ago (Bentley et al. 1996; Cimprich et al. 1996; 
Gatti et al. 1988) and, to date, remains at the forefront of research into the 
DDR. Another PIKK family member, ATM, is also heavily involved in the 
regulation of the DDR and the functions of ATR and ATM are not exclusive 
(Shiotani et al. 2013; Chanoux et al. 2009). To this end, the role of ATM was also 
briefly investigated in this chapter and is thus briefly introduced below. 
6.1.2.1 ATR 
ATR is often termed the ‘master regulator’ of the DDR and its importance in 
organism fecundity is complex. Whereas ATR null mutants are viable in plants 
(Culligan et al. 2004), the gene is essential in yeast (Cha & Kleckner 2002) and 
mammals (Brown & Baltimore 2000). ATR disruption is lethal during mouse 
embryogenesis (Brown & Baltimore 2000) and downregulating the gene in adult 
mice produces the onset of age-related symptoms such as osteoporosis 
(weakening of the bones; Ruzankina et al. 2007). In humans, mutations in the 
ATR gene result in Seckel Syndrome (or microcephalic primordial dwarfism; 
O’Driscoll et al. 2003) due to the vital role ATR plays in responding to a variety 
of DNA lesions, many of which are derived from replication. Interestingly, Seckel 
Syndrome does not result in a predisposition to cancers (O’Driscoll & Jeggo 2003; 
O’Driscoll et al. 2004), despite loss of ATR being associated with genome 
instabilities. 
ATR is thought to be activated in response to the presence of ssDNA, often 
associated with stalled replication forks, since this kinase exerts its function 
during S-phase of the cell cycle. Canonically, ATR is activated in the following 
manner (as detailed in Figure 6-2; for reviews see Fokas et al. 2014; Kidiyoor et 
al. 2016). When ssDNA is formed, ssDNA is coated by RPA. RPA in turn recruits in 
the ATR interacting partner (ATRIP), which is stably complexed to ATR and thus 
recruits ATR to the lesion site. Independently, RPA recruits the clamp loader 
protein RAD17, which loads the 9-1-1 complex (a heterotrimeric complex 
comprising Rad9-Hus1-Rad1). The 9-1-1 complex (via Rad9) recruits the ATR 
activating protein TopBP1, which is required for the activation of ATR; 
preventing this interaction ablates ATR signalling (Mordes et al. 2008) and 
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downstream phosphorylation pathways. TopBP1 interacts with the PRD domain of 
ATR and activates the kinase via its ATR activation domain (AAD; reviewed by 
Mordes et al. 2008). Once activated, ATR can activate (by phosphorylation) the 
kinase check point kinase 1 (CHK1/CHEK1). TopBP1 also aids in bringing CHK1 
into contact with ATR. CHK1 has numerous interaction partners and, once 
activated, it can phosphorylate proteins like Cdc25a to prevent cell cycle 
progression (a G2 arrest) and block or slow late origin firing (Shechter et al. 
2004). CHK1 phosphorylation can also prevent entry to S-phase (Capasso et al. 
2002 and reviewed by Yu 2007). 
 
Figure  6-2: Canonical activation of ATR in eukaryotes 
A full description of the process illustrated in the figure is available in the text. A key of 
shapes used to represent proteins is shown in the dashed box. Figure constructed based 
on information from (Cimprich & Cortez 2008a), (Bartek et al. 2004), (Hammarton et al. 2004) 
and (Lobrich & Jeggo 2007). 
Activation of ATR can also occur from several other sources, such as mechanical 
stress to or deformation of the nuclear envelope (though the mechanism behind 
this is not understood; Kumar et al. 2014), stress from the nucleolus (ATR can 
localise here under mechanical stress), cytoplasmic stress, and even an 
association between ATR and the centrosomes. These mechanisms of ATR 
activation are still being investigated and highlight the diverse range of 
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regulatory functions this kinase can perform in a cell (as reviewed by Kidiyoor et 
al. 2016). 
The function of TbATR has been preliminarily examined in both the PCF and BSF 
of T. brucei, but with conflicting results. In PCF and BSF cells it was initially 
reported that TbATR is a non-essential PK when targeted by RNAi (Forsythe 
2012). However, Jones et al. (2014) reported that loss of TbATR was detrimental 
to BSF proliferation. As many pathways of the DDR (and many of their 
component proteins) are conserved within the kinetoplastids, it is plausible, 
given the role ATR performs in other eukaryotes, that this kinase may also play 
an important role in mediating the DDR. However, limited information is 
available regarding TbATR and its downstream interaction partners in these 
parasites. Several proteins key in the mediation of TbATR activity have yet to be 
identified by sequence homology, such as the T. brucei homolog of ATRIP and 
the CHK1. In contrast, TopBP1 has been identified (Genois et al. 2014) and the 
9-1-1 complex, of which the RAD9 component can directly interact with TopBP1 
to activate ATR in other eukaryotes (ATR activation by TopBP1 is reviewed by 
Burrows & Elledge 2008), has been characterised in detail in L. major 
(Damasceno et al. 2016; Damasceno et al. 2013), perhaps suggesting this arm of 
the ATR pathway may operate. However, the Leishmania 9-1-1 complex harbours 
functional divergence from its known roles in higher eukaryotes: whereas loss of 
RAD9 increases sensitivity to genotoxic stress, Hus1 loss increases survival. Thus, 
exactly how TbATR might act in the kinetoplastid DDR is unclear. 
6.1.2.2 ATM 
Mutations of the ATM gene in humans are hallmarks of the autosomal recessive 
condition known as Ataxia-Telgancietasia (A-T/ ‘Louis-Bar Syndrome’), a 
neurodegenerative and generally debilitating syndrome (Savitsky et al. 1995). 
Unlike ATR, ATM is not essential in yeast (Lustig & Petes 1986) or mammals (Xu 
et al. 1996), where disruption of the gene is associated with genomic fragility 
and infertility (Xu et al. 1996). Despite this, recent evidence suggests ATM may 
be a critical PK; mice harbouring a kinase dead (or catalytically inactive ATM) 
were shown to die during embryogenesis (Yamamoto et al. 2012; Daniel et al. 
2012). Human ATM mutant cells show an increased sensitivity to IR sources, 
indicating ATM is required to detect DSBs. ATM is important for guiding the 
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repair of DSBs by either NHEJ (G1 phase) or HR (S-phase), though more recently 
roles for ATM have been described following replicative stress-induced lesions 
(Schmidt et al. 2014) and in the regulation of ROSs (Ito et al. 2007; Formichi et 
al. 2000; Xie et al. 2001), suggesting we are still far from understanding all roles 
of this PIKK. ATM is recruited to DSBs as an inactive dimer by the MRN complex, 
which the kinase autophosphorylates, leading to release of one ATM monomer 
and activation of the other. ATM can phosphorylate critical downstream 
proteins, such as the variant histone H2AX (generating the histone variant 
γH2AX), the tumour suppressor protein p53 (St. Clair & Manfredi 2006; Zilfou & 
Lowe 2009; Marechal & Zou 2013) and PKs such as checkpoint kinase 2 
(CHK2/CHEK2), resulting in cell cycle stall at G1-S. ATM has also been shown to 
mediate G2-M stalling, though this checkpoint activation may be due to ATM 
acting in conjunction with ATR to repair stalled replication forks (Cimprich & 
Cortez 2008b; Ammazzalorso et al. 2010). For a comprehensive review on the 
role of ATM in other eukaryotes, the reader is referred to Shiloh & Ziv 2013. 
Like ATR, the role of ATM is unclear in T. brucei. Previous data suggested TbATM 
to be essential for PCF and BSF proliferation (Forsythe 2012). Furthermore, T. 
brucei does not appear to undergo NHEJ, and nor does it appear to harbour a 
p53 protein, though a potential homolog of the PK CHK2 is present. Hence, 
regulation of the DSB repair may be diverged from other eukaryotes. 
Components of the MRN complex (TbMRE11 and TbRAD50) have been examined 
in T. brucei (Tan et al. 2002; for TbRAD50 this data is unpublished, J.Stortz and 
M. Prorocic) and Leishmania (Laffitte et al. 2016) and, when knocked out, cells 
become sensitised to genotoxic stress, suggesting the MRN complex may act 
through ATM, but no direct evaluation of this route has been conducted. 
However, it should be noted that ATR has also been shown to interact with the 
MRN complex in other eukaryotes, facilitating activation via TopBP1 (Duursma et 
al. 2013). 
6.2 Chapter Aims 
The aim of this chapter is to explore the role of TbATR in BSF cells in more 
depth and, briefly, to examine the role of TbATM. 




6.3.1 Bioinformatics analysis 
TbATR (a predicted protein ~320.6 kDa in size; 2860 amino acids) is encoded for 
by the gene Tb927.11.14680. TbATM (~468.5 kDa in size; 4277 amino acids) is 
encoded for by the gene Tb927.2.2260 (TriTrypDB v.28). 
6.3.1.1 BLAST Analysis 
Using BLASTp within TritryDB with the protein sequence of the predicted ATR 
homolog of T. brucei retrieved highly conserved orthologues from related 
kinetoplastid organisms, suggesting the PK is present across this grouping (data 
not shown). To identify homologs in other organisms, the same analysis was 
performed using the NCBI database and BLASTp hits were identified using the 
‘SmartBLAST’ feature as described in chapter 4. The top five best ‘hits’ for ATR 
are shown in Table 6-3. 
 
Table  6-3: Top 5 ‘hit’s from the SmartBLAST analysis of TbATR 
The top ‘hits’ retrieved from the SmartBLAST analysis using the protein sequence of TbATR 
(as retrieved from TriTrypDB v28). The analysis was performed in August 2016. 
As expected, the most conserved homologs were from kinetoplastid family 
members. More distantly related, but still well conserved, were characterised 
ATRs from other eukaryotes (Table 6-3 and Table 6-4). ATR from A. thaliana 
showed the greatest identity (45% identity, E value = 2e-126), followed by hits to 
ATR from M. musculus, D. rerio, H. sapiens, and to Rad3 from S. pombe and 
Mec1 (S. cerevisiae); E values between E= e-119 to E=e -98. More distant homology 
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was seen to further PIKK family members: ATM from C. elegans and M. musculus, 
and mTOR from M. musculus and C. elegans (Table 6-4). 
 
Table  6-4: Additional ‘hits’ from the SmartBLAST analysis of TbATR 
Additional ‘hits’ retrieved from the SmartBLAST analysis using the protein sequence of ATR 
(as retrieved from TriTrypDB v28). The analysis was performed in August 2016. 
When the above process was repeated for Tb927.2.2260, encoding the predicted 
homolog of TbATM, it was found that, as described for TbATR, highly conserved 
orthologues can be identified across the kinetoplastid phylum (Table 6-5). Again, 
T. brucei ATM appeared to share highest sequence conservation beyond 
kinetoplastids with ATM from a plant species (G. max; Soybean). 
 
Table  6-5: Top 5 ‘hit’s from the SmartBLAST analysis of TbATM 
The top ‘hits’ retrieved from the SmartBLAST analysis using the protein sequence of TbATM 
(as retrieved from TriTrypDB v28). The analysis was performed in August 2016. 




Table  6-6: Additional ‘hits’ from the SmartBLAST analysis of TbATM 
Additional ‘hits’ retrieved from the SmartBLAST analysis using the protein sequence of 
TbATM (as retrieved from TriTrypDB v28). The analysis was performed in August 2016. 
SmartBLAST analysis with T. brucei TbATM further revealed ATM orthologs from 
other organisms with high confidence (E values between E= e-97 to E=e -73; Table 
6-6). 
For both of T. brucei ATR and ATM, the primary region of homology was within 
the C-terminus region of the kinases, which harbours the highly conserved KD. 
For TbATM, a lower level of sequence conservation was observed. For example, 
~45 % of the sequence of T. brucei ATR could be aligned against A. thaliana ATR 
(Evalue E= 2e-126), of which ~26 % of the sequence was identical. In contrast, for 
TbATM, only 17 % of the T. brucei sequence could be aligned against A. thaliana 
ATM (E value E=2e-97) of which 34 % was identical. 
6.3.1.2 Domain predictions 
PIKKs have a highly conserved structure (as discussed above), with many PIKK-
specific domains, including the FAT and HEAT repeat domains located within the 
N-terminal region, and the FATC located at the C-terminal of the kinase. These 
domains are required to mediate kinase activity and maintain kinase structure 
(as reviewed by Baretić & Williams 2014). To examine whether these domains 
are present in the T. brucei homologs of ATR and ATM, conserved domains were 
searched for using the Interpro and NCBI database webservers. Additionally, the 
kinases were aligned against the corresponding homolog in H. sapiens and S. 
cerevisiae (data shown in chapter 8, section 8.5, Figure 8-29 [TbATR] and Figure 
8-30 [TbATM]) using CLC Genomics Workbench 7. The structure of both T. brucei 
kinases was also modelled using the RaptorX webserver program; however, due 
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to the size of each protein the majority of the N-terminal domain was modelled 
separately from the remaining protein sequence (the sequence size input into 
the program is limited to 2500 aa; both kinases are considerably larger). Data 
from the Raptor analyses are shown in chapter 8, section 8.5, Figure 8-31. 
6.3.1.2.1 TbATR 
Several PIKK-specific domains could be identified in T. brucei ATR (Figure 6-3 A). 
From the predicted structural model of the protein (chapter 8, section 8.5, 
Figure 8-31), the N-terminal region appeared primarily composed of helical 
repeats, in keeping with the presence of the α-solenoid domain (RaptorX analysis 
suggested ~ 70 % of the first 2477 amino acids form α helices). Such a structure 
is in keeping with the likely presence of HEAT repeat domains, though when 
examined at the sequence level very little conservation was observed between 
the predicted human ATR HEAT repeats and the potential location of the T. 
brucei ATR HEAT repeats. FAT, FATC, KD and a UME domain were all readily 
identified, with a similar positioning relative to human ATR. The function of the 
UME domain is still under investigation, but it is associated with nucleolar 
proteins harbouring FAT and FATC domains (as detailed by the SMART; 
http://smart.embl-heidelberg.de/). Importantly, when both the catalytic and 
activation loops of the KD were examined, it was found that the sequence was 
highly conserved between ATRs from T. brucei, H. sapiens and S. cerevisiae, 
highlighting the conservation of the KD (Figure 6-3 B). The PRD domain of T. 
brucei did not appear highly conserved relative to the human ATR PRD domain, 
though its potential position is marked in Figure 6-3 A. Within the PRD domain 
are residues with which the ATR activating protein and TopBP1 can interact. 
These residues include a lysine (K2589) and a His-Val-Leu (HVL) triad; mutation 
of these residues reduces ATR activation by TopBP1 (reviewed by Burrows & 
Elledge 2008). Though a potential homolog of TopBP1 was identified in the T. 
brucei genome, alignment of the human ATR and the T. brucei ATR sequences 
did not reveal conserved residues within the KD region in a similar position 
(chapter 8, section 8.5, Figure 8-29 [TbATR] and Figure 8-30 [TbATM]). Another 
domain conserved across members of the PIKK is an LBE domain (Table 6-2), but 
this could also not be identified in the T. brucei ATR sequence. 
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In humans, ATR is phosphorylated on a threonine (T1989) within the FAT domain, 
which is critical for its activation; the phosphorylation occurs when ATR:ATRIP 
complexes associate with RPA bound ssDNA (Liu et al. 2011). The same modified 
residue is also recognised by TopBP1. However, no clearly positionally conserved 
T residue could be found in T. brucei ATR. 
 
Figure  6-3: Schematic illustration of conserved motifs between the human ATR and the T. 
brucei ATR 
(A) The conserved sequence motifs of TbATR found in the protein sequence of T. brucei 
ATR compared with the conserved sequence motifs of ATR in H. sapiens. The sequence 
motif is annotated above its location. Dark blue bar (T1989 modification), Yellow bar (LBE 
domain), Black bars (K2589 and the HVL motifs respectively required for ATR activation by 
TopBP1), CL (catalytic loop) and AL (activation loop). Not to scale. The domains in the 
figure above are based on the position of the domain as determined using Interpro, NCBI 
searches and from data in the following papers: (Liu et al. 2011; Burrows & Elledge 2008) (B) 
The catalytic (purple arrow) and activation (orange arrow) loops of ATR from H. sapiens, S. 
cerevisiae (Mec1) and T. brucei. The sequence alignment was performed in CLC genomic 
workbench 7. Mec1 accession number: NP_009694.3. 
6.3.1.2.2 TbATM 
As for TbATR, the N-terminal domain of this kinase was predicted to adopt an α-
solenoid structure typical of PIKKs; ~ 57 % of the N-terminal domain (spanning 
the first 2499 amino acids; a schematic of the domain order in TbATM is shown in 
Figure 6-4 A) was predicted to be arranged as α-helices (chapter 8, section 8.5, 
Figure 8-31 C&D). Several PIKK-specific domains could also be identified in the 
sequence of T. brucei ATM, with the notable exception of a FAT domain. As this 
domain is required for stabilisation of the kinase structure and its activation, its 
potential absence or divergence may suggest that the regulation of TbATM 
activity is divergent from that of the human ATM kinase. In addition, neither an 
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LBE or a TAN domain could be identified. The TAN domain of ATM is important 
for the localisation of ATM to a DSB and to prevent telomere shortening (as 
shown from studies in S. cerevisiae; Seidel et al. 2008). 
 
Figure  6-4: Schematic illustration of conserved motifs between the human ATM and the T. 
brucei ATM 
(A) The conserved sequence motifs of ATM found in the protein sequence of T. brucei ATM 
compared with the conserved sequence motifs of ATM in H. sapiens. The sequence motif is 
annotated above its location. Black bar (S1981 modification), Yellow bar (LBE domain), 
Turquoise bar (K3016 [H. sapiens], K4237 [T. brucei]), CL (catalytic loop) and AL (activation 
loop). Not to scale. The domains in the figure above are based on the position of the domain 
as determined using Interpro, NCBI searches and from data in the following papers: (Liu et 
al. 2011; Burrows & Elledge 2008; Seidel et al. 2008). (B) The catalytic (yellow arrow) and 
activation (blue arrow) loops of ATR from H. sapiens, S. cerevisiae Tel1) and T. brucei. The 
sequence alignment was performed in CLC genomic workbench 7. Tel1 accession number: 
KZV13216.1. 
As observed for TbATR, both the catalytic and activation loops (Figure 6-4 B) 
harboured a high level of sequence conservation between the H. sapiens, S. 
cerevisiae and T. brucei ATM (a full alignment is shown in chapter 8, section 8.5, 
Figure 8-30). 
Several key phosphorylation sites have also been identified in human ATM, with 
the most prominent being a serine residue in position 1981 (S1981); ATM is 
autophosphorylated here in order to become activated (Bakkenist & Kastan 
2003). This residue was absent in T. brucei and, interestingly, no 
phosphorylation sites were identified on the T. brucei ATM kinase (Urbaniak et 
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al. 2013), though other post translational modifications may occur. One key 
conserved residue within the C-terminal domain of the T. brucei ATM was found. 
This residue, a lysine at position 3016, is acetylated by the histone 
acetyltransferase Tip60, and is required for ATM activation (Sun et al. 2007). 
Alignment of the human and T. brucei ATM sequences predicted the equivalent a 
lysine to be at position 4237 in T. brucei ATM. 
6.3.2 RNAi cell lines used in this chapter 
Both TbATR BSF RNAi lines used were kindly provided by E. Brown (University of 
York). The TbATM RNAi targeting construct and the subsequently produced BSF 
RNAi cell line were generated, transformed and selected for as described in 
section 2.3 and 2.7.4. One clone was used in this study (cell lines are detailed in 
the table below; Table 6-7). 
 
Table  6-7: RNAi cell lines required for this study 
The STL/TRY number refers to the stabilate number as numbered according to the Mottram 
and McCulloch laboratory systems for stabilate labelling. The plasmid number (pTL) is as 
according to the Mottram laboratory plasmid repository numbering system. Puromycin 
sensitivity was examined prior to freezing. 
6.3.3 Generation of endogenously tagged RNAi cell lines 
6.3.3.1 Generation of C-terminal endogenously tagged TbATR and TbATM 
RNAi cell lines 
To assess gene knockdown following RNAi induction, the TbATM and TbATR genes 
were C-terminally endogenously tagged with the 12 myc epitope in their cognate 
RNAi cell line using the strategy described in section 2.4.1.1.1. The primers and 
restriction sites used for cloning are described in Table 2-2. The constructs were 
assessed by restriction digest analyses (section 2.2.6) and the insert sequences 
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were confirmed by sequence analysis (as per section 2.2.9). The resulting 
constructs (TbATR12myc and TbATM12myc) were linearised by restriction digestion 
(as detailed in section 2.2.6) prior to transformation into the respective RNAi 
cell line; one TbATR RNAi clone (TbATR RNAi CL2) and the sole TbATM RNAi 
clone were transformed. Transformants were selected as detailed in section 
2.7.4 and several clones were recovered and expanded for further analysis. 
6.3.3.2 Confirmation of endogenously tagged TbATR and TbATM in RNAi 
cell lines 
Putatively tagged clones were examined for expression of myc-tagged protein by 
western blot analysis, which was performed as described in section 2.12.1. The 
western blots are shown in Figure 6-5. 
 
Figure  6-5: Confirmation of endogenously 12myc-tagged TbATR and TbATM by western blot 
Western blot analysis performed as per section 2.12.1 on putatively tagged ATR RNAi (A) 
and ATM RNAi transformant clones. The ladder shows size markers in kDa. Wild type (WT) 
427 cells were used as a negative control. Whole cell extracts were resolved on a 3-8% BT 
gel. The following sizes refer to the predicted molecular weight (MW) of the tagged proteins 
(from TriTrypDB) + the MW of the 12myc tag (14.4 kDa). Tb927.2.2260 (TbATM: 482.8 kDa) 
and Tb927.11.14680 (TbATR: 335 kDa). Ladder used: HiMark
TM
 Pre-Stained Protein Standard 
(ThermoFisher). 
Two of four TbATR RNAi transformants expressed myc-tagged protein of 
approximately the expected size. In contrast, only one TbATM RNAi transformant 
revealed a signal, which was seen as multiple bands. The highest molecular 
weight appeared compatible with the expected size of TbATM-12myc, and so 
degradation may explain the smaller species (even though protease and 
phosphatase inhibitors were added). One clone for each gene was expanded for 
further analysis. 
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6.3.3.3 Localisation of TbATR and TbATM 
Despite potentially successfully endogenously tagging TbATR and TbATM in their 
respectively RNAi cell lines, no clear detection of the anti-myc signal could be 
ascertained for either PK by indirect IF using α-myc antiserum to detect the 
epitope tag (data not shown). Even when the cells were subjected to genotoxic 
stress, by growing them in 1 μg/ml-1 PHL or 0.0003 % MMS for 18 hrs, again no 
detectable myc signal could be obtained (data not shown). Endogenously tagging 
TbATR at the N-terminus (in wild type 427 cells) was also attempted, but myc-
tagged transformants were not recovered (data not shown). 
6.3.4 Phenotypic analysis 
6.3.4.1 In vitro growth analysis 
To examine the effect of TbATR or TbATM loss in BSF parasites in vitro, cell 
proliferation was examined (as detailed in section 2.8.1) following RNAi 
knockdown using two TbATR RNAi clones (one harbouring an endogenous myc 
tagged variant) and one endogenously tagged TbATM RNAi clone. The assay was 
performed as detailed in section 2.8.1. 
Approximately 24 hrs after TbATR knockdown, growth of both clones (CL1 and 
CL2) was reduced relative to the non-induced control (Figure 6-6 A). From ~48 
hrs, growth of the RNAi induced cells appeared to recover, but the cell density 
was markedly lower than the controls throughout the experiment. qRT-PCR of 
the untagged clone, and western analysis of the endogenously tagged clone, 
showed growth impairment was accompanied by reduced levels of TbATR RNA 
and loss of detectable TbATR-12myc protein from 24 hrs onwards (Figure 6-6 
B&C). Scanning electron microscope (SEM; as described in section 2.11.7.1; 
Figure 6-7) of cells 36 hrs and 48 hrs post RNAi induction revealed the 
ultrastructure of cells that could be readily seen to be morphologically aberrant 
by light microscopy between 48-72 hrs of growth (data not shown). Commonly, 
large clumps of cells, or enlarged cells with a ‘ruffled’ membrane appearance, 
could be observed. At ~96 hrs post induction, when the loss of proliferation 
appeared much less pronounced, the number of morphologically aberrant cells in 
the populations became reduced for both clones (data not shown) perhaps 
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suggesting selection for RNAi cells that had become insensitive to tetracycline 
RNAi induction. 
In striking contrast, no proliferation defects were observed following RNAi 
knockdown of TbATM (Figure 6-6 D), even after 7 days of growth. The lack of a 
growth defect could not be attributed to impaired RNAi induction, since from 24 
hrs post-induction loss of myc-tagged protein was observed by western blot 
analysis (Figure 6-6 E). These data suggest that TbATM, unlike TbATR, is non-
essential for in vitro BSF proliferation, though generation of a null mutant would 
be necessary to confirm this prediction. 
 
Figure  6-6: In vitro growth analysis of TbATR and TbATM RNAi cell lines 
Growth analysis of TbATR (A) and TbATM (D) RNAi cell lines after induction of gene 
knockdown using tetracycline (1 µg.ml
-1
). The (+) denotes tetracycline induced samples. The 
(-) denotes the uninduced samples. The error bars represent ± SEM, n=3 (A) and ± SEM, 
n=2 (D). For statistical analysis for (A), tet - cells (blue [CL2] and black [CL1] dashed lines) 
were compared with their corresponding tet + cells (blue [CL2] and black [CL1] solid lines) 
at each time point; (*) = p<0.05 as determined by a Mann Whitney U test. (B) qRT-PCR 
analysis, comparing TbATR RNA abundance in TbATR CL1 cells 24 and 36 post RNAi 
induction (+) relative to uninduced (set at 100%). (C) and (E) show western blots to evaluate 
levels of TbATR-12myc and TbATM-12myc, respectively, after 24, 48 and 72 hrs growth with 
(+) and without (-) induction of RNAi. The endogenously myc-tagged proteins were detected 
using α myc antiserum, and EF1α was used as a loading control. White space indicates 
images excised and aligned from a larger blot. 




Figure  6-7: Loss of TbATR results in morphologically aberrant cells 
Representative SEM images of morphological abnormalities in induced (A) cells and non-
induced (B) cells at 36hrs (left images) and 48hrs (right images) post RNAi induction. 
Images were captured on a Jeol 6400 scanning electron microscope (section 2.11.7.1) and 
processed by L.Lemgruber-Soares. Scale bars: top= 5 μm; below= 2 μm. 
In other eukaryotes, loss of ATR prevents S-phase checkpoint activation in the 
face of replicative stress, resulting in the accumulation of DNA lesions and 
chromosomal aberrations (Zeman & Cimprich 2014; Pennarun et al. 2010) as the 
nDNA continues to replicate without ATR signalling for repair. With this in mind, 
the cell cycle profile following TbATR knockdown was examined in vitro by flow 
cytometry (section 2.8.4) and DAPI staining (section 2.8.3 and 2.11.1), as shown 
in Figure 6-8. No such analysis was performed following loss of TbATM. 




Figure  6-8: In vitro cell cycle analysis of TbATR 
The cell cycle following loss of TbATR (A) was examined by DAPI staining to visualise the 
nDNA and the kDNA (section 2.11.1). The number of cells in each category was counted and 
is expressed as a percentage of the total number of cells counted. The error bars show ± 
SEM, n=3. Over 200 cells were counted per experiment. The cell cycle was also examined by 
flow cytometry (C) as per section 2.8.4. The distribution of each population of cells is shown 
according to their DNA content. 50000 events were captured with the number of cells 
normalised to the mode. DNA was stained with propidium iodide (FL-2A channel). Tet + 
(blue line) and Tet – (orange plot) are shown as overlapped histograms. These data are from 
one experiment, a second experiment is shown in chapter 8, section 8.5, Figure 8-32. The 
histograms were generated using FlowJo V10 software (http://www.flowjo.com/). 
Representative images of uninduced cells (C) and cells induced for 48 hrs with 1 μg/ml
-1
 
tetracycline (D). Cells were fixed as per section 2.11.1 and stained with DAPI (to visualise 
the n- and kDNA; cyan) and α KMX-1 antiserum (to visualise tubulin; magenta; section 
2.11.2). The cell body was visualised by differential interference contrast microscopy 
(labelled as DC). Scale bar = 10 μm. Images were captured on an Axioskop 2. 
Loss of TbATR significantly affected cell cycle progression of BSF T. brucei. At 24 
hrs post induction, very few effects on DNA content were seen in the flow 
cytometry analysis, though DAPI staining suggested a small increase in 1N2K 
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cells. These minor effects are in keeping with slight reduction in growth (Figure 
6-8 A) at this time point. However, at 36 hrs post induction, a significant 
increase in 1N2K cells was observed by DAPI counting, suggesting a stall during S-
phase of the cell cycle; this was confirmed by the flow cytometry analysis, 
where both an increase in an S-phase population and cells with 4N DNA content 
was observed. Furthermore, at 36 hrs a significant increase in aberrant cells was 
observed. A notable class of these cells were those with multiple kinetoplasts, 
perhaps consistent with loss of the checkpoint signalling the completion of nDNA 
replication and triggering the onset of cytokinesis, meaning the kinetoplast can 
enter a new round of replication. Often these cells also had enlarged, miss-
shapen or fragmented nuclei (discussed in more detail in section 6.3.5, below; 
‘others’; see Figure 6-8 C&D for representative images). From the flow 
cytometry data (Figure 6-8 B), two populations of cells began to appear outwith 
the normal constraints of the cell cycle; those with < 2N DNA content and those 
with >2N. The former population may correspond with ‘zoid’ cells, which lack a 
nucleus. Indeed, some anucleate cells could be seen following DAPI staining (see 
Figure 6-8 D; lower panel); though, these were a minor population and were 
classed simply as ‘other’ cells. Nonetheless, the detection of this subset of cells 
may provide further evidence that cytokinesis can proceed after TbATR RNAi, 
despite aberrant nuclear division or replication. Multinucleated cells were also 
observed by DAPI staining, in keeping with the flow cytometry observations. In 
some of these cells, the nDNA content was uneven, perhaps suggested the DNA 
had become fragmented; indeed, in some cases it was difficult to judge whether 
the perceived extra kinetoplasts were in fact just pieces of fragmented nDNA. At 
48 hrs post induction, the above effects increased yet further. An increase in 
1N2K cells and further increased numbers of ‘others’, including >2K cells, were 
observed suggesting a persistent S-phase stall and aberrant or perhaps absent 
cytokinesis; these data were supported by further increases in altered DNA 
content seen by flow cytometry. 
6.3.5 Nuclear defects arise in TbATR deficient cell lines 
Gross nuclear defects and chromosomal rearrangements are associated with the 
loss of ATR in eukaryotic cells (Pennarun et al. 2010) and, indeed, from 36 hrs 
post RNAi induction, T. brucei cells with aberrant nuclear content were observed 
by DAPI staining and flow cytometry. To investigate this further, the 
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ultrastructure of the nucleus (section 2.11.7.2) and the position of the telomeres 
(and thus the arrangement of the chromosomes; section 2.10) were examined 
following TbATR knockdown. 
Cells were collected at 24 hrs, 36 hrs and 48 hrs post RNAi induction and first 
stained with DAPI (as per section 2.11.1). Several categories of nuclear defects 
could be clearly assigned to cells and could be seen to increase with time (Figure 
6-9 A). Representative images of the different categories are shown in Figure 6-9 
B. 
 
Figure  6-9: TbATR is required to maintain the nucleus of BSF cells 
(A) Cells were fixed at 24, 36 and 48 hrs post RNAi induction and DAPI stained. The nuclei of 
cells were examined on an Axioskop2 and categorised depending upon the perceived 
defect. Examples of these defects are shown in (B). Each category was expressed as 
percentage of the total number of cells counted. Error bars = ± SEM, n=3. (B) 
Representative images of different nuclear configurations (the nuclei are stained with DAPI; 
green) observed at 36 hrs post induction. Images are captured from the TbATR RNAi CL1 
cell line on a DeltaVision microscope and processed as per section 2.11.8. Scale bar = 5 μm. 
In keeping with the cell cycle analysis, no clear nuclear defects could be 
observed in the majority of cells following RNAi induction. However, as many 
cells were beginning to form large cell clumps at 36 and 48 hrs, it is possible 
that the number of cells with nuclear defects is underestimated. Cells with 
notably abnormal nuclei (such as enlarged), but which could not be classified as 
having a specific phenotype, were simply classed as ‘aberrant’ and increased in 
the RNAi population with time. Beyond these cells, at both 36 hrs and 48 hrs 
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post induction cells with fragmented nuclei (7 % at 48hrs) or nuclei with 
protruding structures (referred to as ‘blebs’; 15 % at 48 hrs), were widespread 
and again increased with time, suggesting either a breakdown of the nuclear 
architecture or potentially incorrectly segregating nDNA. 
To investigate these observations further, the ultrastructure of the nucleus was 
examined by TEM of cells 36 hrs post induction. Images representative of cells 
with aberrant nuclei are shown in Figure 6-10. 
 
Figure  6-10: Internal cellular architecture of TbATR-deficient cells 
Cells were fixed at 36 hrs post RNAi induction (as per section 2.11.7.2) and imaged by TEM 
by L.Lemgruber-Soares. The top left panel shows an uninduced cell. The black arrow (top 
right) indicates extra nuclear membrane. The white triangles (bottom left) highlight the 
presence of three internal flagella. Images were captured on a Tecnai T20 EM microscope 
and processed in Adobe Photoshop (by L.Lemgruber-Soares). Scale bars are as labelled. 
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As expected, in the non-induced population, no nuclear defects could be 
observed. However, at 36 hrs post induction, cells with multiple kinetoplasts 
could be readily detected; in some cases, this was associated with aberrant 
nDNA (Figure 6-10; lower panels), while in others, no clear nuclear defects could 
be detected (Figure 6-10, lower right panel). Additionally, clear changes in 
nuclear architecture or envelope organisation could be seen, consistent with the 
DAPI analysis (as indicated with the black arrow in Figure 6-10; upper right 
panel). 
6.3.5.1 Loss of TbATR is associated with abnormal chromosomal 
rearrangements 
Loss of ATR has been shown to result in chromosomal lesions, including the 
fusion of sister chromatids and telomere destabilisation (Pennarun et al. 2010). 
To investigate a potential role for TbATR in maintaining chromosome structure 
in BSF T. brucei, telomere-fluorescence in situ hybridisation (Telo-FISH) was 
performed. Telo-FISH was performed using a probe designed to detect the T. 
brucei telomeric repeat sequence, TTAGGG. Given the relative number of mini- 
and megbase-chromosomes, it is likely that most Telo-FISH signal detects the 
former. Consistent with previous work (DuBois et al. 2012), in uninduced TbATR 
RNAi cells, the telomeres localised diffusely around the nucleus during 
interphase; often resembling small foci. Upon entry to G2 phase, the telomeres 
were detected as forming a ‘plane’ at the centre of the nucleus. After mitosis 
occurred, the telomeres re-localised to opposite poles of each nucleus. These 
localisation patterns are shown in Figure 6-11, with images captured by SR-SIM 
microscopy (section 2.11.8.1). 




Figure  6-11: Telomere positions in the presence of TbATR 
Telo-FISH was performed on non-induced TbATR CL1 RNAi cells (collected after 36 hrs of 
growth) as described in section 2.8.1. The nDNA and kDNA were stained with DAPI 
(magenta), and the telomeres detected with a FITC conjugated probe (green). Images 
captured on an Elyra super resolution microscope (Zeiss) and processed as per section 
2.11.8. Scale bar = 5 μm. 
Upon loss of TbATR, aberrant telomere arrangements could be observed. Altered 
signals could be seen 36 hrs after RNAi (representative images are shown in 
Figure 6-12 A-D). In some cells, a reduced spread of signal was detected, which 
may be the result of many cells not harbouring the small diffuse foci observed in 
the non-induced cells, but instead, larger, elongated foci could be observed 
(Figure 6-12 A). These data may suggest accumulation of telomeres in these 
regions; whether this is due to chromosome movement or fusion cannot be 
determined in this analysis. In some 1N2K cells (Figure 6-12 A) accumulation of 
signal along a central plane was seen but did not localise to the centre of the 
nucleus, perhaps explaining why some chromosomes might be incorrectly 
segregated during mitosis. Perhaps consistent with this, in some cells in which 
two nuclei appear to be separating (Figure 6-12 B&C) the telomeric signals 
appeared not always to localise to the expected poles. Finally, clear evidence 
for fragmentation of the nucleus was seen, where telomere signal was found in 
many small DAPI stained elements (as shown in Figure 6-12 D). As stated 
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previously, it is possible that cells scored with multiple kinetoplasts may instead 
harbour fragmented pieces of the nucleus. 
 
Figure  6-12: Loss of TbATR is associated with aberrant telomere arrangements 
Telo-FISH was performed on TbATR CL1 RNAi induced cells (collected at 36 hrs post 
induction; A-D) as described in section. The nDNA and kDNA were stained with DAPI 
(magenta) and the telomeres detected with a FITC conjugated probe (green). White arrow 
indicates elongated foci (A). Yellow arrow indicates telomere signal in fragments of the 
nucleus (D). Images were captured on an Elyra super resolution microscope (Zeiss) and 
processed as per section 2.11.8. Scale bar = 5 μm. 
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6.3.6 TbATR is required for cell survival following genotoxic 
stress 
In other eukaryotes, loss of ATR is associated with sensitisation of cells to 
sources of genotoxic stress, including replicative stress (Herr et al. 2015) and 
following UV exposure (Kawasumi et al. 2011). To examine whether loss of 
TbATR sensitised BSF T. brucei to various sources of genotoxic stress, growth of 
the cells was monitored following RNAi induction in the presence or absence of 
MMS, HU or a single UV exposure (performed as per section 2.81). These data are 
shown in Figure 6-13 A&B. 
 
Figure  6-13: In vitro loss of TbATR sensitises BSF T. brucei cells to genotoxic stress 
Growth curves were conducted as described in section 2.8.1. (A) and (B) show growth 
analysis of TbATR RNAi CL1 and CL2, respectively, under a variety of genotoxic stress 
sources: MMS (0.0003 %), UV (1500 J/m
2
) and HU (0.06 mM). The (+) denotes tetracycline 
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induced samples. The (-) denotes the unidnuced samples. The error bars represent ± SEM, 
n=3. For statistical analysis, uninduced cells in the presence of damage were compared 
with the corresponding induced cell line. (*) = p<0.05 as determined by a Mann Whitney U 
test. 
In keeping with the results presented in section 6.3.4, loss of TbATR caused a 
reduced rate of proliferation and the appearance of aberrant cells and, again, 
72-96 hrs post induction, proliferation began to recover. When the RNAi induced 
cells were grown in the presence of MMS (a DNA alkylating agent; at a 
concentration of 0.0003 %) proliferation was reduced relative to the non-induced 
cells exposed to MMS from as early as 24 hrs post induction. At 96 hrs post 
induction, the proliferation of the TbATR CL1 cell line began to recover despite 
being exposed to MMS (Figure 6-13 A; top graph). However, no such effect was 
seen with the TbATR CL2 cell line, where addition of MMS resulted in death after 
RNAi (Figure 6-13 B; top graph), despite the corresponding induced population in 
the absence of damage beginning to recover. 
In addition to becoming sensitive to MMS exposure, loss of TbATR also 
significantly sensitised the cells to hydroxyurea (HU; which stalls replication; 
0.06 mM) and to UV exposure (a crosslinking agent; 1500 J/m2). Taken together, 
loss of TbATR sensitised BSF cells to a range of genotoxic agents, suggesting 
TbATR contributes to the response of T. brucei to different types of DNA lesions. 
6.3.7 TbATM is not required for cell survival following MMS or HU 
exposure 
When the levels of ATM are reduced, human cells become highly sensitised to 
sources of DSBs such as ionising radiation (IR) and more moderately to alkylating 
and cross linking agents (Shiloh & Ziv 2013). In the case of HU exposure, though 
loss of ATM itself does not directly signal HU damage (Kurose et al. 2006; 
Chaturvedi et al. 1999), sensitivity is seen because ATM is can function to 
facilitate the restart of stalled replication forks that arise after this treatment 
(Ewald et al. 2008), though the mechanisms are still being investigated (Trenz et 
al. 2006; Ewald et al. 2008; Sowd et al. 2013). 
The RNAi cell lines used for this study are resistant to the DSB inducing agent 
phleomycin (PHL) and no source of IR was available. As a result, we were limited 
to asking if loss of TbATM causes the expected moderate sensitivity to 
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replicative stress, by measuring growth in the presence of MMS (0.0003 %) or HU 
(0.06 mM), as described in section 2.8.1. However, loss of TbATM in BSF cells 
was not associated with any significant loss of proliferation in the presence of 
either source of genotoxic stress (Figure 6-14), suggesting TbATM is not required 
for cell survival following MMS or HU damage. 
 
Figure  6-14: In vitro loss of TbATM is not associated with increased sensitivity to genotoxic 
stress 
Growth curves were conducted as described in section 2.8.1. Cells were grown in the 
presence of 1 μg/ml
-1
 tetracycline (solid blue line) to induced RNAi or in the absence of 
tetracycline (solid black line) as a control. Cells in the presence of a damage source in the 
induced population are shown by a dashed blue line. The dashed black line represents the 
uniduced population grown in the presence of a genotoxic agent. (A) and (B) show growth 
analysis of TbATM RNAi, under a variety of genotoxic stress sources: MMS (A; 0.0003 %) 
and HU (B; 0.06 mM). Cells were grown continuously in the presence of genotoxic stress. 
Both curves were performed once. 
6.3.8 TbATR deficient cells show increased levels of DNA 
damage-associated markers 
Suppression of ATR by RNAi in other eukaryotes is associated with elevated 
levels of γH2A(X) and RAD51 foci formation (Chanoux et al. 2009; Podhorecka et 
al. 2011).To determine whether loss of TbATR also results in detectable damage 
in T. brucei, indirect IF analysis (section 2.11.2) was performed to examine 
levels of γH2A (as detected by α-γH2A antiserum; section 2.11) after TbATR 
RNAi. Our α-γH2A antiserum stains the nucleus of an undamaged, uninduced 
RNAi (Figure 6-15 C; chapter 8, section 8.5, Figure 8-33) for reasons that remain 
unclear. Thus, the pattern of staining was examined after RNAi and the 
fluorescence intensity of the γH2A signal in the nucleus of multiple cells was 
measured individually using ImageJ (section 2.11.8.3) for both the induced and 
non-induced samples. Figure 6-15 A plots the fold change in fluorescence 
intensity in the RNAi induced nuclei relative to the non-induced samples. 
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From as early as 24 hrs after TbATR knockdown, ~2.5 fold increased levels of 
γH2A were detected, with the fold change increasing at each subsequent time 
point: ~3.5 fold higher 36 hrs post induction and ~5 fold higher after 48 hrs. To 
evaluate this observation further, western blot analysis was performed (as per 
section 2.12.1.2; Figure 6-15 B) at the same time points, confirming increased 
levels of γH2A after RNAi. Indeed, quantification of the western signals revealed 
a similar time-dependent response, with levels of γH2A increased ~5 fold after 
48 hrs (data shown in chapter 8, section 8.5, Figure 8-33 C). 
 
Figure  6-15: Loss of TbATR is associated with increased γH2A in BSF cells 
(A) RNAi induced (+) and non-induced cells were fixed at the time points shown and stained 
with α γH2A and DAPI. The fluorescence intensity signal of γH2A in the nucleus in >200 
cells was measured in ImageJ and the intensity measurements at each time point averaged. 
Fold change in intensity (arbitrary units, AU) is plotted for each induced time point relative 
to the combined average of all undinduced time points (Figure 6-15 A). Error bars represent 
± SEM, n=3. (B). Western blot of whole cell extracts from RNAi induced (Tet+) or uninduced 
(Tet-) cells probed with antisera recognising γH2A and EF1- (as a loading control); an 
intensity plot of the western signals is shown in chapter 8, section 8.5, Figure 8-33 C. (C) 
Representative images of γH2A localisation in induced (Tet+) and uninduced (Tet-) cells 
after 36hrs growth. Indirect IF analysis was performed, with α γH2A (magenta) antiserum 
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(Table 2-7). DNA was stained with DAPI (green). Images were captured on a DeltaVision 
microscope from the RNAi cell line TbATR CL1. Scale bar = 5 µm. 
Beyond the changes in levels of γH2A, imaging the IF on a higher resolution 
microscope (Olympus IX71 DeltaVision Core System; Applied Precision; Figure 6-
15 C) suggested that TbATR RNAi may result in a changed distribution of the 
modified histone. In many RNAi induced cells generalised nuclear staining was no 
longer seen, but instead the signal took the form of multiple puncta, perhaps 
representing nuclear foci of γH2A. The same pattern has been described in ATR-
depleted human cells (Chanoux et al. 2009), as well as after the generation of 
DSBs in T. brucei (Glover&Horn 2012). Though the nature of the DNA damage 
being recognised by γH2A after TbATR RNAi cannot be inferred, the pattern of 
staining may be consistent with genome fragmentation. 
To probe the nuclear damage revealed by staining further, we next looked at 
localisation of RAD51, which is known to relocalise to discrete nuclear foci after 
DSBs induced by ISceI or PHL(Glover et al,. 2013; Devlin et al. 2016). 
Localisation of RAD51 was examined for by indirect IF using α-RAD51 antiserum 
(section 2.11.2) following TbATR knockdown up 48 hrs post induction. These 
data are shown in Figure 6-16 A&B below. 




Figure  6-16: Loss of TbATR is associated RAD51 foci formation 
(A) The cells were fixed and stained with α RAD51 and DAPI as per section. The number of 
cells with nuclear RAD51 foci was counted and expressed as a percentage of the total 
number of cells counted. Over 200 cells were counted per experiment. The error bars 
represent ± SEM, n=3. Significance was determined by performing a Mann Whitney U test. 
(*) means p=0.05. ‘+’ (induced with 1 μg/ml
-1
 tetracycline) ‘-‘ (un-induced) (B) Representative 
images of RAD51 localisation in induced (Tet+) and uninduced (Tet-) cells at 48hrs post 
induction. Indirect IF analysis was performed as per section 2.11.2 with RAD51 being 
detected with α RAD51 (magenta) antiserum (Table 2-7). The morphology of the parasites 
was visualised using DIC imaging. The n- and kDNA were stained with DAPI (green). 
Representative images were captured on a DeltaVision microscope from the RNAi cell line 
TbATR CL1. Scale bar = 5 µm. 
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In keeping with previous work, in the absence of RNAi only a small (~1 %) part of 
the population had detectable nuclear foci detected by anti-RAD51 antiserum, 
with most cells having diffuse staining both in the nucleus and cytoplasm (Devlin 
et al. 2016; Dobson et al. 2011; Hartley & McCulloch 2008). However, 36 and 48 
hrs after TbATR RNAi, in keeping with results in mammalian cells (Chanoux et al. 
2009), loss of TbATR in BSF T. brucei resulted in a significant increase in the 
number of cells with RAD51 foci: after 48 hrs up to 7 % of the population 
harboured foci, though predominantly just a single focus in each cell (Figure 6-
16 B shows the representative localisation of TbRAD51 in an induced and 
uninduced cell; data for the number of foci observed per cell is not shown). The 
apparent decrease in fluorescence intensity following TbRAD51 re-localisation 
from the diffuse nuclear staining to the foci following TbATR depletion cannot 
be explained with this analysis. However it is important to consider that it may 
be of biological relevance (such as degredation of TbRAD51 occuring following 
TbATR depletion) though additional experiments are required to examine this 
effect further. Intriguingly, the timing of RAD51 accumulation into foci was 
delayed relative to the increased levels of γH2A after RNAi, suggesting the 
formation of putative RAD51 repair foci follows the generation of modified 
histone. 
6.3.9 Loss of TbATR is associated with deregulation of silent VSG 
expression sites 
ATR, in other eukaryotes, is required to stabilise stalled replication forks, 
protect and maintain telomere integrity and stability, and prevent breaks within 
common fragile sites (CFSs) including at telomeres (McNees et al. 2010). Given 
the recently revealed link between replication timing and VSG expression site 
(ES) transcription status (Devlin et al. 2016), and the location of VSG ES at 
telomeres, we sought to ask if TbATR RNAi might affect VSG expression. 
To test this hypothesis further, qRT-PCR and RNAseq analyses were performed 
on both TbATR RNAi cell line clones. In the Lister 427 WT strain (from which the 
cell lines in this chapter are derived), 14 unique BESs have been identified 
(Figure 6-17; Hertz-Fowler et al. 2008). The cell lines used in this thesis 
predominantly express VSG221, which is located in BES 1 (telo40); this is the 
active ES. All other ESs are considered transcriptionally silent. 




Figure  6-17: Bloodstream VSG expression sites in the T. brucei Lister 427 strain 
The schematic above depicts the bloodstream expression sites (BESs) annotated in the T. 
brucei Lister 427 genome following TAR (transformation-associated recombination) cloning. 
Identification of ESAGs (expression site associated genes), VSGs (variant surface 
glycoprotein), pseudogenes and other ES features are shown below. Figure reproduced in 
full from (Hertz-Fowler et al. 2008) (all rights reserved). 
6.3.9.1 qRT-PCR analysis reveals de-regulation of silent ESs in the absence 
of TbATR 
To investigate whether loss of TbATR resulted in de-repression of VSG 
transcription in the silent ESs, qRT-PCR analysis was performed to measure RNA 
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transcript abundance for four silent VSGs (VSG13, VSG800, VSG224 and T3 in 
Figure 6-18) 24 and 36 hrs post induction of TbATR RNAi. This analysis was 
performed on both TbATR RNAi clones. Additionally, the RNA level of the 
actively expressed VSG (VSG 221) was examined. Finally, knockdown of TbATR 
for each experiment was tested (Figure 6-18 A&B), and effects on levels of 
general transcription were assessed by examining transcript levels for the 
ORC1/CDC6 gene, encoding a factor central to T. brucei DNA replication 
(Marques et al. 2016).RNA was prepared as per section 2.5.1 and 2.5.2 and the 
qRT-PCR analysis was performed as per section 2.5.3, using the primers detailed 
in Table 2-5. 
 
Figure  6-18: Loss of TbATR is associated with expression of silent VSG RNA transcripts 
The levels of gene expression were assessed by qRT-PCR in RNA samples prepared from 
TbATR RNAi clones CL 1 (A & C) and CL2 (B & D) after growth for 24 or 36 hrs with (+) or 
without induction of RNAi. Error bars = ± SEM (n=3 for CL1, and n=2 for CL2). Each 
biological replicate was performed as a technical triplicate. The CT values for each sample 
were generated by averaging the CT values across the triplicate technical repeats. The 
relative fold change for each gene examined was then determined by calculating the ΔΔCT 
value (equation shown in section) for each gene normalised to an endogenous control (for 
this experiment, actin was used). The levels of RNA for the uninduced samples were set to 1 
(represented by the black line), and the levels in the RNAi induced expressed relative that 
control. The following VSGs were examined: VSG13 (telo 59 and 51; BES 17), VSG221 (telo 
40; BES1), VSG224 (telo65 and 153; BES7), VSGT3 (telo 3 and 28; BES4) and VSG800 (telo 
98; BES5). VSG13 and VSGT3 are located on intermediate chromosomes. VSG224, VSG221 
and VSG800 are located on megabase chromosomes. Named as detailed in (Hertz-Fowler et 
al. 2008). Relative changes of RNA from TbATR and a non-VSG gene, ORC1/CDC6, are also 
shown. 
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For both clones, the level of the TbATR transcript was reduced (by ~60 % for CL1 
and ~50 % for CL2), as expected. For ORC1/CDC6, less than a 2-fold change (and 
thus not considered significant) in transcript levels was observed at both time 
points. VSG221 displayed no clear change in RNA levels, though the abundance 
of this actively expressed VSG may impede detection of changes by CT measures 
(Figure 6-18 A&B). 
In contrast to the limited changes seen for VSG221 and ORC1/CDC6, a modest 
but clear 3-5-fold increase in VSG transcript levels from the silent ESs could be 
detected 24 hrs after TbATR RNAi in both clones. Strikingly, 36 hrs after RNAi a 
much greater increase in silent VSG transcripts was seen, ranging from ~10-25 
fold in CL1 and ~15-35 fold in CL2 (Figure 6-18 C&D). 
Overall, RNA transcripts from previously silent ESs could be detected after 
TbATR loss, either because TbATR is required to maintain transcriptional 
silencing at the sub-telomeres or because loss of ATR leads to elevated VSG 
switching. 
6.3.9.2 Loss of TbATR is associated with the de-repression of Pol I 
associated and surface coat associated genes 
To ask if the effect seen on silent VSGs after loss of TbATR in BSF cells was 
specific to the VSG BES or reflected more widespread changes in transcription, 
cells were sampled at 24 and 36 hrs post induction and RNAseq was performed 
(as per section 2.6) on total RNA. BSF cells were harvested and RNA prepared as 
described in section 2.6 from two biological replicates of induced and uninduced 
TbATR CL1 cells and from a single replicate of TbATR CL2, providing triplicate 
induced and uninduced samples at both time points. PCR analysis was performed 
on the isolated RNA (as per section 2.2.4; primers used are detailed in Figure 6-
19) to test for the presence of gDNA contamination (as shown below); no 
contamination could be clearly detected. The sample concentration was 
measured as per section 2.6 (data shown in chapter 8, section 8.5, Table 8-5) 
and an RNAseq library prepared for each sample as described in section. A 
stranded library was prepared using a TruSeq Stranded mRNA Library Prep Kit 
(Illumina), the library was Paired-End sequenced using an Illumina NextSeq 500 
using a Mid-Output Flow cell generating read lengths of 75 bp. The 
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bioinformatics analysis performed as described in section 2.6.2. The total 
number of reads for each sample, the percentage mapped and the number and 
percentage properly paired as presented in chapter 8, section 8.5, Table 8-6. 
 
Figure  6-19: PCR analysis of RNA samples for RNAseq analysis 
A PCR analysis of RNA extracted for RNAseq analysis was performed using the primers 148 
and 147 (A and B) and primers 139 and 140 (C) as detailed in section (refer to Table 2-3 for 
primer sequences). The figure shows an agarose gel of the PCR reactions. Genome DNA 
(gDNA) was used as positive control and RNase free double distilled water (ddH20) as a 
negative control. S1 = sample 1, S2 = sample 2; 24 and 36 refer to the time points of the 
RNAi induced (+) and uninduced (-) cells in each sample, which represents an independent 
experiment. Size markers are shown in bp. 
To assess the distribution of the sequence fragments per kilobase transcript per 
million bases (fpkm) across each individual replicate, a box plot was generated 
in RStudio using the ‘csboxplot’ command (as per section 2.6.2), plotting the 
log10 transformed fpkm for each read. The box plots for each individual 
replicate at 24 hrs (Figure 6-20A) and 36 hrs (Figure 6-20 B), with or without 
RNAi induction, shows  the spread of data for all replicates at both time points 
were comparable, with similar interquartile ranges of ~ 1 (for 24 hrs) and 1.25 
(36 hrs) and medians of ~2 (for all replicates). 




Figure  6-20: Box plot to assess the distribution of the fpkm for each replicate after 24 and 36 
hrs growth with and without RNAi 
The boxplot was generated in RStudio as per section 2.6.2. The log10 transformed fpkm 
values for each read were plotted for each individual replicate (0, 1, 2) at 24 hrs (A) and 36 
(B) with (Pos) or without (Neg) RNAi induction against TbATR. Outlier values are 
represented as black dots at either end of the box plot. The box represents the interquartile 
range of the values within each sample, within which the median value is indicated by the 
central line. 
6.3.9.3 Loss of TbATR is associated with up-regulation of surface antigen-
associated transcripts 24 hrs after RNAi 
Analysis of the pattern of genes that showed altered RNA levels after TbATR 
RNAi suggested a difference both in the pattern and number of differentially 
expressed genes at 24 and 36 hrs. As a result, the data will be separated into the 
two points. Heatmaps of differentially expressed transcripts after 24 and 36 hrs 
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RNAi induction are shown in the accompanying CD (see files presented in the 
folder RNAseqDatasetATRBSF2016 Heatmaps 24hr.pdf and 36hr.pdf). For a 
complete list of all gene transcripts differentially expressed at 24 hrs post RNAi 
induction, see the accompanying CD (file entitled labelled 
RNAseqDatasetATRBSF2016. 
To ask how many transcripts displayed altered levels after 24 hrs TbATR RNAi, 
fold change (log2 transformed FC) in average FPKM for the three replicates was 
plotted on a volcano plot relative to the significance for each gene (the log10 
transformed p-value), using the CuffDiff software in RStudio (as per section 
2.6.2). The plot was generated using the ‘csvolcano’ command as per section 
(Figure 6-21). At 24 hrs, 150 gene transcripts were judged to be to be 
significantly differentially expressed in the RNAi induced cells relative to the 
uninduced (red dots). 
 
Figure  6-21: Volcano plot showing transcripts differentially expressed at 24 hrs post TbATR 
RNAi induction 
The log10 transformed p-values for each gene identified by RNAseq are plotted against the 
log2 transformed fold change in FPKM (as determined by CuffLinks) in RStudio 
(https://www.rstudio.com/), as described in section 2.6.2. Red dots correspond to 
significantly differentially expressed transcripts. 
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Examination of the 150 genes that displayed differential transcript levels 
revealed surface antigen associated genes to be the most abundant category (52 
%; Figure 6-22 A). Included in this category are ESAGs, VSGs, procyclins (EP and 
GPEET) and procyclin-associated genes (PAGs). Strikingly, virtually all of these 
transcripts were significantly more abundant after TbATR RNAi: ~ 95 % of the 
total number of surface antigen associated genes detected, or 60.5 % of all up-
regulated transcripts; Figure 6-22 B. Indeed, at 24 hrs ~83 % of all changes were 
increases in RNA levels. 
Increased RNA transcripts corresponding to the VSG from seven silent BES were 
seen: BES11 (Tb427.BES122.11), BES15 (Tb427.BES126.15), BES2 
(Tb427.BES129.14), BES10 (Tb427.BES134.6), BES12 (Tb427.BES29.9), BES13 
(Tb427.BES56.13), BES8 (Tb427.BES64.2) and BES5 (Tb427.BES98.12). In 
addition, one of the VSG RNA transcripts tested by qRT-PCR analysis was seen, 
with a comparable fold change (~3 fold: BES5 [Tb427.BES98.12 or VSG800]). 
These data suggest that loss of ATR affects all silent BES. Mapping reads to 
specific ESAGs is more complicated than VSGs due to greater homology, but 
increased RNA levels were predicted for multiple ESAGs from multiple BES, 
suggesting ATR-induced expression changes are not limited to the VSG but 
potentially cover the whole BES. The same pattern of very predominantly 
increased RNA levels were seen for procyclin and PAG genes, suggesting that loss 
of silencing of RNA PolI-transcribed genes may be a common, early response to 
TbATR RNAi. 
The remaining differentially expressed transcripts (Figure 6-22 C;~ 47 %) were 
either hypothetical genes of unknown function (~ 15 %), or genes with predicted 
functions from the genome annotations (~ 31 %). To ask if the later genes 
corresponded with any functional categories, GO term enrichment was evaluated 
for all 150 genes (Figure 6-23). However, all enriched terms corresponded with 
host-parasite interaction, in keeping with the overwhelming focus of surface 
gene expression changes at this time point. Manual examination of the 
annotated genes revealed five predicted peptidases, as well as a gene associated 
with nuclear transport (FC: -1.39), two genes associated with nucleolar RNA 
binding (FC: both > -1.3), an RNA binding protein (FC: 1.677) and two ribosomal 
genes (FC: -1.3, <13.9). These latter genes may indicate nuclear and nucleolar 
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structure alterations that appeared to be seen more clearly after 36 hrs (below). 
Given ATR is predicted to act in repair signalling, changes in repair and kinase 
gene expression levels were sought. No kinases were detected, and only two DNA 
repair associated genes: an apoptosis-associated gene known as Bax (a target of 
the p53 tumour suppressor transcription factor; Miyashita & Reed 1995) and, as 
expected, TbATR (FC: -2.5). 
 
Figure  6-22: Pie charts summarising differentially expressed genes at 24 hrs post TbATR 
RNAi induction 
All differentially expressed genes were classified into four categories: DNA damage 
associated, surface antigen associated, genes with annotations, and hypothetical genes. 
The number of genes in these categories are expressed as a percentage of the total number 
of genes that showed a significant change in transcript level (A; 150 total), as well as those 
that show a significant increase (B, 124) or decrease (C, 26). Genes with annotations refers 
to genes with an annotated putative function in either the Lister 427 or the TREU 927 
reference genome. 




Figure  6-23: GO terms enriched at 24 hrs post knockdown of TbATR in BSF cells 
GO terms were retrieved from TriTrypDB based on the gene annotations associated with 
each gene. SI = symbiont interaction. 
6.3.9.4 Loss of TbATR at 36hrs post induction was primarily associated with 
cell cycle and global gene expression  
At 36 hrs post induction, ~10 fold more transcripts were differentially expressed 
(1431 transcripts in total) as represented by the red dots on the Volcano plot in 
Figure 6-24 (data was plotted as described for 24 hrs post induction in the 
section above). The data is summarised in the pie charts shown in Figure 6-25 A-
C. 




Figure  6-24: Volcano plot showing transcripts differentially expressed at 36 hrs post TbATR 
RNAi induction 
The log10 transformed p-values for each gene identified by RNAseq are plotted against the 
log2 transformed fold change in FPKM (as determined by CuffLinks) in RStudio 
(https://www.rstudio.com/), as described in section 2.6.2. Red dots correspond to 
significantly differentially expressed transcripts. 
At this time point after TbATR RNAi, RNA transcripts of VSGs from nine silent 
BESs were seen, with increased FCs (of ~6-57) relative to 24 hrs. Amongst the 
VSGs were VSG800 and VSGT3, which showed FCs of ~11 and 6, close to the qRT-
PCR analysis (Figure 6-18 C&D). Interestingly, at this time point four genes, 
corresponding to ESAGs 6, 7, 8 and 1, from the active ES (BES1, but referred to 
in the annotations as BES40, based on TAR40; accompanying CD; 
RNAseqDatasetATRBSF2016) were predicted to have reduced RNA levels (FCs of~-
16.5, -9.9, -1.4, -1.9). VSG221 was not seen in the mapping, but these ESAGs 
were the only BES-associated genes predicted to be reduced in transcript level 
after TbATR RNAi, with all others increased. These data are compatible with loss 
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of expression from the active BES in conjunction with the silent BESs becoming 
de-repressed. 
 
Figure  6-25: Pie charts summarising the data recovered at 36 hrs post TbATR 
downregulation 
All differentially expressed genes were classified into four categories: DNA damage 
associated, surface antigen associated genes with annotations and hypothetical genes and 
expressed as a percentage of the total number of genes (1431 for A, 831 for B and 600 for 
C). Genes with annotations refers to genes which were annotated in either the Lister 427 or 
the TREU 927 reference genome. (A) details the overall distribution of the transcripts and 
their corresponding gene annotations across all differentially expressed transcripts (1431 in 
total). (B) details the genes corresponding to transcripts which were up-regulated and (C) 
details the genes corresponding to transcripts which were down-regulated. 
At 36 hrs the majority of differentially expressed transcripts were functionally 
annotated in either the Lister 427 or TREU 927 genes (~ 50 %; Figure 6-25 A). 
Given this, GO term enrichment was analysed again (Figure 6-26) and, perhaps 
significantly given the effects of TbATR loss on nuclear structure and 
chromosome segregation, the most highly enriched terms were those associated 
with regulation of nuclear division, mitosis and the cell cycle. In addition, 
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several nuclear membrane associated and ribosome biogenesis genes showed 
altered expression, which may relate to the changes in nuclear structure 
described above and emerging roles for ATR in monitoring nuclear envelope and 
nucleolus structural integrity (Larsen & Stucki 2016; Kidiyoor et al. 2016). 
 
Figure  6-26: GO terms enriched at 36hrs post knockdown of TbATR in BSF cells 
GO terms were retrieved from TriTrypDB based on the gene annotations associated with 
each gene. 
We again asked if PKs and DNA repair genes displayed altered expression at 36 
hrs. Unlike 24 hrs, differentially expressed transcripts corresponding to PKs 
could be detected, including PKs associated with control of the cell cycle; for 
instance, cdc2-related PKs TbCRK10 (Tb427.03.4670) and TbCRK4 
(Tb427.08.5390) were up-regulated (FC ~1.5 and 1.6), while TbCRK6 
(Tb427tmp.47.0031) was down-regulated (FC -1.4).In addition, several DNA 
damage associated proteins were seen to change expression, with the majority 
up-regulated (65 %; Figure 6-25 B&C; Table 6-8). Potentially, this data suggests 
that in the absence of TbATR, proteins associated with some DNA repair 
pathways are up-regulated. 




Table  6-8: DNA damage associated proteins differentially regulated in BSF T. brucei 36 hrs 
TbATR RNAi induction 
Genes up-regulated are marked as pale pink, and those down-regulated are marked as blue. 
6.3.9.5 Does loss of TbATR induce VSG switching? 
The qRT-PCR and the RNAseq data both suggest that loss of TbATR is associated 
with increased expression of transcripts from the silent ESs. To test whether 
these transcripts are translated and expressed, leading to VSG protein, a 
western blot analysis was performed. Antisera to detect the VSGs shown to be 
up-regulated by qRT-PCR and by RNAseq analysis were unavailable, and so 
antiserum against VSG121 (situated in BES3; referred to as BES15 in the 
spreadsheet in accompanying CD; RNAseqDatasetATRBSF2016; kindly provided by 
L.Glover) was used. In addition, expression of VSG221 in the active BES was 
examined with anti-VSG221 antiserum. The TbATR CL1 cell line was RNAi 
induced and whole cell extracts prepared at 24 and 36 hrs, as well as from non-
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induced cultures (Figure 6-27 A). As a control for VSG221 expression, 2T1 cell 
extracts were also collected at the same time point and, as a control for VSG121 
expression, a cell line predominantly expressing VSG121 was used (strain 1.6; 
kindly provided by L.Glover). Even at 36 hrs post induction in the ATR RNAi cell 
line, expression of VSG121 could not be detected and there was no evidence of 
reduced VSG221 levels (Figure 6-27 B), despite RNAseq suggesting loss of 
transcription from BES1. A low level of VSG221 could be detected in the VSG121 
cells, but this has been seen previously (personal communication D.Paape and 
L.Glover). 
 
Figure  6-27: Some TbATR depleted cells do not express VSG221 on their surface 
Western blotting was performed at 24 and 36hrs post induction (+) in the ATR RNAi CL1 cell 
line as described in section 2.12.2, as well as in uninduced cells (-). 2T1 cells were used as a 
control for the presence of VSG221. The cell line known as 1.6 (kind gift, L.Glover) was used 
as a positive control for the presence of VSG121. Membranes were probed with α-VSG221 
antiserum (A) or α-VSG121 antiserum (kind gift L.Glover; B). EF1α was used as a loading 
control. Sizes markers are shown. (C) Indirect IF analysis was performed as per section 
2.11.4 on TbATR RNAi cells at 36 hrs post induction (Tet+), or in controls without induction 
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(-). Cells were stained with DAPI (green) and α-VSG221 (magenta). The cell body was 
visualised by differential interference contrast (DC) microscopy. Cells were images on a 
Zeiss Axioskop 2 and processed as per section 2.11.8. Images are representative images 
captured from TbATR RNAi CL2.; CL1 cells responded in the same way (data not shown). 
White arrow indicates a cell which has nDNA yet lacks α-VSG221 staining. Scale bar = 20 
μm. 
Next, the presence of VSG221 on the surface of CL1 or CL2 cells induced for 
TbATR RNAi for 36 hrs was examined by indirect IF analysis (performed as per 
section 2.11.4) using the anti-VSG221 antiserum. In a culture that had not been 
induced for RNAi, <0.5 % (of over 200 counted per experiment; this experiment 
was performed as a duplicate) of cells did not have detectable anti-VSG221 
staining. In cells in which TbATR RNAi had been induced, ~ 1 % of the population 
(in over 200 cells counted per experiment) appeared to have lost the VSG221 
coat (Figure 6-27 C shows a representative image). These numbers are in 
keeping with a previous report (DuBois et al. 2012). Further work is needed to 
understand these preliminary data, including asking if increased numbers of cells 
express VSG121 on the surface after TbATR RNAi, which would indicate a VSG 
switch. However, it is also possible the lack of VSG221 on the surface of some 
cells is due to loss of viability, perhaps because protein trafficking is 
compromised. 
6.4 Discussion 
6.4.1 Both T. brucei ATR and ATM harbour a conserved PIKK KD 
The crystal structures of PIKK family members from other eukaryotes have 
provided extensive insight into the organisation of these high molecular weight 
PKs (Baretić & Williams 2014). Generally, the C-terminal domain harbouring the 
KD is highly conserved between family members and the N-terminal domain is 
primarily organised as an α- solenoid arrangement of α-helices (Perry & Kleckner 
2003; Baretić & Williams 2014). In addition, many smaller domains are conserved 
(notably HEAT repeats and FAT, FATC, PRD and LBE domains), each of which are 
important for facilitating kinase activity (Lempiainen & Halazonetis 2009; 
Baretić & Williams 2014; Mordes et al. 2008) either by invoking conformational 
changes or permitting interactions with other proteins. Based on the homology 
searches performed on both T. brucei ATR and ATM, the primary homology 
between the parasite kinases and ATR and ATM homologs in other eukaryotes is 
across the C-termini, in particular the KD. Indeed, remarkable sequence 
Chapter  6  293 
 
 
conservation is found in the predicted catalytic and activation loops of both PKs, 
suggesting they are active kinases (section 6.3.1.2). Additionally, structural 
predictions suggest the presence of the α-solenoid regions, despite difficulty in 
identifying HEAT repeat domains, which are important for protein-protein 
interaction and contribute to the structural stability of these high molecular 
weight proteins. What proteins might interact with T. brucei ATM and ATR are 
currently unknown; for example, Tel2 in human cells binds HEAT repeats of ATR, 
ATM and mTOR (Takai et al. 2007), but its presence in T. brucei has not been 
examined. 
Despite the overall structural conservation, several of the smaller domains 
appeared absent in both T. brucei ATR and ATM. For example, no clear LBE 
domain sequence could be identified. The LBE domain in mTOR is required for 
the binding of the protein ‘lethal with sec thirteen’ (LST8), which is a core 
component of the both the TORC1 and TORC2 complexes (Baretic et al. 2016). In 
T. brucei a potential LST8-like protein (accession number: Tb927.8.4210) could 
be identified, but its role or putative interaction with the T. brucei TOR, ATR or 
ATM PKs is unknown. The PRD domain of both T. brucei ATR and ATM was also 
not clearly detected. This absence may be significant for ATR, as the domain is 
required for the regulation of kinase activity via interaction with TopBP1 
(Mordes et al. 2008; Burrows & Elledge 2008), ATM and the histone 
acetyltransferase Tip60 (Sun et al. 2007). Indeed, the specific residues required 
for TopBP1 activation appear to be lacking in TbATR, though in TbATM a lysine 
residue (K4237) predicted to be acetylated by Tip60 was present. A putative T. 
brucei homolog of TopBP1 has been identified, but a homolog of Tip60 has not, 
meaning it may be important to ask if TbATM and TbATR regulatory interactions 
are different. In this regard, it is notable that the histone acetyltransferase 
HAT3 is important for processing induced DSBs, substrates for ATM and ATR 
activity (Glover & Horn 2014). 
Another striking absence was the lack of both a FAT and a TAN domain within 
the trypanosomatid ATM homolog. These domains are required for kinase activity 
and kinase localisation, respectively (Seidel et al. 2008; Baretić & Williams 
2014). However, the C. elegans ATM-1 protein, which is greatly truncated (649 
aa; Jones et al. 2014), also does not harbour either a FAT or a TAN domain. ATM-
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1 is required to maintain the genomic stability in C. elegans, suggesting that the 
absence of these domains does not necessarily prevent ATM from exerting its 
function. 
6.4.1.1 TbATR is essential for BSF cell survival in vitro 
In other eukaryotes, the essential roles of ATR focus around monitoring the 
nuclear genome for signs of replicative stress (Nam & Cortez 2011; Paulsen & 
Cimprich 2007; Zeman & Cimprich 2014). DNA replication is a complex, multistep 
process that involves many multi-subunit protein complexes (see Masai et al. 
2010 for a review of DNA replication). Though replication is tightly controlled, it 
can be impaired at many steps. For example, should the replisome encounter a 
bulky, alkylated base (perhaps as the result of exposure to a DNA alkylating 
agent such as MMS) progress may be halted, resulting in the generation of a 
stalled replication fork. ATR can function to stabilise the structures that form 
after stalling, preventing further DNA replication by slowing origin firing in the 
vicinity of the lesion, stalling the cell cycle and signalling the proteins required 
to restart the fork (Cimprich & Cortez 2008b; Zeman & Cimprich 2014). If the 
fork fails to resolve, ATR can recruit proteins, such as the MRN complex, to 
remodel the replication fork into a lesion resembling a DSB, thus triggering the 
activation of ATM, and initiating the DDR to resolve the lesion (Sowd et al. 2013; 
Schmidt et al. 2014; Zeman & Cimprich 2014; Ewald et al. 2008; Mazouzi et al. 
2014). Despite extensive and ongoing characterisation of these functions in 
‘model’ eukaryotic cells, TbATR function has not been examined in T. brucei, or 
any kinetoplastid. 
In keeping with mutation of ATR in yeast and mammals, and with a previous 
report from Jones et al (2014), TbATR RNAi suggests the PK is essential, with loss 
resulting in reduced proliferation and cell cycle abnormalities. In contrast, ATR 
null mutants in Arabidopsis are viable (Culligan et al. 2004), with no observable 
growth defects in the absence of DNA damage. Indeed, a clear homolog of ATR is 
not seen in the protozoan parasite Giardia lamblia, though this organism is 
highly susceptible to genotoxic stress (Manning et al. 2011). Thus, the 
importance of ATR is not universal in eukaryotes. In T. brucei, as in yeast and 
mammals, TbATR loss reveals changes to the nuclear cell cycle. However, no 
changes in the kinetoplast cell cycle of T. brucei could be detected. These 
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effects manifest as increased numbers of 1N2K cells and the appearance of 
aberrant cells and cells with more than two kinetoplasts. In human and yeast 
cells, loss of ATR is associated with a stall during S-phase followed by the 
accumulation of cells with aberrant nuclear content (Brown & Baltimore 2000; 
Cha & Kleckner 2002). Further evidence of a nuclear function for T. brucei ATR 
is found in the observation that, 36 hrs after RNAi, ~ 50 % of the population 
harbour aberrant nuclear content: many of the nuclei were enlarged and 
misshapen, fragmented or had nuclear ‘blebs’. Indeed, when the ultrastructure 
of the nucleus was examined by TEM, fragmentation of the nucleus was 
suggested by the presence of inappropriately positioned nuclear membranes 
throughout the cell. These phenotype severities after TbATR RNAi indicate 
widespread nuclear functions for ATR in T. brucei. However, the cell and DNA 
content analyses suggest that in the absence of TbATR, BSF cells do not 
completely halt at S-phase and instead progress through mitosis and the cell 
cycle; perhaps multiple times. Nonetheless, there is evidence of an S-phase 
stall, but why this occurs is known. Potentially, residual levels of TbATR after 
RNAi may be enough to permit the cells that have completed M phase with 
unrepaired damage to implement an S-phase stall. Alternatively, another factor 
may elicit this response. One candidate may be ATM, which in other eukaryotes 
can induce a stall during G1-S-phase in the presence of a DSB lesion (Shiloh & Ziv 
2013). 
The aberrant nuclei following TbATR loss may indicate the presence of 
chromosomal abnormalities. In this regard, examination of the positions of the 
telomeres (and thus locations of the chromosome ends in T. brucei) revealed 
abnormal telomere arrangements. In some cells telomeres could be detected, 
but overall nuclear content was clearly reduced, arguing for profound 
chromosome losses. In other cells, accumulations of telomeres were seen as 
large foci, perhaps due to the fusion of chromosomes. Both these observations 
are consistent with other eukaryotes, where loss of ATR is associated with sister 
chromatid fusions, loss of sister chromatids, chromosome deletions (Pennarun et 
al. 2010) and shortening of telomeres (Ritchie et al. 1999; Bi et al. 2005; Vespa 
et al. 2005; Denchi & de Lange 2007).The large ‘clumps’ of cells observed after 
TbATR RNAi may be explained by these profound chromosome abnormalities, 
suggesting that such cells may occasionally be unable to correctly initiate 
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cytokinesis. However, the presence of some T. brucei cells which lack any 
nuclear DNA (so called ‘zoid’ cells), may indicate that when cytokinesis can 
occur, the ability of the cell to monitor the division of the nucleus is impaired. 
In this regard, growing evidence in both human and yeast cells suggests loss of 
ATR is also associated with cytokinesis and abscission defects (Mackay & Ullman 
2015; Eykelenboom et al. 2013), respectively. 
6.4.1.2 TbATR deficient BSF cells are sensitive to genotoxic stress and 
show increased expression of γH2A and RAD51 
Loss of ATR hyper-sensitises human and yeast cells to a range of genotoxic 
agents such as UV, IR and, additionally in human cells, to HU, cisplatin and other 
chemotherapeutic compounds (Wilsker & Bunz 2007; Hurley et al. 2007; Pépin et 
al. 1995; Morrow et al. 1995). In keeping with observations, BSF T. brucei cells 
exposed to MMS, UV or HU, showed increased sensitivity after TbATR depletion. 
These data suggest that TbATR acts in the response to a similarly wide range of 
DNA lesions, spanning bulky base adducts, DNA strand crosslinks and replication 
stalling agents. 
In addition to sensitising cells to genotoxic stress, cells deficient in ATR also 
increase expression of the modified histone γH2A, and cause relocalisation and 
of the repair associated protein RAD51 (Chanoux et al. 2009; Podhorecka et al. 
2011). γH2A(X) can arise as the result of phosphorylation by ATR and ATM, 
though recently ~ 40 PKs have been implicated in its activation (Benzina et al. 
2015). Nonetheless, H2A phosphorylation after damage in T. brucei and 
Leishmania is unconventional (Glover&Horn 2012; Damasceno et al. 2016), being 
on a threonine (T130) residue; as such, the kinase responsible is not simple to 
predict. γH2A(X) is considered an early marker of a range of DNA damage (as 
reviewed by Kuo & Yang 2008; Mah et al. 2010; Dickey et al. 2009), whereas 
RAD51 catalyses homology-directed repair by associating with RPA-coated ssDNA 
(Chen et al. 2008; Baumann & West 1998; McCulloch & Barry 1999), much of 
which forms at DSBs. In T. brucei, RAD51 foci form readily in BSF cells treated 
with phleomycin (Devlin et al. 2016) or after ISceI-mediated DSB (Glover et al,. 
2013) formation, whereas less foci are observed in cells treated with MMS or UV 
(data not shown). Thus, the pronounced accumulation of RAD51 foci after TbATR 
depletion suggests that at least some of the nucleus accumulates DSBs. 
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However, whether these or other potential lesions are genome-wide or localised 
after loss of TbATR is unknown. 
6.4.1.3 Loss of TbATM is not associated with proliferation defects or 
increased sensitivity to genotoxic stress in BSF T. brucei 
In human cells lacking ATM, chromosomal abnormalities occur, often 
predisposing cells to oncogenic transformations and resulting in genomic 
instabilities (Shiloh & Ziv 2013). Surprisingly, the loss of TbATM in BSF T. brucei 
did not disrupt normal cellular proliferation and nor could aberrant cells 
observed in the culture, suggesting this lifecycle stage does not required TbATM 
for in vitro survival. Even when TbATM was depleted in the presence of MMS or 
HU, no increased proliferation defects were observed, suggesting TbATM plays a 
limited role in the response to alkylation damage or replication stalling. 
From this study, the roles of TbATM remain unclear. Though ATM is considered 
non-essential in other eukaryotes, recent studies have questioned this. Using 
ATM knockout mice and mice harbouring kinase dead ATM (expressed at 
physiologically relevant levels) Yamamoto et al (2012) showed that though mice 
lacking ATM in part phenocopied the human syndrome Ataxia-telangiectasia, 
those harbouring catalytically dead ATM failed to progress past early 
embryogenesis. The authors attribute this effect to the recruitment of the 
inactive kinase to DSB sites, but the inability of the kinase to elicit a damage 
response. Therefore, it is possible that simply depleting ATM may not result in a 
phenotype in T. brucei; expression of kinase-dead ATM variant may provide more 
insight. Additionally, as ATM is primarily activated in the presence of a DSB, 
exposing the TbATM RNAi cell line to this type of lesion may be required to elicit 
a phenotype. Nonetheless, the predicted downstream interaction partners of 
TbATM, such as the MRN complex and RAD51, do result in proliferative defects 
when deleted in T. brucei (McCulloch & Barry 1999; Tan et al. 2002). In addition, 
no predicted sites of phosphorylation could be detected in TbATM (Urbaniak et 
al. 2013), which is unusual since ATM activation in human cells relies on 
autophosphorylation. These data may therefore suggest TbATM functions in a 
highly divergent manner from that of other eukaryotes. 
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6.4.2 Loss of TbATR is associated with increased VSG expression 
from silent expression sites 
Monoallelic expression of a single VSG variant on the surface of a BSF T. brucei 
cell is a complex process (recently reviewed by Günzl et al. 2015; Morrison et al. 
2009; Horn & McCulloch 2010; Glover, et al. 2013). Only one BES is 
transcriptionally active and the remaining 14 (predicted in the Lister 427 strain; 
Hertz-Fowler et al. 2008) are considered transcriptionally silent (though in fact, 
some transcription in the vicinity of the promoters can be detected; Kassem et 
al. 2014). The detailed mechanisms that result in monoallelic expression have 
yet to be fully described, though a variety of factors, including chromatin 
modifiers, telomere associated proteins, the nuclear lamina (DuBois et al. 2012; 
Maishman et al. 2016), and a novel BES-associated factor (Glover et al. 2016), 
have been shown to be involved (Günzl et al. 2015). 
The telomeres of eukaryotic organisms are comprised of repetitive sequences 
(reviewed by Churikov & Price 2001). These repeats allow telomere-mediated 
end-replication, preventing loss of sequence proximal to the chromosome ends, 
which can include genes. However, telomeres during replication often resemble 
DSB-like structures and thus, their presence should be sensed by either ATR or 
ATM, resulting in the activation of the DDR. To circumvent this, the telomeres 
and associated sequences are protected by the sheltrin complex (refer to Palm & 
de Lange 2008 for a review on the Shelterin complex). A component of this 
complex, POT1, interacts with ATR to prevent activation, (Denchi & de Lange 
2007) though in the absence of ATR, telomere ends become short (in keeping 
with advanced aging in adult ATR knockout mice; McNees et al. 2010; Murga et 
al. 2009). Shelterin binding to telomeres can result in silencing of genes in 
proximity with the telomeres; for instance, in yeast up 20 kb from the telomere 
can be silenced (Wyrick et al. 1999). The purpose of this telomere position 
effect (TPE) is not yet fully understood, but is a method by which eukaryotes can 
control gene expression. Evidence for an ATR-related role in TPE has emerged in 
both yeast and Drosophila; ATR (together with ATM) may load components of the 
sheltrin complex, preventing activation of the DDR (Bi et al. 2005; Moser & 
Nakamura 2009; Moser et al. 2009) and mediating TPE. 
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Considering the above roles of ATR in telomere maintenance and TPE, is it 
possible that these functions may account for the profound changes in BES 
expression seen after TbATR RNAi? The fact that changes in BES expression 
preceded a more widespread impact on transcription (below) might indicate 
telomeres are particularly sensitive sites. As previously discussed, the immediate 
proximity of some telomeres and the BESs had led to tests of TPE as a means of 
silencing control and, indeed, loss of RAP1 (Pandya et al. 2013; Yang et al. 
2009), TRF and TIF2 (Jehi et al. 2014; Jehi et al. 2016; each sheltrin associated 
factors) have been shown to result in impaired BES silencing or increased VSG 
recombination. Thus, there is a parallel with the expression of previously silent 
VSG RNA transcripts in the absence of TbATR. However, several observations 
question whether the two outcomes are causally or functionally linked. Careful 
analysis of the extent of TPE in T. brucei has concluded that it stretches for only 
a few kb (Glover & Horn 2006), and does not encompass the whole BES. This 
limited spread appears compatible with the effect of RAP1 loss (Yang et al. 
2009), which is more pronounced proximal to the telomeres of the silent BESs. 
Both these observations appear inconsistent with the RNAseq data, which 
suggest comparably increased transcript levels throughout the silent BES after 
TbATR loss. It is important to note that no proteins to date have been identified 
that interact with TbATR in T. brucei, including RAP1 or any shelterin 
component; indeed, whether POT1 (the best candidate ATR interactor) is 
present in T. brucei is unclear (Dreesen et al. 2007). Recent work has concluded 
that loss of RAP1 in BSF cells, unlike in PCF, causes limited changes in BES 
chromatin structure (Pandya et al. 2013) and it is questionable whether this is 
compatible with the marked accumulation of γH2A after TbATR loss, though 
direct examination of the BES was not performed. If silent BES transcription does 
not result from altered TPE due to TbATR loss, it is possible the telomeres 
themselves have become impaired. No direct evaluation of telomeres after 
TbATR RNAi was conducted, but previous work has shown that the effects of 
telomere attrition after mutation of the telomerase are slow to accumulate 
(Dreesen et al. 2005; Dreesen et al. 2007). In addition, directly excising the 
telomere in either the active or a silent BES by ISceI (Glover et al,. 2013) 
cleavage does not elicit a change in BES transcription or switching. In contrast, 
increased silent BES VSG expression after TbATR RNAi is detectable and rapid (as 
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was clearly seen 24 hrs and 36 hrs post induction by qRT-PCR and RNAseq 
analysis). 
Another explanation for the increased expression of silent BES after TbATR RNAi 
loss may be alterations in the nuclear ultrastructure. Emerging data is revealing 
that ATR plays a crucial role in detecting and responding to structural stress, 
including to the nuclear membrane and to the nucleolus (Kidiyoor et al. 2016; 
Kumar et al. 2014). Strikingly, RNAi of TbNUP1 (DuBois et al. 2012) or TbNUP2 
(Maishman et al. 2016), two distinct proteins that act in the T. brucei nuclear 
lamina, leads to increased expression of silent VSGs (and procyclin), as well as 
leading to malformed nuclei and inappropriately positioned telomeres. In 
addition, RNAi of TbNUP2 results in increased levels of γH2A. Therefore, there is 
marked overlap between the effects of TbATR and TbNUP1 RNAi, though we 
have yet not been able to determine clearly if the loss of TbATR leads to VSG 
switching, as is seen in TbNUP-1 depleted cells (DuBois et al. 2012). However, it 
is unclear whether these overlapping phenotypes indicate a common causal 
effect that leads to alleviation of surface antigen gene silencing. In both NUP1 
and TbNUP2 RNAi studies, a relatively limited number of genes showed increased 
or decreased RNA levels after RNAi: 62 and 142 genes, respectively, increased >2 
fold 48 hrs after RNAi, while no genes and 200, respectively, decreased 2 fold. 
Though a number factors complicate comparisons between experiments (e.g. 
different RNAi strategy, different analysis approach), the effects on 
transcription appear more severe and widespread after TbATR RNAi: >1400 genes 
were significantly affected after 36 hrs following RNAi induction, with a wider 
range of genes affected. In fact, Dubois et al (2012) reported nucleoporin RNAi 
analysis, which did not result in increased surface antigen gene expression, and 
concluded that TbNUP1 may play a specific role in gene silencing. As such, 
effects on nuclear integrity might not account entirely for the observed 
depression of surface antigen genes. Indeed, it is important to emphasise that 
the relatively specific changes in surface antigen expression after 24 hrs of 
TbATR RNAi appeared to precede the emergence of detectable alterations to the 
DNA content, the nucleus and the morphology of the BSF cells. Given this, a 
third hypothesis for the VSG ES changes seen after TbATR RNAi could be 
proposed (see below), though it is plausible that TbATR loss has both BES-
specific and nucleus-wide effects. In this regard, the increased cohort of genes 
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that show altered expression after TbNUP2 RNAi relative to TbNUP1 might be 
explicable by more general nuclear defects after loss of the former lamina 
component, some of which may correlate with the putative roles ATR plays in 
monitoring nucleus (sub) structural integrity. 
The third putative explanation for altered VSG BES expression is that loss of 
TbATR directly affects integrity of the BES. In this model, TbATR plays a role in 
signalling and co-ordinating the repair of lesions within the BES and, in its 
absence, these well-established DDR functions are lost, leading to inefficient 
repair and altered BES expression. Recent work has begun to examine the 
processes that initiate VSG switching, and have linked BES lesions to VSG 
recombination. Some work has modelled VSG switch initiation by the generation 
of DSBs within the active BES (Boothroyd et al. 2009; Glover, Alsford, et al. 
2013), leading to recombination, while another study has indicated the active 
BES is specifically targeted for early DNA replication (Devlin et al. 2016), which 
could generate replication stalls that initiate a VSG switch. Regardless of which 
model operates, TbATR is likely to play a role in recognising and signalling the 
initiating lesions. If such an activity is lost after RNAi, lesion repair would be 
impeded and continued cell cycle progression might lead to cells that no longer 
express the active VSG, which is predicted to be lethal (Aitcheson et al. 2005), 
leading to the selection of cells that have switched to another VSG for short 
term survival. The observation that potentially all of the silent BESs are 
expressed after TbATR RNAi might indicate the most common survival route is 
transcriptional activation of a silent BES. Indeed, such events, coupling BES 
deletion and transcriptional activation, have been detected previously in 
unperturbed cells (Rudenko et al. 1998; Cross et al. 1998) and in HR mutants 
(Devlin et al. 2016; Hartley & McCulloch 2008). Alternatively, elevated levels of 
BES lesions may lead to derepression of all silent BESs, a situation which could 
account for the BSF-specific increases in transcription from silent BESs after 
treatment with nuclear DNA damaging agents and after blocking nuclear DNA 
replication (Sheader et al. 2004); intriguingly, these treatments also result in 
depression of procyclin transcription, as we see after TbATR RNAi. Further work 
is required to test if integrity of the active and silent BESs are undermined after 
TbATR loss, but the inability to repair frequent lesions in the BES, leading to loss 
of the telomeric VSG, might link the repair data reported here with recent 
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proposals that the VSG can provide a homology signal, propagated by TbVEX1 
(Glover et al. 2016) and DOT1B (Batram et al. 2014), to determines BES 
transcription status. 
If the third model is correct, it may be the case that the later expression 
changes might not be the direct effect of TbATR signalling BES lesions, but 
reflect wider functions of TbATR. To ask if we could detect a signalling network, 
the remaining differentially expressed transcripts of annotated genes were 
examined. A number of kinases were identified as being differentially expressed, 
including several associated with control of the cell cycle. In addition, we 
observed changes in genes associated with mitosis, control of the cell cycle and 
RNA regulation, potentially in keeping with the S-phase cell cycle stall and the 
altered nuclear and cell morphology. However, further, protein-focused work 
will be needed to assess if these genes encode direct and indirect targets of 
TbATR’s potentially wide functions in BSF T. brucei. 
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Protein kinases (PKs) contribute extensively to the maintenance of genome 
integrity across the Eukarya. For example, loss of aurora B in human cells 
disrupts chromosome segregation during mitosis resulting in aneuploid cells (as 
reviewed by Carmena et al. 2012), whereas loss of either atypical PK ATR or ATM 
sensitises cells to genotoxic stress and increases genome fragility even in the 
absence of DNA damage (as reviewed by Weber & Ryan 2015; Marechal & Zou 
2013). Considering the multitude of pathways required to protect genome 
integrity from a myriad of lesions types, many aspects of genome repair are 
conserved amongst the Eukarya. However, like all aspects of biology, though a 
common blueprint may describe the processes of DNA damage repair, alterations 
and divergence of this core process are apparent. Given the vast diversity of 
organisms and subsequent variety of cells encompassed within this domain of 
life, it is no surprise that tailoring repair responses to suit the requirements of 
individual organisms and cells has occurred. A further aspect of genome repair is 
the exploitation of such pathways to generate diversity within a cell and 
ultimately a population. The primary function of repair is normally genome 
maintenance and it is clear that cells with defective or altered repair responses, 
when faced with genotoxic lesions, contribute to formation of diseased states, 
such as the onset of cancer (in which de-regulation of kinase activity plays a 
significant role; (Shchemelinin et al. 2006; Lahiry et al. 2010; Gross et al. 2015). 
However, if the generation of a lesion can be implemented within a specific 
region in the genome and the process controlled in a way to prevent loss of 
genome integrity, it is possible that the repair of this lesion may contribute to 
enhanced diversity. One such example is the use of the non-homologous end 
joining (NHEJ) pathway involved in the repair of double stranded breaks (DSBs) 
to generate the enormous variety of the antigen receptors displayed on the 
surface of lymphocyte cells (reviewed by Schatz & Ji 2011), giving rise to the 
complex and sophisticated humoral immune response of the human immune 
system. Another example is the exploitation of homologous recombination (HR) 
to facilitate the switching of the T. brucei VSG surface coat during antigenic 
variation (reviewed by McCulloch et al. 2015). Understanding the lesions which 
form in T. brucei that trigger VSG switching and how lesion repair is signalled 
and executed may yet reveal lineage-specific reactions, which may offer 
therapeutic targets for trypanosomiasis. 
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In 2005, the genomes of three kinetoplastid parasites (T. cruzi, L. major and T. 
brucei) were published and, in a follow up publication, the protein kinase 
complement (or ‘kinome’) of each was analysed (Parsons et al. 2005). In T. 
brucei, the kinome was subject to functional analysis, investigating PKs with 
roles in the progression of the cell cycle (Jones et al. 2014). Other work has 
probed the mechanisms and dynamics of DNA replication and DNA repair in all 
kinetoplastids, which is beginning to reveal divergence (as reviewed by Passos-
Silva et al. 2010; Genois et al. 2014). Perhaps most prominently, NHEJ appears 
not to operate, with greater reliance on micro-homology-mediated end-joining 
(Glover et al. 2011; Zhang & Matlashewski 2015; Peng et al. 2015), while the 
kinetoplastid machinery that dictates nuclear genome replication initiation is 
non-canonical (Marques et al. 2016; reviewed by Tiengwe et al. 2014), as is the 
orchestration of Leishmania genome replication (Marques et al. 2015; Lombraña 
et al. 2016). This project represents the first steps in attempting to link PK 
function and genome maintenance by DNA repair. 
T. brucei, like humans, dedicates ~2 % of the genome to PK genes. However, 
several PK families (e.g the NEK kinase family) have become expanded, and 
homologs of some DNA repair-centric kinases, such as DNA-PK, appear absent 
(Genois et al. 2014). To date, no PK in T. brucei has been shown to function in a 
genome repair pathway. To address this knowledge deficit, two RITseq screens, 
a whole genome and a kinome-focused, were performed in BSF parasites to ask 
which PKs are required for parasite survival in the presence of the alkylating 
agent MMS. In all, at least 11 PKs, based on initial identification in genome wide 
and kinome wide RITseq screens, and revealed to result in sensitisation of BSF 
cells to MMS. In fact, a total of 24 putative damage response PKs were suggested 
from the screens, amongst which only seven were considered ‘false-positives’. A 
total of five PK families were represented within just the 11 validated PKs which 
represent the first examination of PKs in the context of T. brucei DNA and 
cellular repair. Follow up characterisation was undertaken for four of the PKs, 
and some preliminary phenotypic and localisation analysis for several more, 
revealing considerable functional divergence. Additional analysis, perhaps to 
examine further the greater number of kinome-wide candidates, may also reveal 
novel and essential aspects of T. brucei biology in the context of genome repair. 
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Two PKs identified from the genome wide screen were examined in some depth, 
including the generation of BSF gene disruption null mutants for both. As 
previously published (Tu et al. 2006), RNAi knockdown of TbAUK2 did not result 
in obvious phenotypic abnormalities, but pronounced phenotypes were seen 
when the gene was disrupted in BSF cells, revealing a role for this kinase in 
maintaining nuclear genome integrity, potentially by preventing miss-
segregation of the genome during mitosis. Further work is required to 
understand the intimate details of TbAUK2’s role in T. brucei, but preliminary 
data suggest interaction with a helicase involved in DNA repair; though such 
interaction requires confirmation it is notable that AUKs in other eukaryotes, are 
part of wide networks of interacting proteins (chapter 4; Vader & Lens 2008; 
Carmena et al. 2009; Carmena et al. 2012). The second protein, a pseudokinase, 
when disrupted unexpectedly gave rise to an endocytic defect in BSF cells, 
suggesting that T. brucei may also require a functional endocytosis pathway in 
response to genotoxic stress. Again, further investigation is needed to determine 
which aspect of endocytosis is compromised; e.g. is the uptake of material in 
general inhibited, or is intracellular trafficking compromised, which prevents 
movement of material around the cell? Answering such questions will reveal if 
the putative repair defect of the mutants is a secondary phenotype, or if 
genome maintenance is part of the mode of action of the PK. A mitogen 
activated kinase (known as TbKFR1) was also preliminarily examined, and may 
warrant further investigation, as the PK appears to be essential for parasite 
survival (Hua & Wang 1997). However, the role this kinase plays in T. brucei 
remains mysterious, as does its potential conservation in Leishmania. 
Surprisingly, the T. brucei homologs of ATR or ATM (two atypical kinases central 
to the DNA damage response in other eukaryotes;  reviewed by Marechal & Zou 
2013; Shiloh & Ziv 2013; Zeman & Cimprich 2014) were only predicted by the 
kinome screen as having a role in the T. brucei response to MMS. However, when 
TbATM function was examined by RNAi in BSF parasites, it was apparent that loss 
of PK did not compromise cell proliferation even in the presence of MMS 
damage. Thus, a role for TbATM in the T. brucei DDR remains unclear. 
Conversely, loss of TbATR severely impaired parasite survival, which may be 
attributed to the appearance of widespread nuclear defects, as suggested by the 
loss of nuclear structure, aberrant telomere arrangements and DNA damage 
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(seen in the formation of γH2A and RAD51 foci following TbATR knockdown). 
Additionally, loss of TbATR resulted in de-repression of VSG genes in the silent 
BESs, providing the first link between any PK and antigenic variation. However, 
depression of life cycle specific genes, including surface antigen associated 
genes such as procyclin, expression site associated genes (ESAGs) and procyclin 
associated genes (PAGs), suggests loss of TbATR may have a wide impact on gene 
expression controls, some potentially related to RNA PolI function and consistent 
with a role for ATR in sensing (sub)nuclear structural stress, including in the 
nucleolus (Kumar et al. 2014). In the future, it would be interesting to ask 
whether TbATR is associated with particular regions of the T. brucei genome; for 
example, does the kinase play a particular role in monitoring lesions within the 
active VSG BES? For instance, investigating whether the previously silent VSG 
(and other surface antigen) transcripts are expressed as protein, using 
proteomics and IF analyses, will determine whether TbATR has a direct role the 
control of antigenic variation, or a genome-wide surveillance role. It was also be 
interesting to ask whether loss of TbATR has the same effects in PCF cells, the 
lifecycle stage lacking the VSG surface coat. 
Overall, by asking what PKs contribute to BSF T. brucei parasite survival in the 
presence of MMS, it is clear that the process of genome and cellular repair in T. 
brucei may involve a complex network of interactions across a multitude of 
pathways, many of which may still require characterisation in this eukaryotic 
microbe. Given the reliance of many repair pathways on kinase activity to 
phosphorylate downstream interaction partners, this study has opened up 
opportunities for work in the future to investigate DNA damage associated 
kinases in T. brucei. Whether the putative DDR PKs examined in this study may 
be targets for the multitude of kinase inhibitory compounds that have been 
developed (as reviewed by Grant 2009; Gross et al. 2015) still remains an open 
question. Though at least two of the PKs are not essential in culture, it is 
possible that they assume important roles in the mammal. Equally, though 
TbATR (a current chemotherapeutic target; as reviewed by Karnitz & Zou 2015; 
Weber & Ryan 2015; Fokas et al. 2014) and TbKFR1 appear essential, whether 
these PKs harbour parasite specific functions which could be targeted without 
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